col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Bentham Science

2388 Results       Page 1

 [1]  [2] [ Next > ]
  original article Journal Date Title Authors All Authors
1 [GO] Adolescent Psychiatry 2024―Jan―29 Challenges and Opportunities in Mental Health Care for Transitional Age Youth (TAY): Lessons Learned from the COVID-19 Pandemic Hyun Jung Kim, Cynthia Wilson, Timothy Van Deusen, Hun Millard, Zheala Qayyum, Susan Parke
2 [GO] Adolescent Psychiatry 2023―Jun―21 The Impact of COVID-19 on Psychotropic Medication Prescriptions in Adolescents: Analysis of a Federated Research Network Joshua White, Taylor Kohn, Marco-Jose Rivero, Akhil Muthigi, Jamie Thomas, Armin Ghomeshi, et al. (+4)
3 [GO] Adolescent Psychiatry 2021―Feb―03 Challenges of Covid-19 on Adolescent Psychiatric Service Provision in an Independent Inpatient and Outpatient Setting Laura Bond, Aileen Murtagh, Sophia Morgan
4 [GO] Anti-Cancer Agents in Medicinal Chemistry 2021―Feb―08 COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods Faroogh Marofi, Ramyar Azizi, Roza Motavalli, Ghasem Vahedi, Maryam Nasimi, Mehdi Yousefi, et al. (+6)
5 [GO] Anti-Infective Agents 2024―Mar―11 Evidence of Neutralizing Antibodies Indicating the Cure of PatientsInfected with COVID-19 Within one Month of Infection Yasir M. Abdulateef, Zainab N. Ayad, Haitham Noaman, Marwa F. Fadhel, Mahammad Z. Taha, Fatima M. Rafeeq, Ahmed Y. Salih
6 [GO] Anti-Infective Agents 2024―Feb―14 Pyolytics: A Step Forward to Address Respiratory Hypoxia in Coronavirus Infection Ilnur Yagudin, Darya Suntsova
7 [GO] Anti-Infective Agents 2024―Feb―02 Hierarchical Virtual Screening of SARS-CoV-2 Main Protease Potential Inhibitors: Similarity Search, Pharmacophore Modeling, and Molecular Docking Study Huda Mando, Iyad allous
8 [GO] Anti-Infective Agents 2023―Jul―18 Novel and Predictive QSAR Model and Molecular Docking: New Natural Sulfonamides of Potential Concern Against SARS-Cov-2 Nathalie Moussa, Hoda Mando
9 [GO] Anti-Infective Agents 2023―Jul―17 Safety and efficacy of Imatinib, Nilotinib, and Artesunate in COVID-19 patients: a systematic review of current evidence Esmaeil Mehraeen, Ehsan Ghavimehr, Ali Zand, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Hamid Zaferani Arani, et al. (+3)
10 [GO] Anti-Infective Agents 2023―May―03 Role of Molnupiravir in the Treatment of COVID-19 Vaishali M. Patil, Aman Sharma, Meenakshi Dahiya, Gaurav Pratap Singh, Anirudh Malik
11 [GO] Anti-Infective Agents 2022―Sep―27 Therapeutic uses of antihistamines in the management of COVID-19: a narrative review Hesamoddin Hosseinjani, Mahshid Ataei, Omid Arasteh, Armin Salek Maghsoudi, Shokoufeh Hassani
12 [GO] Anti-Infective Agents 2022―Sep―23 Successful combination of remdesivir and convalescent plasma to treat a patient with rituximab-related B-cell deficiency and prolonged COVID-19: A case report Giorgio Raho, William Cordeddu, Davide Firinu, Stefano Del Giacco, Goffredo Angioni
13 [GO] Anti-Infective Agents 2022―Aug―02 Therapeutic Potentials of Black Seeds (Nigella sativa) in the Management of COVID-19 -A Review of Clinical and In-silico Studies Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramaniam, Sudha Muthusamy, Mirunalini Gobinath, Mohamed Rafiullah
14 [GO] Anti-Infective Agents 2022―Jul―31 Is It Possible to Control the Outbreak of COVID-19 in Dharavi, Asia’s Largest Slum Situated in Mumbai? Ranjan K. Mohapatra
15 [GO] Anti-Infective Agents 2022―Jul―31 The Effectiveness and Safety of Remdesivir for the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis Timotius Ivan Hariyanto
16 [GO] Anti-Infective Agents 2022―May―19 Comparison of efficacy of remdesivir with supportive care alone in the treatment of critically sick adult and child COVID-19 patients: A randomized clinical trial Ahmad Hormati, Sajjad Ahmadpour, Mohammad Reza Ghadir, Seyed Yaser Foroghi Ghomi, Javad Tafaroji, Zahra Movahedi, et al. (+3)
17 [GO] Anti-Infective Agents 2022―May―16 Hydroxychloroquine and Mortality in SARS-Cov-2 Infection; The HOPE- Covid-19 Registry. Iván J. Núñez-Gil, Luis Ayerbe, Cristina Fernandez-Pérez, Vicente Estrada, Charbel Maroun Eid, Ramón Arroyo-Espliguero, et al. (+26)
18 [GO] Anti-Infective Agents 2022―May―11 Recent evidence-based treatments for COVID-19: A Review Faraat Ali, Varisha Anjum, Garima Chauhan, Asad Ali, Javed Ahamad
19 [GO] Anti-Infective Agents 2022―Apr―30 Post COVID-19: Risk-factors, prevention and management of black fungus Aimen Salman, Suneela Dhaneshwar, Shaik Shafiulla
20 [GO] Anti-Infective Agents 2022―Apr―26 Antiviral Potential of Medicinal Plants for the COVID-19 Yashika Sharma, Sulochana Kaushik, Sanjit Boora, Pawan Kumar, Ajit Kumar, Jaya Parkash Yadav, Samander Kaushik
21 [GO] Anti-Infective Agents 2022―Apr―06 Second Wave of Covid-19 with Seasonal Influenza (Flu) in Uttar Pradesh, Northern India: A Cohort Study Nadeem Rais, Akash Ved, Rizwan Ahmad, Kehkashan Parveen, Om Prakash, Darakhshan Gazala Bari, et al. (+3)
22 [GO] Anti-Infective Agents 2022―Mar―30 ‘Black Fungus’- An alarming infection during novel coronavirus- A Review Raneet Das, Jayita Roy, Sumel Ashique
23 [GO] Anti-Infective Agents 2021―Dec―24 Use of the genus Satureja as food supplement: possible modulation of the immune system via intestinal microbiota during SARS-CoV-2 infection? Abdelkarim Ezaouine, Badreddine Nouadi, Yousra Sbaoui, Mariam El Messal, Fatima Chegdani, Faïza Bennis
24 [GO] Anti-Infective Agents 2021―Dec―03 In silico drug repurposing for the identification of antimalarial drugs as candidate inhibitors of SARS-CoV-2 Praveen Kumar Pasla, Pugazhenthan Thangaraju, Sree Sudha TY, Sri Chandana M, Rizwaan Abbas S
25 [GO] Anti-Infective Agents 2021―Dec―01 'Mucormycosis' A Fungal Infection Threatening India During COVID-19' - A Review Sumel Ashique
26 [GO] Anti-Infective Agents 2021―Oct―04 Anti-HIV Integrase Inhibitors as New Candidates for the Treatment of COVID-19: A Narrative Literature Review Sofia Salari, Hedyieh Karbasforooshan, Hesamoddin Hosseinjani
27 [GO] Anti-Infective Agents 2021―Jul―20 Screening of phytochemicals from Curcuma longa for their inhibitory activity on SARS-CoV-2: An in-silico study Preeya Negi, Lalita Das, Surya Prakash, Vaishali M. Patil
28 [GO] Anti-Infective Agents 2021―May―09 Essentials in the Treatment of Covid-19 Fatemeh Mehrabi Rad, Hossein Elyasi, Hadis Rahimi, Amir Zamani, Amirhossein Nafari
29 [GO] Anti-Infective Agents 2021―Feb―18 A recent update on the clinical trials and effectiveness of drugs used in COVID-19, MERS and SARS Coronaviruses. Seyed Sajad Hosseini Balef, Zohreh Karimi, Ala Azari, Seyed Sadeq Sadraie, Parisa Hasanjani, Yasaman Sadeghi, et al. (+4)
30 [GO] Anti-Infective Agents 2021―Jan―19 Understanding the Dynamics of COVID-19 Outbreak: Structure, Diagnosis, Prevention and Treatment Rohan R. Narkhede, Rameshwar S. Cheke, Sachin D. Shinde, Vitthal G. Kuchake, Nilesh M. Mahajan, Vaishali M. Patil
31 [GO] Anti-Infective Agents 2020―Nov―19 Postpartum Posterior Reversible Encephalopathy Syndrome in A Patient Suspected to COVID-19 Fatemeh Ramezanpour, Ashraf Zarvani, Athena Sharifi-Razavi
32 [GO] Anti-Infective Agents 2020―Oct―21 Novel Coronavirus Disease (COVID-19): A Narrative Review Based on Current Status Rina Das, Dinesh Kumar Mehta, Meenakshi Dhanawat
33 [GO] Anti-Infective Agents 2020―Oct―11 The Effectiveness and Safety of Remdesivir for the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis Timotius Ivan Hariyanto, Felix Kwenandar, Karunia Valeriani Japar, Vika Damay, Andree Kurniawan
34 [GO] Anti-Infective Agents 2020―Oct―07 Covid-19: Outbreak to Global Deepika Paliwal, Shoaib Khan, Anindita Chaki
35 [GO] Anti-Infective Agents 2020―Oct―07 Does metformin satisfy as an option for host directed therapy in COVID-19? Pugazhenthan Thangaraju, Atul Jindal, Sajitha Venkatesan, Meenalotchini Prakash Gurunthalingam, Nanditha Venkatesan, Eswaran Thangaraju
36 [GO] Anti-Infective Agents 2020―Sep―28 Coronavirus Disease-19 (COVID-19): Systematic analysis of situation in Pakistan-Responses and potential advancements Muhammad Imran Din, Jawayria Najeeb, Maryam Zaheer Kiyani, Rida Khalid
37 [GO] Anti-Infective Agents 2020―Sep―28 Drug Repositioning: A Smart Approach for Combating SARS-CoV-2 Supriya Roy, Suneela Dhaneshwar
38 [GO] Anti-Infective Agents 2020―Sep―02 Is it possible to control the outbreak of COVID-19 in Dharavi, Asia's largest slum situated in Mumbai? Ranjan K. Mohapatra, Mizanur Rahman
39 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2023―Dec―15 Galectin-3 in Blood Serum and Lymphocytes as a Marker of Myocardial Damage in Patients with Arterial Hypertension and COVID-19 Nataliia Pokrovska, Nataliia Denysenko, Iryna Fomenko, Helen Sklyarova, Andrii Basylevych, Eugene Sklyarov, et al. (+2)
40 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2023―Oct―16 Anti- SARS-CoV-2 IgG and IgM Levels in Iraqi General Population Amina Hamed Alobaidi, Hussein Inam Mustafa, Ahmed Mutar Salih, Abdulghani Mohamed Alsamarai
41 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2023―Sep―13 Glucocorticoids, COVID-19 and cryptococcosis Wanessa Maria dos Santos, Alexandre Paula Rogerio
42 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2022―Mar―29 Post COVID-19 Syndrome Clinical Manifestations: A Systematic Review Muhammad Abdel-Gawad, Mariam S Zaghloul, Sherief Abd-elsalam, Mai Hashem, Sameh A. Lashen, Aya M. Mahros, et al. (+5)
43 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2020―Dec―03 Covid-19: Urgent call to action Amal A. Mohamed, Omnia I. Tantawi, Lamiaa Abdelfattah Fathalla, Dalia M. Abd El-Hassib, Naglaa El-Toukhy Ramadan El-Toukhy, Wafaa Salah, et al. (+3)
44 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2020―Jun―01 Novel Coronavirus Disease and the Current Scenario of the Global Health Emergency Geetanjali Baruah, Jagajjit Sahu
45 [GO] Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2020―Mar―25 Are there any Therapeutic Options Currently Available for Wuhan Coronavirus? Simone Carradori
46 [GO] Applied Clinical Research Clinical Trials and Regulatory Affairs 2020―Sep―18 Lessons Learned from the COVID-19 Pandemic Samra Abouchacra, Mohamad Yaman, Satish Chandrasekhar Nair
47 [GO] Applied Clinical Research Clinical Trials and Regulatory Affairs 2020―Mar―16 Coronavirus (COVID19) Outbreak: A Test of Viral Muscle Versus the Human Tussle Karthyayani Priya Satish, Satish Chandrasekhar Nair
48 [GO] Applied Drug Research Clinical Trials and Regulatory Affairs 2023―Mar―01 Misery of Long Haulers of COVID-19 - A Review Varun Kumar, Deepak Garg
49 [GO] Applied Drug Research Clinical Trials and Regulatory Affairs 2022―Mar―30 Preliminary results of the combined BlockACE2® Prevention and BlockACE2® functional food scheme for the prevention of COVID-19 in working population. Clinical trial , controlled, randomized, triple-blind, phase II. Beatriz H. Aristizabal-B, Clara I. Aristizabal-B, Bernardo Agudelo-J, Luis Miguel Gomez- O, Luz Elena Cano-R, Beatriz Estella Lopez-M, et al. (+2)
50 [GO] Applied Drug Research Clinical Trials and Regulatory Affairs 2021―May―19 The Pandemic Will Change the Face of Healthcare and Health Research? Satish Chandrasekhar Nair
51 [GO] CNS & Neurological Disorders - Drug Targets 2023―Apr―19 SARS-CoV-2 Infection to Premature Neuronal Aging and Neurodegenerative Diseases: Is there any Connection with Hypoxia? Latchoumycandane Calivarathan, Narmadhaa Sivagurunathan
52 [GO] CNS & Neurological Disorders - Drug Targets 2023―Feb―15 Impact of COVID-19 on anxiety and depression - biopsychosocial factors Zuleide Maria Ignácio, Amanda Gollo Bertollo, Agatha Carina Leite Galvan, Maiqueli Eduarda Dama Mingoti, Claudia Dallagnol
53 [GO] CNS & Neurological Disorders - Drug Targets 2022―Dec―27 Relation between apolipoprotein e in alzheimer’s disease and sars-cov-2 and their treatment strategy: A review Alex Joseph, Anu Kunnath Ramachandran, Subham Das, Gurupur Gautham Shenoy, Jayesh Mudgal
54 [GO] CNS & Neurological Disorders - Drug Targets 2022―Dec―06 Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerationsand Management in COVID-19 Pandemic Sumit Sharma
55 [GO] CNS & Neurological Disorders - Drug Targets 2022―Oct―18 Thoughts of Death, Depression and Guilt in a Healthcare Worker Who Infected Her Husband with SARS-CoV-2: A Case Report Isabella Berardelli
56 [GO] CNS & Neurological Disorders - Drug Targets 2022―Aug―30 Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine Ismail Rammouz, Jalal Doufik, Rachid Aalouane, Saïd Boujraf
57 [GO] CNS & Neurological Disorders - Drug Targets 2022―Jul―04 Psychiatric Manifestations of COVID-19: A Literature Review Aksha Khatun, T. Tamilanban, V. Chitra
58 [GO] CNS & Neurological Disorders - Drug Targets 2022―May―19 Mechanistic insight and possible mechanism of seizure in Covid-19: The nuances and focal points Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Abdur Rauf, Fahad A. Alhumaydhi, Małgorzata Kujawska, Gaber El-Saber Batiha
59 [GO] CNS & Neurological Disorders - Drug Targets 2022―May―17 Treatment of major depression with psychotic features and Cotard’s syndrome after COVID-19 infection in a previously healthy patient: a case report Hasan Mervan Aytac
60 [GO] CNS & Neurological Disorders - Drug Targets 2022―Apr―22 Letter to the Editor regarding “Traumatic Brain Injury in COVID-19 patients with the manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm” Zeba Sami, Amaan Javed
61 [GO] CNS & Neurological Disorders - Drug Targets 2022―Apr―20 Crosstalk Between SARS-CoV-2 Infection and Neurological Disorders: A Review Asim Azhar, Mohammad Akram Wali, Qudsia Rashid, Wajihul Hasan Khan, Khaled Al-hosaini, Mohammad Owais, Mohammad Amjad Kamal
62 [GO] CNS & Neurological Disorders - Drug Targets 2022―Jan―13 Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia Maria Antonietta Barbieri, Gianluca Bagnato, Carmelo Ioppolo, Antonio Giovanni Versace, Natasha Irrera
63 [GO] CNS & Neurological Disorders - Drug Targets 2022―Jan―13 Link of COVID-19 and Neurodegenerative Disorders Mohammad Amjad Kamal
64 [GO] CNS & Neurological Disorders - Drug Targets 2021―Dec―24 COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration? Adejoke Onaolapo, Olakunle Onaolapo
65 [GO] CNS & Neurological Disorders - Drug Targets 2021―Aug―20 Implication of COVID-19 on neurological complications with specific emphasis on alzheimer’s and parkinson’s disease Ankita Sood, Ravi Goyal, Harshdeep Singh, Tapan Behl, Sandeep Arora, Balraj Saini, Rajwinder Kaur
66 [GO] CNS & Neurological Disorders - Drug Targets 2021―Aug―15 Mini-review on SARS-CoV-2 infection and neurological manifestations: A Perspective Vishal Chavda, Arif Tasleem Jan, Dhananjay Yadav
67 [GO] CNS & Neurological Disorders - Drug Targets 2021―Mar―10 Persons with co-existing neurological disorders: Risk analysis, considerations and management in COVID-19 pandemic Sumit Sharma, Sonali Batra, Saurabh Gupta, Vivek Kumar Sharma, Md Habibur Rahman, Mohammad Amjad Kamal
68 [GO] CNS & Neurological Disorders - Drug Targets 2021―Feb―26 Treatment of catatonia with asenapine in a patient with schizotypal personality disorder, psychotic depression and septic shock from SARS-CoV-2 - A case report. F. Fiaschè, B. Adriani, I. Mancinelli, A. Taranto
69 [GO] CNS & Neurological Disorders - Drug Targets 2021―Feb―17 Neurological associations of SARS-CoV-2 infection: A Systematic Review Amaan Javed
70 [GO] CNS & Neurological Disorders - Drug Targets 2020―Dec―24 Thoughts of death, depression, and guilt in a healthcare worker who infected her husband with SARS-CoV-2: A case report. Isabella Berardelli, Antonio Vaia, Maurizio Pompili
71 [GO] CNS & Neurological Disorders - Drug Targets 2020―Nov―23 COVID-19 Outbreak: Neurological Manifestations beyond Cough and Fever Saurabh Kumar, Divya Dwivedi, Madhu Chopra
72 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2023―Nov―10 Assessing the Frequency of COVID-19 in Patients Undergoing Primary Percutaneous Coronary Intervention (PCI) Mahdi Zahedi, Faezeh Davanloo
73 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2023―Nov―03 Decentralization and Virtualization of INR-based Anticoagulation Control During the COVID-19 Pandemic Abdulrahman Almesned, Abdullah Alqwaee, Bayan Abusiryeh, Ahmad Almeman
74 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2023―Oct―15 Evaluation of Clinical Characteristics and Outcomes of Chest Trauma Patients with COVID-19 Infection Undergoing Emergency Surgeries Mojtaba Ahmadinejad, Ali Soltanian, Haleh Pak, Maryam Zolfaghari, Izadmehr Ahmadinejad
75 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2022―Jun―15 Congenital Bleeding Disorders and COVID-19 ─ an Emphasis on the Role of Thrombosis as One of the Main Causes of Morbidity and Mortality in COVID-19 Akbar Dorgalaleh, Fatemeh Narouei, Mansur Asadi, Hassan Morovati Khamsi, Mohammad Saeed Gholami
76 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2022―Apr―22 Pre-admission beta-blocker therapy and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression Timotius Ivan Hariyanto, Joshua Edward Hananto, Denny Intan, Andree Kurniawan
77 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2021―Dec―02 A Composite study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India Gopal Krishana Bohra, Abhishek Purohit, Deepak Kumar, Mahendra Kumar Garg, Naresh Kumar Midha, Ravi Manglia, et al. (+7)
78 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2021―Sep―28 Outcome after acute ischemic stroke treatment during Covid-19 outbreak in South-East Tuscany Maurizio Acampa, Valentina Peresso, Pietro Enea Lazzerini, Carlo Domenichelli, Francesca Guideri, Rossana Tassi, et al. (+10)
79 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2021―Sep―14 Post-Discharge Prophylactic Anticoagulation in COVID-19 Patients: A Clinical Dilemma Prakrati Yadav, Deepak Kumar, Durga Shankar Meena, Naresh Kumar Midha, Gopal Krishana Bohra, Mahendra Kumar Garg, Abhishek HL Purohit
80 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2021―Aug―13 Is there a link between lung parenchyma lesions , BMI , CRP , D-dimer and acute pulmonary embolism in patients infected with COVID-19 ? Amer Hamadé, Lucas Jambert, Jonathan Tousch, Philippe Feuerstein, Karima Hammas, Samuel Degoul, et al. (+10)
81 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2021―Aug―13 Cardiovascular considerations of Remdesivir and Favipiravir in the treatment of COVID-19 Mohammad Amin Shahrbaf, Mohammadreza Tabary, Isa Khaheshi
82 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2021―Mar―15 Thromboembolic complications in severe COVID-19: Current antithrombotic strategies and future perspectives Juan J. Rodriguez, Oscar C. Munoz, Mateo Porres-Aguilar, Debabrata Mukherjee
83 [GO] Cardiovascular & Haematological Disorders - Drug Targets 2020―Jul―02 Overview of Covid-19 regarding the cardiovascular situation in the light of current reports Suna Aydin, Ramazan Fazil Akkoc, Suleyman Aydin
84 [GO] Cardiovascular & Hematological Agents in Medicinal Chemistry 2022―May―16 Outcome and Complications of Hemoperfusion in Patients with COVID-19 in Intensive Care Unit: A Cross-Sectional Study Mahboobeh Darban, Maliheh Yarmohamadi, Majid Mir Mohammadkhani, Saeedehsadat Mousavizade Jazaeri
85 [GO] Cardiovascular & Hematological Agents in Medicinal Chemistry 2022―Apr―03 Effect of Aspirin on the prevention of pro-thrombotic states in hospitalized COVID-19 patients: Systematic review Masoumeh Abdi, Zahra Hosseini, Fatemeh Shirjan, Leila Mohammadi, Sahel Shafiee Dolat Abadi, Nilofar Massoudi, et al. (+2)
86 [GO] Central Nervous System Agents in Medicinal Chemistry 2022―Mar―30 COVID-19: Urgent Need to Redesign Anti-inflammatory Strategies for CNS Protection Rüdiger Hardeland
87 [GO] Clinical Cancer Drugs 2021―Dec―13 Hydroxychloroquine (HCQ) exhibits better binding to the main protease (Mpro) compared to spike protein (S protein) of SARS-CoV-2: An in-silico analysis Deepa R. Bandi, SubbaRao V. Tulimilli, Durai Ananda Kumar T., Chandi Kumari Chitturi, Anjalidevi S. Bettadapura, Suma M. Natraj, SubbaRao V. Madhunapantula
88 [GO] Clinical Cancer Drugs 2021―Jan―01 COVID-19 Related Publications Focusing on Cancer: Systematic Review of a Delicate Balance Mahdi F. Naimi, Maira Khan, Mary Mahler, Urban Emmenegger
89 [GO] Clinical Cancer Drugs 2020―Jun―24 1+1 > 2: Integration of the host-directed Traditional Chinese Medicine and the virus-targeted Modern Medicine in control of COVID-19 Jianjun Sun
90 [GO] Clinical Practice and Epidemiology in Mental Health 2023―Sep―08 The Effectiveness of Telephone-based Psychological Services to COVID-19 Mojgan Khademi, Roya Vaziri-Harami, Amin Mahouram Mashadi, Pegah Seif, Abbas Babazadehdezfoly
91 [GO] Clinical Practice and Epidemiology in Mental Health 2023―Aug―15 Physical Activity Reduces Depression among Healthcare Workers during the COVID-19 Pandemic in Jordan Abdulhakeem Okour, Basil Amarneh
92 [GO] Clinical Practice and Epidemiology in Mental Health 2023―Aug―15 Burnout among Brazilian Dentists during the COVID-19 Pandemic: A Cross-sectional Study Juliane Kely F. Silva, Fernando M. Carvalho, Carolina F. Azevedo, Marcos Vinicius S. Silva, Arthur Igor C. Lima, Liliane Lins-Kusterer
93 [GO] Clinical Practice and Epidemiology in Mental Health 2023―Jul―17 The Impact of COVID-19 Confinement on Reading Behavior Mahmoud A. Alomari, Omar F. Khabour, Karem H. Alzoubi, Aseel Aburub
94 [GO] Clinical Practice and Epidemiology in Mental Health 2023―Jun―21 Mental Health: Pandemics, Epidemics and Tau Protein Ghinwa M. Barakat, Ghaith Assi, Noura B. El Khoury
95 [GO] Clinical Practice and Epidemiology in Mental Health 2023―Apr―20 Vaccination as a Significant Factor Influencing the Psychoemotional State of Medical Students During the Sars-Cov-2 Pandemic: An International Aspect Maria V. Sankova, Vladimir N. Nikolenko, Tatiana M. Litvinova, Beatrice A. Volel, Marina V. Oganesyan, Andjela D. Vovkogon, et al. (+3)
96 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Dec―21 Fear of COVID-19 and Stress and Coping Strategies among Nurses during the COVID-19 Pandemic’s Second Wave: A Quasi-Intervention Study Doaa I. Omar, Samar A. Amer, Abeer E abdelmaksoud
97 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Dec―01 Changes in Mental Health Needs during COVID-19 in the Republic of Georgia: A Longitudinal Follow-up Study Nino Makhashvili, Ketevan Pilauri, Amy Mulick, Jana Darejan Javakhishvili, Lela Sturua, Daniela C. Fuhr, Bayard Roberts
98 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Nov―29 Prevalence of Mood Disorders and Associated Factors at the Time of the COVID-19 Pandemic: Protocol for a Community Survey in La Manouba Governorate, Tunisia Uta Ouali, Amina Aissa, Salsabil Rjaibi, Nada Zoghlami, Yosra Zgueb, Amine Larnaout, et al. (+11)
99 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Nov―29 Prevalence of Mood Disorders and Associated Factors at the Time of the COVID-19 Pandemic: Protocol for a Community Survey in La Manouba Governorate, Tunisia Uta Ouali, Amina Aissa, Salsabil Rjaibi, Nada Zoghlami, Yosra Zgueb, Amine Larnaout, et al. (+11)
100 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Nov―25 Evaluation of Vulnerability Factors for Developing Stress and Depression due to COVID-19 Spread and its Associated Lockdown Ahmed Alhusban, Karem H. Alzoubi, Sayer Al-Azzam, Khawla Q Nuseir
101 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Nov―01 Use of Digital Technologies in Home Office Work during the COVID-19 Pandemic Lucio Lage Gonçalves, Antonio Egidio Nardi, Hugo dos Santos, Douglas Rodrigues, Anna Lucia Spear King
102 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Oct―27 Emotional Contagion Scale and Mental Health Status during the First Wave of COVID-19 Pandemic, National Assessment Samar A. Amer, Eman Elsayed Abd-Ellatif, Peter Hughes, Hadi Mahdi Ghazai Al-Enazi, Ahmed AlHasan, Mostafa A. Amer, et al. (+2)
103 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Aug―24 Psychosocial Impact of Lockdown on Children due to COVID-19: A Cross-Sectional Study Mahdi Alnamnakani, Shuliweeh Alenezi, Hani Temsah, Mohamad Alothman, Rozan Esam Murshid, Hana Alonazy, Haitham Alqurashi
104 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Jul―15 Trends in Insomnia, Burnout, and Functional Impairment among Health Care Providers over the First Year of the COVID-19 Pandemic Ahmed Yassin, Abdel-Hameed Al-Mistarehi, Aref A. Qarqash, Ola Soudah, Reema A. Karasneh, Sayer Al-Azzam, et al. (+4)
105 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Jun―30 Trends of Prevalence Estimates and Risk Factors of Depressive Symptoms among Healthcare Workers Over one Year of the COVID-19 Pandemic Ahmed Yassin, Abdel-Hameed Al-Mistarehi, Ola Soudah, Reema Karasneh, Sayer Al-Azzam, Aref A. Qarqash, et al. (+6)
106 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Mar―15 Exercise in Older Adults to Prevent Depressive Symptoms at the Time of Covid-19: Results of a Randomized Controlled Trial with Follow-Up Mauro Giovanni Carta, Cesar Ivan Aviles Gonzalez, Luigi Minerba, Massimiliano Pau, Mario Musu, Fernanda Velluzzi, et al. (+8)
107 [GO] Clinical Practice and Epidemiology in Mental Health 2022―Jan―07 Quality of Life of People with Cancer in the Era of the COVID-19 Pandemic in India: A Systematic Review Kusum K. Rohilla, C Vasantha Kalyani, Sweety Gupta, Amit Gupta, Manoj Gupta
108 [GO] Clinical Practice and Epidemiology in Mental Health 2021―Dec―24 PTSD and Depression in Healthcare Workers in the Italian Epicenter of the COVID-19 Outbreak Claudia Carmassi, Virginia Pedrinelli, Valerio Dell’Oste, Carlo Antonio Bertelloni, Chiara Grossi, Camilla Gesi, et al. (+2)
109 [GO] Clinical Practice and Epidemiology in Mental Health 2021―Dec―22 Sex, Digital Devices, Social Media, and Social Isolation: A Study on Sexual Behavioral During COVID -19 Pandemic Isabela A. Melca, Antonio E. Nardi, Lucio L. Gonçalves, Rachel M. Ferreira, Mariana S. K. Lins de Padua, Anna L. S. King
110 [GO] Clinical Practice and Epidemiology in Mental Health 2021―Nov―24 A Qualitative Study Regarding COVID-19 Inpatient Family Caregivers’ Need for Supportive Care Angelo Picardi, Marco Miniotti, Paolo Leombruni, Antonella Gigantesco
111 [GO] Clinical Practice and Epidemiology in Mental Health 2021―Sep―16 The Use of Distance Learning and E-learning in Students with Learning Disabilities: A Review on the Effects and some Hint of Analysis on the Use during COVID-19 Outbreak Donatella Rita Petretto, Stefano Mariano Carta, Stefania Cataudella, Ilaria Masala, Maria Lidia Mascia, Maria Pietronilla Penna, et al. (+3)
112 [GO] Clinical Practice and Epidemiology in Mental Health 2021―Jul―12 Impacts on and Care of Psychiatric Patients during the Outbreak of COVID-19 Pavarud Puangsri, Vinn Jinanarong, Apichai Wattanapisit
113 [GO] Clinical Practice and Epidemiology in Mental Health 2021―Apr―16 Fear of COVID-19 among Peruvian People Living in Disadvantaged Communities: A Cross-Sectional Study Carlos Sotomayor-Beltran, Hernan Matta-Solis, Rosa Perez-Siguas, Eduardo Matta-Solis, Lourdes Matta-Zamudio
114 [GO] Clinical Practice and Epidemiology in Mental Health 2020―Aug―18 School Closure and Children in the Outbreak of COVID-19 Donatella Rita Petretto, Ilaria Masala, Carmelo Masala
115 [GO] Combinatorial Chemistry & High Throughput Screening 2023―Nov―14 Network Pharmacology and Experimental Validation of Qingwen Baidu Decoction Therapeutic Potential in COVID-19-related Lung Injury Ju Yang, Zhao Zhang, Honghong Liu, Jiawei Wang, Shuying Xie, Pengyan Li, et al. (+5)
116 [GO] Combinatorial Chemistry & High Throughput Screening 2023―Mar―31 The potential effect of dapsone on the inflammatory reactions in Covid-19: Staggering view Engy Elekhnawy, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-saber Batiha
117 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19
118 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking Sisir Nandi
119 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation
120 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu
121 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain
122 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening
123 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Dec―04 Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies
124 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Nov―11 Insights into the structural complexities of SARS-CoV-2 for therapeutic and vaccine development Manaf AlMatar, Aizi Nor Mazila Ramli, Choong Xin Yi
125 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Nov―05 The Understanding of the Potential Linkage between COVID-19, Type-2 Diabetes, and Cancer(s) Could Help in Better Drug Targets and Therapeutics Mohammad Mobashir
126 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Oct―18 Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation Zhenjie Zhuang
127 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Oct―18 Perspective on the COVID-19 Coronavirus Outbreak Gerald Lushington
128 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Oct―18 Analysis of Chinese Herbal Formulae Recommended for COVID-19 in Different Schemes in China: A Data Mining Approach LiWei Yin
129 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Oct―18 Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy Mingzhu Wang
130 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Oct―18 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu
131 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Oct―10 Bioinformatics analysis to identify intersection genes, associated pathways and therapeutic drugs between COVID-19 and Oral candidiasis Zhihui Liu, Liuqing Yang, Jinling Yu, Handan Huang, Lu Tao, Ying Gao, Jingjing Yao
132 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Aug―30 Synthesis, Molecular Docking, c-Met inhibitions of 2,2,2-Trichloro-ethylidene-cyclohexane-1,3-dione Derivatives Together With Their Application as Target SARS-CoV-2 main Protease (Mpro) And as Potential Anti-Covid-19 Rafat M. Mohareb, Fahad M. Almutairi, Abdo A. Elfiky, Mahmoud A.A. Mahmoud, Wagnat W. Wardakhan, Mervat S. Mohamed, Ali Saber Abdelhameed
133 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Aug―19 In silico identification of novel SARS-CoV-2 main protease and non-structural protein 13 (nsp13) inhibitors through consensus docking and free binding energy calculations. Emilio Mateev, Maya Georgieva, Alexander Zlatkov
134 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Aug―17 Evaluations of FDA-approved drugs targeting 3CLP of SARS-CoV-2 employing a repurposing strategy. Syed Sayeed Ahmad, Mohammad Khalid
135 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Aug―17 Molecular interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 protein complex Sultan F. Alnomasy, Bader S. Alotaibi, Ziyad M. Aldosari, Ahmed H. Mujamammi, Ahmad Alzamami, Pragya Anand, et al. (+3)
136 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Aug―05 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation Uma Sankar-Gorla
137 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Aug―05 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Acharya Balkrishna
138 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jul―15 Molecular Docking and Virtual Screening Based Prediction of Drugs for COVID-19 Sekhar Talluri
139 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jul―15 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation Uma Sankar Gorla
140 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jul―15 Tinocordiside from Tinospora cordifolia(Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Anurag Varshney
141 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jul―15 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening Samir Chtita
142 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jul―14 Analysis of the molecular mechanism of Huangqi herb treating COVID-19 with myocardial injury by pharmacological tools, programming software and molecular docking Yan Zhou, Yuguang Chu, Jingjing Shi, Yuanhui Hu
143 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jun―30 An Overview on Immunity Booster Foods in Coronavirus Disease (COVID-19) Nusrat Sahiba, Ayushi Sethiya, Dinesh K. Agarwal, Shikha Agarwal
144 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jun―08 South African (501Y.V2) and the United Kingdom (B.1.1.7) SARS-CoV-2 spike (S) protein variants demonstrate a higher binding affinity to ACE2 Anwar Mohammad, Jehad Abubaker, Fahd Al-Mulla
145 [GO] Combinatorial Chemistry & High Throughput Screening 2022―May―11 Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus: In Silico Study Immunomodulatory Drugs Dikdik Kurnia, Ika Wiani, Achmad Zainuddin, Devi Windaryanti, Christine Sondang Gabriel
146 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Apr―28 Neglected Tropical Diseases (NTDs) and COVID-19 Pandemic in Africa: Special Focus on Control Strategies Abdullahi Tunde Aborode, Emmanuel Adebowale Fajemisin, Emmanuel Ademola Aiyenuro, Muhammed Alakitan, Matthew Olaide Ariwoola, Jegede Oluwatoyin Imisioluwa, et al. (+2)
147 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Apr―25 Can the Written Word Fuel Pharmaceutical Innovation? Part 1. an emerging vista from von Economo to COVID-19 Gerald H. Lushington, Mary I. Zgurzynski
148 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Apr―18 Favipiravir in SARS-CoV-2 infection: Is it Worthwhile? Gaber El-Saber Batiha, Mohamed Moubarak, Hazem M. Shaheen, Ali Muhammad Zakariya, Ibe Michael Usman, Abdur Rauf, et al. (+6)
149 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Mar―16 Covid-19 Vaccines available in India Mohammad Mukim, Pratishtha Sharma, Mohsina F.P, Faheem I.P, Rajiv Kukkar, Rakesh Patel
150 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Mar―16 Crosstalk between SARS-CoV-2 Infection and Type II Diabetes Asim Azhar, Wajihul Hasan Khan, Khaled Al-hosaini, Qamar Zia, Mohammad Amjad Kamal
151 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Mar―01 Therapeutic mechanism of Xiaoqinglong decoction against COVID-19 based on network pharmacology and molecular docking technology Hai-Li Li, Jian-Peng Zhou, Jing-Min Deng
152 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Feb―10 Repurposing Ayush-64 for COVID-19: A Computational Study Based on Network Pharmacology and Molecular Docking Abdul Nazeer K.A.
153 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jan―28 Natural products against COVID-19 inflammation: a mini-review Simone Mendes Lopes, Herbert Igor Rodrigues de Medeiros, Marcus Tullius Scotti, Luciana Scotti
154 [GO] Combinatorial Chemistry & High Throughput Screening 2022―Jan―13 Computational Chemistry in the Fight Against SARS-CoV-2. Abbas Khan, Dong-Qing Wei
155 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Dec―01 Can We Use mTOR Inhibitors for COVID-19 Therapy? Ina Y. Aneva, Solomon Habtemariam, Maciej Banach, Parames C. Sil, Kasturi Sarkar, Adeleh Sahebnasagh, et al. (+3)
156 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Nov―23 Potential Papain-like Protease Inhibitors against COVID-19: A Comprehensive In Silico Based Review Neetu Agrawal, Shilpi Pathak, Ahsas Goyal
157 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Sep―17 Polyphenolic Natural Products Active In Silico against SARS-CoV-2 Spike Receptor Binding Domains and Non-Structural Proteins - A Review Mark Tristan Quimque, Kin Israel Notarte, Xela Amor Adviento, Mikhail Harvey Cabunoc, Von Novi de Leon, Felippe Steven Louis delos Reyes, et al. (+10)
158 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Aug―12 COVID-19: Finally on wane, with reduced lethality Deepak Sharma
159 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Aug―06 Current perspective of COVID-19 on neurology: A mechanistic insight Rajesh Kumar, Seetha Harilal, Leena K Pappachan, P R Roshni, Bijo Mathew
160 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Aug―05 Role of potential COVID-19 immune system associated genes and the potential pathways linkage with type-2 diabetes Nawal Helmi, Dalia Alammari, Mohammad Mobashir
161 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Jul―12 COVID-19 candidate genes and pathways potentially share the association with lung cancer Afnan M. Alnajeebi, Hend F.H. Alharbi, Walla Alelwani, Nouf A. Babteen, Wafa Alansari, Ghalia Shamlan, Areej A. Eskandrani
162 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Jun―02 Identification of Generalized Peptide Regions for Designing Vaccine Effective for All Significant Mutated Strains of SARS-CoV-2 Subhamoy Biswas, Smarajit Manna, Tathagata Dey, Shreyans Chatterjee, Sumanta Dey
163 [GO] Combinatorial Chemistry & High Throughput Screening 2021―Feb―04 An Urgent Industrial Scheme both for Total Synthesis, and for Pharmaceutical Analytical Analysis of Umifenovir as an Anti-Viral API for Treatment of COVID-19 Akbar Dadras, Mohammad Amin Rezvanfar, Abolghasem Beheshti, Sedigheh Sadat Naeimi, Seyyed Amir Siadati
164 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Nov―24 Catechin Derivatives as Inhibitor of COVID-19 Main Protease (Mpro): Molecular Docking studies unveils an opportunity against CORONA Muhammad Nouman Arif
165 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Nov―11 In-silico analysis of angiotensin converting enzyme 2 (ACE2) of livestock, pet and poultry animals to determine its susceptibility to SARS-CoV- 2 infection Aman Kumar, Anil Panwar, Kanisht Batra, Sachinandan Dey, Sushila Maan
166 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Nov―11 Tinocordiside from Tinospora cordifolia (Giloy) May Curb SARS-CoV-2 Contagion by Disrupting the Electrostatic Interactions between Host ACE2 and Viral S-Protein Receptor Binding Domain Acharya Balkrishna, Subarna Pokhrel, Anurag Varshney
167 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Nov―06 A Computational Approach for Identifying Potential Phytochemicals Against Non-structural Protein 1 (Nsp1) of SARS-CoV-2 Alamgir Hossain
168 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Nov―03 Exploring the Potential Mechanism of Shufeng Jiedu Capsule for Treating COVID-19 by Comprehensive Network Pharmacological Approaches and Molecular Docking Validation Zhenjie Zhuang, Xiaoying Zhong, Huanhuan Zhang, Huiqi Chen, Boxiang Huang, Dongqun Lin, Junmao Wen
169 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Oct―27 Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study Wei Yu, Xiaomin Wu, Jiayi Ren, Xiaochun Zhang, Yueming Wang, Chengming Li, et al. (+6)
170 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Oct―01 Analysis of Chinese herbal formulae recommended for COVID-19 in different schemes in China: A data mining Approach LiWei Yin, YaCen Gao, ZiPing Li, MengYu Wang, KaiXin Chen
171 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Sep―15 In silico modeling of small molecule carboxamides as inhibitors of SARS-CoV 3CL protease: An approach towards combating COVID-19 Pathan Mohsin Khan, Vinay Kumar, Kunal Roy
172 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Sep―03 Discovery of Some Antiviral Natural products to fight against Novel Corona Virus (SARS-CoV-2) using Insilico approach Ashish Shah, Vaishali Patel, Bhumika Parmar
173 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―30 Molecular Docking Studies of Bioactive Nicotiflorin against 6W63 Novel Coronavirus 2019 (COVID-19) Raghvendra Dubey, Kushagra Dubey
174 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―24 The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking Sisir Nandi, Mohit Kumar, Mridula Saxena, Anil Kumar Saxena
175 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―21 Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials against COVID-19: An in-silico Evaluation Uma Sankar Gorla, GSN Koteswara Rao, Uma Sankar Kulandaivelu, Rajasekhar Reddy Alavala, Siva Prasad Panda
176 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―19 Potential Leads from Liquorice against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies Saurabh K. Sinha, Satyendra K. Prasad, Md Ataul Islam, Sushil K. Chaudhary, Shashikant Singh, Anshul Shakya
177 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―14 Molecular Docking and Virtual Screening based prediction of drugs for COVID-19 Sekhar Talluri
178 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―08 Theoretical Study of the Molecular Mechanism of Maxingyigan Decoction Against COVID-19: Network Pharmacology-based Strategy Mingzhu Wang, Deyu Fu, Lei Yao, Jianhua Li
179 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Aug―05 Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking Screening Samir Chtita, Assia Belhassan, Adnane Aouidate, Salah Belaidi, Mohammed Bouachrine, Tahar Lakhlifi
180 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Jul―29 Could Targeting HMGB1 be useful for the Clinical Management of COVID-19 Infection? Mustafa Çelebier, İbrahim Celalettin Haznedaroğlu
181 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Jul―27 Viral Evolution will Automatically Resolve COVID-19 Pandemic Deepak Sharma
182 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Jul―16 Doctoral Degree Surplus and Dwindling Quality: A Perilous Blend for Young Scientists in Tackling COVID-19 Like Pandemics Deepak Sharma
183 [GO] Combinatorial Chemistry & High Throughput Screening 2020―Apr―08 Perspective on the COVID-19 Coronavirus Outbreak Gerald H. Lushington
184 [GO] Coronaviruses 2024―Mar―18 Which Laboratory and Clinical Feature are different in Pregnant and Non-pregnant Women with COVID-19? A Cross-sectional Study in the West of Iran Elaheh Talebi-Ghane, Nahid Radnia, Fariba Daneshvar, Maryam Garousian, Saeed Bashirian, Salman Khazaei, Neda Alimohammadi
185 [GO] Coronaviruses 2024―Mar―05 A Comprehensive Report on Long COVID, Emerging Challenges, and Research Priorities in the Pandemic Mohd Mustafa, Kashif Abbas, Safia Habib
186 [GO] Coronaviruses 2024―Mar―01 Comparison of Changes in Liver Function Tests in Pregnant Women with Mild and Severe COVID-19 Parichehr Pooransari, Razieh Pouransari, Mahboobeh Gharib Laki, Zhila Abedi Asl, Samira Yavari, Reza Hosseiniara
187 [GO] Coronaviruses 2024―Mar―01 The Level of Knowledge and Performance of Iranian Medical Students in The Second Year of the COVID-19 Pandemic Mohammad Shahin Shahvardizadeh, Faranak Rezaei, Shahnaz Halimi, Somayeh Delfani, Pegah Shakib, Setareh Soroush
188 [GO] Coronaviruses 2024―Feb―14 Biochemical and Familial Factors Influencing COVID-19 Disease Progression Rıza Altunbaş, Aziz Batu, Adnan Türkel, Ali Akin, Umut Tendik
189 [GO] Coronaviruses 2024―Feb―13 A Comparison Between the Photodynamic Action of “Hypocrellin A” and “Pheophorbide A” Against Bacteria and SARS-CoV-2 Virus --- A MiniReview Siu Kan Law
190 [GO] Coronaviruses 2024―Feb―01 Investigating the Relationship between COVID-19 In-hospital Death and Acute Kidney Injury Ramin Haghighi, Nikoo Fereyduny, Mohammad Bagher Oghazian, Ashkan Haghighi, Amir Bigdeli, Amirhossein Sahebkar
191 [GO] Coronaviruses 2024―Feb―01 Impact of MDRs on COVID-19 Patients Among Developing Countries Alok Bharadwaj
192 [GO] Coronaviruses 2024―Jan―29 In silico Evaluation of Anacyclus pyrethrum Composition for Inhibition of Spike RBD-ACE-2 Interaction to Treat COVID-19 Anand Kumar Pandey, Jayanti Awasthi, Kislay Chaturvedi, Ayush Mishra, Shivangi Yadav, Soumya Rathore, Preeti Birwal
193 [GO] Coronaviruses 2024―Jan―29 COVID-19 Vaccines: A Comprehensive Review of Development, Action Mechanisms, and Global Implications Sandhya Rajbahadur Yadav, Pushpalata Chougule
194 [GO] Coronaviruses 2024―Jan―26 Antiviral Medications: Unravelling their Significance in Context to COVID-19 Rishabh Chalotra, Amanjot Singh, Shivani Chib, Swati Gautam, Muhammed Amanat, Kakul Chaudhary, et al. (+2)
195 [GO] Coronaviruses 2024―Jan―26 Use of COVID-19 Personal Protective Equipment (PPE) Among Healthcare Workers in Teaching Hospitals of Khorramabad, Iran Mehdi Zibaei, Shahnaz Halimi, Faranak Rezaei, Setareh Soroush, Pegah Shakib
196 [GO] Coronaviruses 2024―Jan―26 In silico Designing of a Multi-epitope-based Subunit Vaccine against SARS-CoV-2 (Delta Variant) by Exploiting Its Structural Proteins: A Reverse Vaccinomics and Immunoinformatics Approach Sajal Kumar Halder, Ashish Ranjan Sharma, Tawsif Al Arian, Samantha Saha, Aparna Shil, Md. Oliullah Rafi, et al. (+5)
197 [GO] Coronaviruses 2024―Jan―26 Immune-endocrine Interactions and Remodelling of Metabolic Homeostasis of Testicular Cells During SARS-CoV-2 Infection Suvendu Ghosh, Debosree Ghosh, Partha Singha
198 [GO] Coronaviruses 2023―Dec―27 Immunization against COVID-19: A Comprehensive Review on the Leading Vaccines Ananyaa Srinivasan, Vijaishree Rajesh, Dharani Thamilvanan, Sanjeev K Ganesh, Subathra Devi. C
199 [GO] Coronaviruses 2023―Dec―20 Natural Products as Inhibitors of Coronavirus: An Update Ritu Kalia, Sanjay Jachak, Akash Dey
200 [GO] Coronaviruses 2023―Dec―19 Comparison of Women's Sexual Activity Before and After being Infected with COVID-19 Zohreh Keshavarz, Naimeh Shariatifar, Malihe Nasiri, Zahra Kiani
201 [GO] Coronaviruses 2023―Dec―19 Analyzing Uttarakhand's COVID-19 Outbreak: Demographic Insights and Strategies for Future Pandemic Prevention Gaurav Joshi, Akshara Pande, Omdeep Gupta, Anoop Nautiyal, Sanjay Jasola, Prashant Gahtori
202 [GO] Coronaviruses 2023―Dec―19 Methodical and Immunological Insights of Prime COVID-19 Vaccines Wilson Pearl Evangeline, Sakthivel Nathan Divyasri, Chandrasekaran Akshaya, Sekaran Sruthi, Selvaraj Barathi, Rangasamy Kirubakaran, KN ArulJothi
203 [GO] Coronaviruses 2023―Dec―12 The Interweaving of Pain and Perfection: A Qualitative Inquiry about the Experiences of Pregnant Women during Pregnancy and Childbirth in the COVID-19 Pandemic in Iran Akram Parandeh, Batool Nehrir, Mohammad Mehdi Salaree, Mona Larki, Somayeh Makvandi, Leila Karimi
204 [GO] Coronaviruses 2023―Dec―12 In silico Molecular Docking of SARS-CoV-2 Surface Proteins with Benzimidazole Scaffolds: Strategy to Discover Lead Compounds Monika Meghani, Shikha Sharma, Nitin Kumar, Biswa Mohan Sahoo
205 [GO] Coronaviruses 2023―Dec―08 Relationship between COVID-19 and Neurological Disorder Shivendra Mani Tripathi, Pratik Kumar Vishwakarma, Smriti Ojha, Sudhanshu Mishra
206 [GO] Coronaviruses 2023―Dec―07 Recent Scenario of the Indian Healthcare System Post COVID-19 Emergence and in Severely Ill Patients Sushant Mishra, Shushank Mahajan, Able Mogha, Abhinav Yadav, Wandeep Dagar, Isha Chawla, Meenakshi Dhanawat
207 [GO] Coronaviruses 2023―Dec―07 Exploring Effective Therapeutic Approaches for COVID-19: A Review on Progress and Prospects Oritoke M. Okeowo, Nzube F. Olung, Omamuyovwi M. Ijomone, Ayotunde S. Adeagbo
208 [GO] Coronaviruses 2023―Dec―07 Maternal and Neonatal Outcomes after Vaccination with SARS-CoV-2: A Systematic Review and Meta-analysis of Cohort Studies Anand Vijayakumar Palur Ramakrishnan, Roopa Satyanarayan Basutkar, Sugash Murugan, Shonitha Sagadevan, Oorvashree Sri Hari, Shanmuga Priyan
209 [GO] Coronaviruses 2023―Dec―01 COVID-19 Vaccine Practices and Perceptions Among an Academic Healthcare Community Samiksha Prasad, Waseem Wahood, Darisel Ventura Rodriguez, Amanda J. Chase
210 [GO] Coronaviruses 2023―Nov―15 Utilization of Telehealth in Kenya During COVID-19 Calvin R. Wei, Godwin C. Lang'at
211 [GO] Coronaviruses 2023―Nov―15 COVID-19 Pandemic and its Economic Impact on the Global Economy: A Computable General Equilibrium Approach Esambe Sone, Jong-Hwan Ko
212 [GO] Coronaviruses 2023―Nov―15 Colchicine with Infliximab Compared to Infliximab in Hospitalized Patients with COVID-19 Pneumonia: An Open-label Randomized Trial Mahdi Yadollahzadeh, Somayyeh Nasiripour, Najmeh Moradi Shahrbabak, Nader Rezaie, Mohsen Farrokhpour, Mehdi Azimi, et al. (+4)
213 [GO] Coronaviruses 2023―Nov―15 Exploring the Efficacy of Traditional Herbs in Combating COVID-19: A Comprehensive Review Anil Sao, Tulsidas Nimbekar, Garla Venkateswarlu, Mohit Mishra, Aditya Kate, Meenakshi Kanwar Chauhan, Chandrashekhar Mahadeo Chakole
214 [GO] Coronaviruses 2023―Nov―15 Off-label Use of Medicines in COVID-19: A Lesson For Future Aliasghar Hemmati, Hoda Mojiri-Forushani
215 [GO] Coronaviruses 2023―Nov―15 Why Poor Countries were the Least Affected by COVID-19? Haitham Ahmed Al-Madhagi
216 [GO] Coronaviruses 2023―Nov―15 New SARS-CoV-2 Mpro Inhibitor by Ascorbic Acid: Design, Molecular docking, Lipinski’s Rule and ADMET Analysis Mohammad Rashid, Md Tanwir Athar, Abdulrahman Salman Alazmi, Deepak Kumar, Raj Kumar, Keun Woo Lee, Aisha Alnami
217 [GO] Coronaviruses 2023―Nov―07 Enterococcal Infections: A Comparative Analysis between the Pandemic and the Pre-pandemic Period Neha Sharad, Smriti Srivastava, Vandana V Kiro, Sharin Varma, Sharad Srivastav, Aparna Ningombam, et al. (+2)
218 [GO] Coronaviruses 2023―Nov―06 Pandemic Preparedness for COVID-19: Research, Healthcare, and Pharmaceutical Perspectives Israel Mani, Manikandan B.N, Amarabalan B, Mohamudha Parveen R, Mohan Pandi
219 [GO] Coronaviruses 2023―Nov―06 Polyherbal Syrup for Coronavirus Infection: Formulation and Evaluation K. Kranthi Kumar, Sunil Kumar Kadiri, Sampath. A. G
220 [GO] Coronaviruses 2023―Nov―02 Biomarkers can Predict COVID-19 Disease Utkarsh Sharma, Shikha Sharma
221 [GO] Coronaviruses 2023―Nov―01 Traditional Therapies Involving Nutrition for the Management of COVID-19 Ramesh M, Arunachalam Muthuraman, Krishnan Anand
222 [GO] Coronaviruses 2023―Nov―01 Amidst Cytokine Storm in Metabolic Diseases: Can 2-deoxy-D-glucose (2- DG) Cure COVID-19? Shweta Shrivastava, Ayush Kumar, Manish Kumar Jeengar, Elsy Xavier, Prashant Tiwari
223 [GO] Coronaviruses 2023―Oct―26 COVID-19: Different Strains of Corona, Vaccine Efficacy, Treatment, Medical Ethics, and Future Perspectives Sonia Singh, Ashima Ahuja, Raghavan Ramankutty, sarada Ramaswamy
224 [GO] Coronaviruses 2023―Oct―25 Molecular Docking Analysis of SARS-CoV-2 Inhibitor N3 (6LU7) against Selected Flavonoids and Vitamins Sunil Junapudi, Yasodha Krishna Janapati, Susmitha Uppugalla, Timothy Harris, Muhammad Yaseen, Muhammad Latif
225 [GO] Coronaviruses 2023―Oct―24 Phytochemical Profiling of Borassus flabellifer Haustorium and its Potential Role in Combating COVID-19-Associated Encephalopathy: A Computational Perspective Noorul Samsoon Maharifa Haja Mohaideen, Hemalatha Srinivasan
226 [GO] Coronaviruses 2023―Oct―17 Computational Investigation of Endophytic Fungal (Penicillium citrinum CGJ-C2) Compound and its In-silico Derivatives on the Inhibition of RNA-dependent RNA Polymerase of SARS-CoV2 Jagadeesha Poyya, Ananda Danagoudar, Chandrasekhar G Joshi, Ajay S Khandagale, Raju N. G
227 [GO] Coronaviruses 2023―Oct―15 Efficiency of CAT and L-SIGN as Alternative or Co-receptors for SARS-CoV-2 Spike Protein CHAINEE DAS, VENKATA SATISH KUMAR MATTAPARTHI
228 [GO] Coronaviruses 2023―Oct―11 Ultrastructural Blood Cell Changes in Patients with COVID-19 Yulian Kyyak, Olga Barnett, Olha Labinska, Orysia Kysil, Marta Halkevych
229 [GO] Coronaviruses 2023―Oct―11 Mental Health and Stigmatization Linked to the COVID-19 Pandemic Sunil Kumar Kadiri, Shakshi Mundhra, Prashant Tiwari
230 [GO] Coronaviruses 2023―Sep―18 Barriers and Motivating Factors in Receiving COVID-19 Vaccination among the Healthcare Workers of Tehran Military Hospitals Mahmoudreza Hashemi Rafsanjani, Majid Nouri, Ali Omrani Nava, Mohammad Darvishi
231 [GO] Coronaviruses 2023―Sep―14 Mechanistic Insights on Viral Factors Involved in Asymptomatic COVID-19 Pathogenesis Satinder Kaur, Renu Bala, Prakash Chandra Mishra, Vineeta Singh, Rachna Hora
232 [GO] Coronaviruses 2023―Sep―11 A Registry-based Audit of a Current Situation of Clinical Research in COVID-19 Using Artificial Intelligence Techniques: A Systematic Review Pugazhenthan Thangaraju, sree sudha ty, Hemasri Velmurugan, Eswaran Thangaraju, Kaumudi Chirumamilla, Tulika Chakrabarti, Prasun Chakrabarti
233 [GO] Coronaviruses 2023―Sep―06 Investigation of Reported Anaphylaxis Post COVID-19 Vaccination in Subjects with History of Allergies and Anaphylaxis Aditya P. Desai, Aryan P. Desai, Victoria S. Ochs, Prashant V. Desai
234 [GO] Coronaviruses 2023―Aug―25 In Silico Study of Alkaloid Compounds with Computational Approach for Selection of Drug Leads for COVID-19 Arli Aditya Parikesit, Stephanie Audrey Victoria, Ihsan Tria Pramanda
235 [GO] Coronaviruses 2023―Aug―23 Multidrug-resistant Tuberculosis and its Implication with COVID-19 Anil Kumar Chhillar, Jasmine Arya, Sweety Dahiya
236 [GO] Coronaviruses 2023―Aug―23 Ethical Challenges at the Time of the Covid-19 Pandemic - A Systematic Review Pugazhenthan Thangaraju, Hemasri Velmurugan
237 [GO] Coronaviruses 2023―Aug―23 Analysis of Research Publication on Logistics at the Time of COVID-19: A Scientometric Study Pugazhenthan Thangaraju, Ku Krishna Verma, Hemasri Velmurugan, Himanshu Nirmal Chanu, Tulika Chakrabarti, Prasun Chakrabarti, Sajitha Venkatesan
238 [GO] Coronaviruses 2023―Aug―10 My Quarantine Diary: a tool for self-care and learning about COVID-19 Alan Maicon de Oliveira, Luana Michelly Aparecida da Costa, Guilherme José Aguilar, Luiz Ricardo Albano dos Santos, Wilbert Dener Lemos Costa, Dantony de Castro Barros Donato, et al. (+2)
239 [GO] Coronaviruses 2023―Aug―04 Criticism of the HAS Opinion of July 21st, 2022, on Maintaining of the SARS-Cov-2 Vaccine Mandate for Healthcare Workers Jérôme Sainton
240 [GO] Coronaviruses 2023―Aug―01 Mucormycosis: A serious catastrophe involving COVID-19 patients Neha Dangi, Himanshu Mehendiratta, shikha sharma
241 [GO] Coronaviruses 2023―Jul―27 Impact of Prolonged use of COVID-19 Drugs on the Human Neurological System using Insilco Drug-gene Interaction Prachi Srivastava, Wayez Naqvi, Prekshi Garg
242 [GO] Coronaviruses 2023―Jul―26 Assessment Of Traces Of Sars-Cov-2 Rna In A Laboratory Setting Using In Vitro-Diagnostic Rt-Qpcr Arbind Kumar, Sanjay Kumar, Suresh Kumar, Lal Chand Pal, Sahdev Choudhary
243 [GO] Coronaviruses 2023―Jul―10 Explaining why Africa had much lower COVID-19 fatalities per million than Europe and North America Alberto Boretti
244 [GO] Coronaviruses 2023―Jun―26 A Case Report on Covid-19 Causing New Onset of Diabetes Even with No History Amit Sharma, Manisha Vohra, Mohammad Amir, Ian Osoro
245 [GO] Coronaviruses 2023―Jun―09 A systematic review of covid-19 impact on cardiovascular diseases Mohd Zafar Khan, Mohammad Khushtar, Juber Akhtar, Mohammad Irfan Khan, Mohammad Ahmad, Ishana Chand
246 [GO] Coronaviruses 2023―May―09 Finding the potential inhibitory activity of Vilanterol Versus Budesonide towards SARS-CoV-2 Mpro: A molecular dynamics simulation approach Afzal Hussain, Ashfaq Hussain
247 [GO] Coronaviruses 2023―Apr―18 Coronavirus Disease (COVID-19): Features, Diagnosis, Treatments, and Impacts Ayush Dogra, Bhawna Goyal
248 [GO] Coronaviruses 2023―Apr―11 COVID-19: Mortality rate (in time) An Analysis of Publicly Available Data from 11 Countries to Calculate the Mortality Rate of COVID-19 Rien Bosma
249 [GO] Coronaviruses 2023―Apr―04 Herbal Medicines Used for the Management of COVID-19 Virender Kumar, Yogesh Kumar, Rajat Huria, Suryadev Kumar, Tarun Kalson, Deepak Jangra, et al. (+2)
250 [GO] Coronaviruses 2023―Mar―30 Moisturizer and COVID-19: Are We Missing a Trick? Srinivasan Tantravahi, Chenna R Galiveti
251 [GO] Coronaviruses 2023―Mar―30 Exploring the Possibility of use of SARS-CoV-2 Antiserum as an Alternative for Plasma Therapy Basavraj Nagoba, Ajay Gavkare, Abhijit Rayate
252 [GO] Coronaviruses 2023―Mar―30 Different Variants of SARS-COV-2: A Comprehensive Review on Mutation Patterns and Pathogenicity Mohammad Faheem Khan, Fahmina Rizvi, Mohsin Ali Khan, Waseem Ahmad Ansari, Kajim Ali, Mohd. Aamish Khan
253 [GO] Coronaviruses 2023―Feb―28 The Use of Antivirals Against COVID-19 Infection will Reduce the Number of Fatalities in Australia Alberto Boretti
254 [GO] Coronaviruses 2023―Jan―03 A recent update on SARS-CoV-2 transmission and its variants: Transmission, pathogenic mechanism, and treatment Vishal Mishra, Veer Singh, Shreyans K Jain
255 [GO] Coronaviruses 2022―Dec―12 Emergence of BA.4/BA.5 Omicron Sub-lineages and Increased SARS-CoV-2 Incidence in Senegal Moussa Moise Diagne, Amadou Diallo, Safietou Sankhe, Ndeye Marieme Top, Mouhamed Kane, Maimouna Mbanne, et al. (+6)
256 [GO] Coronaviruses 2022―Dec―07 COVID-19 mortality and the cytokine storm: An added value for APOE genotyping Luis Diambra, Reza Rastmanesh
257 [GO] Coronaviruses 2022―Dec―06 An In-Silico Multi-Targeted Approach in Search of Potential Drug Candidate(s) Against SARS-CoV-2 Lung Infection Joohee Pradhan, Kapish Kapoor, Vishnu Das, Ayushi Bhatnagar, Sunita Panchawat
258 [GO] Coronaviruses 2022―Nov―24 Landscape Analysis of Quercetin: A Potential Candidate Against SARS-CoV-2 Kamal Niaz, Furqan Shafqat, Shafeeq Ur Rehman, Omazia Nasir, Ayesha Sarwar
259 [GO] Coronaviruses 2022―Aug―30 Computational Study Reveals the Inhibitory Effects of Chemical Constituents from Azadirachta Indica (Indian Neem) against Delta and Omicron Variants of SARS-CoV-2 Mohammad Faheem Khan, Waseem Ahmad Ansari, Fahmina Rizvi, Mohsin Ali Khan, Zaw Ali Khan
260 [GO] Coronaviruses 2022―Aug―19 Examining the Causes of Maternal Mortality in Pregnant Women since the Beginning of the COVID-19 Pandemic in Hamadan Province, Western Iran: A Research Article Samereh Ghelichkhani, fariba keramat, Ebrahim Jalili, faezeh moshayedi, Seyedeh Zahra Masoumi, azam midwifery, et al. (+3)
261 [GO] Coronaviruses 2022―Aug―04 The COVID-19 Crisis: Impact on the Education System and How to Change the Way of Learning Bentham Science Publisher Bentham Science Publisher
262 [GO] Coronaviruses 2022―Jul―06 COVID-19 and Tuberculosis: Two Knives in a Sheath Meenakshi Sundaram Kishore Kumar, Attuluri Vamsi Kumar, Thomas Alphonsa, Sangeetha Rajendran, Krishnamurthy Rajamanickam, Alemtoshi A, et al. (+4)
263 [GO] Coronaviruses 2022―Jun―24 Overview of SARS-CoV-2 and possible targets for the management of COVID-19 infections Arunachalam Muthuraman, Muthusamy Ramesh, Aswinprakash Subramanian, Jagadeesh Dhamodharan, Lim Khian Giap
264 [GO] Coronaviruses 2022―Jun―08 The COVID-19 Pandemic: To Improve Public Acceptance, Don’t Keep Them in the Dark, Educate Them Joseph M. Rosen, Jill R. Sensenig
265 [GO] Coronaviruses 2022―Jun―03 In Silico Modeling of COVID-19 Pandemic Course Differentiation Using the FOD Model Irena Roterman, Katarzyna Stapor, Piotr Fabian, Leszek Konieczny
266 [GO] Coronaviruses 2022―May―27 Engineered Soluble ACE2 Protein and SARS-CoV-2 Variants of Concern (VOCs) Wattana Leowattana
267 [GO] Coronaviruses 2022―Apr―11 COVID-19 Stress on Mental and Hair Health: A Marker for Diseases in the Post-Pandemic Era? Daniela Xavier Accorsi, Ingrid Aparecida Mendes dos Santos, Juliana Xavier Accorsi, Ursulandréa Sanches Abelan, Celso Martin Júnior, Silvia Bohac, et al. (+3)
268 [GO] Coronaviruses 2022―Mar―29 Traditional therapies involving nutrition for the management of COVID-19 Ramesh M, Arunachalam Muthuraman, Krishnan Anand
269 [GO] Coronaviruses 2022―Mar―25 Functional role of natural antioxidants for controlling oxidative stress associated with SARS-Cov-2 infection Subramani Parasuraman, Venkata Kanthi Vaishnavi Vedam, Chakradhara Rao S Uppugunduri
270 [GO] Coronaviruses 2022―Mar―03 Recent advances in understanding SARS-CoV-2 infection and updates on potential diagnostic and therapeutics for COVID-19 Damini Verma, Amit K. Yadav, Navneet Chaudhary, Maumita Das Mukherjee, Pramod Kumar, Anil Kumar, Pratima R Solanki
271 [GO] Coronaviruses 2022―Feb―06 The Concept Of Repurposing In Covid-19 Infection Lata Potey, Anshu Chaudhary Dudhe, Dhanashri Tumme, Rupesh Dudhea, Prafulla Sable
272 [GO] Coronaviruses 2022―Jan―24 Green tea catechins against COVID-19? Lower COVID-19 morbidity and mortality in countries with higher per capita green tea consumption. Maksim Storozhuk
273 [GO] Coronaviruses 2022―Jan―19 Assessment of Stress, Anxiety and Depression Level Among COVID-19 Positive Patients Admitted in Rural Tertiary Care Hospital Ramakant Yadav, Neha Dubey, Shweta Jain, Ankur Vaidya, Raj Kumar
274 [GO] Coronaviruses 2022―Jan―18 Onco-immunological Aspect of COVID-19: Current Progress and Perceptions Suman Kumar Ray, Sukhes Mukherjee
275 [GO] Coronaviruses 2022―Jan―18 LONG TERM NEUROLOGICAL EFFECTS AFTER ACUTE SARS-CoV-2 INFECTION Mohammad Asif
276 [GO] Coronaviruses 2022―Jan―07 Is there a rendezvous for SARS-CoV-2 and Agmatine? Nandkishor Kotagale, Brijesh Taksande, Nazma Inamdar
277 [GO] Coronaviruses 2021―Nov―23 Impact on Pharmaceutical Industry due to Sudden Pandemic Attack (COVID-19) Sudhanshu Mishra, Disha Sharma, Shobhit Prakash Srivastava, Swati Verma, Rishabha Malviya
278 [GO] Coronaviruses 2021―Oct―23 Liver and Covid-19 - a review and clinical approach David L Fisher, Stephen Malnick
279 [GO] Coronaviruses 2021―Sep―16 Alternative Management Of Cushing's Syndrome During Covid-19 Pandemic Serghei Covantev, Stanislav I. Volkov, Kristina I. Samsonova
280 [GO] Coronaviruses 2021―Sep―16 Cytokine Storm and Immunomodulation in COVID-19: a Review Amir Mohammad Arsh, Suhana Mishra, Vishwas Tripathi, Amaresh Mishra
281 [GO] Coronaviruses 2021―Sep―13 Cordycepin and its nucleoside analogs for the treatment of systemic COVID-19 infection
282 [GO] Coronaviruses 2021―Sep―09 Total Stromal Fraction (TSF) - Fortified Adipose tissue-derived Stem Cells Source: An Emerging Regenerative Realm Against COVID-19 Induced Pulmonary Compromise Madhan Jeyaraman, Sathish Muthu, Rashmi Jain, Ajay SS, Neha Garg, Prabhu Mishra, et al. (+10)
283 [GO] Coronaviruses 2021―Aug―23 Withdrawal Notice: Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2) Ashu Chaudhary
284 [GO] Coronaviruses 2021―Aug―06 History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) Amaresh Mishra, Nisha Nair, Vishwas Tripathi, Yamini Pathak, Jaseela Majeed
285 [GO] Coronaviruses 2021―Jul―29 COVID-19 Vaccines: Fabrication Techniques and Current Status Ayushi Mahajan, Lakhvir Kaur, Gurjeet Singh, RK Dhawan, Lovepreet Singh, Anureet Kaur
286 [GO] Coronaviruses 2021―Jul―12 Identification of flavonoids as potent inhibitors against MERS-CoV 3C-like protease Fatemeh Abdi, Shahrzad Javanshir
287 [GO] Coronaviruses 2021―Jul―12 SARS-CoV-2: Evaluation and Evolution Loay Bedda, Fayrouz Mahmoud, Radwa Elkhateib, Alyaa Dawoud, Hassan Gamal, Abdallah S. Abdelsattar, Ayman El-Shibiny
288 [GO] Coronaviruses 2021―Jun―02 Immunosuppressant Drugs And Covid-19: Associated Risks, Drug-Drug Interactions & Contraindications Debjyoti Talukdar, Diane Ignacio, Madan Mohan Gupta
289 [GO] Coronaviruses 2021―Mar―30 Lipid lowering natural products targeting hPCSK9 may prevent the severity of COVID-19 infection Ajoy Basak, Jaishree Vaijanathappa, Sarmistha Basak
290 [GO] Coronaviruses 2021―Mar―30 Graphene versus coronavirus: A study of the graphene properties that can help to combat coronavirus T. Guerra, I. O. Assis, A. B. Guerra
291 [GO] Coronaviruses 2021―Mar―16 Administration of exogenous surfactant and cytosolic phospholipase A2α inhibitors may help COVID-19 infected patients with chronic disease Mohammed Abdalla Hussein
292 [GO] Coronaviruses 2021―Mar―10 Transmission, Prevention and Therapeutic Strategies for COVID-19: Updates and Challenges Habibur Rahman
293 [GO] Coronaviruses 2021―Mar―10 New Perspectives for SARS-CoV-2 Rapid Detection Latifa Khattabi, Mustapha Mounir Bouhenna, Feriel Sellam
294 [GO] Coronaviruses 2021―Mar―03 Effect of miRNAs, proinflammatory cytokines and ACE2 in COVID-19 pathophysiology Hari Om Singh, Kamini Jakhar, Vijay Nema, Asha Krishnaraj, Ranjana Choudhari
295 [GO] Coronaviruses 2021―Mar―01 Therapeutically Important Natural Products and their Derivatives as a Target for Treatment of COVID-19 (SARSCoV2) Ashu Chaudhary
296 [GO] Coronaviruses 2021―Mar―01 Economic Fluctuations- the Aftermath of COVID 19 Pandemic Saishiv Adithya, Koyeli Girigoswami
297 [GO] Coronaviruses 2021―Feb―26 SARS-CoV-2: Molecular biology and therapeutic target. Vivek Pandey, Ankita Pathak, Mohammad Shahar Yar, Yuba Raj Pokharel
298 [GO] Coronaviruses 2021―Feb―25 Antimicrobial Resistance: The Potent Enemy Lurking Behind COVID-19 Rohini Kanwar, Amit Kumar, Jyoti Rathee, Surinder K. Mehta
299 [GO] Coronaviruses 2021―Feb―24 World’s proposed safeguard against COVID-19 - A brief review Sumanta Dey, Anindita Dey, Shreyans Chatterjee, Papiya Nandy, Ashesh Nandy
300 [GO] Coronaviruses 2021―Feb―24 Controlling Coronavirus Infection: ‘Plan B’ based on non-vaccine/drug interventions Ram Kumar Dhaked
301 [GO] Coronaviruses 2021―Feb―24 Clinical evidence and therapeutic treatments at the time of the coronaviruses responsible for SARS: a perspective and points of view with a focus on vascular endothelium. Gerardo Tricarico, Barbara Zavan, Valter Travagli
302 [GO] Coronaviruses 2021―Feb―24 Current Trends and Future Strategies for the Global Impact of COVID-19 Pandemic Ashutosh Chauhan, Ankit Kumar, Sandeep Goyal, Sunil Kumar Joshi, Deepak Kumar Semwal
303 [GO] Coronaviruses 2021―Feb―23 Virtual Screening of the Flavonoids Compounds with the SARS-CoV-2 3C-like Protease as the Lead Compounds for the COVID-19 Gabriella Patricia Adisurja, Arli Aditya Parkesit
304 [GO] Coronaviruses 2021―Feb―23 Functionalized photocatalytic nanocoatings for inactivating COVID-19 virus residing on surfaces of public and healthcare facilities Manjunatha Channegowda
305 [GO] Coronaviruses 2021―Feb―23 Angiotensin Converting Enzyme-2: A Doorway for SARS-CoV-2 Vikas Pandey, Indu Lata Kanwar, Tanweer Haider, Vishal Gour, Monika Vishwakarma, Avijit Kumar Bakshi, et al. (+2)
306 [GO] Coronaviruses 2021―Feb―17 The synergic role of environmental contaminants on the immunological effects of viral diseases, such as COVID-19 Winfred Espejo, José E Celis, Paulina Bahamode
307 [GO] Coronaviruses 2021―Feb―17 Screening for Potential Traditional Herbal Inhibitors Against 3-Chymotrypsin-Like Main Protease (3CLpro) from Four Different Coronaviruses-: An in-silico Approach Prachi Singh, Mohamed Rafiq, Raghavendra Pralhada Rao
308 [GO] Coronaviruses 2021―Feb―17 Immunological response of the respiratory tract in the SARS-CoV-2 infection Sanjiv Singh, Punita Aggarwal, Velayutham Ravichandiran
309 [GO] Coronaviruses 2021―Feb―17 Prevention and management of SARS-CoV-2 infection among the health care workers Juhi Sharma, Divakar Sharma
310 [GO] Coronaviruses 2021―Feb―12 Mesenchymal stem cells: A potent cell source for COVID-19 Mohammad Ramazii, Delnia Ebadi, Maryam Farzaneh, Farhoodeh Ghaedrahmati, Seyed Esmaeil Khoshnam
311 [GO] Coronaviruses 2021―Feb―12 High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies Khalid P, Arun A. Bhagwath, Rekha P.D, Sharif Hamed R. Almutiri, Ziyad Abdullah Al Zeyadi, Suman V. Budihal
312 [GO] Coronaviruses 2021―Feb―11 An epidemiology, evolution, transmission, and therapeutics of COVID-19 Outbreak: an update on the status Karan Singh, Amit Kumar Mittal, Akash Gujral
313 [GO] Coronaviruses 2021―Feb―09 An Integrated In-Silico Approach to Develop Epitope-Based Peptide Vaccine against SARS-CoV-2 Prekshi Garg, Neha Srivastava, Prachi Srivastava
314 [GO] Coronaviruses 2021―Feb―09 COVID19 pandemic: An overview of its origin, current status and ongoing clinical trials Kartik Majila, Seema Lal, Mohammad Faiz Ahmad
315 [GO] Coronaviruses 2021―Feb―04 Pathogenesis and immune status in COVID-19 pneumonia - A minireview George Laylson da Silva Oliveira, Nidia Aparecida Martines, Joelma da Costa Barbosa Oliveira
316 [GO] Coronaviruses 2021―Feb―03 COVID-19 invades several important organs other than lungs: Organs crosstalk Manal A. Hamed
317 [GO] Coronaviruses 2021―Feb―03 Promiscuous Biological Features of Newly Emerged SARS-CoV-2 Facilitate its Unrestrained Outbreak: An Update Asim Azhar, Khaled Al-hosaini, Parvez Anwar Khan, Abdul M Oanz, Qamar Zia, Saeed Banawas, et al. (+3)
318 [GO] Coronaviruses 2021―Jan―31 Adjuvant Therapies of COVID-19 - A Literature Review Naina Mohamed Pakkir Maideen
319 [GO] Coronaviruses 2021―Jan―28 Diagnosis and possible use of Traditional Medicinal Plant to combat COVID-19 M. Beyau Konyak, Richa Naredi, Ekta Rana, Ramendra Pati Pandey
320 [GO] Coronaviruses 2021―Jan―28 Antiviral Effects of Asian Natural Products Targeting SARS, MERS, and COVID-19. Jafrin Jobayer Sonju, Md Rafi Anwar, Md. Abul Kalam Azad, Umme Habiba Sultana, Kumar Kulldeep Niloy, Sajan Das
321 [GO] Coronaviruses 2021―Jan―19 History and global status of the new coronavirus covid-2019 and aspects of previous infections of sars-cov and mers-cov: A systematic review Amanda Pinato Alves da Costa, Vinicius Lisboa da Rocha, Rogério Rodrigo Ramos, José Martins Pinto Neto, Wagner Rafael da Silva, Luis Lenin Vicente Pereira, et al. (+4)
322 [GO] Coronaviruses 2021―Jan―19 In silico insight into the inhibitory effects of active antidiabetic compounds from medicinal plants against SARS-CoV-2 replication and posttranslational modification Habibu Tijjani, Adamu Idris Matinja, Ahmed Olatunde, Maryam Haladu Zangoma, Abubakar Mohammed, Muhammad Akram, et al. (+2)
323 [GO] Coronaviruses 2021―Jan―18 A coadunation of biological and mathematical perspectives on the pandemic COVID-19: A Review Sahar Qazi, Kayenat Sheikh, Mo Faheem, Arshad Khan, Khalid Raza
324 [GO] Coronaviruses 2021―Jan―13 COVID-19 and the challenges of chemotherapy: The failure case of hydroxychloroquine in the clinical treatment of SARS-CoV-2 infection Pollyanna Stephanie Gomes, Patrícia A. Machado, Andre M. O. Gomes, Andrea C. Oliveira, Jerson L. Silva, Herbert Leonel de Matos Guedes
325 [GO] Coronaviruses 2021―Jan―13 COVID-19 (SARS-CoV2): Consequences, Possible Therapeutics and Future Directions for Prevention & Treatment Ashu Chaudhary
326 [GO] Coronaviruses 2021―Jan―13 Immunity modulators, Repurposed drugs and Candidate Vaccines for COVID-19: A Review Rashmy Nair, Ravindra Singh Rao, Placheril Joseph John, Poonam Khandelwal
327 [GO] Coronaviruses 2021―Jan―12 A Mini Review on COVID-19 Therapeutics: Current Status and Future Directions Niranjan Kaushik, Vikram Sharma, Vikas Sharma
328 [GO] Coronaviruses 2021―Jan―11 Cellular senescence and COVID-19 Farhan Rahman Chowdhury, Tofazzal Islam
329 [GO] Coronaviruses 2021―Jan―11 Hydroxychloroquine Sulfate (Plaquenil): A possible candidate for Pandemic SARS-CoV-2 or (COVID-19) ? Subhash Chandra, Sarla Saklani, Hassan Y. Aboul-Enein
330 [GO] Coronaviruses 2021―Jan―08 Stroke and COVID-19 pandemic: the dilemma Sherif Mohamed, Seham Abd El-Mohsen, Osama Abo El-Hassan, Azza AbdelHaffez, Nashwa Abd El-Aziz
331 [GO] Coronaviruses 2021―Jan―06 Safe Use of Sodium Dodecyl Sulfate (SDS) to Deactivate SARS-CoV-2: An Evidence-Based Systematic Review Ashok Kumar, Waseem Ahmad Ansari, Tanveer Ahamad, Mohammad Saquib, Mohammad Faheem Khan
332 [GO] Coronaviruses 2021―Jan―04 Is COVID-19 a systemic disease? Sherif Mohamed, Khaled Saad, Ghada Elgohary, Azza AbdElHaffez, Nashwa Abd El-Aziz
333 [GO] Coronaviruses 2021―Jan―04 Remdesivir (GS-5734) for COVID-19 Treatment: Past and Recent Updates Santhosh Arul, Haripriya Dayalan
334 [GO] Coronaviruses 2021―Jan―03 Psychological Impact of Coronavirus (COVID-19) Disease on Cancer Patients Gaurav Dhiman
335 [GO] Coronaviruses 2020―Dec―31 Repositioning of Drugs as a promising strategy to fight COVID-19 Vivek Yadav, Jurnal Reang, Vinita Sharma, Jaseela Majeed, Swaminathan Jambulingam, Ramesh Goyal, Rajiv Kumar Tonk
336 [GO] Coronaviruses 2020―Dec―31 A critical appraisal of the risk of bias in systematic reviews and metaanalyses pertaining to COVID-19 Amit Dang, Sheshank Madiraju, Jagan Mohan Venkateswara Rao P, Navya Sri Gurram, Sandeep Digijarala, Sumit Dang, Vallish BN
337 [GO] Coronaviruses 2020―Dec―31 2019 Novel Coronavirus: A review on Epidemiology, Pathophysiology, Diagnosis and Current Clinical Trials in Vaccine Development Megala Jayaraman, Sabari Krishna B. B., Parijat Dutta, Jayesh Telang, Sreshta Adhikari, Arpan Neeraj Pardeshi
338 [GO] Coronaviruses 2020―Dec―31 Pleiotropic effects of Nitric Oxide on SARS-CoV-2 Infections Barbara Terroni, Juliana Romano Lopes, Chung Man Chin, Jean Leandro Dos Santos
339 [GO] Coronaviruses 2020―Dec―29 Management of COVID-19 very elderly patients in Nursing Homes and Long-Term Care Facilities: Description of a new model and experience in a medicalized Nursing Home Ignacio Novo-Veleiro, Martín Vidal-Vazquez, Néstor Vázquez-Agra, Eduardo-David Otero Rodríguez, Paula Andújar-Plata, Belen Calvo-Martínez, et al. (+5)
340 [GO] Coronaviruses 2020―Dec―24 A Perspective On The Impact of COVID-19 Pandemic in Basic Science Research and its Future implications Yam Nath Paudel, Efthalia Angelopoulou, Bhupendra Raj Giri, Christina Piperi, Iekhsan Othman, Mohd. Farooq Shaikh
341 [GO] Coronaviruses 2020―Dec―24 In-silico Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors against Main Protease of SARS-CoV-2 Ravi S Patel, Akash G Vanzara, Nimisha R Patel, Ajit M Vasava, Sachin M Patil, Kishore S Rajput
342 [GO] Coronaviruses 2020―Dec―23 Current Drug Trends for the Treatment of SARS-CoV-2 Márcio Robert Mattos da Silva, Melanie Tavares, Ralph Santos-Oliveira, Eduardo RicciJúnior
343 [GO] Coronaviruses 2020―Dec―23 Boosting innate immunity during SARS-CoV-2 clearance Abhishesh Kumar Mehata, Deepa Dehari, Anuj Kumar Mehta, Alim Miya
344 [GO] Coronaviruses 2020―Dec―21 Impact of Metaheuristic Techniques in Pandemic of COVID-19 Vijay Kumar, Dilbag Singh, Manjit Kaur
345 [GO] Coronaviruses 2020―Dec―21 The Significance of Angiotensin-Converting Enzyme-2 (ACE2) in SARSCov-2 Infection and COVID-19 Carolina Restini, Trevor Belavek, Rafael Bernal, Vanessa Ibrahim, Kelly Irwin, Minjung Kim, Courtney Merlo
346 [GO] Coronaviruses 2020―Dec―21 Molecular insights into Resveratrol and its analogs as SARS-CoV-2 (COVID-19) protease inhibitors Vaishali M. Patil, Rohan R. Narkhede, Neeraj Masand, Rameshwar S. Cheke, Krishnan Balasubramanian
347 [GO] Coronaviruses 2020―Dec―21 Remdesivir, A Potential Drug for COVID-19 Treatment: A New Hope Kuldeep Singh, Dilpreet Singh, Karan Razdan
348 [GO] Coronaviruses 2020―Dec―15 Coronavirus Pandemic: Role of Bats And Zoonotic Transmission in Humans Baljinder Singh, Jasleen Kaur, Sumeet Gupta
349 [GO] Coronaviruses 2020―Dec―15 Review on Diagnostic Methods for SARS-CoV-2 Chandrashekhar Chauriya, Mahesh Sahu, Anuj Kumar Singh, Amita Verma
350 [GO] Coronaviruses 2020―Dec―10 COVID-19: how nuclear medicine can provide a differential diagnosis in very dubious case Maria Silvia De Feo, Viviana Frantellizzi, Giuseppe De Vincentis
351 [GO] Coronaviruses 2020―Dec―10 The Genomes of SARS-CoV-2 and Related Coronaviruses: Are Accessory Proteins Key for Pathogenesis? Saikat Samanta, Rudra Prasad Saha
352 [GO] Coronaviruses 2020―Dec―10 Nigella Sativa: An immunity booster as pandemic treatment solution against SARS-CoV-2 Afzal Hussain, Ashfaq Hussain, Chandan Kumar Verma
353 [GO] Coronaviruses 2020―Dec―10 The role of nanoparticles as nanocarriers for the controlled release of some potential existing antiviral drugs for SARS-CoV-2 management: A Review Onome Ejeromedoghene, Joshua I. Orege, Justina U. Onwuka, Philip A. Adebule, Teddy Ehianeta, Bright O. Okonkwo, Richard O. Akinyeye
354 [GO] Coronaviruses 2020―Dec―10 SARS-CoV-2: Origin, pathogenesis and Therapeutic Interventions Ipsita G Kundu, NNV Radharani, Amit S Yadav, Srinivas Patnaik, Gopal C Kundu
355 [GO] Coronaviruses 2020―Dec―05 Recent developments and opportunities in fighting COVID-19 Vikram Rao, Subrat Kumar Bhattamisra
356 [GO] Coronaviruses 2020―Dec―05 Outbreak of coronavirus disease 2019 (COVID-19) and its manifestation Bikash Debnath, Waikhom Somraj Singh, Kuntal Manna
357 [GO] Coronaviruses 2020―Dec―05 Major drugs used in COVID-19 treatment: molecular mechanisms, validation and current progress in trials Md. Asaduzzaman Khan, Shad Bin Islam, Mejbah Uddin Rakib, Didarul Alam, Md. Munnaf Hossen, Mousumi Tania, Asaduzzaman Asad
358 [GO] Coronaviruses 2020―Dec―05 Safety and Efficacy of Convalescent Plasma Therapy for the Management of COVID-19: A Systematic Review Sitaram Khadka, Muhammad Saleem, Dhan Bahadur Shrestha, Pravash Budhathoki
359 [GO] Coronaviruses 2020―Dec―05 Covid-19: An update on the clinical features, diagnosis, and treatment strategies. Manan Abdulrahman Alhkbany
360 [GO] Coronaviruses 2020―Dec―05 Therapeutic options for the treatment of 2019-novel coronavirus in India: A systematic review Pratyay Kumar Pahari, Sonal Vyas, Shahbaz Aman, Uday Singh, Kusheswar Prasad Singh, Rohit Tiwari, Meenakshi Dhanawat
361 [GO] Coronaviruses 2020―Dec―04 Chemi-Informatic approach to investigate putative pharmacoactive agents of plant origin to eradicate COVID-19 Amit Joshi, Vandna Sharma, Joginder Singh, Vikas Kaushik
362 [GO] Coronaviruses 2020―Dec―04 In silico identification of potential inhibitors of SARS-CoV-2 papain-like protease from natural sources: A natural weapon to fight COVID-19 Bimal Debnath, Pradip Debnath, Rajat Ghosh, Sudhan Debnath
363 [GO] Coronaviruses 2020―Dec―04 Coronavirus (Covid-19) and employee health Ali Mehrabi Tavana, Mohamadkarim Bahadori
364 [GO] Coronaviruses 2020―Nov―24 COVID-19: A daily dose of yoga to cope with anxiety Surabhi Gautam, Rima Dada
365 [GO] Coronaviruses 2020―Nov―24 Is there any role for IL-6 inhibition in COVID-19? Rebecca Cannon, Satyajit Das
366 [GO] Coronaviruses 2020―Nov―24 The emergence of novel coronavirus disease, global treatment update and its containment strategies in overpopulated countries: A Review Fazli Azim, Md Shahidul Islam, Hedaeytullah Saju, Kaniz Fatema, Aneela Hayat, Mostofa Kamal, et al. (+3)
367 [GO] Coronaviruses 2020―Nov―20 COVID-19 Effect: Time to Change the Way of Research Vikas Sharma
368 [GO] Coronaviruses 2020―Nov―20 Structure, transmission, diagnostic symptoms, host and entry mechanism of covid-19: A review Prashant Swapnil, Mukesh Meena, Tansukh Barupal, Yashwant Sompura, Deepa Hada
369 [GO] Coronaviruses 2020―Nov―20 A Journey of Coronaviruses from Sporadic Outbreaks to COVID -19 Pandemic Suresh Kumar, Perumal Nagarajan
370 [GO] Coronaviruses 2020―Nov―19 Clinical spectrum, geographical variability of COVID-19 and its implications Md. Hasanul Banna Siam, Abdullah Al Mosabbir, Nahida Hannan Nishat, Ahsan Ahmed, Mohammad Sorowar Hossain
371 [GO] Coronaviruses 2020―Nov―19 Psychological and Mental Health Issues During SARS-CoV-2 Global Pandemic: A Critical Analysis Tahmeena Khan, Iqbal Azad, Alfred J. Lawrence
372 [GO] Coronaviruses 2020―Nov―17 Impact of Novel Coronavirus (COVID-19) on Pregnant Women: A Review Saima Habeeb, Manju Chugani
373 [GO] Coronaviruses 2020―Nov―17 Current advances in novel SARS-CoV-2 disease (COVID-19) treatment and intervention strategies Mohammad Khalid Parvez, Kartika Padhan
374 [GO] Coronaviruses 2020―Nov―17 Anticipating on a post covid-19 world and the pivotal role of science and technology Saeed Khan, Tusha Sharma, Basu Dev Banerjee, Scotty Branch, Shea Harrelson
375 [GO] Coronaviruses 2020―Nov―13 COVID-19 Pandemic: Current Scenario, Challenges and Future Perspectives Ovais Ahmad Zargar, Rabia Hamid, Rohina Bashir, Mohammad Afzal Zargar
376 [GO] Coronaviruses 2020―Nov―13 Structure based drug design approach to identify potential SARS-CoV-2 polymerase inhibitors. Preeya Negi, Surya Prakash, Vaishali M. Patil
377 [GO] Coronaviruses 2020―Nov―11 Novel Coronavirus Disease 2019 (COVID-19) Current Update; Perspective on Epidemiology, Diagnosis, Drug Targets and Vaccines Sunil L. Harer, Priyanka A. Sonar
378 [GO] Coronaviruses 2020―Nov―05 Antiviral potential of coconut (Cocos nucifera L.) oil and COVID-19 Ramesh S.V., Pandiselvam R, Hebbar K. B., Manikantan M.R., Shameena Beegum P.P., Shelly Praveen, Sruthi N. U
379 [GO] Coronaviruses 2020―Oct―27 A Mini-review on Cardiovascular and Hematological Complications of COVID-19 Moein Masjedi, Pegah Jafari
380 [GO] Coronaviruses 2020―Oct―27 The Current Outbreak of COVID-19 with reference to India Harshita Gupta
381 [GO] Coronaviruses 2020―Oct―27 Review of the Times When One-Third of the Mankind is Under Lockdown due to Coronavirus Pramod Gware, Deepanshu Gulati
382 [GO] Coronaviruses 2020―Oct―27 Vaccine development against SARS-CoV-2: from virology to vaccine clinical trials Kimia Kardani, Azam Bolhassani
383 [GO] Coronaviruses 2020―Oct―27 Manuscript title: “COVID-19 pandemic: care for Indian cancer patients” Sandeep Kumar
384 [GO] Coronaviruses 2020―Oct―23 Nanomaterial: A Sustainable Way to Fight against COVID-19 Atish K. Maldhure
385 [GO] Coronaviruses 2020―Oct―18 Combination of Hydroxychloroquine, Melatonin and Mercaptopurine as possible intervention for prophylaxis and treatment of Novel COVID-19 infection Gyan Vardhan, Vikas Kumar, Megha Agrawal, Puneet Dhamija
386 [GO] Coronaviruses 2020―Oct―15 A Study about the impact of weather, life expectancy and tourism on the transmission of COVID-19 Pardeep Bishnoi, Prabhat Kumar, Abhijeet Singh, Mukesh Sahu, Vikrant Bansal
387 [GO] Coronaviruses 2020―Oct―15 Synthetic Lung Surfactant Treatment for Covid-19 Pneumonia Frans J. Walther, Alan J. Waring
388 [GO] Coronaviruses 2020―Oct―15 Emergence of a new zoonotic covid-19 that creates a pandemic: Update on current pharmacotherapeutics and future prospective of plasma therapy Farazul Hoda, Rishabh Verma, Saurabh Rastogi, Asif Iqubal, Syed Ehtaishamul Haque, Mohd. Akhtar, Abul Kalam Najmi
389 [GO] Coronaviruses 2020―Oct―15 Possible benefits of reformulating antiviral drugs with nanoemulsion system in the treatment of novel coronavirus infection Manish Kumar, Chandra Prakash Jain
390 [GO] Coronaviruses 2020―Oct―15 In-silico Structure-Based Drug Discovery of Candidate Drugs against Novel Protein Receptor Complex Nsp10-Nsp16 of SARS-CoV-2 using Drug Repurposing Approach Abhishek Sengupta, Pooja Vijayaraghavan, Priyansh Srivastava, Lovely Gupta, Chaitanya Chandwani, Priyanka Narad
391 [GO] Coronaviruses 2020―Oct―07 Impact of Online Teaching on Students’ Education and Health in India during Pandemic of COVID-19 Avadhesh Kumar Yadav
392 [GO] Coronaviruses 2020―Oct―07 Impact of BCG Vaccine to Fight Against the Pandemic of Corona (COVID-19): A Review Rana Mazumder, Subhabrota Majumdar
393 [GO] Coronaviruses 2020―Oct―07 Coronavirus disease 2019 (COVID-19): Current situation and therapeutic options Veer Singh, Vishal Mishra
394 [GO] Coronaviruses 2020―Oct―07 COVID-19 Epigenetics and Implications for Public Health Verda Tunalıgil, Gülsen Meral, Ahmet Katı, Dhrubajyoti Chattopadhyay, Amit Kumar Mandal
395 [GO] Coronaviruses 2020―Oct―07 Nutritional intervention for the treatment and prevention against novel coronavirus-19 Abdul Wahab, Fahad Hassan Shah
396 [GO] Coronaviruses 2020―Sep―29 Dual modulators of selected plant secondary metabolites targeting COVID-19 Main protease and Interleukin-2: An in-silico approach based novel hypothesis Thangavelu Prabha, Vijay K. Kapoor, Palanisamy Selvamani, Subbiah Latha, Thangavel Sivakumar, Selvaraj Jubie
397 [GO] Coronaviruses 2020―Sep―29 Hydroxychloroquine Induced DRESS (Drug Rash with Eosinophilia and Systemic Symptoms Syndrome) Mimicking SARS-COV-2 Illness: A Case Report with Review Maitri M. Patel, Dhruvkumar M. Patel, Mukundkumar V. Patel, Jayanti K. Gurumukhani, Suyog Y. Patel, Harsh D. Patel
398 [GO] Coronaviruses 2020―Sep―26 COVID-19 infection: A review of summarized Clinical trials study for the treatment Afzal Hussain, Ashfaq Hussain, Chandan Kumar Verma
399 [GO] Coronaviruses 2020―Sep―22 Novel Corona-Virus Disease 2019 (COVID-19): A Perilous LifeThreatening Epidemic Surya Goel, Ram Dayal
400 [GO] Coronaviruses 2020―Sep―22 Discovery of Potential Inhibitors of SARS-CoV-2 (COVID-19) Main Protease (Mpro) from Nigella Sativa (Black Seed) by Molecular Docking Study S. L. Khan, F. A. Siddiqui, S. P. Jain, G. M. Sonwane
401 [GO] Coronaviruses 2020―Sep―22 COVID-19: Mitigation is good! Prophylactics are better! Treatment is the best! Prabagaran Narayanasamy
402 [GO] Coronaviruses 2020―Sep―21 Understanding the role of HDL during COVID-19 infection Iti Garg, Swati Srivastava, Bhuvnesh Kumar
403 [GO] Coronaviruses 2020―Sep―21 COVID-19: Insights into Structure-Function Relationship, Drug Targets and Drug Design Strategies for novel-Coronavirus 2019 Snigdha Bhardwaj, Shaminder Singh, Sonam Bhatia
404 [GO] Coronaviruses 2020―Sep―18 Coronavirus: history, genome structure and pathogenesis Poonam B, Prabhjot Kaur Gill
405 [GO] Coronaviruses 2020―Sep―18 A Review on Catastrophic Evolution of SARS-CoV to SARS-CoV2-A Global Pandemic Sushmita Krishnan, Darshini Subramanian, Sri Sakthi Priyadarshini Rajamani
406 [GO] Coronaviruses 2020―Sep―16 Insights into the Positive Role of a Higher Education Institution in the Prevention of Misinformation During Pandemics: The Health Committee Model During COVID-19 Dalal Hammoudi Halat, Marwan Akel, Fatima Hajj, Hassan HajjHussein, Rawad Kansoun, Ehsan Sharif-Askari, et al. (+2)
407 [GO] Coronaviruses 2020―Sep―16 Yoga may prevent cytokine storm in COVID-19 Surabhi Gautam, Rima Dada
408 [GO] Coronaviruses 2020―Sep―16 Utilizing Zebra fish animal model as a helping hand for COVID-19 infection Yashbir Singh, Heenaben Patel, Amit Chaudhary, Deepa S
409 [GO] Coronaviruses 2020―Sep―16 Dental care during the COVID-19 pandemic. Caio Vinicius G. Roman-Torres, Marcelo de Melo Quintela
410 [GO] Coronaviruses 2020―Sep―16 Prediction of infection and death ratio of CoVID-19 virus in Turkey by using artificial neural network (ANN) Andaç Batur Çolak
411 [GO] Coronaviruses 2020―Sep―16 Covid-19: An Insight over the Third Respiratory Global Emergency of the Century Sonali Batra, Sumit Sharma, Payal Verma, Nikhil Arora
412 [GO] Coronaviruses 2020―Sep―16 Can Cannabinoids Suppress the Cytokines Cascade in Patients with Coronavirus Disease COVID-19? A mini-review Hanane Zaki, Mohammed Bouachrine
413 [GO] Coronaviruses 2020―Sep―15 Vitamin D3 Deficiency and COVID-19. Olen R. Brown, Martin R. Hullender
414 [GO] Coronaviruses 2020―Sep―12 SARS-CoV-2 and its Predicted Potential Natural Inhibitors: A Review and Perspective Priyanka Samji, Manoj Kumar Rajendran, Vidya P Warrier
415 [GO] Coronaviruses 2020―Sep―09 Dealing with COVID-19: lessons learned from the Italian experience Silvana Mirella Aliberti, Francesco De Caro, Giovanni Boccia, Rosario Caruso, Mario Capunzo
416 [GO] Coronaviruses 2020―Sep―05 A Brief outlook on possible available solutions, therapies and suggestions for COVID-19 Rashmi Saxena Pal, Yogendra Pal, Pranay Wal, Ankita Wal, Nikita Saraswat
417 [GO] Coronaviruses 2020―Sep―05 COVID-19: A comparative study of SARS, MERS and COVID-19 Chandra Mohan, Vinod Kumar
418 [GO] Coronaviruses 2020―Sep―05 Impacts and consequences of COVID-19 epidemic on global economy Pallavi Nayak, Vijay Mishra, Manvendra Singh, Murtaza M. Tambuwala
419 [GO] Coronaviruses 2020―Sep―05 COVID-19 Pandemic: Age and Temperature Related Effects Gursharan Kaur, Amandeep Singh, Raj Kumar Narang, Gurmeet Singh
420 [GO] Coronaviruses 2020―Sep―05 Non-Pharmaceutical Interventions are measures to control coronavirus disease-2019 (COVID-19) transmission in India Ponnuswamy Vijayaraghavan, Srikrishnan Rajendran Sriramkumar
421 [GO] Coronaviruses 2020―Sep―05 The outbreak of Novel Coronavirus a New Type of Threat in 2020: Genesis, Detection, Treatment, and Management Dinesh Mohan S, Santhosha D, Gupta VRM, Mrunalini S
422 [GO] Coronaviruses 2020―Sep―02 Novel Coronavirus in India Outbreaks around World: A Statistical Analysis of Odisha, India & World Debabrata Singh, Suman Sekhar Sarangi, Milu Acharya, Surjeet Sahoo, Shakti Ketan Prusty, Sudhanshu Rout
423 [GO] Coronaviruses 2020―Aug―27 Virtual screening of potential therapeutic inhibitors against spike, helicase and polymerase of SARS-CoV-2 (COVID-19) Ayesha Tazeen, Farah Deeba, Aftab Alam, Rafat Ali, Romana Ishrat, Anwar Ahmed, et al. (+2)
424 [GO] Coronaviruses 2020―Aug―27 A Mini Review: Origin, Treatments, Preventions, Real Facts and Viability of the Recent Pandemic of Novel Coronavirus-2019 Prashant Kantrao Vibhute, Satish Babulal Jadhav, Satish Ashruba Dake, Bhaskar Sadashiv Dawane
425 [GO] Coronaviruses 2020―Aug―26 The COVID-19 and Munchausen Syndrome Yadollah Abolfathi Momtaz
426 [GO] Coronaviruses 2020―Aug―22 Measuring Asymptomatic Growth of COVID-19; A Powerful Mechanism for Controlling the Disease Spread Keith Lau
427 [GO] Coronaviruses 2020―Aug―19 Dengue, Influenza and COVID-19 in Brazil: The "Perfect Storm" Rosineide Marques Ribas, Paola Amaral de Campos, Cristiane Silveira de Brito, Paulo Pinto Gontijo Filho
428 [GO] Coronaviruses 2020―Aug―19 An Overview on Covid-19: Clinical Features, Treatment and Prevention Shahid Ud Din Wani, Surya Prakash Gautam, Zulfkar Latief Qadrie
429 [GO] Coronaviruses 2020―Aug―16 COVID-19: A Review on Epidemiology, Clinical Features and Possible Potential Drugs Based on Available Case Studies Kirtikumar C. Badgujar, Dipak V. Patil, Dipak V. Dhangar, Vikrant P. Patil, Ashish B. Badgujar
430 [GO] Coronaviruses 2020―Aug―16 COVID-19: The Unprecedented Malady-A Holistic Review Viney Chawla, Pooja A Chawla
431 [GO] Coronaviruses 2020―Aug―03 Homology Modeling of Coronavirus Structural Proteins and Molecular Docking of Potential Drug Candidates for the Treatment of COVID-19 Ahmed Adebayo Ishola, Nnaemeka Tobechukwu Asogwa
432 [GO] Coronaviruses 2020―Aug―02 Coordinated Roadmap to Grip Pandemic Covid-19 Rohini S. Kharwade, Sachin M. More
433 [GO] Coronaviruses 2020―Jul―30 Favipiravir in the Spotlight: In search of treatment against COVID-19 Marcus Vinícius Nora de Souza, Victor Facchinetti
434 [GO] Coronaviruses 2020―Jul―30 Off label medication to combat COVID-19: Review Results to Date. Amita Verma, Anuj Kumar Singh, Aman K. Das, Netra P. Neupane
435 [GO] Coronaviruses 2020―Jul―30 Self-Protection of Medical Workers in Traditional Hospitals and Clinics against SARS-CoV-2 Infection Suneel Prajapati, Pankaj Gupta, Digvijay Verma, Shilpi Singh, Ashish Tripathi, Mahima Sharma, et al. (+2)
436 [GO] Coronaviruses 2020―Jul―22 A Note on Estimating the Case Fatality Ratio for Novel Corona Virus Disease (Covid-19) Prafulla Kumar Swain
437 [GO] Coronaviruses 2020―Jul―22 SARS-CoV-2 Therapy: Old drugs as new interventions Puneet K. Samaiya, Mahendra Kumar
438 [GO] Coronaviruses 2020―Jul―14 Study of the Relationships Between COVID-19, Associated Diseases, and Vitamins Alice Barros Câmara, Igor Augusto Brandão
439 [GO] Coronaviruses 2020―Jul―14 Amantadine Can be Used as a Drug for SARS-Cov-2 Treatment? Zeynep Gunes Ozunal, Sevki Sahin
440 [GO] Coronaviruses 2020―Jul―14 Symptoms, transmission, prevention and treatment of pandemic corona virus: A review Tinsae Kebede, Dharmendra Kumar, Pramod Kumar Sharma
441 [GO] Coronaviruses 2020―Jul―10 Pathogenesis, Clinical Manifestation, Diagnosis, Pathological Findings, Treatment Options, Preventive Measures and Risk Factors Of Covid-19 Mohammad Asif, Anshuman Patel, May Bin-Jumah, Sadaf Jamal Gilani, Iqra Rahat, Mohamad Taleuzzaman, et al. (+3)
442 [GO] Coronaviruses 2020―Jul―10 Covid-19: Doomsday, Shoved Away? Zahid Dar, Lucky Chauhan, Monika Chauhan, Navpreet Kaur, Tanzeer Kaur, Neelima Dhingra
443 [GO] Coronaviruses 2020―Jul―02 Revealing potential binding affinity of FDA approved therapeutics targeting Main protease (3CLpro) in impairing novel coronavirus (SARS-CoV-2) replication that causes COVID-19 D. Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela, V. Venugopal
444 [GO] Coronaviruses 2020―Jul―02 The comprehensive appraisal of COVID-19, it’s clinical panorama from virology till management and beyond. Iftikhar Haider Naqvi, Saiyeda Nayema Zehra Rizvi
445 [GO] Coronaviruses 2020―Jul―02 Potential Drug Options for Treatment Process of COVID-19: A Review Tinsae Kebede, Dharmendra Kumar, Pramod Kumar Sharma
446 [GO] Coronaviruses 2020―Jul―02 Impact and Inescapable Effects of Coronavirus: History to Modern Pandemic Episode Suman K Ray, Yamini Meshram, Sukhes Mukherjee
447 [GO] Coronaviruses 2020―Jun―29 A note on the potential BCG vaccination - COVID-19 molecular link Alex Y. Strongin, Alex Sloutsky, Piotr Cieplak
448 [GO] Coronaviruses 2020―Jun―26 Activity of some novel Chalcone substituted 9-anilinoacridines against Coronavirus (COVID19): A computational approach Rajagopal Kalirajan
449 [GO] Coronaviruses 2020―Jun―26 Potential immunotherapy against SARS-CoV-2: Strategy and status Abid H. Banday, Shameem A. Shah, Sheikh J. Ajaz
450 [GO] Coronaviruses 2020―Jun―24 Critical insight into the attributes of emerging novel Coronavirus (COVID-19) in India and across the world Gaurav M Doshi, Hemen S Ved, Ami P Thakkar
451 [GO] Coronaviruses 2020―Jun―24 COVID-19: Opinion in Prevention and dietary based management hypothesis Ashraf Talaat Youssef
452 [GO] Coronaviruses 2020―Jun―22 The COVID-19 and Ageism in Social Media Yadollah Abolfathi Momtaz
453 [GO] Coronaviruses 2020―Jun―22 Unfortunate Welcome of Evil nCovid-19 in 2020: From Despair to Hope Ravi Varala, Haribabu Bollikolla
454 [GO] Coronaviruses 2020―Jun―17 Coronavirus (COVID-19) Effects on Psychological Health of Indian Poultry Farmers Gaurav Dhiman
455 [GO] Coronaviruses 2020―Jun―17 Update on the SARS-CoV-2 (COVID-19) Outbreak: A Global Pandemic Challenge Abhishek Kumar Soni
456 [GO] Coronaviruses 2020―Jun―17 COVID-19: could irisin become the handyman myokine of the 21th century? Alessia Catalano
457 [GO] Coronaviruses 2020―Jun―17 COVID-19: Morphology, Characteristics, Symptoms, Prevention, Clinical Diagnosis and Current Scenario Tansukh Barupal, Praveen Kumar Tak, Mukesh Meena
458 [GO] Coronaviruses 2020―Jun―17 Repurposing of RdRp Inhibitors against SARS-CoV-2 through Molecular Docking Tools. Rohit Bhatia, Raj Kumar Narang, Ravindra Kumar Rawal
459 [GO] Coronaviruses 2020―Jun―17 Understanding the Molecular Mechanism(s) of SARS-CoV2 Infection and Propagation in Human to Discover Potential Preventive and Therapeutic Approach Sibi Raj, Vaishali Chandel, Brijesh Rathi, Dhruv Kumar
460 [GO] Coronaviruses 2020―Jun―15 A Preliminary Review on Novel Coronavirus Disease: COVID-19 Miranji Katta, Satish Rapaka, Ramkumar Adireddi, Jagadeeshwara Rao Emandi
461 [GO] Coronaviruses 2020―Jun―07 The Relationship between Opium Use and Coronavirus Infection, A Brief Research Report from Iran Hadi Khoshab, Mohammadreza Rajabalipour
462 [GO] Current Aging Science 2023―Aug―16 Depression Symptoms amongst Older Brazilian and Chinese Women submitted to different Social Distancing Measures Rigidness during Covid-19 Outbreak Lucimere Bohn, Clarice Martins Lucena, André Pereira dos Santos, Sitong Chen, Pedro Pugliesi Abdalla
463 [GO] Current Aging Science 2023―May―26 Prevalence of COVID-19 Among 8000 Patients at a Hospitalized and Mortality in Old Age Jose Maria Pereira de Godoy, Maria Regina Pereira de Godoy, Maria Lucia Machado Salomão, Flavia Queiroz
464 [GO] Current Aging Science 2022―Dec―29 COVID-19 and brain aging: what are the implications of immunosenescence? Josiane Budni, Gabriela Serafim Keller, Eduarda Behenck Medeiros, Maria Laura Cecconi dos Santos, Adrielly Vargas Lidio, Ewa Kucharska
465 [GO] Current Aging Science 2022―Mar―05 Sleep Quality and Quality of Life Among Older Adults During COVID-19 Pandemic: A Cross-sectional Study Pedro Pugliesi Abdalla, Elzier Sampaio de Queiroz Neto, Ana Carolina Silveira de Souza Lage, Sérgio Gomes, Maria das Dores Bezerra de Freitas, Simão Pedro-Costa, et al. (+4)
466 [GO] Current Alzheimer Research 2023―Apr―19 Impact of Covid-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons With Alzheimer's Disease in Lima, Peru Nilton Custodio, Marco Malaga, Rosa Montesinos, Diego Chambergo, Fiorella Baca, Sheila Castro, et al. (+5)
467 [GO] Current Alzheimer Research 2022―Sep―12 Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19 Christos Tsagkaris, Muhammad Bilal, Irem Aktar, Youssef Aboufandi, Ahmet Tas, Abdullahi Tunde Aborode, et al. (+9)
468 [GO] Current Analytical Chemistry 2024―Jan―11 Label-free Electrochemical Nanobiosensors using Au-SPE for COVID-19 Detection: A Comparative Review of Different Biomarkers and Recognition Elements Babak Mikaeeli Kangarshahi, Seyed Morteza Naghib
469 [GO] Current Applied Materials 2022―Jan―17 Nanoformulation of Glycyrrhizic acid as a potent antiviral agent against Covid-19 Sayani Ghosh, Prasun Patra
470 [GO] Current Biochemical Engineering 2020―Mar―12 Potential Pathway that Could Treat Coronaviruses (COVID-19) Angela Paul Peter, Chew Kit Wayne, Pau Loke Show, Tau Chuan Ling
471 [GO] Current Bioinformatics 2023―Dec―07 Optimized Hybrid Deep Learning for Real-Time Pandemic Data Forecasting: Long and Short-Term Perspectives Sujata Dash, Sourav Kumar Giri, Subhendu Kumar Pani, Saurav Mallik, Mingqiang Wang, Hong Qin
472 [GO] Current Bioinformatics 2023―Nov―22 SCV Filter: A Hybrid Deep Learning Model for SARS-CoV-2 Variants Classification Han Wang, Jingyang Gao
473 [GO] Current Bioinformatics 2023―Jul―31 An Explainable Multichannel Model for COVID-19 Time Series Prediction Hongjian He, Jiang Xie, Xinwei Lu, Dingkai Huang, Wenjun Zhang
474 [GO] Current Bioinformatics 2023―Jun―07 Mapping Drug-gene Interactions to Identify Potential Drug Candidates Targeting Envelope Protein in SARS-CoV-2 Infection Zhumur Ghosh, Byapti Ghosh, Troyee Das, Gourab Das, Nilkanta Chowdhury, Angshuman Bagchi
475 [GO] Current Bioinformatics 2023―Feb―28 Genomic Characterization of Emerging SARS-CoV-2: A Systematic Review Shikha Sharma, Rinkle Rani, Nidhi Kalra
476 [GO] Current Bioinformatics 2022―Oct―18 Identification of Potential Inhibitors Against SARS-CoV-2 Using Computational Drug Repurposing Study Hasan Zulfiqar
477 [GO] Current Bioinformatics 2022―Jul―19 Predicting COVID-19 Severity integrating RNA-Seq Data using Machine Learning Techniques Javier Bajo-Morales, Daniel Castillo-Secilla, Luis Javier Herrera, Octavio Caba, Jose Carlos Prados, Ignacio Rojas
478 [GO] Current Bioinformatics 2022―May―25 Structural & Functional Analyses of SARS COV-2 RNA-dependent RNA polymerase Protein and Complementary vs Synthetic Drugs against COVID-19 & the Exploration of Binding Sites for Docking Molecular Dynamics Simulation & Density Functional Theory Studies Ahsanullah Unar, Mahrukh Imtiaz, Truong Tan Trung, Maria Rafiq, Muhammad Qaiser Fatmi, Tassadaq Hussain Jafar
479 [GO] Current Bioinformatics 2022―Mar―29 COVID-19 Biomarkers Recognition & Classification Using Intelligent Systems Javier Bajo-Morales, Juan Carlos Prieto-Prieto, Luis Javier Herrera, Ignacio Rojas, Daniel Castillo-Secilla
480 [GO] Current Bioinformatics 2021―Jul―28 Identification of Potential Inhibitors against SARS-Cov-2 using Computational Drug Repurposing Study Hasan Zulfiqar, Fu-Ying Dao, Hao Lv, Hui Yang, Peng Zhou, Wei Chen, Hao Lin
481 [GO] Current Bioinformatics 2021―Jun―28 Mechanism of Actions of Dexamethasone against COVID-19 predicted by Alpha Shape Analysis of Binding Sites Mengxu Zhu, Avirup Ghosh, Hong Yan
482 [GO] Current Biotechnology 2023―Jun―13 Design of a Multi-epitope Vaccine against Covid-19: An In silico Approach Deepak Chand Sharma, Kaushal Kishor Mishra, Asheesh Kumar Mishra, Vandita Anand, Anjana Pandey, Savita Budhwar
483 [GO] Current Biotechnology 2022―Dec―19 An Insight into the immunomodulatory effects of Probiotics in the prevention of Covid-19 disease Jyotirmoy Das, Smita Bordoloi, kalyani pathak
484 [GO] Current Biotechnology 2022―Jun―15 Role of Functional Food Additives to Regulate the Immune Response to Covid-19 Ravindra Verma, Meenakshi Pal Bagel
485 [GO] Current Biotechnology 2021―Feb―25 Aptamer based Diagnosis: A Cost Effective and Suitable Point of Care Testing Method Against SARS Coronavirus-2 (SARs-CoV-2) and Other Rapidly Spreading Diseases Vivek Kumar, Gulab Singh Yadav, Basu Dev Banerjee
486 [GO] Current Biotechnology 2021―Feb―18 Evaluating the risk of Covid-19 transmission from conjunctival and lacrimal discharge: A Review Shalini Sanyal, Sujata Law
487 [GO] Current Biotechnology 2020―Dec―15 An Insight into Pandemic COVID-19: Structure, Epidemiology and Therapeutics Shanthipriya Ajmera, H. B. Ranjitha, Divya Ajmeera, D. Jayasree, M. Ramchander
488 [GO] Current Cancer Drug Targets 2022―Oct―18 COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide Ning-Ning Liu
489 [GO] Current Cancer Drug Targets 2022―Jul―29 COVID-19 Pandemic: Experiences in China and Implications for its Prevention and Treatment Worldwide Ning-Ning Liu
490 [GO] Current Cancer Drug Targets 2022―Jul―15 Cross Talk between COVID-19 and Breast Cancer Hamendra Singh Parmar
491 [GO] Current Cancer Drug Targets 2022―Jul―15 Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues Barbara Seliger
492 [GO] Current Cancer Drug Targets 2022―Feb―16 The Interactions among Hypertension, Cancer, and COVID-19: Perspectives from Ca2+/cAMP Signalling Leandro Bueno Bergantin
493 [GO] Current Cancer Drug Targets 2021―Feb―17 Cross talk between COVID-19 and breast cancer Hamendra Singh Parmar, Aakruti Nayak, Pramod Kumar Gavel, Hemchandra Jha, Shivani Bhagwat, Rajesh Sharma
494 [GO] Current Cancer Drug Targets 2020―Dec―08 Expression and clinical significance of SARS-CoV-2 human targets in neoplastic and non-neoplastic lung tissues Karthikeyan Subbarayan, Kamatchi Ulagappan, Claudia Wickenhauser, Barbara Seliger
495 [GO] Current Cancer Drug Targets 2020―Apr―14 COVID-19 Pandemic: Experiences in China and implications for its prevention and treatment worldwide Ning-Ning Liu, Jing-Cong Tan, Jingquan Li, Shenghui Li, Yong Cai, Hui Wang
496 [GO] Current Cancer Therapy Reviews 2021―Jul―06 Molecular landscape of lung epithelium contributes to high severity and comorbidities for COVID-19 and lung cancer Nilesh Kumar Sharma, Sachin C Sarode, Gargi S Sarode, Shankargouda Patil
497 [GO] Current Cardiology Reviews 2024―Feb―22 Cardiac Complications and COVID-19: A Review of Life-threatening Co-morbidities Zeinab Eftekhar, Habib Haybar, Alireza Mohebbi, Najmaldin Saki
498 [GO] Current Cardiology Reviews 2022―Dec―04 COVID-19 Severity: Lung-Heart Interplay
499 [GO] Current Cardiology Reviews 2022―Oct―18 Cardiovascular Manifestations of COVID-19 Sneha Nandy
500 [GO] Current Cardiology Reviews 2022―Aug―19 Takotsubo Cardiomyopathy and COVID-19: A Case Report and Literature Review José Gabriel Solís, Edgar Francisco Carrizales-Sepúlveda, Raymundo Vera-Pineda, Eliu Jefte Morales-Rendón, José de Jesús Ortíz-Corona, Ramiro Flores-Ramírez
501 [GO] Current Cardiology Reviews 2022―Aug―17 Possible long term cardiovascular effects of COVID-19 Gloria Anahi Lugo, Hamasah Nizami, Fiyad Haniff, Lilly Su, Denise Marsh, Shefali Gupta, et al. (+2)
502 [GO] Current Cardiology Reviews 2022―Jul―31 The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High Giuseppe Calcaterra
503 [GO] Current Cardiology Reviews 2022―Jul―31 COVID-19 Pandemic and the Impact on the Cardiovascular Disease Patient Care Prashanth Kulkarni
504 [GO] Current Cardiology Reviews 2022―Jul―15 The Deadly Quartet (Covid-19, Old Age, Lung Disease, and Heart Failure) Explains Why Coronavirus-Related Mortality in Northern Italy Was So High Leonid N. Maslov
505 [GO] Current Cardiology Reviews 2022―Jun―28 A systematic review of arterial dissections in COVID-19 patients. Betsy Abraham, Sherman David Mathew, Kannan Sridharan
506 [GO] Current Cardiology Reviews 2022―May―13 In-stent thrombosis and COVID-19 infection: Current insights on the mechanistic relationship Ahmed El-Medany, Vanessa Kandoole, Nicholas Lonsdale, Gemina Doolub, Ioannis Felekos
507 [GO] Current Cardiology Reviews 2022―May―11 Impact Of Metabolic Risk Factors On Covid-19 Clinical Outcomes: An Extensive Review Rafael B. Azevedo, Débora C.R. Wandermurem, Flávia C.F. Libório, Maíra K. Machado, Natália M. Ushijima, Ramon S. Narde, et al. (+2)
508 [GO] Current Cardiology Reviews 2022―Mar―22 COVID-19 Vaccine-Induced Pro-thrombotic Immune Thrombocytopenia (VIPIT): state of the art Giuseppe Calcaterra, Pier Paolo Bassareo, Cesare De Gregorio, Francesco Barilla, Francesco Romeo, Jawahar L. Mehta
509 [GO] Current Cardiology Reviews 2022―Feb―24 Elucidating the Role of Cardiac Biomarkers in COVID-19: A Narrative Evaluation with Clinical Standpoints and a Pragmatic Sukhes Mukherjee, Suman Kumar Ray, Ashwin Kotnis, Jagat R Kanwar
510 [GO] Current Cardiology Reviews 2021―Dec―24 Lesson from the pandemic: people should always stay physically active Antonio Crisafulli
511 [GO] Current Cardiology Reviews 2021―Oct―04 Defining Vulnerable Patients with Heart Failure - Opportunistic Lessons from Covid-19 Sakinesakine Satici, Pupalan Iyngkaran, Malcolm Battersby, Sharon Andrew, Maximilian de Courten
512 [GO] Current Cardiology Reviews 2021―Apr―20 Cardiovascular Complications in Major 21st Century Viral Epidemics and Pandemics: an Insight into COVID-19 Muzna Hussain, Patrick Collier, Rohit Moudgil
513 [GO] Current Cardiology Reviews 2021―Feb―12 Stress and physical inactivity: two explosive ingredients for the heart in COVID-19 pandemic times Olívia Moraes Ruberti, Guilherme Defante Telles, Bruno Rodrigues
514 [GO] Current Cardiology Reviews 2021―Jan―29 Loneliness and social isolation: determinants of cardiovascular outcomes: Implications in COVID-19 era Tanya Sharma, Prasad R. Padala, Jawahar L. Mehta
515 [GO] Current Cardiology Reviews 2020―Dec―11 COVID-19 Severity: Lung-Heart Interplay Gayatri Puri, Vikram Pal Singh, Amarjit S. Naura
516 [GO] Current Cardiology Reviews 2020―Nov―04 Cardiovascular manifestations of COVID-19 Sneha Nandy, Siu-Hin Wan, Jorge Brenes-Salazar
517 [GO] Current Cardiology Reviews 2020―Jul―31 The Deadly Quartet (Covid-19, old age, lung disease, and heart failure) explain why coronavirus-related mortality in northern Italy was so high Giuseppe Calcaterra, Pier Paolo Bassareo, Francesco Barilla, Domenico Sergi, Marcello Chiocchi, Francesco Romeo, Jawahar L. Mehta
518 [GO] Current Cardiology Reviews 2020―Jun―22 COVID-19 pandemic and the impact on the cardiovascular disease patient care Prashanth Kulkarni, Manjappa Mahadevappa, Srinivas Alluri
519 [GO] Current Cardiology Reviews 2020―May―19 The COVID-19 Pandemic: A Challenge for the Cardiovascular Health Antonio Crisafulli, Pasquale Pagliaro
520 [GO] Current Chemical Biology 2021―Oct―12 Natural compounds as heme oxygenase-1 inducers to reduce the deleterious consequences following SARS-CoV-2 infection Valeria Sorrenti, Valeria Consoli, Salvo Grosso S., Luca Vanella
521 [GO] Current Chemical Biology 2020―Nov―04 Docking Simulations Exhibit Bortezomib and other Boron-containing Peptidomimetics as Potential Inhibitors of SARS-CoV-2 Main Protease Iván R Vega-Valdez, Melvin N Rosalez, José M Santiago-Quintana, Eunice D Farfán-García, Marvin A Soriano-Ursúa
522 [GO] Current Chinese Chemistry 2022―Jan―28 Identification of novel inhibitors of SARS-CoV-2 Mpro from NCI database by drug repurposing approach Afzal Hussain, Ashfaq hussain
523 [GO] Current Chinese Chemistry 2021―Mar―23 Discovery of potential inhibitors of the receptor-binding domain (RBD) of pandemic disease-causing SARS-CoV-2 Spike Glycoprotein from Triphala through molecular docking Sharuk L. Khan, Falak A. Siddiqui, Mohd Sayeed Shaikh, Nitin V. Nema, Aijaz A. Shaikh
524 [GO] Current Chinese Medical Science 2020―Aug―16 Impact of Positive Contact History in COVID-19 Infectivity in Nowshera KP, Pakistan Hamzullah Khan
525 [GO] Current Chinese Medical Science 2020―Mar―04 Epidemic Features and Control of the 2019 Novel Coronavirus Yanmin Zhang
526 [GO] Current Chinese Science 2024―Jan―09 Computational Approaches Molecular Docking and MD Simulation Establishes the Potential COVID-19 Main Protease Inhibitors from Natural Products Areesh Zehra, Raquibun Nisha, Abhishek Kumar, Durgesh Nandan, Iqrar Ahmad, Debarshi Kar Mahapatra, et al. (+3)
527 [GO] Current Chinese Science 2022―Apr―05 In-Silico Study of Some Dexamethasone Analogs and Derivatives against SARs-CoV-2 Target: A Cost-Effective Alternative to Remdesivir for Various COVID Phases Ruchi Pandey, Itishree Dubey, Iqrar Ahmad, Debarshi Kar Mahapatra, Harun Patel, Pranesh Kumar
528 [GO] Current Chinese Science 2022―Feb―25 In-silico investigation of Immunodominant antigenic regions, Helper T lymphocyte and Cytotoxic T lymphocyte epitopes credentials for SARS-CoV-2 Vaccination Manikandan Selvaraj, Lakshmanan Loganathan, John Marshal Jayaraj, Krishnasamy Gopinath, Kannan Rajendran, Mehboobali Pannipara, et al. (+2)
529 [GO] Current Chinese Science 2022―Feb―14 Computational studies of Budesonide Vs. Vilanterol: Asthma drugs against SARS-CoV-2 Mpro Afzal Hussain, Ashfaq Hussain
530 [GO] Current Chinese Science 2021―Mar―03 Effectiveness of a Lockdown Policy During a Global Pandemic Yung Chin Shih
531 [GO] Current Chinese Science 2020―Dec―11 Recovery of a 91-year-old COVID-19 patient with medical and psychological support Dong Zhang, Chunrong Liu, Li Li
532 [GO] Current Clinical Pharmacology 2020―Dec―26 QT Interval Monitoring and Drugs Management During COVID-19 Pandemic Alessio Gasperetti, Marco Schiavone, Claudio Tondo, Gianfranco Mitacchione, Maurizio Viecca, Massimo Galli, et al. (+2)
533 [GO] Current Computer - Aided Drug Design 2024―Jan―05 In Silico Study on Natural Chemical Compounds from Citric Essential Oils as Potential Inhibitors of an Omicron (BA.1) SARS-CoV-2 Mutants’ Spike Glycoprotein Olha Ovchynnykova, Jordhan D. Booth, Trey M. Cocroft, Kostyantyn M. Sukhyy, Karina Kapusta
534 [GO] Current Computer - Aided Drug Design 2023―Nov―06 Computer-aided Design of Wide-spectrum Coronavirus Helicase NSP13 Cage Inhibitors: A Molecular Modelling Approach Vadim Shiryaev, Yuri Klimochkin
535 [GO] Current Computer - Aided Drug Design 2023―Oct―19 Exploring the Molecular Mechanism of Niuxi-Mugua Formula in Treating Coronavirus Disease 2019 via Network Pharmacology, Computational Biology, and Surface Plasmon Resonance Verification Wei Wang, Xu Cao, Yi-nan Cao, Lian-lian Liu, Shu-ling Zhang, Wen-ying Qi, et al. (+5)
536 [GO] Current Computer - Aided Drug Design 2023―Aug―25 A computational approach for designing and validating small interfering RNA against SARS-CoV-2 variants Anupam Mukherjee, Kishore Dhotre, Debashree Dass, Anwesha Banerjee, Vijay Nema
537 [GO] Current Computer - Aided Drug Design 2023―Aug―23 Investigation of Iminosugars as Antiviral Agents against SARS-CoV-2 Main Protease: Inhibitor Design and Optimization, Molecular Docking, and Molecular Dynamics Studies to Explore Potential Inhibitory Effect of 1-Deoxynojirmycin Series Vashima Miglani, Parul Sharma, Anudeep Kumar Narula
538 [GO] Current Computer - Aided Drug Design 2023―Aug―18 The Potential Roles of Ficus carica Extract in the Management of COVID-19 Viral Infections: A Computer-Aided Drug Design Study Mahmoud Hamed, Maha Khalifa, Mahmoud A. El Hassab, Mohammed A. S. Abourehab, Omkulthom Al kamaly, Ashwag S. Alanazi, et al. (+2)
539 [GO] Current Computer - Aided Drug Design 2023―Jul―26 Discovery of a Potential Allosteric Site in the SARS-CoV-2 Spike Protein and Targeting Allosteric Inhibitor to Stabilize the RBD Down State Using a Computational Approach Jinfeng Liu, Tong Li, Zheng Yan, Wei Zhou, Qun Liu, Haibing Hua
540 [GO] Current Computer - Aided Drug Design 2023―Jun―13 Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant Based on an Immunoinformatics Approach Ahad Yamchi, Ibrahim Farhani, Hamid Madanchi, Vahid khazaei, Mehdi behrouzikhah, Hamidreza abbasi, et al. (+3)
541 [GO] Current Computer - Aided Drug Design 2023―May―31 Synthesis, Docking Study of Some Novel Chromeno[4',3'-b]Pyrano [6,5-d]Pyrimidine Derivatives Against COVID-19 Main Protease (Mpro) (6LU7, 6M03) Radineh Motamedi, Safieh Soufian, Zahra Rostami Ghalhar, Mahdiyeh Jalali, Hooman Rahimi
542 [GO] Current Computer - Aided Drug Design 2023―Apr―03 Graph Convolutional Capsule Regression (GCCR): A Model for Accelerated Filtering of Novel Potential Candidates for SARS-CoV-2 Based on Binding Affinity Dayanand Vinod, Aravind Krishnan
543 [GO] Current Computer - Aided Drug Design 2023―Mar―30 Computer-Aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review Mariana Martinelli Junqueira Ribeiro
544 [GO] Current Computer - Aided Drug Design 2023―Jan―23 Molecular Docking, ADMET Analysis and Molecular Dynamics (MD) Simulation to Identify Synthetic Isoquinolines as Potential Inhibitors of SARS-CoV-2 MPRO Ricardo Silva Porto, Paulo Ricardo dos Santos Correia, Alesson Henrique Donato de Souza, Andres Reyes Chaparro, Aldo Yair Tenorio Barajas
545 [GO] Current Computer - Aided Drug Design 2023―Jan―13 Identification of Kaempferol as viral entry inhibitor and DL-Arginine as viral replication inhibitor from selected plants of Indian traditional medicine against COVID-19: An in silico guided in vitro approach Lekshmi R Nath, Adithya J, Maneesha Murali, Bhagyalakshmi Nair, Feby Benny, Rajalakshmi P.M, et al. (+3)
546 [GO] Current Computer - Aided Drug Design 2023―Jan―02 Revisiting the South Indian traditional plants against several targets of SARS-CoV-2 - An In silico approach Srikanth Jupudi, Srikala Rajala, Narasimha Rao Gaddam, Gomathi Swaminathan, Jaya Preethi Peesa, Kalirajan Rajagopal, Mohammed Afzal Azam
547 [GO] Current Computer - Aided Drug Design 2022―Nov―18 Computational search for potential COVID-19 drugs from ayurvedic medicinal plants to identify potential inhibitors against SARS-CoV-2 targets V. Alagarsamy, V. Raja Solomon, P. Shyam Sundar, V. S. Kulkarni, M. T. Sulthana, A. Dharshini Aishwarya, et al. (+2)
548 [GO] Current Computer - Aided Drug Design 2022―Sep―23 Prophylactic and therapeutic potential zinc metallodrugs drug discovery: Identification of SARS-CoV-2 replication and spike/ACE2 inhibitors Hadley S. Clayton, Mpho P. Ngoepe, Kgaugelo C. Tapala
549 [GO] Current Computer - Aided Drug Design 2022―Sep―12 Computational evidence based perspective on the plausible repositioning of fluoroquinolones for COVID-19 treatment Vikas Yadav
550 [GO] Current Computer - Aided Drug Design 2022―Aug―17 Some flavolignans as potent SARS-CoV-2 inhibitors via molecular docking, molecular dynamic simulations and ADME Analysis Adnan Cetin
551 [GO] Current Computer - Aided Drug Design 2022―Jun―17 Quinic and digallic acids from Pistacia atlantica Desf. leaves extracts as potent dual effect inhibitors against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 Mebarka Imane Benguechoua, Khedidja Benarous, Ziyad Benahmed, Sarah Boukhalkhal, Artur M. S. Silva, Mohamed Yousfi
552 [GO] Current Computer - Aided Drug Design 2021―Feb―03 Cluster analysis of coronavirus sequences using computational sequence descriptors: With applications to SARS, MERS and SARS-CoV-2 (CoVID-19) Marjan Vračko, Subhash C. Basak, Tathagata Dey, Ashesh Nandy
553 [GO] Current Computer - Aided Drug Design 2021―Jan―20 COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace? Subhash C. Basak, Lemont B. Kier
554 [GO] Current Computer - Aided Drug Design 2020―Sep―25 Design and in-silico screening of Peptide Nucleic Acid (PNA) inspired novel pronucleotide scaffolds targeting COVID-19 Bichismita Sahu, Santosh Kumar Behera, Rudradip Das, Tanay Dalvi, Arnab Chowdhury, Bhaskar Dewangan, et al. (+2)
555 [GO] Current Computer - Aided Drug Design 2020―Apr―23 Hispidin and Lepidine E: two Natural Compounds and Folic acid as Potential Inhibitors of 2019-novel coronavirus Main Protease (2019-nCoVMpro), molecular docking and SAR study Talia Serseg, Khedidja Benarous, Mohamed Yousfi
556 [GO] Current Computer - Aided Drug Design 2020―Mar―16 A Generic Computer-Assisted Four-Pronged Approach for the Management of Emerging Global Pathogens: Some Comments on COVID-19 Subhash C. Basak, Subhabrata Majumdar, Marjan Vracko, Ashesh Nandy, Apurba Bhattacharjee
557 [GO] Current Computer-Aided Drug Design 2022―Dec―04 Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVMpro), Molecular Docking and SAR Study
558 [GO] Current Computer-Aided Drug Design 2022―Oct―18 Cluster Analysis of Coronavirus Sequences using Computational Sequence Descriptors: With Applications to SARS, MERS and SARS-CoV-2(CoVID-19)
559 [GO] Current Computer-Aided Drug Design 2022―Oct―18 COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace? Subhash Basak
560 [GO] Current Computer-Aided Drug Design 2022―Jul―15 Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVMpro), Molecular Docking and SAR Study Talia Serseg
561 [GO] Current Diabetes Reviews 2024―Feb―28 Recent Patterns and Assessment of Long-term Complications following SARS-CoV-2 Infection and Vaccination in the Context of Diabetes Prevalence among Blood Donors Turki Mohammed M Alqahtani, Mohammed Abdullah Ali Alghamdi, Mirza Rafi Baig, Fahad A. Al-Abbasi, Rizwan Shiek, Sultan Alhayyani, et al. (+3)
562 [GO] Current Diabetes Reviews 2023―Apr―27 Microbial crosstalk between SARS-CoV-2 and Diabetes Mellitus - A Mini Review Supriya Kheur, Sushmita Ghosal, Karishma Madhusudan Desai
563 [GO] Current Diabetes Reviews 2022―Oct―18 Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management Natalia Vallianou
564 [GO] Current Diabetes Reviews 2022―Sep―14 COVID-19 & Diabetes Mellitus: Mutual Interplay of Two Diseases Gabriel Minárik, Patrik Krumpolec, Dominik Kodada, Nikola Nyariova, Vanda Repiska
565 [GO] Current Diabetes Reviews 2022―Aug―27 Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms Pranay Wal, Jyotsana Dwivedi, Ankita Wal, Shivangi Kushwaha
566 [GO] Current Diabetes Reviews 2022―Aug―23 Anxiety, Depression, and Fear among People with and without Diabetes During the Transmission of SARS-CoV-2 Omicron Variant Asirvatham Alwin Robert, Abdulrahman Al Dawish, Raseel Mohammed Al Dawish, Safa Muqhim Al Mutairi, Maryam Salem Alanazi, Mohamed Abdulaziz Al Dawish
567 [GO] Current Diabetes Reviews 2022―Jul―31 Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. Natalia G Vallianou
568 [GO] Current Diabetes Reviews 2022―Jun―13 Psychological Outcomes of the COVID-19 Pandemic on People with Type 1 Diabetes Globally: A Scoping Review Jennifer L. Maizel, Brittney N. Dixon, Ashby F. Walker
569 [GO] Current Diabetes Reviews 2022―Apr―27 Colostrum Antibodies and Cytokines in Puerperal Women with Diabetes Before and During the COVID-19 Pandemic: A Systematic Review Rosane Nassar Meireles Guerra, Cláudia Regina Silva dos Santos Cunha, Marcela Patrícia Macêdo Belo Fort, Eremita Val Rafael, Rebeca Aranha Arrais e Silva Santos, Mônica Virginia Viegas Lima-Aragão, et al. (+2)
570 [GO] Current Diabetes Reviews 2022―Apr―12 The Insights on Why Diabetes Prevalence May Increase Amid or Post COVID 19 Pandemic Ntethelelo Sibiya, Nomusa Mzimela, Bonisiwe Mbatha, Phikelelani Ngubane, Andile Khathi
571 [GO] Current Diabetes Reviews 2022―Mar―16 Diabetic Ketoacidosis (DKA), a Leading Risk Factor for Mucormycosis (Black Fungus), During the Era of Coronavirus Disease-2019 (COVID-19): An Overview Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Darakhshan Gazala Bari, Om Prakash
572 [GO] Current Diabetes Reviews 2022―Feb―25 Impact of Diabetes in COVID-19 Associated Mucormycosis and Its Management: A Non-Systematic Literature Review Muhammed Rashid, Asha K. Rajan, Girish Thunga, Vishal Shanbhag, Sreedharan Nair
573 [GO] Current Diabetes Reviews 2022―Feb―10 Association Between Statin Use and Poor Outcomes in COVID-19 Patients with Diabetes Mellitus: A Systematic Review Jessica Audrey, Wismandari Wisnu, Dicky L. Tahapary
574 [GO] Current Diabetes Reviews 2022―Jan―19 Cytokines in COVID-19 Patients with Diabetes: Systematic Review Teena P. George, Salini Scaria Joy, Mohammad Rafiullah, Khalid Siddiqui
575 [GO] Current Diabetes Reviews 2021―Nov―18 Does Insulin Use Worsen the Prognosis of COVID-19 Patients with Type 2 Diabetes Mellitus? A Current Update Elvan Wiyarta, Wismandari Wisnu
576 [GO] Current Diabetes Reviews 2021―Sep―01 SARS-COV-2 in type 2 diabetic patients: Possible roles of exercise training as a medicine Mehdi Kushkestani, Mohsen Parvani, Yaser Kazemzadeh
577 [GO] Current Diabetes Reviews 2021―Aug―15 Diabetes Mellitus during the Pandemic Covid-19: Prevelance, Pathophysiology, Mechanism, and Management: An updated overview Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Tauheed Ishrat, Om Prakash, et al. (+3)
578 [GO] Current Diabetes Reviews 2021―Aug―09 The Impact of Deranged Glucose Metabolism and Diabetes in The Pathogenesis and Prognosis of The Novel Sars-Cov-2: A Systematic Review of Literature Victor Okoliko Ukwenya, Sunday Aderemi Adelakun, Temiloluwa Adeola Fuwape, Ayotunde Samuel Adeagbo
579 [GO] Current Diabetes Reviews 2021―Jun―02 Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities on COVID-19 Suruchi Singh, Pankaj Bhatt, Satish Kumar Sharma, Tejinder Kaur
580 [GO] Current Diabetes Reviews 2021―Mar―01 Integrated Nutritional Supports for Diabetic Patients during COVID-19 Infection: A Comprehensive Review A.K. Obidul Huq, Abu Naim Mohammad Bazlur Rahim, S. M. Golam Moktadir, Ielias Uddin, Mohammad Zahidul Manir, Muhammad Abu Bakr Siddique, et al. (+2)
581 [GO] Current Diabetes Reviews 2021―Feb―17 Risk Mortality, prevalence, and possible therapeutics to treat diabetic patients infected with nCOVID-19 Sumel Ashique, Navjot K Sandhu
582 [GO] Current Diabetes Reviews 2021―Jan―03 Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, Theodora Stratigou, Gerasimos Socrates Christodoulatos, Irene Karampela, Maria Dalamaga
583 [GO] Current Diabetes Reviews 2020―Nov―12 COVID-19 in People with Diabetes: Perspectives from Saudi Arabia Asirvatham Alwin Robert, Mohamed Abdulaziz Al Dawish
584 [GO] Current Diabetes Reviews 2020―Oct―22 COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region Mohamed Abdulaziz Al Dawish, Asirvatham Alwin Robert
585 [GO] Current Diabetes Reviews 2020―Oct―13 Important Role of Relaxation Techniques on Immune Functions, Glycemic Control, and Stress in Diabetic patients with COVID-19: A Review Ayman Abdalla Mahmoud Mohamed, Motaz Alawna
586 [GO] Current Drug Delivery 2022―Dec―07 Efficacy of Dexamethasone for the Treatment of COVID-19 Infection: A Perspective Review Shadma Wahab
587 [GO] Current Drug Delivery 2022―Oct―05 Current therapeutic strategies and possible effective drug delivery strategies against COVID-19 Debabrata Ghosh Dastidar, Dipanjan Ghosh, Swarnarsree Ghosh, Gopal Chakrabarti
588 [GO] Current Drug Delivery 2022―Apr―28 Liposome, Nanoliposome and Allied Technologies in Covid-19 Vaccines: Key Roles and Functionalities Zeinab Kabarkouhi, Mehrnoush Mehrarya, Behnaz Gharehchelou, Zahra Jalilian, Ronak Jalili, Milint Neleptchenko Wintrasiri, M. R. Mozafari
589 [GO] Current Drug Delivery 2021―Sep―06 siRNA as a potential therapy for COVID-19 Ahmad Aljaberi, Eman M. Migdadi, Khalid M Abu Khadra, Mahmoud Abu Samak, Iman A Basheti, Nizar Al-Zoubi
590 [GO] Current Drug Delivery 2021―Apr―02 Novel Pulmonary Delivery of Antiviral Drugs for Treating COVID-19 in Patients with Parkinson’s Disease Nazrul Islam, Shafiqur Rahman
591 [GO] Current Drug Delivery 2021―Mar―01 Predicted SARS-CoV-2 miRNAs associated with epigenetic viral pathogenesis and the detection of new possible drugs for Covid-19 Zafer Çetin, Tuncay Bayrak, Hasan Oğul, Eyüp İlker Saygılı, Esra Küpeli Akkol
592 [GO] Current Drug Delivery 2020―Oct―07 Epidemiological Situation and Efficacy of Dexamethasone for the treatment planning of COVID-19: A perspective review Shadma Wahab, Irfan Ahmad, Shazia Usmani, Md. Parwez Ahmad
593 [GO] Current Drug Delivery 2020―Sep―17 Role of novel drug delivery systems in coronavirus disease-2019 (covid-19): time to act now Neeraj Mittal, Varun Garg, Sanjay Kumar Bhadada, O. P. Katare
594 [GO] Current Drug Delivery 2020―Sep―17 The Use of cyclodextrin or its complexes as a potential treatment against the 2019 novel coronavirus. A mini-review. Fatmi Sofiane, Taouzinet Lamia, Skiba Mohamed, Iguer-Ouada Mokrane
595 [GO] Current Drug Delivery 2020―Aug―29 Nanocarriers in the delivery of hydroxychloroquine to the respiratory system: An alternative to COVID-19? Iago Dillion Lima Cavalcanti, Sandrelli Meridiana de Fátima Ramos dos Santos Medeiros, Daniel Charles dos Santos Macêdo, Isabella Macário Ferro Cavalcanti, Mariane Cajubá de Britto Lira Nogueira
596 [GO] Current Drug Discovery Technologies 2024―Mar―06 In Silico Evaluation of NO-Sartans against SARS-CoV-2 Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi, Prashant Kesharwani, Amirhossein Sahebkar
597 [GO] Current Drug Discovery Technologies 2023―Dec―27 In Silico Screening of Some Active Phytochemicals to Identify Promising Inhibitors Against SARS-CoV-2 Targets V. Alagarsamy, V. Raja Solomon, S. Murugesan, P. Shyam Sundar, MD. Muzaffar-Ur-Rehman, Ala Chandu, et al. (+4)
598 [GO] Current Drug Discovery Technologies 2023―Apr―20 The Open, Randomized, Positive Control Clinical Trial of Guluronic Acid (G2013) on SARS-CoV-2 Patients Abbas Mirshafiey, Zahra Aghazadeh, Davod Sanaee Delir, Hamid Reza Gholamrezaie, Arezoo Sadoughi, Amir Nezami Asl, et al. (+8)
599 [GO] Current Drug Discovery Technologies 2022―Oct―20 Hesperidin: A Potential Therapeutic agent against COVID-19 Ashwani K. Dhingra, Bhawna Chopra, Vaibhav Rathi, Sameer Sapra
600 [GO] Current Drug Discovery Technologies 2022―Oct―12 In silico analysis of the antidepressant fluoxetine and related drugs at SARS-CoV-2 main protease (Mpro) and papain-like protease (PLpro) João Batista Teixeira Rocha, Pedro José Tronco Pauletto, Folorunsho Bright Omage, Cássia Pereira Delgado, Pablo Andrei Nogara
601 [GO] Current Drug Discovery Technologies 2022―Sep―12 In-silico designing of a multi-epitope vaccine against SARS-CoV2 and studying the interaction of the vaccine with Alpha, Beta, Delta, and Omicron variants of concern Santanu Paul, Aranya Pal, Nibedita Pyne
602 [GO] Current Drug Discovery Technologies 2022―Jan―28 Structure-Based Drug Design and Development of Novel Synthetic Compounds with Anti-Viral Property against SARS-COV-2 Reshma Tendulkar, Aasma Chouhan, Avika Gupta, Aaliya Chaudhary, Chandani Dubey, Sushil Shukla
603 [GO] Current Drug Discovery Technologies 2022―Jan―18 Computational Approach to Combat COVID-19 Infection: Emerging Tool for Accelerating Drug Research Biswa Mohan Sahoo, Subrat Kumar Bhattamisra, Sarita Das, Abhishek Tiwari, Varsha Tiwari, Manish Kumar, Sunil Singh
604 [GO] Current Drug Discovery Technologies 2020―Dec―29 ACE2 as a potential target for management of novel coronavirus (nCoV- 2019) Elham Foroozanfar, Mohamad Forouzanfar, Tahereh Farkhondeh, Saeed Samarghandian, Fatemeh Forouzanfar
605 [GO] Current Drug Discovery Technologies 2020―Sep―26 Identification of Main Protease of Coronavirus SARS-CoV-2 (Mpro)Inhibitors from Melissa officinalis Olusola O. Elekofehinti, Opeyemi Iwaloye, Courage D. Famusiwa, Olanrewaju Akinseye, Joao B. T. Rocha
606 [GO] Current Drug Discovery Technologies 2020―Aug―26 COVID-19 Infection and Vitamin D: Current Scenario and Future Prospect Leila Peivasteh-Roudsari, Behrouz Tajdar-Oranj, Parisa Sadighara
607 [GO] Current Drug Metabolism 2023―Jul―29 miRNAs in SARS-CoV-2 Infection: An Update
608 [GO] Current Drug Metabolism 2023―Jun―08 Metabolism Pathways of Major Therapeutics for Treating Monkeypox Mono- and Co-infection with Human Immunodeficient Virus or SARS-CoV-2 Bingfang Yan, Daisy Yan
609 [GO] Current Drug Metabolism 2023―Jan―10 Quantification of Vitamin D at Different Levels of Clinical Worsening of COVID-19 Fernando Luiz Affonso Fonseca, Lai Yu Tsun, Thaciane Alkmim Bibo, Glaucia Luciano da Veiga, Ana Carolina Macedo Gaiatto, Nicolle de Godoy Moreira e Costa, et al. (+9)
610 [GO] Current Drug Metabolism 2022―Oct―18 Review on the Clinical Pharmacology of Hydroxychloroquine Sulfate for the Treatment of COVID-19 Cheng Cui
611 [GO] Current Drug Metabolism 2022―Oct―18 Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population Xueting Yao
612 [GO] Current Drug Metabolism 2022―Jul―04 Pharmacokinetics and Metabolism of Traditional Chinese Medicine in the Treatment of COVID-19 Xiaofang Xu, Qian Shen, Hui Wang, Zian Zeng, Meng Liu, Guang Wu, et al. (+2)
613 [GO] Current Drug Metabolism 2022―Mar―22 miRNAs in SARS-CoV-2 Infection: An Update Asim Azhar, Wajihul Hasan Khan, Khaled Al-hosaini, Mohammad Amjad Kamal
614 [GO] Current Drug Metabolism 2020―Jul―11 Updates on the Pharmacology of Chloroquine against Coronavirus Disease 2019 (COVID-19): A Perspective on its Use in the General and Geriatric Population Xueting Yao, Zhe Hou, Cheng Cui, Miao Zhang, Siqi Tu, Haiyan Li, Dongyang Liu
615 [GO] Current Drug Metabolism 2020―Jun―10 Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19 Cheng Cui, Siqi Tu, Valerie Sia Jie En, Xiaobei Li, Xueting Yao, Haiyan Li, Dongyang Liu
616 [GO] Current Drug Research Reviews 2023―Nov―30 A Hidden Pandemic? Abuse of Gabapentinoids: A Brief Review of Recent Studies Gamze Zengin İspir, Mustafa Danışman, Kübra Sezer Katar
617 [GO] Current Drug Research Reviews 2023―Jul―07 NOX-2 Inhibitors may be Potential Drug Candidates for the Management of COVID-19 Complications Bimalendu Chowdhury, Biswa Mohan Sahoo, Akankshya Jena, K. Hiramani, Amulyaratna Behera, Biswajeet Acharya
618 [GO] Current Drug Research Reviews 2023―Jun―09 “Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-Age Women: A Multi-centric Observational Study.” Naina Kumar, Neha Gangane, Ipsita Mohapatra, Charushila Rukadikar, Vijayan Sharmila, K. Pushpalatha, et al. (+10)
619 [GO] Current Drug Research Reviews 2022―Nov―24 Controversies around COVID-19 Vaccines and Antidepressants: Scope and Perspective in Malaysia Ng Chong Guan, Siew Weng Hou, Aya Ahmed Abousheishaa, Low Sue Yin, Abdul Rasyid bin Sulaiman, Kok Chee Khin
620 [GO] Current Drug Research Reviews 2022―Aug―27 Are herbal-peptides effective as adjunctive therapy in Coronavirus disease COVID-19? Elahe Aleebrahim-Dehkordi, Faezeh Soveyzi, Shirin Saberianpour, Mahmoud Rafieian-Kopaei
621 [GO] Current Drug Research Reviews 2022―May―31 Molnupiravir in COVID-19: A scoping review Shilpa Kaore, Shubham Atal
622 [GO] Current Drug Research Reviews 2022―Apr―30 COVID-19 and Obesity: Reevaluating the Relationship through Ca2+/cAMP Signalling Leandro Bueno Bergantin
623 [GO] Current Drug Research Reviews 2022―Mar―05 JAK inhibitors as a Barrier to the Destructive Cytokine Storm in COVID-19 Ali Saeedi-Boroujeni‬, Majid Asadi-Samani
624 [GO] Current Drug Research Reviews 2021―Dec―31 Neuroinflammation, diabetes, and COVID-19: Perspectives coming from Ca2+/cAMP signalling Leandro Bueno Bergantin
625 [GO] Current Drug Research Reviews 2021―Nov―22 An Insight to ncovid-19 associated coagulopathy Sumel Ashique, Tahamina Khatun
626 [GO] Current Drug Research Reviews 2021―Aug―09 Clinical Efficacy of Remdesivir and Favipiravir in the Treatment of Covid-19 Patients: Scenario So Far Manisha Saini, Minakshi Rana, Karun Bhatti, Rina Das, Dinesh Kumar Mehta, Ram Mohan Chidurala
627 [GO] Current Drug Research Reviews 2021―Jul―02 Potential Drugs for the Treatment of COVID-19: Synthesis, Brief History and Application Ekhlass Uddin, Raisul Islam, Nur Amin Bitu, Md. Saddam Hossain, ABM Nazmul Islam, Ali Asraf, et al. (+3)
628 [GO] Current Drug Safety 2023―Nov―30 Association of Cardiovascular Events with COVID-19 Vaccines using Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study Mohd Amir, S. Latha, Ruchika Sharma, Anoop Kumar
629 [GO] Current Drug Safety 2023―Aug―18 Evaluation of High-dose versus Standard-dose of Dexamethasone on Mortality among the Mechanically Ventilated COVID-19 Patients Pramodini B. Kale-Pradhan, Regina Pacitto, Christopher A. Giuliano, Leonard B. Johnson
630 [GO] Current Drug Safety 2023―Jun―15 Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report Wiem Daly, Imen Aouintia, Ghozlane Lakhoua, Widd Kaabi, Ons Charfi, Sana Debbeche, et al. (+3)
631 [GO] Current Drug Safety 2023―May―04 Side Effects Reported by Moroccan Medical Students Who Received COVID-19 Vaccines Badreddine Moukafih, Leila Belaroussi, Sanae Achour, Abdeslam El Kartouti
632 [GO] Current Drug Safety 2023―Apr―09 The Safety and Effectiveness of Antifungal Medications in the Management of Mucormycosis during the COVID-19 Pandemic Joseph M Pappachan, Dhanya Jose, Krishna S Nair, Alagesan Murali
633 [GO] Current Drug Safety 2023―Mar―31 Covid-19 vaccination program for children: An electronic assessment of symptoms Rohit Kamboj, Naman Kumar, Arjun Khora, Riya Loomba, Nikhil Sharma, Abhishek Kumar, et al. (+4)
634 [GO] Current Drug Safety 2023―Mar―30 Myocarditis and Pericarditis related to mRNA COVID-19 Vaccination: A Case Report Elena María Pérez López, Diego Rangel Sousa, Jorge Navarro Roldán
635 [GO] Current Drug Safety 2023―Jan―19 Perception and practices of self-medication practices among health science students during the ongoing COVID-19 pandemic in Mangalore, India Nitin Joseph, Jeniya Jain
636 [GO] Current Drug Safety 2022―Sep―29 Need for focused pharmacovigilance in the face of rapid COVID-19 vaccine development Sankha Shubhra Chakrabarti, Upinder Kaur
637 [GO] Current Drug Safety 2022―Aug―04 Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An observational study Dhanya Jose, Nitin Dhupdale, Jagadish A. Cacodcar, Umesh Kamat
638 [GO] Current Drug Safety 2022―Aug―02 Efficacy of Sinopharm Vaccine among Stem Cell Transplant Recipient during two peaks of Delta and Omicron variants of COVID-19 Ali Ghasemi, Rozita khodashahi, Mohsen Aliakbarian, Ebrahim Khaleghi, Baran Razmkhah, Mehrsa Vahdatinia, et al. (+2)
639 [GO] Current Drug Safety 2022―Jun―21 Impact Of The Vaccination Against Covid-19 On Frontline Health Workers Marcello M. C. Magri, David E Uip, Flaviane K. Rodrigues, Elisangela R. Lima, Glaucia L. da Veiga, Beatriz da C. A. Alves, et al. (+5)
640 [GO] Current Drug Safety 2022―Jun―15 A case of de novo annular-plaque type psoriasis following Oxford-AstraZeneca COVID-19 vaccination Namrata Chhabra, Anju George C
641 [GO] Current Drug Safety 2022―May―20 Critical Clinical Evaluation of Covid-19 Patients with Tuberculosis in the Indian Sub-Continent Hemalatha Selvaraj, Kumudha Damadarosamy, Kiruthiga Natarajan, K. Reeta Vijaya Rani, Kanagaraj Duraisamy, Rachel Parise, et al. (+4)
642 [GO] Current Drug Safety 2022―May―16 Perception and self-medication practices among the general population during the ongoing COVID-19 pandemic in Mangalore, India Nitin Joseph, Sumith Marian Colaco, Ronel Valentine Fernandes, Sarvesh G. Krishna, Sourav I Veetil
643 [GO] Current Drug Safety 2022―May―11 Hyper-eosinophilic syndrome with myocarditis after inactivated SARS-CoV-2 vaccination - a case study Ashutosh Tiwari, Gaurav Karna, Sankha Shubhra Chakrabati, Prasan Kumar Panda, Upinder Kaur
644 [GO] Current Drug Safety 2022―Apr―30 Self-Medication during the Era of COVID-19; Potential Implications for Drug Policy Makers and Pharmacovigilance Tauqeer Hussain Mallhi, Yusra Habib Khan, Muhammad Hammad Butt, Muhammad Salman
645 [GO] Current Drug Safety 2022―Apr―27 An investigation on self-medication practice during COVID-19 pandemic among Indian population Rohit Kamboj, Sweta Kamboj, Priyanka Kriplani, Kumar Guarve, Anuj Joginath, Sachin Kumar, Surya Prakash Guatam
646 [GO] Current Drug Safety 2022―Apr―06 Artificial Intelligence in Pharmacovigilance and Covid-19 Kamini Bhardwaj, Rabnoor Alam, Ajay Pandeya, Pankaj Kumar Sharma
647 [GO] Current Drug Safety 2022―Apr―06 Coronavirus Disease 2019 and Hypertension: How Anti-Hypertensive Drugs Affect COVID-19 Medications and Vice Versa Aida Doostkam, Alireza Hosseinpour, Kamyar Iravani, Leila Malekmakan, Abdolreza Haghpanah, Fatemeh Masjedi, et al. (+3)
648 [GO] Current Drug Safety 2022―Mar―29 Use of Polypharmacy and Emergence of COVID-19 Variants - Is It Co-Related? Mayank Agarwal, Prasan Kumar Panda
649 [GO] Current Drug Safety 2022―Mar―18 Clinical Outcomes of Zinc Supplementation Among COVID-19 Patients Andrew D. Berti, Pramodini B. Kale-Pradhan, Christopher A. Giuliano, Bianca N. Aprilliano, Christopher R. Miller, Basma T. Alyashae, et al. (+2)
650 [GO] Current Drug Safety 2022―Feb―09 Active Symptom-Based Surveillance of Adverse Events Following Immunization among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala Maria Jose, Priyanka Rajmohan, Joe Thomas, Swathi Krishna, Beena Antony, Unnikrishnan U G, et al. (+5)
651 [GO] Current Drug Safety 2021―Dec―01 Clozapine and COVID-19: A Case Report and Clinical Considerations Dylan Lahiff, Peggy Chatham, Gregory Sullivan, Adam J. Fusick
652 [GO] Current Drug Safety 2021―Oct―23 Famotidine Possible Cutaneous Rash in Covid-19 Patients: An Adverse Effect Case Series Mohammadreza Salehi, Hossein Khalili, Zahra Jahani, Mehrnaz Rasoolinegad, Fereshte Ghiasvanad
653 [GO] Current Drug Safety 2021―Jul―29 A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients Mahanjit Konwar, Miteshkumar Maurya, Debdipta Bose
654 [GO] Current Drug Safety 2021―Jul―29 Assessment of COVID-19 treatment advised in different ethnic populations B Arjun, P R Krishnendu, S M Zachariah, L K Pappachen
655 [GO] Current Drug Safety 2021―Jul―28 Hydroxychloroquine and Azithromycin Combination in The Management of COVID-19 Infection: Safety and Effectiveness Challenges Ahmed Essam Abou Warda, Mahmoud Tammam, Rabab Ahmed El-Gazar, Rania Mohammad Sarhan, Sayed Gaber
656 [GO] Current Drug Safety 2021―Jul―28 COVID-19: Are Experimental Drugs Cure or Ill? Bensu Karahalil, Aylin Elkama
657 [GO] Current Drug Targets 2023―Jul―30 Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysautonomia
658 [GO] Current Drug Targets 2023―Jul―30 Molecular Modeling Targeting Transmembrane Serine Protease 2 (TIMPRSS2) as an Alternative Drug Target Against Coronaviruses
659 [GO] Current Drug Targets 2023―Mar―06 High-Throughput Screening for the Potential Inhibitors of SARS-CoV-2 with Essential Dynamic Behavior Zhiwei Yang, Xinhui Cai, Qiushi Ye, Yizhen Zhao, Xuhua Li, Shengli Zhang, Lei Zhang
660 [GO] Current Drug Targets 2022―Dec―06 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Vieira
661 [GO] Current Drug Targets 2022―Dec―06 Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion Upinder Kaur
662 [GO] Current Drug Targets 2022―Nov―17 Coagulopathy and COVID-19 Victoria A. Ploplis
663 [GO] Current Drug Targets 2022―Oct―26 COVID-19 induces Cytokine Storm and Dysfunctional Hemostasis Victoria A. Ploplis, Jermilia Charles
664 [GO] Current Drug Targets 2022―Oct―18 ACE2 as a Key Target for Treatment of COVID-19 Related Cardiovascular Diseases: Current Progress and Prospect Shuainan Li
665 [GO] Current Drug Targets 2022―Oct―18 Role of Poly(ADP-ribose) Polymerase (PARP1) in Viral Infection and its Implication in SARS-CoV-2 Pathogenesis Jyotika Rajawat
666 [GO] Current Drug Targets 2022―Oct―14 Cell Entry and Unusual Replication of SARS-CoV2 Francis J. Castellino, Nathan McCann
667 [GO] Current Drug Targets 2022―Oct―12 Current Drug Targets (CDT) special issue on Covid-19 and Coagulopathy Fibrinolysis in COVID-19: impact on clot lysis and modulation of inflammation Lirlândia P. Sousa, Michelle A. Sugimoto, Luiza O. Perucci, Luciana P. Tavares, Mauro M. Teixeira
668 [GO] Current Drug Targets 2022―Oct―06 COVID-19 and Thrombosis: Clinical Aspects Tetsumei Urano, Atsushi Yasumoto, Kenji Yokoyama, Hisanori Horiuchi, Eriko Morishita, Yuko Suzuki
669 [GO] Current Drug Targets 2022―Sep―27 Tissue factor and COVID-19: an update Nigel Mackman, Ana Teresa Azevedo Sachettor
670 [GO] Current Drug Targets 2022―Sep―23 Gastrointestinal system, COVID-19 and potential mechanisms associated with coagulopathy Silvio Danese, Federica Furfaro, Roberto Gabbiadini, Ferdinando D’Amico, Alessandra Zilli, Arianna Dal Buono, et al. (+2)
671 [GO] Current Drug Targets 2022―Sep―19 Neurological Complications of SARS-CoV-2 Infection and COVID-19 Vaccines: From Molecular Mechanisms to Clinical Manifestations Manuel Yepes
672 [GO] Current Drug Targets 2022―Aug―27 Fibrinogen, Fibrin, and Fibrin Degradation Products in COVID-19 Kadri Kangro, Alisa S. Wolberg, Matthew J. Flick
673 [GO] Current Drug Targets 2022―Aug―11 Central effects of Ivermectin in alleviation of Covid-19-induced dysautonomia Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha
674 [GO] Current Drug Targets 2022―Aug―05 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Vieira
675 [GO] Current Drug Targets 2022―Aug―05 Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion Upinder Kaur
676 [GO] Current Drug Targets 2022―Jul―15 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Simões e Silva
677 [GO] Current Drug Targets 2022―Jul―15 Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion Sankha Shubhra Chakrabarti
678 [GO] Current Drug Targets 2022―Jun―24 The Role of Host-Cellular Responses in COVID-19 Endothelial Dysfunction Thomas E. Moran, Daniel E. Hammers, Shaun W. Lee
679 [GO] Current Drug Targets 2022―Apr―20 Current drug targets for gut microbiota biocorrection during the SARS-CoV-2 pandemic: a systematic review. Maria V. Sankova, Vladimir N. Nikolenko, Marine V. Oganesyan, Anastasia A. Bakhmet, Lilia V. Gavryushova, Sergey V. Sankov, Mikhail Y. Sinelnikov
680 [GO] Current Drug Targets 2022―Mar―17 Free ISG15 and protein ISGylation emerging in SARS-CoV-2 infection Angeles C. Tecalco Cruz
681 [GO] Current Drug Targets 2021―Nov―04 Potential implications of angiotensin-converting enzyme 2 blockades on neuroinflammation in SARS-CoV-2 infection Deepraj Paul, Suresh Kumar Mohankumar, Rhian S Thomas, Chai Boon Kheng, Duraiswamy Basavan
682 [GO] Current Drug Targets 2021―Oct―23 A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2 Sai Krishna Guguloth, A R Lakshmi, Radhika Rajendran, Kaushik Rajaram, Thirunavukkarasu Chinnasamy, Jian-Dong Huang, et al. (+3)
683 [GO] Current Drug Targets 2021―Sep―07 Exploring the SARS-CoV-2 main protease (Mpro) and RdRp targets by updating current structure-based drug design utilizing co-crystals to combat COVID-19 Heena Tarannum, Sisir Nandi
684 [GO] Current Drug Targets 2021―Aug―09 Molecular Modeling Targeting Transmembrane Serine Protease 2 (TMPRSS2) as an Alternative Drug Target Against Coronaviruses Igor José dos Santos Nascimento, Edeildo Ferreira da Silva-Júnior, Thiago Mendonça de Aquino
685 [GO] Current Drug Targets 2021―Mar―22 ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect Shuainan Li, Benzhi Cai, Wenya Ma, Fan Yang, Yan Xu, Binbin Xu
686 [GO] Current Drug Targets 2021―Mar―10 Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability utilizing Natural Agents Sisir Nandi, Harekrishna Roy, Asha Gummadi, Anil Saxena
687 [GO] Current Drug Targets 2021―Feb―16 Small-molecule antiviral agents in ongoing clinical trials for COVID-19 Çağla Begüm Apaydın, Gözde Çınar, Gökçe Cihan-Üstündağ
688 [GO] Current Drug Targets 2021―Jan―26 Role of Poly(ADP-ribose) polymerase (PARP1) in viral infection and its implication in SARS-CoV-2 pathogenesis Jyotika Rajawat, Abhishek Chandra
689 [GO] Current Drug Targets 2020―Dec―29 Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19 Amritpal Kaur, Gaurav Chaudhary, Pargat Singh, Sandeep Arora, Rajwinder Kaur
690 [GO] Current Drug Targets 2020―Dec―29 A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2 Mohana Das, Manish Kumar, Abhishek Jha, Kanchan Bharti, Shomedeep Mondal, Brahmeshwar Mishra
691 [GO] Current Drug Targets 2020―Dec―03 Remdesivir (GS-5734) in COVID-19 Therapy: The Fourth Chance Dinesh Singh Moirangthem, Laishram Surbala
692 [GO] Current Drug Targets 2020―Nov―27 Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection? Vivek Gupta, Madhan Kumar Murthy, Shripad Patil
693 [GO] Current Drug Targets 2020―Oct―21 Downregulation of Membrane-bound Angiotensin Converting Enzyme 2 (ACE2) Receptor has a Pivotal Role in COVID-19 Immunopathology Cristina Vieira, Lucas Nery, Ludimila Martins, Luiz Jabour, Raphael Dias, Ana Cristina Simões e Silva
694 [GO] Current Drug Targets 2020―Oct―14 COVID-19 and Renal Diseases: An Update Letícia Bitencourt Cota, Ana Luisa Pedrosa, Stephanie Bruna Camilo Soares de Brito, Ana Cláudia Fontoura Fróes, Sarah Tayná de Carvalho, Giulio Gori Fonseca, et al. (+3)
695 [GO] Current Drug Targets 2020―Oct―07 Therapeutic Options for Treatment of COVID-19: A Review from Repur-posed Drugs to New Drug Targets Bushra Akhtar, Faqir Muhammad, Ali Sharif, Abdul Hannan
696 [GO] Current Drug Targets 2020―Sep―25 Targeting host cell proteases to prevent SARS-CoV-2 invasion Upinder Kaur, Sankha Shubhra Chakrabarti, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso, Sasanka Chakrabarti
697 [GO] Current Drug Targets 2020―Jun―17 Facts and myths: Efficacies of repurposing chloroquine and hydroxychloroquine for the treatment of COVID-19 Md. Abdul Alim Al-Bari
698 [GO] Current Drug Therapy 2023―Aug―01 COVID-19 Research, Public Health, and Biomedical Basis Da Yong Lu, Ting Ren Lu
699 [GO] Current Drug Therapy 2023―Jun―02 Ayush Kwath: a major contribution of Ayurveda in preventing COVID-19 infection Rohit Sharma, Priya Katoch, Kirti Raina, Rohit Sharma, Ashun Chaudhary
700 [GO] Current Drug Therapy 2023―May―03 Natural product-derived phytochemicals as potential inhibitors of angiotensin converting enzyme 2 (ACE2): promising drug candidates for COVID-19 Aparna D. Palshetkar, Aarti. U. Rasal, Aruna Murugan, Namita D. Desai
701 [GO] Current Drug Therapy 2023―Feb―28 Evaluation of the Effectiveness of Remdesivir in the Treatment of COVID-19 Outpatients: A retrospective cohort study Akram Asghari, Seyed Yaser Foroughi Ghomi, Abolfazl Mohammadbeigi, Abbas Ahmadi, Sajjad Ahmadpour, Mansoureh Shakeri, et al. (+5)
702 [GO] Current Drug Therapy 2023―Feb―03 Safety Profile of Molnupiravir with Significant Effect on COVID-19: A Review Ashok Pattnaik, Tuhin Mukherjee, Payel Mal, Abhay Kumar Upadhyay, Satyajit Mohanty, Nikita Nayak, et al. (+3)
703 [GO] Current Drug Therapy 2022―Apr―30 Overview of Drug Therapy of COVID-19 with Safety and the Potential Clinical Benefits Rajesh Basnet, Sandhya Khadka, Buddha Bahadur Basnet, Til Bahadur Basnet, Sanjeep Sapkota
704 [GO] Current Drug Therapy 2021―Jul―20 Nanoantioxidant/Antioxidant therapy in 2019-nCoV: A new approach to reactive oxygen species mechanisms Ali Fathijouzdani, Rezvan Heidarimoghadam, Maryam Hazhirkamal, Akram Ranjbar
705 [GO] Current Drug Therapy 2021―Jul―20 In silico approach to predict the SARS-CoV2 derived candidate miRNAs as potential antiviral therapy So�h Kavousi Pour, Shiva Mohammadi, Ebrahim Eftekhar, Sajad Jalili, Elham Arabizadeh, Pooneh Mokaram, et al. (+2)
706 [GO] Current Drug Therapy 2021―May―05 Comparison of clinical characteristics, laboratory findings and imaging manifestations of COVID-19 in sulfur mustard-exposed survivors and others: a case-control study Seyed Reza Hosseini Zijoud, Seyed Mohammad Javad Hosseini, Seyed Ali Mirhosseini, Jennifer Swann, Majid Mirzaei Nodoushan, Mojtaba Sharti, et al. (+6)
707 [GO] Current Drug Therapy 2020―Nov―13 Therapeutic agents for COVID-19: An Overview Sreejan Manna, Mainak Mal, Manas Bhowmik, Dipika Mandal
708 [GO] Current Drug Therapy 2020―Aug―16 COVID-19: Pathogenesis and Pharmacological Basis for Use of Passive Antibody Therapy Smriti Ojha, Hina Chadha, Seema Mahor
709 [GO] Current Drug Therapy 2020―Jul―20 CORONAVIRUS and COVID-19: A Systematic Review and perspective Harshal Ashok Pawar, Anjali Harshal Pawar, Sandip Ashok Pawar, Prashant Ashok Pawar
710 [GO] Current Enzyme Inhibition 2020―Dec―29 Molecular Docking Demonstration of the Liquorice Chemical Molecules on the Protease and ACE2 of COVID-19 Virus. İsmail Koyuncu, Mustafa Durgun, Nuri Yorulmaz, Sahin Toprak, Ataman Gonel, Nihayet Bayraktar, Murat Caglayan
711 [GO] Current Enzyme Inhibition 2020―Jun―24 The preliminary identification of potential vaccine targets for SARS-CoV2 and Computer-aided synthesis ("small interfering RNA design") M Mouhcine, Y Kadili, H Filali
712 [GO] Current Enzyme Inhibition 2020―May―25 A Perspective of Viruses and the Outbreak of a Novel Coronavirus SARS-CoV-2 Satya P. Gupta
713 [GO] Current Functional Foods 2024―Mar―12 Exploration of the Synergistic Effects of Phytoconstituents of Ashwagandha, Amla, and Ginger as a Potent Immunity-Boosting Agent for Covid-19 Affected Individuals Raktimava Das Sarkar, Aryama Bose, Anandamoy Rudra
714 [GO] Current Gene Therapy 2023―Nov―10 Prediction of SARS-CoV-2 Infection Phosphorylation Sites and Associations of these Modifications with Lung Cancer Development Wei Li, Gen Li, Yuzhi Sun, Liyuan Zhang, Xinran Cui, Yuran Jia, Tianyi Zhao
715 [GO] Current Gene Therapy 2023―Jul―30 Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage
716 [GO] Current Gene Therapy 2022―Aug―05 Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review Jingwen Li
717 [GO] Current Gene Therapy 2021―Sep―08 Computational Analysis Illustrates the Mechanism of Qingfei Paidu Decoction in Blocking the Transition of COVID-19 Patients from Mild to Severe Stage Xinhai Li, Liu Xiang, Yue Lin, Qiang Tang, Fanbo Meng, Wei Chen
718 [GO] Current Gene Therapy 2020―Aug―26 Feasibility of mesenchymal stem cell therapy for COVID-19:A mini review Jingwen Li, Xinyi Wang, Na Li, Ying Jiang, Heqing Huang, Tao Wang, et al. (+2)
719 [GO] Current Genomics 2024―Feb―07 COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2 Rohitas Deshmukh, Ranjit K Harwansh, Akash Garg, Sakshi Mishra, Rutvi Agrawal, Rajendra Jangde
720 [GO] Current Genomics 2024―Jan―21 Molecular Determination of Tumor Necrosis Factor-alpha, Interleukin-8, Interleukin-10, and C-X-C Chemokine Receptor-2 Genetic Variations and their Association with Disease Susceptibility and Mortality in COVID-19 Patients Badr A Alsayed, Rashid Mir, Mohammad Muzaffar Mir, Tarig M.S. Alnour, Shereen Fawzy, M. Ahmed Mesaik, Dnyanesh Amle
721 [GO] Current Genomics 2023―Oct―25 Using Chaos-Game-Representation for Analysing the SARS-CoV-2 Lineages, Newly Emerging Strains and Recombinants Amarinder Singh Thind, Somdatta Sinha
722 [GO] Current Genomics 2023―Feb―03 New short RNA motifs potentially relevant in the SARS-CoV-2 genome Miguel Angel Fuertes, Carlos Alonso
723 [GO] Current Genomics 2022―Oct―18 The Covid-19, Epidemiology, Clinic and Prevention Alessandro Antonelli
724 [GO] Current Genomics 2022―Oct―18 Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection?
725 [GO] Current Genomics 2021―Dec―23 Exploring the Lethality of Human-Adapted Coronavirus through Alignment-Free Machine Learning Approaches Using Genomic Sequences Rui Yin, Zihan Luo, Chee Keong Kwoh
726 [GO] Current Genomics 2021―Dec―23 Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection? Concetta Cafiero, Alessandra Micera, Agnese Re, Loredana Postiglione, Andrea Cacciamani, Beniamino Schiavone, et al. (+2)
727 [GO] Current Genomics 2021―Dec―17 Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein Sergio Forcelloni, Anna Benedetti, Maddalena Dilucca, Andrea Giansanti
728 [GO] Current Genomics 2021―Sep―22 Accumulating Impact of Smoking and Co-morbidities on Severity and Mortality of COVID-19 Infection: A Systematic Review and Meta-analysis Rupesh Kumar, Avdhesh Kumar Rai, Mayur Mausoom Phukan, Anowar Hussain, Debajit Borah, Bhaskarjyoti Gogoi, et al. (+2)
729 [GO] Current Genomics 2020―Apr―28 The Covid-19, Epidemiology, Clinic and Prevention Alessandro Antonelli, Giusy Elia, Silvia Martina Ferrari, Rudy Foddis, Salvatore De Marco, Alfonso Cristaudo, Poupak Fallahi
730 [GO] Current HIV Research 2023―Dec―28 The Interrelationship Between HIV Infection and COVID-19: A Review of the Literature Yiyu Wang, Yu Lai
731 [GO] Current HIV Research 2023―Dec―01 Factors Associated with Fatal COVID-19 Outcomes among People Living with HIV: A Cohort Study Elena Drobyshevskaya, Aleksey Lebedev, Alexander Pronin, Marina Bobkova
732 [GO] Current HIV Research 2023―Jul―18 Late Diagnosis at Entry on Care in an HIV Clinic in Mexico City: Possibly COVID-19 Pandemic Impact Elizalde-Barrera Cesar Ivan, Juarez-Mendoza Carlos Virgilio
733 [GO] Current HIV Research 2022―Aug―26 HIV and COVID-19: A Tale of Two Pandemics Aditya Kurdekar, Shruti Verma, Kamisetti Venkataramaniah
734 [GO] Current HIV Research 2022―Aug―05 The Course of COVID-19 in Four Patients with HIV During the Pandemic Melda Turken
735 [GO] Current HIV Research 2022―Aug―05 Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment SeyedAhmad SeyedAlinaghi
736 [GO] Current HIV Research 2022―Aug―02 Impact of the COVID-19 pandemic on HIV epidemic and testing in the Czech Republic in 2020 Sekera Jan Carlos, Machala Ladislav, Dzúrová Dagmar
737 [GO] Current HIV Research 2022―Aug―01 BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV) Anna Gidari, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Samuele Sabbatini, Elisabetta Schiaroli, et al. (+4)
738 [GO] Current HIV Research 2022―Jul―15 The Course of COVID-19 in Four Patients with HIV During the Pandemic Melda Turken
739 [GO] Current HIV Research 2022―Jul―15 Prevalence of COVID-19-like Symptoms among People Living with HIV, and Using Antiretroviral Therapy for Prevention and Treatment Zahra Ahmadinejad
740 [GO] Current HIV Research 2022―Jun―24 SARS-CoV-2/COVID-19: Clinical course among subjects HIV-1-infected in Sao Paulo Mariana A. Monteiro, Gabriela Silva Prates, Ana Paula R. Veiga, Marcello M. C. Magri, Maria R. P. Gascon, Mauricio D Ferreira, et al. (+8)
741 [GO] Current HIV Research 2022―Jun―15 Post-lockdown rebounding high-risk behaviors and HIV testing among MSM in China in the era of COVID-19 pandemic Jiahui Yang, Mengyao Yi, Han-Zhu Qian, Yuqing Chen, Qidi Zhou, Xianhong Li
742 [GO] Current HIV Research 2022―Mar―04 Changing Characteristics of Patients Living with HIV/AIDS after COVID-19 Pandemics in Turkey Hayat Kumbasar Karaosmanoglu, Birgul Mete, Alper Gunduz, Dilek Yildiz Sevgi, Ozlem Altuntas Aydin, Ilyas Dokmetas, Fehmi Tabak
743 [GO] Current HIV Research 2021―Dec―20 Predictors of COVID-19 vaccine acceptability among patients living with HIV in northern Nigeria: A mixed methods study Zubairu Iliyasu, Aminatu A. Kwaku, Amina A. Umar, Fatimah Tsiga-Ahmed, Nafisa S. Nass, Hadiza M. Abdullahi, et al. (+3)
744 [GO] Current HIV Research 2021―Sep―01 It is not always COVID-19: Case report about an undiagnosed HIV man with dyspnea Michela Pontolillo, Katia Falasca, Jacopo Vecchiet, Claudio Ucciferri
745 [GO] Current HIV Research 2020―Dec―02 The course of COVID-19 in four patients with HIV during the pandemic Melda Turken, Hividar Altan, Sabri Atalay, Sukran Kose
746 [GO] Current HIV Research 2020―Nov―27 How does the covid-19 pandemic affect the target 90-90-90? Hayat Kumbasar Karaosmanoglu
747 [GO] Current HIV Research 2020―Jul―12 Prevalence of COVID-19-like symptoms among people living with HIV, and using antiretroviral therapy for prevention and treatment SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mahboubeh Hajiabdolbaghi, Mehrnaz Rasoolinejad, Ladan Abbasian, Malihe Hassan Nezhad, et al. (+3)
748 [GO] Current Hypertension Reviews 2024―Jan―23 Association of COVID-19 and Arterial Stiffness Assessed using Cardiovascular Index (CAVI) Valery Podzolkov, Anna Bragina, Aida Tarzimanova, Lyubov Vasilyeva, Ilya Shvedov, Natalya Druzhinina, et al. (+5)
749 [GO] Current Hypertension Reviews 2023―Jan―09 Post COVID-19 Lockdown in Ghana: What is the Wellbeing Status of the Young Adults? Moses Monday Omoniyi, Afrifa Daniel, Asamoah Benjamin, Kwofie Emmanuel Amankrah, Asamoah-Mensah Anthony, Medes Francis Osei, et al. (+4)
750 [GO] Current Hypertension Reviews 2022―Aug―17 Unravelling the Mechanistic Role of ACE2 and TMPRSS2 in Hypertension: a Risk Factor for COVID-19 Nalini Govender, Olive Khaliq, Jagidesa Moodley, Thajasvarie Naicker
751 [GO] Current Hypertension Reviews 2022―Apr―09 ACEi/ ARB and Deaths of COVID-19 Patients Gulam Navi Azad, Anoop Kumar
752 [GO] Current Hypertension Reviews 2021―Jun―04 Predictive Factors for the Care and Control of Hypertension based on the Health Belief Model among hypertensive patients during the COVID-19 epidemic in Sirjan, Iran Reza Sadeghi, Mahmood Reza Masoudi, Athina Patelarou, Narges Khanjani
753 [GO] Current Hypertension Reviews 2021―Jan―31 COVID-19, Angiotensin-Converting Enzyme 2 and Renin-Angiotensin System Inhibition: Implications for Practice Vasiliki Katsi, George Pavlidis, George Charalambous, Dimitrios Tousoulis, Konstantinos Toutouzas
754 [GO] Current Hypertension Reviews 2020―Aug―11 Angiotensin-converting Enzyme 2 roles in the Pathogenesis of COVID-19 Azra Kenarkoohi, Maryam Maleki, Tahereh Safari, Mohamadreza Kafashian, Fateme Saljoughi, Shahla Sohrabipour
755 [GO] Current Immunology Reviews 2020―Nov―13 Thymosin α1; Potential Therapeutic Implications of an Immunoregulatory Drug in the Treatment of Lymphocytopenia Associated with COVID-19 Milad Shirvaliloo
756 [GO] Current Immunology Reviews 2020―Nov―13 Can Mandated BCG Vaccine Promote herd Immunity Against Novel Coronavirus?. A Potential Solution at Hand to Tackle Covid-19 Pandemic Ashok Arasu, Pavithra Balakrishnan, Thirunavukkarasu Velusamy, Thiagarajan Ramesh
757 [GO] Current Immunology Reviews 2020―Oct―01 COVID-19: Update on Pathogenesis and Treatment Strategies Rakesh Kumar Chauhan, Pramod Kumar Sharma, Shikha Srivastava
758 [GO] Current Materials Science 2023―Jan―12 Semantics of COVID-19 Web Data: Ontology Learning and Population Sarika Jain, Sumit Sharma
759 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2024―Mar―11 Evaluation of the Atherogenic Effect of Covid-19 Pneumonia on Coronary and Carotid Arteries in Patients who Recovered from the Disease Semih Sağlık, Necip Nas
760 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2024―Mar―01 Does Postlong Coronavirus 2019 Disease Affect Renal Stiffness without any Chronic Systemic Disorders? Serdal Çitil, Yusuf Aksu
761 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2024―Mar―01 Clinical Application of MRI in Coronavirus Disease 2019: A Bibliometric Analysis Jinqun Hu, Jian Xiong, Jing Jiang, Ying Wei, Fayang Ling, Shichun Luo, et al. (+5)
762 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2024―Feb―28 Disease Course and Pulmonary Involvement of COVID-19 during the Delta Variant Period in Germany: A Comparative Study of Vaccinated and Unvaccinated Patients at a Tertiary Hospital Andrea Steuwe, Alexandra Ljimani, Marcel Andree, Tobias Wienemann, Nadine Lübke, Andreas Walker, et al. (+4)
763 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2024―Feb―21 A Novel Approach to the Technique of Lung Region Segmentation Based on a Deep Learning Model to Diagnose COVID-19 X-ray Images Xuejie Ding, Qi Zhou, Zifan Liu, Jamal Alzobair Hammad Kowah, Lisheng Wang, Xialing Huang, Xu Liu
764 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2024―Jan―19 Implication of Bone Mineral Density and Body Composition Parameters for Length of Hospital Stay in Patients with COVID-19 Wenmin Guan, Tingting Zhang, Jing Sun, Xuan Wei, Wei Wei, Ying Yan, et al. (+9)
765 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Nov―08 Clinical and Temporal Radiological Findings from Critical Patients with COVID-19 Pneumonia: A Descriptive Study Ye Tian, Yuqiong Wang, Min Liu, Xu Huang, Yi Zhang, Xiaojing Wu, et al. (+4)
766 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Oct―27 Comparison of Computed Tomography Findings between Adult and Pediatric COVID-19 Patients Yeliz Dadalı, Sercan Özkaçmaz, Erdal Ünlü, Ayşe Özkaçmaz, Muhammed Alparslan, İlyas Dündar, et al. (+4)
767 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Aug―18 COVID-19 Detection using Hybrid CNN-RNN Architecture with Transfer Learning from X-Rays Deepti Deshwal, Pardeep Sangwan, Naveen Dahiya, Umesh Kumar Lilhore, Surjeet Dalal, Sarita Simaiya
768 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Aug―11 The evaluation of subcutaneous and visceral adipose tissue changes by computed tomography in coronavirus disease 2019 and comparison with quantitative analysis of lung involvement Murat Vural, Betul Akdal Dolek, Ozgul Ucar, Erdem Ozkan, Utku Eren Ozkaya
769 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Jun―21 Kikuchi-Fujimoto Disease in the Axilla after COVID-19 Vaccination: A Case Report Hye Jin Baek, Eun Cho, Kyungsoo Bae, Kyung Nyeo Jeon, Jin Il Moon, Sung Eun Park, et al. (+2)
770 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―May―16 Reversible Intracranial Cytotoxic Edema Associated with COVID-19: A Case Report Güngör ÇAKMAKCI, Mustafa ÇETİNER, Gönül AKDAĞ, Fatma AKKOYUN ARIKAN, Sibel CANBAZ KABAY
771 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―May―11 A Novel Combined Model to Predict the Prognosis of COVID-19: Radiological-Metabolic Scoring Seray Akçalar Zorlu, Ayşegül Öz
772 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Apr―27 A Lightweight AMResNet Architecture with an Attention Mechanism for Diagnosing COVID-19 Lihe Jiang, Xu Liu, Qi Zhou, Jamal Alzobair Hammad Kowah, Huijun Li, Mingqing Yuan
773 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Apr―27 Clinical characteristics and high-resolution computed tomography findings of 805 patients with mild or moderate infection from SARS-CoV-2 Omicron subvariant BA.2 Xue-Qin Chen, Ai-Jing Li, Yu-Ning Pan, Meng-Yin Gu, Quan-Liang Mao, Xin-Zhong Ruan, et al. (+2)
774 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Apr―18 Analysis of Covid-19 CT chest image classification using Dl4jMlp classifier and Multilayer Perceptron in WEKA Environment Babu Devasenapati S, Shashank Rebelli
775 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Apr―18 Atypical cytotoxic lesion and hemorrhagic involvement of the corpus callosum in severe COVID-19 infection José David Cardona Ortegón, Angela Patricia Guarnizo Capera, Manuela Gallo Tapias, Valentina Ferrer Valencia
776 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Apr―05 Concurrent diffuse dural and leptomeningeal enhancements in brain Magnetic Resonance Imaging following a mild COVID-19 infection: A Novel Case Report and Review of Literature Masoud Ghiasian, Rashed Bawand, Mustapha Samadyan
777 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Feb―17 Thromboembolic Disorder in COVID-19 infection Raza Mushtaq, Shawn Lee, Joseph Gunderson
778 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Feb―15 Predicting severe COVID-19 infection on initial diagnosis: comparison and validation of CT imaging triage tools Lutfi Ali S Kurban, Maysam Abu Sa’a, Aser Soliman Ahmed Farghal, Hussain Ali Aby Ali, Rizwan Syed, Khaled Al Zwae
779 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2023―Jan―10 Chest CT Features of Patients with COVID-19 Pneumonia Following Hospital Discharge Zhenguo Qiao, Dong Liu, Fangfang Fu, Aihua Ye, Chunhong Hu
780 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Dec―26 A Review of COVID-19 Diagnostic Approaches in Computer Vision Cemil Zalluhoğlu
781 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Sep―29 A Deep Learning based Solution (Covi-DeteCT) Amidst COVID-19 Kavita Pandey
782 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Aug―20 Imaging profile after treatment with Tocilizumab in COVID-19: a case series. Donato Lacedonia, Pasquale Tondo, Giulia Scioscia, Paolo Fuso, Cosimo C. De Pace, Ennio V. Sassani, Maria Pia Foschino Barbaro
783 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Aug―04 Deep learning based COVID-19 detection using medical images: Is insufficient data handled well? Caren Babu, Rahul Manohar O, D Abraham Chandy
784 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Aug―02 Primary SARS-CoV-2 Pneumonia Screening in Adults: Analysis of the Correlation between High-Resolution Computed Tomography Pulmonary Patterns and Initial Oxygen Saturation Levels. Batil Alonazi, Mohamed A. Mostafa, Ahmed M. Farghaly, Salah A. Zindani, Jehad A. Al-Watban, Feras Altaimi, et al. (+3)
785 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jun―21 Comparing the sensitivity and specificity of lung CT-scan with RT-PCR for diagnosis of COVID-19 Akram Asghari, Seyed-Hasan Adeli, Mahmoud Parham, Mohammad Bagherzade, Sajjad Ahmadpour, Rasoul Shajari, et al. (+9)
786 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jun―21 Key Radiological Features of COVID-19 Chest CT Scans with a Focus on Special Subgroups: A Literature Review. Noor Nouaili, Rachael Garner, Sana Salehi, Marianna La Rocca, Dominique Duncan
787 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jun―16 Evaluation of CT Scan Diagnostic Value in the Novel Coronavirus Disease and Presenting a Corona CT Severity Index Abdolmajid Taheri, Majid Asadi-Samani, Ebrahim Saedi Dezaki, Soleiman Kheiri, Elham Taheri
788 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jun―13 A Deep Learning Model for Diagnosing COVID-19 and Pneumonia through X-ray. Xiangbin Liu, Wenqian Wu, Jerry Chun-Wei Lin, Shuai Liu
789 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jun―07 Usefulness of high-resolution computed tomography in early diagnosis of patients with suspected COVID-19. Alma Angélica Ronzón-Ronzón, Brenda Aida Acevedo Salinas, José Agustín Mata Chapol, Dalia María Soto Valdez, Silvia Refugio Sánchez, Briceida López Martínez, et al. (+2)
790 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―May―11 Comparison of Chest CT and RT-PCR Assay for Indication of Disease Course of Coronavirus Disease 2019 (COVID-19) Pneumonia Yi-fan Zhang, Qiong Zhao
791 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―May―11 The Relationship Between Splenomegaly And Lung Involvement Patterns And Severity Score In COVID-19 Pneumonia Yusuf Aksu, Ali Ugur Uslu, Gulten Tarhan, Mustafa Karagülle, Şaban Tiryaki
792 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―May―11 Post COVID-19 Vaccination acute Disseminated Encephalomyelitis: A case report Amit Garg, Parveen Kumar Batra, Pranav Gupta
793 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Apr―28 Detection of COVID-19 Incidentally in 68Ga-PSMA PET/CT for Restaging of Prostate Cancer Berna Okudan, Bedri Seven, Betül Ural, Mustafa Çapraz
794 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Apr―05 Low-Dose COVID-19 CT Image Denoising Using CNN and its Method Noise Thresholding Manoj Diwakar, Neeraj Kumar Pandey, Ravinder Singh, Dilip Sisodia, Chandrakala Arya, Prabhishek Singh, Chinmay Chakraborty
795 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Apr―05 Clinical Characterizations and Radiological Findings of COVID-19: 4 Cases Report Zhenguo Qiao, Dong Liu, Fangfang Fu, Aihua Ye, Chunhong Hu
796 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Mar―11 Frequency of Ipsilateral Axillary Lymphadenopathy After the Inactivated COVID-19 Vaccine Aynur Turan, Hatice Kaplanoğlu, Veysel Kaplanoğlu
797 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jan―14 Special Issue on Computational Approaches for COVID-19 Disease Medical Image Analysis Gaurav Dhiman
798 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2022―Jan―12 Correlation of Indeterminate Lesiıons of Covid-19 Pneumonia Detected on Computed Tomography with RT-PCR Results Nevin Aydin, Çağatay Cihan, Tercan Us, Yasemin Öz, Cigdem Oztunali, Şenay Yılmaz, et al. (+5)
799 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Dec―30 Clinical Value of COVID-19 Chest Radiography and High-Resolution CT Examination Dan Wang, Yalei Shang, Yuehua Chen, Jianguo Xia, Weizhong Tian, Tao Zhang, et al. (+2)
800 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Dec―30 Radiology During the COVID-19 Pandemic: Mapping Radiology Literature in 2020 Nosaiba Al-Ryalat, Lna Malkawi, Ala'a Abu Salhiyeh, Faisal Abualteen, Ghaida Abdallah, Bayan Al Omari, Saif Aldeen AlRyalat
801 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Nov―25 Dynamic Imaging Changes of COVID-19 Pneumonia at Different Stages Xiao-Yan Lv, Wei-Hong Xing, Xi Ma, Li-Hong Xing, Yu Zhang, Yi-Bo Lu, et al. (+5)
802 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Nov―05 COVID 19/Any Respiratory Pandemic- What a Radiology Resident Must Know and Report Preethi Philomina, Anindita Mishra
803 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Oct―21 The Role of Lung Ultrasound Before and During the COVID-19 Pandemic: A review article Mustafa J. Musa, Mohamed Yousef, Mohammed Adam, Awadalla Wagealla, Lubna Boshara, Dalia Belal, Ahmed Abukonna
804 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Oct―05 Artificial intelligence against COVID-19 Pandemic: A Comprehensive Insight Azhar Equbal, Sarfaraz Masood, Iftekhar Equbal, Shafi Ahmad, Noor Zaman Khan, Zahid A. Khan
805 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Sep―27 Dedicated COVID-19 Resource Center in Radiology Journals: Its Citation Metrics and Altmetrics Impact Nosaiba Al-Ryalat, Lna Malkawi, Saif Aldeen AlRyalat
806 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Sep―17 Heterogeneity Analysis of Chest CT Predict Individual Prognosis of COVID-19 Patients Bo Yang, Bei Zhang, Lichen Gao, Jian Zhang, Huaiming Qiu, Wencai Huang
807 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Sep―17 Imaging Findings for Identifying and Evaluating Complications after Lung Transplantation in Patients with Advanced COVID-19: Two Case Reports Junhan Pan, Manhua Zhu, Weili Han, Feng Chen
808 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Sep―13 A Novel Multicolour-thresholding Auto-detection Method to Detect the Location and Severity of Inflammation in Confirmed SARS-COV-2 Cases Using Chest X-ray Images Mohammed Alqahtani, Mohamed Abbas, Ali Alqahtani, Mohammad Alshahrani, Abdulhadi Alkulib, Magbool Alelyani, Awad Almarhaby
809 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Sep―10 Advanced deep learning algorithms for infectious disease modeling using clinical data- A Case Study on CoVID-19 Ajay Kumar, Smita Nivrutti Kolnure, Kumar Abhishek, Pranav Nerurkar, Muhammad Rukunuddin Ghalib, Achyut Shankar
810 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Sep―02 COVID-19 Imaging-based AI Research - A Literature Review Cheng Ge, Lili Zhang, Liangxu Xie, Ren Kong, Hong Zhang, Shan Chang
811 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Aug―30 The Role of CO-RADS Scoring System in the Diagnosis of COVID-19 Infection and its Correlation with Clinical Signs Şenol Çomoğlu, Sinan Öztürk, Ahmet Topçu, Fatma Kulalı, Aydın Kant, Resul Sobay, et al. (+10)
812 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Aug―16 CT imaging research progress in 2019 novel coronavirus pneumonia Zhi Yong Shen, Xun Cheng Yan, Xiao Dong You, Xue Wen Zhang
813 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Aug―15 Coronavirus Disease 2019: Hysteresis Effect of Chest CT and the Correlation with its Severity Kui Li, Wei Wang, Lei Wu, Changwu Zhao, Zicheng Jiang, Shengxi Liu, Tao Li
814 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jul―14 Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review M. Rubaiyat Hossain Mondal, Subrato Bharati, Prajoy Podder
815 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jul―06 Diagnostic Performance Of Radiology Residents In Thoracic Ct Imaging In Emergency Radiology During The Covid-19 Pandemic Vefa Cakmak, Duygu Herek, Pinar Cakmak
816 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jun―30 Coronavirus Disease (COVID-19) compared with Middle East Respiratory Syndrome (MERS): A Radiological Perspective Ghazi Alshumrani, Ali Al bshabshe, Wesam Faried Mousa
817 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jun―29 Chemotherapy-Induced Pulmonary Toxicity Mimicking COVID-19 Pneumonia Sebnem Karasu, Kazim Ayberk Sinci, Yasar Yildiz, Cesur Gumus, Ozgur Tosun
818 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jun―24 The feasibility of low dose chest CT acquisition protocol for the imaging of COVID-19 pneumonia Eray Atlı, Sadık Ahmet Uyanık, Umut Öğüşlü, Halime Çevik Cenkeri, Birnur Yılmaz, Burçak Gümüş
819 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jun―04 Could chest CT findings taken on admission in symptomatic patients with COVID-19 be related to the prognosis and clinical outcome of the disease? Yasemin Gunduz, Alper Karacan, Oguz Karabay, Ali Fuat Erdem, Osman Kindir, Mehmet Halil Ozturk
820 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―May―22 Chest CT Imaging in the Diagnosis of COVID-19: Rapid Publications are not Equal to Quality of Research Zhonghua Sun
821 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―May―09 Utility of Lung Ultrasound in Decision making to prioritize hospital admission for COVID-19 patients: A Developing Country Perspective Samy Zaky, Mohamed A. Metwally, Mohamed El Badry, Ali A Hasan, Sherief Abd-Elsalam, Fathiya El-Raey, et al. (+23)
822 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Apr―15 Corona virus-related Disease Pandemic: A Review on Machine Learning Approaches and Treatment Trials on Diagnosed Population for Future Clinical Decision Support Reyana A, Sandeep Kautish
823 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Feb―25 COVID-19: Role of Robotics, Artificial Intelligence, and Machine learning during pandemic Gurpreet Kour Sodhi, Simarpreet Kaur, Gurjot Singh Gaba, Lavish Kansal, Ashutosh Sharma, Gaurav Dhiman
824 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Feb―19 A Comparison of CT Manifestations between Coronavirus Disease 2019 (COVID-19) and Other Types of Viral Pneumonia Haixia Mao, Xiaoshan Li, Xiaoming Lin, Lijuan Zhou, Xiuping Zhang, Yang Cao, et al. (+4)
825 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Feb―19 Clinical characteristics and CT imaging features of COVID-19 on admission: A retrospective study Changchun Liu, Jianping Cai, Mengmeng Zhang, Huizhen Li, Chunyan Liu, Jian Dong, Jinghui Dong
826 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Feb―16 Visual and quantitative assessment of COVID-19 pneumonia on chest CT: The relationship with disease severity and clinical findings Furkan Kaya, Petek Şarlak Konya, Emin Demirel, Neşe Demirtürk, Semiha Orhan, Furkan Ufuk
827 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Feb―16 COVID-19: Challenges and its Technological Solutions using IoT Farhana Ajaz, Mohd Naseem, Sparsh Sharma, Mohammad Shabaz, Gaurav Dhiman
828 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jan―13 Inspiratory and Expiratory Chest High-Resolution CT: Small-Airway Disease Evaluation in Patients with COVID-19 Renjun Huang, Jingfen Zhu, Jianguo Zhou, Yalei Shang, Xiaoming Lin, Shengbin Gong, et al. (+3)
829 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jan―13 Texture Analysis in the Evaluation of Covid-19 Pneumonia in Chest X-Ray Images: a Proof of Concept Study Armando Ugo Cavallo, Jacopo Troisi, Marco Forcina, Pier-Valerio Mari, Valerio Forte, Massimiliano Sperandio, et al. (+4)
830 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jan―13 An Efficient Method for Coronavirus Detection Through X-rays using deep Neural Network P. Srinivasa Rao, Pradeep Bheemavarapu, P. S. Latha Kalyampudi, T. V. Madhusudhana Rao
831 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2021―Jan―01 Chest Radiograph (CXR) Manifestations of the Novel Coronavirus Disease 2019 (Covid-19) - A Mini-Review Wai Yee Chan, Marlina Tanty Ramli Hamid, Nadia Fareeda Muhammad Gowdh, Kartini Rahmat, Nur Adura Yaakup, Chee Shee Chai
832 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2020―Dec―24 Age-Related Pattern and Distribution of Covid-19 on Pulmonary Computed Tomography Omar Muayad Sultan, Dhia Mahdey Alghazali, Haider Al-Tameemi, Mohammed Abed, Dhaffer Abdullah Hawiji, Muthana Naser Abu Ghniem, et al. (+2)
833 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2020―Nov―24 Deep Transfer Learning for COVID-19 Prediction: Case Study for Limited Data Problems Saleh Albahli, Waleed Albattah
834 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2020―Jun―04 A Deep Neural Network to Distinguish COVID-19 from other Chest Diseases using X-ray Images Saleh Albahli
835 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2020―Apr―16 CT Diagnosis of Coronavirus Infection Euishin Edmund Kim
836 [GO] Current Medical Imaging Formerly Current Medical Imaging Reviews 2020―Mar―22 Diagnostic Value of Chest CT in Coronavirus Disease 2019 (COVID-19) Zhonghua Sun
837 [GO] Current Medical Imaging Reviews 2022―Dec―09 A Deep Neural Network to Distinguish COVID-19 from other Chest Diseases Using X-ray Images Saleh Albahli
838 [GO] Current Medical Imaging Reviews 2022―Dec―09 Texture Analysis in the Evaluation of COVID-19 Pneumonia in Chest X-Ray Images: A Proof of Concept Study Armando Ugo Cavallo
839 [GO] Current Medical Imaging Reviews 2022―Dec―09 Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review M. Rubaiyat Hossain Mondal
840 [GO] Current Medical Imaging Reviews 2022―Dec―09 COVID-19: Challenges and its Technological Solutions using IoT Farhana Ajaz
841 [GO] Current Medical Imaging Reviews 2022―Dec―09 COVID-19: Role of Robotics, Artificial Intelligence and Machine Learning During the Pandemic Gurpreet Kour Sodhi
842 [GO] Current Medical Imaging Reviews 2022―Oct―18 Inspiratory and Expiratory Chest High-resolution CT: Small-airway Disease Evaluation in Patients with COVID-19 Renjun Huang
843 [GO] Current Medical Imaging Reviews 2022―Oct―18 Diagnostic Value of Chest CT in Coronavirus Disease 2019 (COVID-19) Zhonghua Sun
844 [GO] Current Medical Imaging Reviews 2022―Oct―18 Clinical Characteristics and CT Imaging Features of COVID-19 on Admission: A Retrospective Study Changchun Liu
845 [GO] Current Medical Imaging Reviews 2022―Jul―17 A Deep Neural Network to Distinguish COVID-19 from other Chest Diseases Using X-ray Images Albahli, S
846 [GO] Current Medical Imaging Reviews 2022―Jul―17 Texture Analysis in the Evaluation of COVID-19 Pneumonia in Chest X-Ray Images: A Proof of Concept Study Cavallo, AU
847 [GO] Current Medical Imaging Reviews 2022―Jul―17 Diagnosis of COVID-19 Using Machine Learning and Deep Learning: A Review Mondal, MRH
848 [GO] Current Medicinal Chemistry 2024―Feb―04 Role of Ferroptosis in the Progression of COVID-19 and the Development of Long COVID Wen Zhao, Siyuan Wang, Yuxin Han, Hongkun Zhang, Jiacen Cao, Shasha Dong, et al. (+4)
849 [GO] Current Medicinal Chemistry 2024―Jan―29 Time Course of Biochemical and Metabolic Parameters During and After COVID-19 Zohreh-al-sadat Ghoreshi, Mojtaba Abbasi-jorjandi, Gholamreza Asadikaram, Mohsen Sharif-zak, Mohammad Khaksari Haddad, Ali Afgar, et al. (+3)
850 [GO] Current Medicinal Chemistry 2024―Jan―22 Atorvastatin Effect on COVID-19 Outcomes: A Propensity Score Matched Study on Hospitalized Patients Mohamad Amin Pourhoseingholi, Omid Yazdani, Mehdi Azizmohammad Looha, Seyed Amir Ahmad Safavi-Naini, Romina Esbati, Saba Ilkhani, et al. (+12)
851 [GO] Current Medicinal Chemistry 2024―Jan―22 Genetic and Epigenetic Determinants of COVID-19 Susceptibility: A Systematic Review Amin Gasmi, Laura Kassym, Alain Menzel, Wajiha Anzar, Maryam Dadar, Yuliya Semenova, et al. (+6)
852 [GO] Current Medicinal Chemistry 2024―Jan―21 Natural and Synthetic Coumarins as Potential Drug Candidates Against SARS-CoV-2/CoViD-19 Iara da Silva Santos, Letícia Oliveira Magalhães, Roberta Katlen Fusco Marra, Camilo Henrique da Silva Lima, Lidilhone Hamerski, Magaly Girão Albuquerque, Bárbara Vasconcellos da Silva
853 [GO] Current Medicinal Chemistry 2023―Dec―15 Promises and Pitfalls of Calcineurin Inhibitors in COVID-19: A Systematic Review and Meta-analysis of Controlled Trials Behrooz Heydari, Adeleh Sahebnasagh, Mohammad Ali Omrani, Saeed Azimi, Mohammad Hossein Dehghani, Amin Salehi-Abargouei, et al. (+2)
854 [GO] Current Medicinal Chemistry 2023―Nov―29 Structure and Function of the SARS-CoV-2 6-HB Fusion Core and Peptide-Based Fusion Inhibitors: A Review Guodong Liang, Yue Li, Ruijuan Li, Yuheng Ma, Heiya Na
855 [GO] Current Medicinal Chemistry 2023―Nov―28 SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections Mohammad A. Khanfar, Mohammad I. Saleh
856 [GO] Current Medicinal Chemistry 2023―Sep―19 How does the Immunological System Change during the SARS-COV-2 Attack? A Clue for the New Immunotherapy Discovery Mohammad Mahdi Hajihasani, Najmeh Kaffash Farkhad, Ali Mahmoudi, Amirhossein Sahebkar
857 [GO] Current Medicinal Chemistry 2023―Sep―11 Identifying luteolin as a potential drug for treating lung adenocarcinoma with COVID-19 affection based on integration analysis of pharmacology and transcriptome Ping Peng, Na Li, Ni Zhang, Xiangning Fu, Shu Peng, Yujie Zhao, Bo Ai
858 [GO] Current Medicinal Chemistry 2023―Sep―11 Antiviral Compounds to Address Influenza Pandemics: An Update from 2016-2022 Roberto Romeo, Laura Legnani, Maria Assunta Chiacchio, Salvatore V. Giofrè, Daniela Iannazzo
859 [GO] Current Medicinal Chemistry 2023―Jul―30 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis
860 [GO] Current Medicinal Chemistry 2023―Jul―30 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection
861 [GO] Current Medicinal Chemistry 2023―Jul―30 The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants
862 [GO] Current Medicinal Chemistry 2023―Jul―30 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
863 [GO] Current Medicinal Chemistry 2023―Jul―18 Potential drugs in COVID-19 management Geir Bjørklund, Amin Gasmi, Sadaf Noor, Alain Menzel, Nataliia Khanyk, Yuliya Semenova, et al. (+5)
864 [GO] Current Medicinal Chemistry 2023―Jul―07 Fluvastatin: a choice for COVID-19 associated mucormycosis management Amirhossein Sahebkar, Alireza Tavakkoli, Thomas P. Johnston
865 [GO] Current Medicinal Chemistry 2023―Jun―21 Severity of COVID-19 in pregnant women: a review on the potential role of regulatory T cells Elham Abdollahi, Amirhossein Sahebkar, Nafiseh Saghafi, Mahmoud Mahmoudi, Amir Abbas Momtazi-Borojeni, Sara Mirzaeian, et al. (+2)
866 [GO] Current Medicinal Chemistry 2023―May―22 Discovery of Novel Cysteine Protease Inhibitors for the Treatment of Coronavirus (COVID-19) Surya K. De
867 [GO] Current Medicinal Chemistry 2023―May―16 Long COVID-19 syndrome and sudden cardiac death: the phantom menace Michael Spartalis, David Zweiker, Eleftherios Spartalis, Dimitrios C. Iliopoulos, Gerasimos Siasos
868 [GO] Current Medicinal Chemistry 2023―May―16 The impact of lncRNA-GAS5/miRNA-200/ACE2 molecular pathway on the severity of COVID-19 Amr M. Abdelhamid, Ghada Ayeldeen, Olfat G. Shaker, Eman Amer, Mai A. Zaafan, Mohamed R. Herzalla, Mofida A. Keshk
869 [GO] Current Medicinal Chemistry 2023―May―05 Recent Discovery of Peptidomimetics for the Treatment of Coronavirus (COVID-19), Human coronavirus, and Enteroviruses Surya K. De
870 [GO] Current Medicinal Chemistry 2023―May―04 Hydrogen sulfide: physiological roles and therapeutic implications against COVID-19 Amirhossein Sahebkar, Sajad Abolfazli, Nima Ebrahimi, Eftekhar Morabi, Mohammad Amin Asgari Yazdi, Gokhan Zengin, et al. (+2)
871 [GO] Current Medicinal Chemistry 2023―Apr―09 Perspectives and Prospects on the application of DNA Aptamer in SARS-CoV-2 Xiaoxiao Hu, Yunyi Liu, Bei Hu, Xiaming Pei, Juan Li
872 [GO] Current Medicinal Chemistry 2023―Mar―31 SARS-CoV-2 Infection, Inflammation, Immunonutrition, and Pathogenesis of COVID-19 Ligen Yu, Mohd Khanapi Abd Ghani, Alessio Aghemo, Debmalya Barh, Matteo Bassetti, Fausto Catena, et al. (+12)
873 [GO] Current Medicinal Chemistry 2023―Mar―31 Traditional Chinese Medicine as the preventive and therapeutic remedy for COVID-19 Geir Bjørklund, Amin Gasmi, Torsak Tippairote, Pavan Kumar Mujawdiya, Alain Menzel, Roman Lysiuk, et al. (+3)
874 [GO] Current Medicinal Chemistry 2023―Feb―24 Sleep, dietary melatonin supplementation, and COVID-19 Geir Bjørklund, Amin Gasmi, Yuliya Semenova, Sadaf Noor, Asma Gasmi Benahmed
875 [GO] Current Medicinal Chemistry 2023―Feb―23 Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity Amirhossein Sahebkar, Sepideh Karkon Shayan, Elham Nasrollahi, Yaser Bahramvand, Mahdi Zarei, Ahmadreza Atarodi, et al. (+6)
876 [GO] Current Medicinal Chemistry 2023―Feb―06 Is BMI Associated with Covid-19 Severity? A Retrospective Observational Study Marcello Candelli, Giulia Pignataro, Angela Saviano, Veronica Ojetti, Maurizio Gabrielli, Andrea Piccioni, et al. (+4)
877 [GO] Current Medicinal Chemistry 2022―Dec―07 The Role of Interleukin-6 in the Pathogenesis, Prognosis and Treatment of Severe COVID-19 Ilias Giannakodimos
878 [GO] Current Medicinal Chemistry 2022―Dec―07 Current Scenario and Future Prospect in the Management of COVID-19 Pobitra Borah
879 [GO] Current Medicinal Chemistry 2022―Dec―07 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis Stamatios Lampsas
880 [GO] Current Medicinal Chemistry 2022―Dec―07 The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic Rajesh Kumar
881 [GO] Current Medicinal Chemistry 2022―Dec―07 Targeting COVID-19 in Parkinsons Patients: Drugs Repurposed Firoz Anwar
882 [GO] Current Medicinal Chemistry 2022―Dec―07 COVID-19 Vaccine Race: Analysis of Age-Dependent Immune Responses against SARS-CoV-2 Indicates that more than Just One Strategy May Be Needed Mercedes Jimenez
883 [GO] Current Medicinal Chemistry 2022―Dec―07 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARSCoV- 2 Infection Michele Costanzo
884 [GO] Current Medicinal Chemistry 2022―Dec―07 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA Dependent RNA Polymerase (RdRp) Shabana Bibi
885 [GO] Current Medicinal Chemistry 2022―Oct―18 Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed Firoz Anwar
886 [GO] Current Medicinal Chemistry 2022―Oct―18 SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus Michele Costanzo
887 [GO] Current Medicinal Chemistry 2022―Oct―18 In Vitro Data of Current Therapies for SARS-CoV-2 Ioanna Anastasiou
888 [GO] Current Medicinal Chemistry 2022―Oct―05 COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved Alicia B. Pomilio, Arturo A. Vitale, Alberto J. Lazarowski
889 [GO] Current Medicinal Chemistry 2022―Oct―05 Looking for SARS-CoV-2 therapeutics through computational approaches Marilisa Leone, Marian Vincenzi, Flavia Anna Mercurio
890 [GO] Current Medicinal Chemistry 2022―Sep―23 Novel Proline derivatives for Treating COVID-19 Surya K. De
891 [GO] Current Medicinal Chemistry 2022―Sep―06 Putative Therapeutic Impact of Inflammasome Inhibitors against COVID-19-Induced ARDS Seyed Mohammad Nabavi, Aysa Rezabakhsh, Seyed Fazel Nabavi, Adeleh Sahebnasagh, Ahad Shahbazi, Mojde Rahmani, et al. (+8)
892 [GO] Current Medicinal Chemistry 2022―Aug―30 Cannabinoids receptors in Covid-19: Perpetrators and victims Athanasios Alexiou, Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb
893 [GO] Current Medicinal Chemistry 2022―Jul―28 SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
894 [GO] Current Medicinal Chemistry 2022―Jul―04 Imaging markers of neurologic damage in COVID-19: a systematic review Sara Tavares Araújo, Clara Tavares Araújo, Rafael Silva e Castro, Lara Machado de Oliveira Brügger, Nathália Gualberto Souza e Silva, Debora Marques de Miranda, Ana Cristina Simões e Silva
895 [GO] Current Medicinal Chemistry 2022―Jun―28 Review on In silico Methods, High-throughput Screening Techniques, and Cell Culture Based In Vitro Assays for SARS-CoV-2.. Yuksel Cetin, Seyma Aydinlik, Aysen Gungor, Tugce Kan, Timucin Avsar, Serdar Durdagi
896 [GO] Current Medicinal Chemistry 2022―May―07 Chronic systemic low-grade inflammation and modern lifestyle: the dark role of gut microbiota on related diseases with a focus on pandemic COVID-19 Tiziana Mundula, Edda Russo, Lavinia Curini, Francesco Giudici, Andrea Piccioni, Francesco Franceschi, Amedeo Amedei
897 [GO] Current Medicinal Chemistry 2022―Mar―02 COVID-19 Effects on Geriatric Populationand Failures of Aminoquinoline Therapy: Compilation of Studies from EU, USA, and China; Safety and Efficacy of Vaccinesin the Prevention & Treatment of COVID-19 Narasimha M. Beeraka, SubbaRao V Tulimilli, M V Greeshma, Siva Dallavalasa, Yaowen Zhang, Wenjing Xiao, et al. (+6)
898 [GO] Current Medicinal Chemistry 2022―Feb―16 Perspectives and Prospects on mRNA Vaccine Development for COVID-19 Lihui Jin, Zhenyuan Han, Pengjun Zhao, Kun Sun
899 [GO] Current Medicinal Chemistry 2022―Feb―14 Aptamer-based Emerging Tools for Viral Biomarker Detection: A focus on SARS-CoV-2 Prabir Kumar Kulabhusan, Parsa Pishva, Eda Çapkın, Prajakta Tambe, Meral Yüce
900 [GO] Current Medicinal Chemistry 2021―Oct―27 The Role of Endothelial Related Circulating Biomarkers in COVID-19. A Systematic Review and Meta-analysis Stamatios Lampsas, Paraskevas Tsaplaris, Panteleimon Pantelidis, Evangelos Oikonomou, Georgios Marinos, Georgios Charalambous, et al. (+9)
901 [GO] Current Medicinal Chemistry 2021―Sep―02 The impact of Vaccination worldwide on SARS-CoV-2 infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants Douglas Henrique Pereira Damasceno, Arthur Aguiar Amaral, Cecília Andrade Silva, Ana Cristina Simões e Silva
902 [GO] Current Medicinal Chemistry 2021―Aug―23 Cordycepin as a Promising Inhibitor of SARS-CoV-2 RNA dependent RNA polymerase (RdRp) Shabana Bibi, Mohammad Mehedi Hasan, Yuan-Bing Wang, Stavros P. Papadakos, Hong Yu
903 [GO] Current Medicinal Chemistry 2021―Jul―27 Natural Products with tandem Anti-inflammatory, Immunomodulatory and Anti-SARS-CoV/2 effects: A Drug Discovery Perspective against SARS-CoV-2 Luana N. O. Leal da Cunha, Tiago Tizziani, Gabriella B. Souza, Monalisa A. Moreira, José S. S. Neto, Carlos V. D. dos Santos, et al. (+8)
904 [GO] Current Medicinal Chemistry 2021―Jun―24 Interfering Reactive Cysteine Proteome in Covid-19 Disease Marcos Martinez-Banaclocha
905 [GO] Current Medicinal Chemistry 2021―Jun―15 Natural Substances in the Fight of SARS-CoV-2: A Critical Evaluation Resulting from the Cross-Fertilization of Molecular Modeling Data with the Pharmacological Aspects Davide Gentile, Vincenzo Patamia, Virginia Fuochi, Pio M. Furneri, Antonio Rescifina
906 [GO] Current Medicinal Chemistry 2021―May―27 COVID-19: The significance of platelets, mitochondria, vitamin D, serotonin and the gut microbiota István Bókkon, Gábor Kapócs, András Vucskits, Attila Erdöfi-Szabó, Jan Vagedes, Felix Scholkman, Henrik Szőke
907 [GO] Current Medicinal Chemistry 2021―May―27 Interfering with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy Patrick Müller, Hannah Maus, Stefan Josef Hammerschmidt, Philip Knaff, Volker Mailänder, Tanja Schirmeister, Christian Kersten
908 [GO] Current Medicinal Chemistry 2021―May―22 Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni N. Roviello
909 [GO] Current Medicinal Chemistry 2021―May―10 SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm That Implicates For Therapeutic Strategies Zhao-Zhong Chong, Nizar Souayah
910 [GO] Current Medicinal Chemistry 2021―May―05 Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics Rahul Sharma, Dharmendra Khokhar, Bhanushree Gupta, Purnendu Saxena, Kallol Kumar Ghosh, Arvind Kumar Geda, Kamil Kuca
911 [GO] Current Medicinal Chemistry 2021―Apr―06 The Main Receptors Involved with COVID-19: a Systematic Review and Meta-analysis Alice Barros Câmara, Igor Augusto Brandão
912 [GO] Current Medicinal Chemistry 2021―Mar―30 Protein-ligand Docking Simulations with AutoDock4 Focused on the Main Protease of SARS-CoV-2 Walter Filgueira de Azevedo Junior, Gabriela Bitencourt-Ferreira, Joana Retzke Godoy, Hilda Mayela Aran Adriano, Wallyson André dos Santos Bezerra, Alexandra Martins dos Santos Soares
913 [GO] Current Medicinal Chemistry 2021―Feb―19 Advances of Inorganic Materials in the Detection and Therapeutic Uses Against Coronaviruses Sathish Veerasamy, Manivannan Chandrakumar, Malathi Balasubramaniyan, Ramesh Kumar Arumugam, Thanasekaran Pounraj
914 [GO] Current Medicinal Chemistry 2021―Feb―15 Renin Angiotensin System in Central Nervous System diseases and its interaction with COVID-19 Katharina Lanza, Raphael Dias, Rafaela dos Santos Oliveira, Luís Belotto, Aline Silva Miranda, Ana Cristina Simões e Silva
915 [GO] Current Medicinal Chemistry 2021―Feb―10 Nucleoside Inhibitors of Coronaviruses Anastasia A. Zenchenko, Mikhail S. Drenichev, Sergey N. Mikhailov
916 [GO] Current Medicinal Chemistry 2021―Jan―26 Natural Products as Potential Agents Against SARS-CoV and SARS-CoV-2 Joanda Paolla Raimundo e Silva, Chonny Alexander Herrera Acevedo, Thalisson Amorim de Souza, Renata Priscila Barros de Menezes, Zoe L. Sessions, Lucas Silva Abreu, et al. (+6)
917 [GO] Current Medicinal Chemistry 2021―Jan―14 Deep learning in the quest for compound nomination for fighting COVID-19 Maria Mernea, Eliza. C. Martin, Andrei-José Petrescu, Speranta Avram
918 [GO] Current Medicinal Chemistry 2021―Jan―08 Machine Intelligence Techniques for the Identification and Diagnosis of COVID-19 Sumera Zaib, Nehal Rana, Areeba Noor, Imtiaz Khan
919 [GO] Current Medicinal Chemistry 2020―Dec―10 The role of Interleukin-6 in the pathogenesis, prognosis and treatment of severe COVID-19 Ilias Giannakodimos, Georgia-Vasiliki Gkountana, Dimosthenis Lykouras, Kiriakos Karkoulias, Sotiris Tsakas
920 [GO] Current Medicinal Chemistry 2020―Oct―28 COVID-19 vaccine race: analysis of age-dependent immune responses against SARS-CoV-2 indicates that more than just one strategy may be needed. Nuria E. Campillo, Mercedes Jimenez, Matilde Canelles
921 [GO] Current Medicinal Chemistry 2020―Oct―28 COVID-19: innovative antiviral drugs required for long-term prevention and control of coronavirus diseases Norman A. Ratcliffe, Helena C. Castro, Izabel C. Paixão, Cicero B. Mello
922 [GO] Current Medicinal Chemistry 2020―Oct―28 Recent Advances towards Drug Design Targeting the Protease of 2019 novel coronavirus (2019-nCoV) Sehrish Bano, Abdul Hameed, Mariya Al-Rashida, Shafia Iftikhar, Jamshed Iqbal
923 [GO] Current Medicinal Chemistry 2020―Oct―27 Evidence and the main adverse effects regarding drug therapies in the war against COVID-19 Mauricio Mora-Ramírez, Paulina Melgoza-Hernández, Sebastian Eduardo Toledo-Ramírez, Juan Manuel Mejía Aranguré
924 [GO] Current Medicinal Chemistry 2020―Oct―06 COVID-19 related coagulopathy: what is known up to now Ana Luísa Batista Pena, Rafael Arantes Oliveira, Renata Gomes Severo, Ana Cristina Simões e Silva
925 [GO] Current Medicinal Chemistry 2020―Sep―09 Current scenario and future prospect in the management of COVID-19 Pobitra Borah, Pran Kishore Deb, Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, et al. (+2)
926 [GO] Current Medicinal Chemistry 2020―Sep―05 Targeting COVID-19 in Parkinson’s patients: Drugs repurposed. Firoz Anwar, Salma Naqvi, Fahad A. Al-Abbasi, Nauroz Neelofar, Vikas Kumar, Ankit Sahoo, Mohammad Amjad Kamal
927 [GO] Current Medicinal Chemistry 2020―Sep―03 Renin-angiotensin system (RAS) and immune system profile in specific subgroups with COVID-19 Ludimila de Barcelos Ubaldo Martins, Luiz Gustavo Pessoa Pires Jabour, Cristina Cerqueira Vieira, Lucas Crepaldi Carvalho Nery, Raphael Figuiredo Dias, Ana Cristina Simões e Silva
928 [GO] Current Medicinal Chemistry 2020―Jul―22 Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19 Mark Laws, Yasmin M. Surani, Md. Mahbub Hasan, Yiyuan Chen, Peiqin Jin, Taha AlAdhami, et al. (+6)
929 [GO] Current Medicinal Chemistry 2020―Jul―11 Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions Anil K. Sharma, Varruchi Sharma, Arun Sharma, Suresh Pallikkuth
930 [GO] Current Medicinal Chemistry 2020―Jul―02 The chronicle of COVID-19: possible strategies to curb the pandemic Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Githa Elizabeth Mathew, Simone Carradori, Bijo Mathew
931 [GO] Current Medicinal Chemistry 2020―May―13 In vitro data of current therapies for SARS-CoV-2 Ioanna A. Anastasiou, Ioanna Eleftheriadou, Anastasios Tentolouris, Dimitrios Tsilingiris, Nikolaos Tentolouris
932 [GO] Current Medicinal Chemistry 2020―Apr―16 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus Michele Costanzo, Maria Anna Rachele De Giglio, Giovanni Nicola Roviello
933 [GO] Current Molecular Medicine 2023―Jun―14 Therapeutic Management with Repurposing Approaches: A Mystery During COVID-19 Outbreak Paranjeet Kaur, Sanjeev Kumar Sahu, Soumik Chaudhury, Deepali Gupta, Palak Anand, Manish Chaudhary, et al. (+7)
934 [GO] Current Molecular Medicine 2023―Apr―18 Emerging treatment approaches for COVID-19 infection: A Critical Review Alok Bharadwaj, Rasanpreet Kaur, Saurabh Gupta
935 [GO] Current Molecular Medicine 2023―Apr―11 Covid-19 prevention and treatment by targeting Fc-fusion proteins: An experience to fight emerging diseases Fahimeh Ghasemi, Hamed Zare, Tahereh Farkhondeh, Hamid Bakherad, Hengame Sharifi, Maryam Hosseinzade Shirzeyli, Saeed Samarghandian
936 [GO] Current Molecular Medicine 2022―Dec―26 Therapeutic challenges in COVID-19 Amit K Maiti
937 [GO] Current Molecular Medicine 2022―Dec―06 Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview Saiyad Bastaminejad
938 [GO] Current Molecular Medicine 2022―Dec―06 Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study Siyamak Shahab
939 [GO] Current Molecular Medicine 2022―Nov―07 Direct SARS-CoV-2 Detection System Utilizing Simple-to-Use Capillary Gel Electrophoresis Sample-to-Result Varoujan Amirkhanian, Neo Yang, Meya Kuo, Jerry Liu, Eric Tsai
940 [GO] Current Molecular Medicine 2022―Aug―05 Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview Saiyad Bastaminejad
941 [GO] Current Molecular Medicine 2022―Jul―17 Quercetin and its Relative Therapeutic Potential Against COVID-19: A Retrospective Review and Prospective Overview Bastaminejad, S
942 [GO] Current Molecular Medicine 2022―Jul―17 Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study Shahab, S
943 [GO] Current Molecular Medicine 2022―Jan―07 Nucleic Acid-Based Vaccines Platform Against Covid-19 Pandemic Roghayyeh Baghban, Shirin Mahmoodi
944 [GO] Current Molecular Medicine 2021―Nov―18 The Pandemic of Coronavirus Disease 2019 (COVID-19) Nurshamimi Nor Rashid
945 [GO] Current Molecular Medicine 2021―Oct―14 Molecular Insights of SARS-CoV-2 Infection and Molecular Treatments Lama Abdurrahman, Xiaoqian Fang, Yonghong Zhang
946 [GO] Current Molecular Medicine 2021―Oct―05 The Relation of the Viral Structure of SARS-CoV2, High-Risk Condition, and Plasma Levels of IL-4, IL-10, and IL-15 in COVID-19 Patients compared to SARS and MERS Infections Leila Mousavizadeh, Ramin Soltani, Kosar Abedini, Sorayya Ghasemi
947 [GO] Current Molecular Medicine 2021―Sep―13 The Platelet Role in Severe and Fatal Forms of COVID-19. Edgar L. Esparza-Ibarra, Jorge L. Ayala-Luján, Brenda Mendoza-Almanza, Irma González-Curiel, Susana Godina-González, Marisa Hernández-Barrales, Gretel Mendoza-Almanza
948 [GO] Current Molecular Medicine 2021―Sep―13 An inventory of diagnostic tools for detection of COVID-19 Akansha Bhatt, Zeeshan Fatima, Munindra Ruwali, Saif Hameed
949 [GO] Current Molecular Medicine 2021―Aug―16 Low pH and temperature of airway surface liquid are key determinants that potentiate SARS-CoV-2 infectivity Nilesh Kumar Sharma, Sachin C Sarode
950 [GO] Current Molecular Medicine 2021―Aug―04 Combating the progression of novel coronavirus SARS-CoV-2 infectious Disease: Current state and future prospects in molecular diagnostic and drug discovery Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Sharad Thakur, Sanjay Kumar
951 [GO] Current Molecular Medicine 2021―May―12 To vaccinate or not to vaccinate; that is the question! (New insights on COVID-19 Vaccination) Sarah El-Nakeep
952 [GO] Current Molecular Medicine 2021―Apr―08 COVID-19 and ARDS: Update On Preventive And Therapeutic Venues Arun Narota, Gayatri Puri, Vikram Pal Singh, Ashwani Kumar, Amarjit S Naura
953 [GO] Current Molecular Medicine 2021―Feb―24 SARS-CoV-2 proteins: Are they useful as targets for COVID-19 drugs and vaccines? Mohammed Elimam Ahamed Mohammed
954 [GO] Current Molecular Medicine 2021―Feb―19 Phyto-compounds from a rather poisonous plant, Strychnos nux-vomica, show high potency against SARS-CoV-2 RNA-dependent RNA polymerase Acharya Balkrishna, Subarna Pokhrel, Anurag Varshney
955 [GO] Current Molecular Medicine 2020―Dec―04 Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective Maryam Darvish, Mahshid Shahverdi
956 [GO] Current Molecular Medicine 2020―Dec―04 Molecular characterization of SARS-CoV-2 Miribane Dërmaku-Sopjani, Mentor Sopjani
957 [GO] Current Molecular Medicine 2020―Nov―19 Addressing the importance of Stem cell-based therapy: a Perspective in the treatment of COVID-19 Christine Ibrahim, Hanna Semaan, Marwan El-Sabban, Fadia Najjar, Aline Hamade
958 [GO] Current Molecular Medicine 2020―Nov―16 Do genetic factors predispose people to COVID-19: A review article Ava Nasrolahi, Karimeh Haghani, Ali Gheysarzadeh, Salar Bakhtiyari
959 [GO] Current Molecular Medicine 2020―Sep―24 Quercetin and its relative therapeutic potential against COVID-19: A retrospective review and prospective overview Saiyad Bastaminejad, Salar Bakhtiyari
960 [GO] Current Molecular Medicine 2020―Jul―14 NPC1 as a Modulator of Disease Severity and Viral Entry of Sars-CoV-2 Cecilia Vial, Juan Francisco Calderón, Andrés D. Klein
961 [GO] Current Molecular Medicine 2020―May―21 Triazavirin - Potential inhibitor for 2019-nCoV Coronavirus M protease: A DFT study Siyamak Shahab, Masoome Sheikhi
962 [GO] Current Molecular Pharmacology 2022―Nov―23 Thwarting coronavirus infections by tapping host targets: The ‘Greek gift sacrifice’ to curb the menace of drug resistance Pobitra Borah, Sangeeta Hazarika
963 [GO] Current Molecular Pharmacology 2022―Sep―12 COVID-19 and diabetes: will novel drugs for diabetes help in COVID-19? Pranav Kumar Prabhakar, Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Gomaa Mostafa-Hedeab, Rupal Dubey
964 [GO] Current Molecular Pharmacology 2022―Jan―13 Polysaccharides to combat viruses (Covid-19) and microbes: New updates Manaf AlMatar, Essam A. Makky, Aizi Nor Mazila Ramli, Nesibe Ebru Kafkas, Fatih Köksal
965 [GO] Current Molecular Pharmacology 2021―Oct―14 Pharmacotherapy for SARS-CoV-2 and Seizures for drug repurposing presumed on Mechanistic Targets Divya Goel, Ankit Srivastava, Ángel Aledo-Serrano, Anuja Krishnan, Divya Vohora
966 [GO] Current Molecular Pharmacology 2021―Sep―07 Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Petra Krafcikova, Evzen Boura, Murali Aarthy, Muthuraja Arun Pravin, Sanjeev Kumar Singh
967 [GO] Current Molecular Pharmacology 2021―Sep―03 Impact of Sitagliptin in Non-Diabetic Covid-19 Patients Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Athanasios Alexiou, Gaber El-Saber Batiha
968 [GO] Current Molecular Pharmacology 2021―Aug―12 Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19 Sundaresan Bhavaniramya, Vanajothi Ramar, Selvaraju Vishnupriya, Ramasamy Palaniappan, Ashokkumar Sibiya, Vaseeharan Baskaralingam
969 [GO] Current Molecular Pharmacology 2020―Sep―01 COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management Asis Bala, Abhijit Sengupta, Motlalepula Gilbert Matsabisa, Hlupheka P Chabalala
970 [GO] Current Molecular Pharmacologye 2023―Jul―30 Impact of Sitagliptin on Non-diabetic Covid-19 Patients
971 [GO] Current Nanomaterials 2021―Jan―06 Nanotechnology based approaches for COVID-19: A Path forward Suraj N. Mali, Amit P. Pratap
972 [GO] Current Nanomedicine 2020―Oct―07 COVID-19: Structure, Replication and Its Global Scenario Swati Chauhan
973 [GO] Current Nanoscience 2023―Jul―17 The Role Of Biosensors In Detection Of SARS-Cov-2: State-Of-The-Art And Future Prospects Amit Prabhakar, Deepti Verma, Nimisha Roy, Abhipsha Khadanga, Amar Dhwaj
974 [GO] Current Nanoscience 2023―Feb―03 Current Advances in Nanomaterial-associated Micro- and Nano-devices for SARS-CoV-2 Detection Tijjani Adam, Th. S. Dhahi, Subash C.B. Gopinath, U. Hashim, Aeshah M Mohammed, Mohammed Mohammed, M.N.A. Uda
975 [GO] Current Nanoscience 2022―May―12 An Adaptive Fuzzy Neural Network Technique for Coronavirus-Based Bio-Nano Communication Systems Mohammed S. Alzaidi, Ghalib H. Alshammri, K. S. Al Noufaey
976 [GO] Current Nanoscience 2021―Nov―18 Role of lipid Nanoparticles in COVID-19 inrepurposing drugs and vaccines Rajesh Basnet, Til Bahadur Basnet, Buddha Bahadur Basnet, Sandhya Khadka, Sanjeep Sapkota
977 [GO] Current Nanoscience 2021―Nov―18 Application of silver nanoparticles as a new alternative antiviral agent for SARS-CoV-2: A Review Reena Jamunkar, Kamlesh Shrivas, Deepak Sinha, Sanyukta Patel, Alka Patle, Antresh Kumar, Subhash Banerjee
978 [GO] Current Nanoscience 2021―Feb―10 Can Machine Learning and Nanotechnology help the fight against current COVID-19 crisis? Venkatasubbaiah Rashmi, Kanchana V., Jha Prakash Kumar, Konasur Rajesh Sanjay
979 [GO] Current Nanoscience 2020―Oct―15 Prevention, diagnosis and treatment of COVID-19: a nanotechnological perspective Pankaj Kumar Tyagi, Shruti Tyagi, Mansi Mishra, Kavya Dashora
980 [GO] Current Neuropharmacology 2023―Oct―09 Abusive use of Zolpidem as a Result of COVID-19 and Perspectives of Continuity of the Problem in the Post-Pandemic Period Wesley Dawison de Lima, Michael Douglas da Silva, Eurico de Souza Costa, Francisco Irochima Pinheiro, Eduardo Pereira de Azevedo, Ricardo Ney Cobucci, et al. (+2)
981 [GO] Current Neuropharmacology 2023―Jul―30 Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19
982 [GO] Current Neuropharmacology 2023―Jun―16 Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19 Cindy Bandala, Eleazar Lara-Padilla, Noemí Cárdenas-Rodríguez, Samuel Reyes-Long, Alfredo Cortés-Algara, Itzel Jatziri Contreras-García, et al. (+5)
983 [GO] Current Neuropharmacology 2022―Dec―07 Emerging Evidence for Neuropsycho-Consequences of COVID-19 Jingwen Li
984 [GO] Current Neuropharmacology 2022―Jul―17 Emerging Evidence for Neuropsycho-Consequences of COVID-19 Li, JW
985 [GO] Current Neuropharmacology 2022―Mar―11 Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19-related trauma Sergio De Filippis, Ginevra Lombardozzi, Marta Matrone, Emanuela Amici, Giada Trovini, Filippo Perrini, et al. (+3)
986 [GO] Current Neuropharmacology 2021―Dec―24 Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19 George B. Stefano, Pascal Büttiker, Simon Weissenberger, Radek Ptacek, Fuzhou Wang, Tobias Esch, et al. (+2)
987 [GO] Current Neuropharmacology 2021―Jul―30 Fluvoxamine and amantadine: central nervous system acting drugs repositioned for COVID-19 as early intervention Konrad Rejdak, Paweł Grieb
988 [GO] Current Neuropharmacology 2021―Jun―30 The impact of SARS-Cov-2 on the Nervous system and Mental Health Mohamed Said Boulkrane, Victoria Ilina, Roman Melchakov, Mikhail Arisov, Julia Fedotova, Lucia Gozzo, et al. (+5)
989 [GO] Current Neuropharmacology 2021―Apr―08 C-Phycocyanin-derived Phycocyanobilin as a Potential Nutraceutical Approach for Major Neurodegenerative Disorders and COVID-19-induced Damage to the Nervous System Giselle Pentón-Rol, Javier Marín-Prida, Mark F. McCarty
990 [GO] Current Neuropharmacology 2021―Mar―31 Drugs used in the treatment of multiple sclerosis during COVID-19 pandemic: a critical viewpoint Marika Alborghetti, Gianmarco Bellucci, Antonietta Gentile, Chiara Calderoni, Ferdinando Nicoletti, Ruggero Capra, et al. (+2)
991 [GO] Current Neuropharmacology 2021―Mar―16 The Stress of the COVID-19 Pandemic: Beyond the Data Samina Salim
992 [GO] Current Neuropharmacology 2021―Jan―14 Crosstalk Between Covid-19 And Associated Neurological Disorders: A Review Subham Das, Alex Joseph
993 [GO] Current Neuropharmacology 2021―Jan―14 PTSD in the COVID-19 Era Farah Chamaa, Hisham F. Bahmad, Batoul Darwish, Jana M. Kobeissi, Malak Hoballah, Sibell Bou Nassif, et al. (+4)
994 [GO] Current Neuropharmacology 2020―May―07 Emerging evidence for neuropsycho-consequences of COVID-19 Jingwen Li, Xi Long, Qing Zhang, Xi Fang, Fang Fang, Xuefei Lv, et al. (+6)
995 [GO] Current Neurovascular Research 2023―Feb―03 APOE4: A Culprit for the Vulnerability of COVID-19 in Alzheimer's Patients Neetu Agrawal, Ahsas Goyal, Prashant Singh Kushwah, Shilpi Pathak
996 [GO] Current Neurovascular Research 2022―Dec―27 Apolipoprotein-ε4 allele (APOE-ε4) as a Mediator of Cognitive Loss and Dementia in Long COVID-19 Kenneth Maiese
997 [GO] Current Neurovascular Research 2022―Dec―06 Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19 Kenneth Maiese
998 [GO] Current Neurovascular Research 2022―Oct―18 Clinical Characteristics of Inpatients with Coronavirus Disease 2019 and Acute Ischemic Stroke: From Epidemiology to Outcomes Shiling Chen
999 [GO] Current Neurovascular Research 2022―Oct―18 Pericytes Within A Pulmonary Neurovascular Unit in Coronavirus Disease 2019 Elicited Pathological Changes Zhen He
1000 [GO] Current Neurovascular Research 2022―Jul―31 Clinical Characteristics of Inpatients with Coronavirus Disease 2019 and Acute Ischemic Stroke: From Epidemiology to Outcomes Shiling Chen
1001 [GO] Current Neurovascular Research 2022―Jul―31 Pericytes Within A Pulmonary Neurovascular Unit in Coronavirus Disease 2019 Elicited Pathological Changes Zhen He
1002 [GO] Current Neurovascular Research 2022―Jul―17 Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19 Kenneth Maiese
1003 [GO] Current Neurovascular Research 2022―Jul―17 Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic Mengmeng Ma, Jiajia Bao, Jinghuan Fang, Changling Li, Yanbo Li, Wenjing Ge, et al. (+3)
1004 [GO] Current Neurovascular Research 2021―Dec―24 The Oversight of Circadian Clock Genes for the Detection, Prevention, and Treatment of COVID-19 Infection Kenneth Maiese
1005 [GO] Current Neurovascular Research 2021―Sep―28 Acute Ischaemic Stroke Incidence after Coronavirus Vaccine in Indonesia: Case Series Rakhmad Hidayat, Dinda Diafiri, Ramdinal Aviesena Zairinal, Ghafur Rasyid Arifin, Faiza Azzahroh, Nita Widjaya, et al. (+5)
1006 [GO] Current Neurovascular Research 2021―Mar―16 Impact of Headache Frequency and Sleep during the COVID-19 Pandemic among Migraine Patients Mengmeng Ma, Jiajia Bao, Jinghuan Fang, Changling Li, Yanbo Li, Wenjing Ge, et al. (+3)
1007 [GO] Current Neurovascular Research 2020―Dec―23 Pericytes within a pulmonary neurovascular unit in coronavirus disease 2019-elicited pathological changes Zhen He
1008 [GO] Current Neurovascular Research 2020―Dec―04 Circadian Clock Genes: Targeting Innate Immunity for Antiviral Strategies Against COVID-19 Kenneth Maiese
1009 [GO] Current Neurovascular Research 2020―Nov―12 Clinical characteristics of inpatients with Coronavirus disease 2019 and acute ischemic stroke: from epidemiology to outcomes Shiling Chen, Chao Pan, Ping Zhang, Yingxin Tang, Zhouping Tang
1010 [GO] Current Neurovascular Research 2020―Jul―28 Neurological Complications in COVID-19 Patients and its Implications for Associated Mortality Hanin A. AboTaleb
1011 [GO] Current Neurovascular Research 2020―May―22 Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research Mehmet Bostanciklioglu, Ebru Temiz
1012 [GO] Current Neurovascular Research 2020―Apr―26 The mechanistic target of rapamycin (mTOR): Novel Considerations as an Antiviral Treatment and Possibilities for COVID-19 Kenneth Maiese
1013 [GO] Current Nutraceuticals 2023―Feb―22 The Potential Role of Probiotics in the Management of COVID-19 Sangeeta Huidrom, Mirza Atif Beg, Shalu Bawa, Shruti Malhotra
1014 [GO] Current Nutraceuticals 2022―Feb―25 Role of natural plant products against Hemagglutinin-esterase (HE) of human coronavirus Mantasha Idrisi, Mohd. Shahid, Falaq Naz, Yasir Hasan Siddique
1015 [GO] Current Nutrition & Food Science 2024―Mar―01 Opportunities and Regulatory Challenges of Functional Foods and Nutraceuticals During COVID-19 Pandemic Jobin Jose, Keyidaule Ndang, Madhusoodhana Ballakkuraya Chethana, Chikmagalur Srinath Chinmayi, Khatheeja Afrana, Gopika Gopan, et al. (+5)
1016 [GO] Current Nutrition & Food Science 2023―Jul―19 Role of Indian Medicinal Plants for Immunity Booster against SARS-CoV-2 Infection: An updated review Neelam Yadav, Kavita Verma, Yoganchal Mishra, Neha Kapoor
1017 [GO] Current Nutrition & Food Science 2022―Dec―06 Bioactive Compounds from Medicinal Plants and their Possible Effect as Therapeutic Agents against COVID-19: A Review Khairan Khairan
1018 [GO] Current Nutrition & Food Science 2022―Oct―05 Can postbiotics prevent or improve SARS-CoV-2? Nader Khani, Aziz Homayouni-Rad, Roya Abedi Soleimani
1019 [GO] Current Nutrition & Food Science 2022―Aug―03 Bioactive Compounds from Medicinal Plants and their Possible Effect as Therapeutic Agents against COVID-19: A Review
1020 [GO] Current Nutrition & Food Science 2022―Jul―17 Bioactive Compounds from Medicinal Plants and their Possible Effect as Therapeutic Agents against COVID-19: A Review Khairan, K
1021 [GO] Current Nutrition & Food Science 2022―Jun―07 Mediterranean Diet adherence and physical activity level in adolescents during the lockdown under the COVID-19 pandemic: A cross-sectional study in Greek Island of Rhodes Charistoula Chatzinikola, Vasileios Papavasileiou, Antonios Koutelidakis
1022 [GO] Current Nutrition & Food Science 2022―May―27 Nutrition Intervention for Undernourished Older People amid the COVID-19 Pandemic Fatmah Fatmah
1023 [GO] Current Nutrition & Food Science 2022―May―13 Enhancing the Immune System with Vitamin D: Especial Emphasis on Prevention of COVID-19 and Complications Abida Parveen, Bushra Parveen, Sultan Zahiruddin, Rabea Parveen, Nidhi Agarwal, Shahid Husain Ansari, Sayeed Ahmad
1024 [GO] Current Nutrition & Food Science 2022―Apr―22 Vitamin D focused approach of nutritional therapy for the management of SARS-CoV-2 pandemic: A Review Deepika Pawar, Anita Kumari, Rotimi E. Aluko, Ashwani Kumar
1025 [GO] Current Nutrition & Food Science 2022―Apr―18 Nutrition and Immunity to Combat Infectious Diseases: The Importance of Traditionally Fermented Vegetables in a Mediterranean Diet against COVID-19 Aline Issa, Jacqueline Doumit
1026 [GO] Current Nutrition & Food Science 2022―Apr―06 Vitamin K: A Simple and Efficient Add-on to the Current Treatment Regime of COVID-19 Souparnika Sreelatha, Nayana Devang, Aradhana Marathe
1027 [GO] Current Nutrition & Food Science 2022―Mar―25 Role of Nutrition in COVID-19: Present Knowledge and Future Guidelines Maruti J. Dhanavade, Kails D. Sonawane
1028 [GO] Current Nutrition & Food Science 2022―Mar―14 Nutrition and a Balanced Diet in the Elderly During the COVID-19 Pandemic Özge Esgin, Tayyibe Erten
1029 [GO] Current Nutrition & Food Science 2021―Dec―24 Comparison of the General Dietary Habits and Lifestyle between Before and During COVID-19 among the Saudi Adult's Population in Riyadh Nouf A. ALkharashi
1030 [GO] Current Nutrition & Food Science 2021―Oct―12 Possible effect of Astaxanthin on obesity related increased COVID-19 infection morbidity and mortality Elif Didem Örs, Şenay Burçin Alkan, Abdullah Öksüz
1031 [GO] Current Nutrition & Food Science 2021―Sep―07 Impact of Nutrition in the Management of Nutritional Status of Covid-19 Patients Shashi Soni, Uroosa Noor, Ena Gupta
1032 [GO] Current Nutrition & Food Science 2021―May―12 Clinical and Nutritional Implications of Kidney Disease and COVID-19 Hazel Ester Anderson Vasquez, Cristhy Albornoz, Luis D´Marco, Daniela Ariza, Valery Morillo, Ruben Carrasquero, et al. (+3)
1033 [GO] Current Nutrition & Food Science 2021―Feb―25 The Effect of Potato Almond Orange Cookies on Their Weight, BMI, Hemoglobin, and Lymphocyte Status of Undernourished Older People during COVID-19 Pandemic
1034 [GO] Current Nutrition & Food Science 2021―Jan―13 Bioactive Compounds from Medicinal Plants and Their Possible Effect as Therapeutics Agents against COVID-19: A Review Khairan Khairan, Rinaldi Idroes, Trina E. Tallei, Muhammad J. Nasim, Claus Jacob
1035 [GO] Current Nutrition & Food Science 2020―Nov―03 Winning Back the Consumer’s Confidence and Ensuring Consumer Safety in the COVID-19 Regime is Necessary for Revival of the Processed Food Industry Arabinda Mahanty, Srikanta Lenka, Prakash C. Rath
1036 [GO] Current Nutrition & Food Science 2020―Aug―24 Milk Oligosaccharides and Lectins as Candidates for Clinical Trials Against Covid-19 Mourad Errasfa
1037 [GO] Current Organic Synthesis 2023―Mar―22 Recent Discovery of Triazine Derivatives as Protease Inhibitors for the Treatment of Coronavirus-19 (COVID-19) Surya K. De
1038 [GO] Current Organic Synthesis 2022―Dec―06 Molecular Descriptors of Some Chemicals that Prevent COVID-19 Sourav Mondal
1039 [GO] Current Organic Synthesis 2022―Jul―17 Molecular Descriptors of Some Chemicals that Prevent COVID-19 Sourav Mondal
1040 [GO] Current Organic Synthesis 2022―Apr―18 Synthesis and molecular docking and of new 1,2,3-triazole carbohydrates with COVID-19 proteins Naoufel Ben Hamadi, Ahlem Guesmi, Faisal K. Algathami, Lotfi Khezami, Wided Nouira, Wesam Abd El-Fattah
1041 [GO] Current Organic Synthesis 2020―Dec―09 Molecular descriptors of some chemicals that prevent COVID-19 Sourav Mondal, Nilanjan De, Anita Pal, Wei Gao
1042 [GO] Current Organic Synthesis 2020―Sep―25 Therapeutic Options and Treatment Strategies Against COVID-19 in China Zhiwei Miao, Yan Cai, Jing Meng, Weihong Zhou
1043 [GO] Current Organocatalysis 2023―Oct―11 More Widespread use of Ivermectin for the Treatment of COVID-19 Infec-tion could have Saved Many Alberto Boretti, Bimal K. Banik
1044 [GO] Current Organocatalysis 2020―Sep―09 Asymmetric Organocatalyzed Warfarin Synthesis in aqueous and nonaqueous media: A discussion in the era of COVID-19 pandemic Anirban Mondal, Kartick C. Bhowmick
1045 [GO] Current Pediatric Reviews 2023―Aug―22 SARS-CoV-2 Encephalitis versus Influenza Encephalitis: More Similarities than Differences Kam Lun Hon, Alexander K.C. Leung, Yok Weng Tan, Karen K. Y. Leung, Paul K. S. Chan
1046 [GO] Current Pediatric Reviews 2023―Jul―18 COVID-19 associated croup Kam Lun Hon, Yok Weng Tan, Karen K. Y. Leung, Wun Fung Hui, Swee Fong Tang, Su Yun Qian, Wa Keung Chiu
1047 [GO] Current Pediatric Reviews 2023―Apr―19 Extracorporeal membrane oxygenation (ECMO) in an infant with COVID-19: A case report with literature review Raffaele Falsaperla, Marco Simone Vaccalluzzo, Ausilia Desiree Collotta, Martino Ruggieri, Salvatore Agati
1048 [GO] Current Pediatric Reviews 2023―Feb―27 Mask wearing and childhood COVID-19: A local perspective KL Hon, Yok W Tan, KKY Leung
1049 [GO] Current Pediatric Reviews 2023―Feb―15 A Review of the Effects of the COVID-19 Pandemic on Children and Adolescents’ Mental Health Beatrice Mofoluwaso Fasogbon, Damilola Deborah Omoleye, Oluwayemisi Olubukola Abidakun, Rachael Oluwadamilola Akinje, Oluwaseun Hannah Ademuyiwa
1050 [GO] Current Pediatric Reviews 2022―Oct―18 COVID-19 and Comorbidities: Is Inflammation the Underlying Condition in Children? A Narrative Review Giulia Pinna
1051 [GO] Current Pediatric Reviews 2022―Aug―26 Elimination, containment, and mitigation of COVID-19: A personal story about international travels K.L. Hon, Karen K.Y. Leung
1052 [GO] Current Pediatric Reviews 2022―Jul―31 Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review André Luís Vieira Drumond Yuri Márcio Campos
1053 [GO] Current Pediatric Reviews 2022―Jun―20 Pediatric COVID-19 acute encephalopathy and mortality. Kam Lun Hon, Yok Weng Tan, KKY Leung, Wing Lum Cheung, Wun Fung Hui, Fung Shan Chung, Alcy Torres
1054 [GO] Current Pediatric Reviews 2021―Dec―21 COVID-19 vaccination in children: an open question Giuseppe Campagnani, Flaminia Bardanzellu, Maria Cristina Pintus, Vassilios Fanos, Maria Antonietta Marcialis
1055 [GO] Current Pediatric Reviews 2021―Dec―07 Recent insights into COVID-19 in children and clinical recommendations Jairo Castellar-López, Wendy Villamizar-Villamizar, Aldo Amaranto-Pallares, Wendy Rosales-Rada, Maria De Los Angeles Vélez Verbel, Aileen Chang, et al. (+2)
1056 [GO] Current Pediatric Reviews 2021―Nov―25 Maternal SARS-CoV-2 Infection, Its Vertical Transmission and Impact on Overall Perinatal Outcomes: A Narrative Review Naina Kumar, Vikas Bhatia
1057 [GO] Current Pediatric Reviews 2021―Sep―25 Renal involvement in pediatric patients with COVID-19: an up-to-date Yuri Márcio Campos, André Luís Vieira Drumond, Mariane de Matos Gamonal, Milena Pereira Parreira, Ana Cristina Simões e Silva
1058 [GO] Current Pediatric Reviews 2021―Sep―21 Coronavirus disease 2019 (COVID-19) and Pregnancy: A narrative review Mandana Zafari, Mohammad Taha Saadati Rad, Fatemeh Mohseni
1059 [GO] Current Pediatric Reviews 2021―May―31 Impact of COVID-19 Lockdown on Lethality of Suicide Cases Asma H Almaghrebi
1060 [GO] Current Pediatric Reviews 2021―May―27 COVID-19 IN CHILDREN: A NARRATIVE REVIEW Jennifer F Ha
1061 [GO] Current Pediatric Reviews 2021―May―16 COVID-19 and Children’s Mental Health: Identifying Challenges and the New Normal Aniruddh Behere, Brittany N. Barber Garcia
1062 [GO] Current Pediatric Reviews 2021―Apr―07 Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Review Sofia Βenou, Shamez Ladhani, Gabriel Dimitriou, Despoina Gkentzi
1063 [GO] Current Pediatric Reviews 2021―Mar―30 COVID-19 in Pediatrics: a Diagnostic Challenge Amal A. Mohamed, Nouran Mohamed, Sherief Abd-Elsalam, Sanaa Mohammed ElSadek, Hoda Hegazy Ahmed, Hams Ahmed Taha, et al. (+2)
1064 [GO] Current Pediatric Reviews 2020―Nov―24 Respiratory Therapeutic Strategies in Children and Adolescents with COVID-19: a Critical Review Giovana Pascoali Rodovanski, Susana da Costa Aguiar, Bruna Samantha Marchi, Patricia do Nascimento Oliveira, Livia Arcêncio, Danielle Soares Rocha Vieira, Cristiane Aparecida Moran
1065 [GO] Current Pediatric Reviews 2020―Nov―13 COVID-19 and Comorbidities: is Inflammation the Underlying Condition in Children? A narrative Review Giulia Pinna, Lavinia Sanfilippo, Pier Paolo Bassareo, Vassilios Fanos, Maria Antonietta Marcialis
1066 [GO] Current Pharmaceutical Analysis 2022―Oct―18 New Coronavirus Outbreak Anastasios Economou
1067 [GO] Current Pharmaceutical Analysis 2021―Mar―10 Crisis in Crisis: COVID-19 and alcohol compete to kill people in Iran Mahdi Naeim
1068 [GO] Current Pharmaceutical Analysis 2020―Nov―04 Therapeutic Monitoring of Plasma Digoxin for COVID-19 Patients Using a Simple UPLC-MS/MS Method Yaru Xing, Lin Yin, Mingquan Guo, Huichun Shi, Tangkai Qi, Lin Wang, et al. (+5)
1069 [GO] Current Pharmaceutical Analysis 2020―Apr―28 New Coronavirus Outbreak Anastasios Economou
1070 [GO] Current Pharmaceutical Biotechnology 2024―Jan―23 Obesity and its Relationship with Covid-19: A Review of the Main Pharmaceutical Aspects Katharine Hodel, Ananda Fonseca, Islania Barbosa, Caio Medina, Brenda Alves, Carine Maciel, et al. (+5)
1071 [GO] Current Pharmaceutical Biotechnology 2023―May―26 Weapons and Strategies against COVID-19: A Perspective Raghav Mishra, Kajal Chaudhary, Isha Mishra
1072 [GO] Current Pharmaceutical Biotechnology 2023―Mar―28 Recent Trends on Production Sources, Biosynthesis Pathways and Antiviral Efficacies of Artemisinin: A Candidate Phytomedicine Against SARS-CoV-2 Adil Hussain
1073 [GO] Current Pharmaceutical Biotechnology 2023―Mar―02 Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2: A Review Rupesh K. Gautam, Ashutosh Pareek, Yashumati Ratan, Aishwarya Rajput, Vivek Jain, Dinesh Kumar Mishra
1074 [GO] Current Pharmaceutical Biotechnology 2023―Feb―27 Comparative pharmacological efficacy of COVID-19 vaccines against the variants of concerns (VOCs) of SARS-CoV-2: Recent clinical Studies on Booster dose Ruitai Fan, Di Zhao, Xiaoyan Wang, Junqi Liu, Chinnappa AU, Vijaya Basavaraj, et al. (+4)
1075 [GO] Current Pharmaceutical Biotechnology 2023―Feb―03 Convalescent Plasma Therapy against COVID-19: An update on the changing facets of the ongoing Pandemic Saquib Shahabe Abullais, Suraj Arora, Shadma Wahab, Vishakha Grover, Mohammed Yahya Al-Shahrani, Shaik Mohamed Shamsudeen, et al. (+3)
1076 [GO] Current Pharmaceutical Biotechnology 2023―Jan―03 Biosensors - A Miraculous Detecting Tool in Combating the War against COVID-19 Rohitas Deshmukh, Sakshi Mishra, Rajesh Singh
1077 [GO] Current Pharmaceutical Biotechnology 2022―Dec―07 The Potential Mechanism of N-acetylcysteine in Treating COVID-19 Nan Zhou
1078 [GO] Current Pharmaceutical Biotechnology 2022―Dec―07 Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review Muhammad Idrees
1079 [GO] Current Pharmaceutical Biotechnology 2022―Dec―07 The use of Pseudotyped Coronaviruses for the Screening of EntryInhibitors: Green Tea Extract Inhibits the Entry of SARS-CoV-1, MERSCoV,and SARS-CoV-2 by Blocking Receptor-spike Interaction Jeswin Joseph
1080 [GO] Current Pharmaceutical Biotechnology 2022―Dec―07 The Plausible Role of Indian Traditional Medicine in Combating Corona Virus (SARS-CoV 2): A Mini-Review J. Adithya
1081 [GO] Current Pharmaceutical Biotechnology 2022―Dec―07 Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2 Kazem Abbaszadeh-Goudarzi
1082 [GO] Current Pharmaceutical Biotechnology 2022―Oct―26 Prediction models based on miRNA-disease relationship: Diagnostic relevance to multiple diseases including COVID-19 Anil K. Sharma, Varruchi Sharma, Mukesh Yadav, Nirmala Sehrawat, Vikas Kumar, Sunil Kumar, et al. (+3)
1083 [GO] Current Pharmaceutical Biotechnology 2022―Oct―18 The Potential Mechanism of N-acetylcysteine in Treating COVID-19 Nan Zhou
1084 [GO] Current Pharmaceutical Biotechnology 2022―Jul―17 Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review M Idrees
1085 [GO] Current Pharmaceutical Biotechnology 2022―Jul―17 Targeted Delivery of CRISPR/Cas13 as a Promising Therapeutic Approach to Treat SARS-CoV-2 K Abbaszadeh-Goudarzi
1086 [GO] Current Pharmaceutical Biotechnology 2022―Jul―14 Therapeutic approaches for intravascular microthrombi-induced acute respiratory distress syndrome (ARDS) in COVID-19 infection Gopika KM, Sivajith S, Aadharsa Sugunan, M. S. Sudheesh
1087 [GO] Current Pharmaceutical Biotechnology 2022―May―31 COVID-19-Associated Coagulopathy: Role of Vitamins D and K Bruk Getachew, Harold E. Landis, Kebreten F. Menaye, Yousef Tizabi
1088 [GO] Current Pharmaceutical Biotechnology 2022―May―07 A Multi-dimensional Review on Severe Acute Respiratory Syndrome CoronaVirus-2 Ketan Ghosh, Bumba Chattopadyay, Tapas Maity, Ayan Acharya
1089 [GO] Current Pharmaceutical Biotechnology 2022―Apr―22 Impacts of COVID-19 in breast cancer: from molecular mechanism to treatment approach Maria Carolina Stipp, Claudia Rita Corso, Alexandra Acco
1090 [GO] Current Pharmaceutical Biotechnology 2022―Apr―05 Gut Microbiota might act as a potential therapeutic pathway in COVID-19 Nahid Hosseinzadeh Gharajeh, Hadi Pourjafar, Hoda Derakhshanian, Hamed Mohammadi, Abolfazl Barzegari, Solat Eslami
1091 [GO] Current Pharmaceutical Biotechnology 2022―Mar―08 Development and Challenges of Nasal Spray Vaccines for Short-term COVID-19 Protection Jinxiang Xi
1092 [GO] Current Pharmaceutical Biotechnology 2022―Mar―08 Does SARS-CoV-2 affect male urogenital system? Krzysztof Balawender, Anna Pliszka, Anita Krowiak, Maksymilian Sito, Beniamin Oskar. Grabarek, Dariusz Borońc,
1093 [GO] Current Pharmaceutical Biotechnology 2022―Mar―05 Therapeutic targeted approaches for Covid-19 treatment Jyotika Rajawat, Gauri Misra, Anup K Anvikar, Benedetta Era
1094 [GO] Current Pharmaceutical Biotechnology 2022―Jan―17 An Updated Review on the Role of Single Nucleotide Polymorphisms in COVID-19 Disease Severity: A Global Aspect Jun Wei Ng, Eric Tzyy Jiann Chong, Ping-Chin Lee
1095 [GO] Current Pharmaceutical Biotechnology 2021―Aug―10 The use of pseudotyped coronaviruses for the screening of entry inhibitors: Green tea extract inhibits the entry of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 by blocking receptor-spike interaction Jeswin Joseph, Thankamani Karthika, V.R. Akshay Das, V. Stalin Raj
1096 [GO] Current Pharmaceutical Biotechnology 2021―Jul―12 Drug repurposing: an alternative strategy to treat COVID-19 Pengyu Han, Huifang zheng, Pingping Wen, Li Pan, Dan Geng, Diangxing Sun
1097 [GO] Current Pharmaceutical Biotechnology 2021―Jun―07 Identification of novel drug candidates for the inhibition of catalytic cleavage activity of coronavirus 3CL-like protease enzyme Arun Bahadur Gurung, Khalid Mashay Al-Anazi, Mohammad Ajmal Ali, Joongku Lee, Mohammad Abul Farah
1098 [GO] Current Pharmaceutical Biotechnology 2021―May―09 Current Overviews on COVID-19 Management Strategies Pankaj Kumar Rai, Zeba Mueed, Abhiroop Chowdhury, Ravi Deval, Dinesh Kumar, Mohammad A. Kamal, et al. (+3)
1099 [GO] Current Pharmaceutical Biotechnology 2021―May―03 Potential Candidates against COVID-19 Targeting RNA-Dependent RNA Polymerase: A Comprehensive Review Neetu Agrawal, Ahsas Goyal
1100 [GO] Current Pharmaceutical Biotechnology 2021―Apr―13 Olive oil consumption can prevent non-communicable diseases and COVID-19 : Review Debabrata Majumder, Mousumi Debnath, Kamal Nayan Sharma, Surinder Singh Shekhawat, G.B.K.S Prasad, Debasish Maiti, Seeram Ramakrishna
1101 [GO] Current Pharmaceutical Biotechnology 2021―Mar―23 Herbal Medicine in Fighting Against COVID-19: New Battle with an Old Weapon Ranjit K. Harwansh, Shiv Bahadur
1102 [GO] Current Pharmaceutical Biotechnology 2021―Feb―17 Unravelling The Immune Modulatory Effect Of Indian Spices To Impede The Transmission Of Covid-19: A Promising Approach Aswathy R Devan, Bhagyalakshmi Nair, Ayana R Kumar, Jaggaiah N Gorantla Gorantla, T. S. Aishwarya, Lekshmi R Nath
1103 [GO] Current Pharmaceutical Biotechnology 2021―Jan―28 Pathogenesis of COVID-19, Disease outbreak: A Review Himanshu Sharma, Sonia Singh, Shilpi Pathak
1104 [GO] Current Pharmaceutical Biotechnology 2021―Jan―28 Phenylbenzopyrone of flavonoids as a potential scaffold to prevent SARS-CoV-2 replication by inhibiting its MPRO main protease Angamba Meetei Potshangbam, Potshangbam Nongdam, A. Kiran Kumar, R.S. Rathore
1105 [GO] Current Pharmaceutical Biotechnology 2021―Jan―04 The Role of Pharmaceutical Biotechnology in the Fight against Viral Pandemics Nikolaos E. Labrou
1106 [GO] Current Pharmaceutical Biotechnology 2020―Dec―29 The potential mechanism of N-acetylcysteine in treating COVID-19 Nan Zhou, Xiaofan Yang, Aie Huang, Zhenbing Chen
1107 [GO] Current Pharmaceutical Biotechnology 2020―Nov―30 Touting Traditional Knowledge and Herbal Medicine to Combat and Prevent COVID-19 Selvaraj Arokiyaraj, Savariar Vincent, Dinesh K. Vannam
1108 [GO] Current Pharmaceutical Biotechnology 2020―Nov―12 Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach Against COVID-19 Acharya Balkrishna, Rashmi Mittal, Vedpriya Arya
1109 [GO] Current Pharmaceutical Biotechnology 2020―Nov―12 Potential implications of black seed and its principal constituent Thymoquinone in the treatment of COVID-19 patients Masood Alam Khan, Hina Younus
1110 [GO] Current Pharmaceutical Biotechnology 2020―Nov―05 Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19 Nidia Cabral-Hipólito, Brenda Molina-Ramírez, María-de-la-Luz Sevilla-González, Rocío MezaVelázquez, Rubén García-Garza, Sergio-Everardo Velázquez Gauna, et al. (+7)
1111 [GO] Current Pharmaceutical Biotechnology 2020―Oct―28 The Binding of Remdesivir to SARS-CoV-2 RNA-Dependent RNA polymerase May Pave The Way Towards the Design of Potential Drugs for COVID-19 Treatment. Clement Agoni, Mahmoud E.S. Soliman
1112 [GO] Current Pharmaceutical Biotechnology 2020―Oct―11 Targeted delivery of CRISPR/Cas13 as a promising therapeutic approach to treat SARS-CoV-2 Kazem Abaszadeh Goudarzi, Mohammad Hadi Nematollahi, Hashem Khanbabaei, Hossein Hosseini Nave, Hamid Reza Mirzaei, Hossein Pourghadamyari, Amirhossein Sahebkar
1113 [GO] Current Pharmaceutical Biotechnology 2020―Aug―26 Repositioning of drugs to counter COVID-19 pandemic - An Insight Sai M. Akilesh, Rajesh J, Dhanabal Palanisamy, Ashish Wadhwani
1114 [GO] Current Pharmaceutical Biotechnology 2020―Aug―08 The Plausible role of Indian Traditional Medicine in combating Corona Virus (SARS-CoV 2): a mini-review Bhagyalakshmi Nair, Lekshmi R. Nath
1115 [GO] Current Pharmaceutical Biotechnology 2020―Jul―03 Effect of the Phytochemical Agents Against the SARS-CoV and Selected Some of them for Application to COVID-19: A Mini-Review Muhammad Idrees, Shamshad Khan, Nazakat Hussain Memon, Zhiyong Zhang
1116 [GO] Current Pharmaceutical Design 2024―Feb―22 Safety Profile of Paxlovid in the Treatment of COVID-19 Bing Lv, Xin Gao, Guoqiang Zeng, Hui Guo, Faping Li
1117 [GO] Current Pharmaceutical Design 2023―Dec―27 Challenging Axillary Lymph-Nodes on PET/CT in Cancer Patients throughout Covid-19 Vaccination Era Alessia Giordano, Rosj Gallicchio, Mariarita Milella, Rebecca Storto, Anna Nardelli, Teresa Pellegrino, et al. (+3)
1118 [GO] Current Pharmaceutical Design 2023―Dec―15 Biosensor Detection of COVID-19 in Lung Cancer: Hedgehog and Mucin Signaling Insights Harneet Marwah, Janmejay Pant, Jiten Yadav, Kamal Shah, Hitesh Kumar Dewangan
1119 [GO] Current Pharmaceutical Design 2023―Nov―29 Potential Targets and Mechanisms of Bitter Almond-Licorice for COVID-19 Treatment Based on Network Pharmacology and Molecular Docking Qiwei Hong, Xinyue Shang, Yanan Wu, Zhenlin Nie, Bangshun He
1120 [GO] Current Pharmaceutical Design 2023―Nov―29 Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants Arijit Samanta, Ashif Ahamed, Syed Sahajada Mahafujul Alam, Safdar Ali, Mohd Shahnawaz Khan, Abdulaziz Mohammed Alamrid, et al. (+2)
1121 [GO] Current Pharmaceutical Design 2023―Nov―06 AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in Humans Israa M. Shamkh, Mahmoud Elkazzaz, Enas. S. Radwan, Jawayria Najeeb, Md Tabish Rehman, Mohamed F. AlAjmi, et al. (+12)
1122 [GO] Current Pharmaceutical Design 2023―Nov―02 Computational Approaches to Designing Antiviral Drugs against COVID-19: A Comprehensive Review Mohan P. Singh, Nidhi Singh, Divya Mishra, Saba Ehsan, Vivek K. Chaturvedi, Anupriya Chaudhary, et al. (+2)
1123 [GO] Current Pharmaceutical Design 2023―Oct―26 Exploration of Molecular Targets and Mechanisms of Curcumin in the Treatment of COVID-19 with Depression by an Integrative Pharmacology Strategy Dongwei Zhu, Xianmei Zhou
1124 [GO] Current Pharmaceutical Design 2023―Oct―11 The Potential of Cannabidiol for Acute Respiratory Distress Syndrome in COVID-19 Saeid Azimi, Fatemeh Saghafi, Mohammad Hossein Mohammadi, Mohammad Hossein Moghimi, Seyed Ali Akhavan, Masoud khataminia, et al. (+5)
1125 [GO] Current Pharmaceutical Design 2023―Sep―06 Salivary antiviral and antibacterial properties in the encounter of SARS-CoV-2 Nooshin Mohtasham, Rahimeh Bargi, Alieh Farshbaf, Maryam Vahabzadeh Shahri, Kiana Kamyab Hesari, Farnaz Mohajertehran
1126 [GO] Current Pharmaceutical Design 2023―Aug―16 Acute Kidney Injury (AKI) in COVID-19: In silico Identification of LncRNA-MiRNA-Gene Networks and Key Transcription Factors Somayeh Hashemi Sheikhshabani, Zeinab Amini-Farsani, Nesa Kazemifard, Parastoo Modarres, Sharareh Khazaei Feyzabad, Zahra Amini-Farsani, et al. (+3)
1127 [GO] Current Pharmaceutical Design 2023―Jul―30 Nanotechnology-based Approaches and Investigational Therapeutics against COVID-19
1128 [GO] Current Pharmaceutical Design 2023―Jul―30 Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp
1129 [GO] Current Pharmaceutical Design 2023―May―17 Electroacupuncture in Regulating Gastrointestinal Symptoms of COVID-19: A Mini-review Xianqiang Yu, Yingjie Wang
1130 [GO] Current Pharmaceutical Design 2023―May―11 Exploring the potential mechanism of action of ursolic acid against gastric cancer and COVID-19 using network pharmacology and bioinformatics analysis Hailiang Huang, Zhiyao Liu, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang
1131 [GO] Current Pharmaceutical Design 2023―Jan―03 Experimental and Computational Approaches for SARS-CoV-2 Theranostics Ijaz Gul, Mohammad Amjad Kamal
1132 [GO] Current Pharmaceutical Design 2022―Dec―21 In-Silico Study of Resveratrol as Multi-Edged Potent Inhibitor against SARS-Cov-2 and Variants of Concern Using Molecular Dynamic Simulation and PCA Analysis Amaresh Kumar Sahoo, Vishal Singh, Vidhu Agarwal, Pritish Kumar Varadwaj
1133 [GO] Current Pharmaceutical Design 2022―Dec―07 Therapeutic Applications of Fucoidans and their Potential to Act against COVID-19 Dhananjay Yadav, Minseok Song
1134 [GO] Current Pharmaceutical Design 2022―Dec―06 In Silico Studies Reveal Antiviral Effects of Traditional Indian Spices on COVID-19 Brijesh Kumar
1135 [GO] Current Pharmaceutical Design 2022―Dec―06 Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) Evellyn Claudia Wietzikoski Lovato
1136 [GO] Current Pharmaceutical Design 2022―Dec―06 Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 Shadma Wahab
1137 [GO] Current Pharmaceutical Design 2022―Dec―06 Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 Yasanandana S. Wijayasinghe
1138 [GO] Current Pharmaceutical Design 2022―Dec―06 Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 Md. Tabish Rehman
1139 [GO] Current Pharmaceutical Design 2022―Dec―06 Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective Freah Alshammary
1140 [GO] Current Pharmaceutical Design 2022―Dec―06 COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2 Rajesh Kumar
1141 [GO] Current Pharmaceutical Design 2022―Dec―06 Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments Clodoveo Ferri
1142 [GO] Current Pharmaceutical Design 2022―Dec―06 The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic Marina Darenskaya
1143 [GO] Current Pharmaceutical Design 2022―Dec―06 Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients Kholoud F. Aliter
1144 [GO] Current Pharmaceutical Design 2022―Dec―06 Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations Urooj Fatima
1145 [GO] Current Pharmaceutical Design 2022―Dec―06 COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol
1146 [GO] Current Pharmaceutical Design 2022―Dec―06 Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management Hussien Ahmed H. Abdelgawad
1147 [GO] Current Pharmaceutical Design 2022―Dec―06 Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Khojasteh Malekmohammad
1148 [GO] Current Pharmaceutical Design 2022―Dec―06 miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis Rohit Satyam
1149 [GO] Current Pharmaceutical Design 2022―Dec―06 Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm Monireh Torabi-Rahvar
1150 [GO] Current Pharmaceutical Design 2022―Dec―06 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections Arquimedes Gasparotto Junior
1151 [GO] Current Pharmaceutical Design 2022―Nov―24 Host-Cell Surface Binding Targets in SARS-COV-2 for Drug Design Sayyed Abbas Tabatabai, Hanieh Maleksabet, Elham Rezaee
1152 [GO] Current Pharmaceutical Design 2022―Nov―08 Current insights and molecular docking studies of the drugs under clinical trial as rdrp inhibitors in COVID-19 treatment Amita Verma, Pradeep Kumar, Irine Pauly, Ankit Kumar Singh, Adarsh Kumar, Yogesh Singh, et al. (+2)
1153 [GO] Current Pharmaceutical Design 2022―Oct―28 Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease Öner Özdemir, Azize Yasemin Göksu Erol, Ümmügülsüm Dikici
1154 [GO] Current Pharmaceutical Design 2022―Oct―26 Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19 Vivek P Chavda, Lalitkumar K Vora, Rajeev K. Singla, Aayushi B. Patel, Priyal Shah, Vladimir N. Uversky, Vasso Apostolopoulos
1155 [GO] Current Pharmaceutical Design 2022―Oct―21 Vaccination against SARS-CoV-2 protects from COVID-19-induced endothelial dysfunction Evangelos Oikonomou, Stamatios Lampsas, Nektarios Souvaliotis, Savvas Sarantos, Gerasimos Siasos, Garyphallia Poulakou, et al. (+10)
1156 [GO] Current Pharmaceutical Design 2022―Oct―20 State-of-the-art tools to elucidate the therapeutic potential of TAT-peptide (TP) conjugated repurposing drug against SARS-CoV-2 spike glycoproteins Mohammad Azam Ansari, Mohammad N. Alomary, Qazi Mohammad Sajid Jamal, Yosif Almoshari, Ahmed Salawi, Suliman A. Alhmahmoud, Johra Khan
1157 [GO] Current Pharmaceutical Design 2022―Oct―18 Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19 Shadma Wahab
1158 [GO] Current Pharmaceutical Design 2022―Oct―18 COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy Md. Rahman
1159 [GO] Current Pharmaceutical Design 2022―Oct―18 COVID-19 Vaccines in Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol
1160 [GO] Current Pharmaceutical Design 2022―Sep―27 Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19 Kang-Hsi Wu, Yu-Hua Chao, Te-Fu Weng, Ju-Pi Li
1161 [GO] Current Pharmaceutical Design 2022―Sep―09 Tetraspanin-enriched Microdomain Containing CD151, CD9, and TSPAN 8 - Potential Mediators of Entry and Exit Mechanisms in Respiratory Viruses Including SARS-CoV-2 RamaRao Malla, Mohammad Amjad Kamal
1162 [GO] Current Pharmaceutical Design 2022―Aug―02 Herbal medicines as potential inhibitors of SARS-CoV-2 infection Soodabeh Rostami, Shima Gharibi, Hajar Yaghoobi, Zary Nokhodian, Parisa Shoaei, Armina Alaghband Bahrami, et al. (+2)
1163 [GO] Current Pharmaceutical Design 2022―Aug―01 COVID-19: Pathophysiology, transmission, and drug development for therapeutic treatment and vaccination strategies Vishal Kumar Singh, Himani Chaurasia, Richa Mishra, Ritika Srivastava, Aditya K. Yadav, Jayati Dwivedi, et al. (+2)
1164 [GO] Current Pharmaceutical Design 2022―Jul―22 Cytokine Release Syndrome in Pathogenesis and Treatment of COVID-19 Tao Hu, Chi Hin Cho
1165 [GO] Current Pharmaceutical Design 2022―Jul―22 An Update on Promising Agents against COVID-19: Secondary Metabolites and Mechanistic Aspects Maryam Jamshidnia, Robert D. E. Sewell, Mahmoud Rafieian-Kopaei
1166 [GO] Current Pharmaceutical Design 2022―Jul―17 Natural Agents Modulating ACE-2: A Review of Compounds with Potential against SARS-CoV-2 Infections Gasparotto A.
1167 [GO] Current Pharmaceutical Design 2022―Jul―14 A review of current evidence from cardiovascular manifestations and outcomes in patients with COVID-19 Shirin Saberianpour, Elahe Aleebrahim-Dehkordi, Elaheh Mazaheri, Ali Hasanpour-Dehkordi
1168 [GO] Current Pharmaceutical Design 2022―Jul―14 Prolonged NHE Activation may be Both Cause and Outcome of Cytokine Release Syndrome in COVID-19 Medine Cumhur Cure, Erkan Cure
1169 [GO] Current Pharmaceutical Design 2022―Jul―14 Therapeutic potential of P2X7 purinergic receptor modulation in the main organs affected by the COVID-19 cytokine storm Júlia Leão Batista Simões, Leilane Dayane Sobierai, Stefany Maciel Pereira, Miriam Vitória Rodrigues dos Santos, Margarete Dulce Bagatini
1170 [GO] Current Pharmaceutical Design 2022―Jul―04 COVID-19 Challenge: A Quest for Effective Vaccine Strategies Against Circulating and Emerging SARS-CoV-2 Variants Ruchika Yogesh, Noopur Srivastava, Syed Nasir Abbas Bukhari
1171 [GO] Current Pharmaceutical Design 2022―Jun―21 Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, Dilia Giuggioli, Lorenzo Dagna, Antonio Tavoni, et al. (+78)
1172 [GO] Current Pharmaceutical Design 2022―Jun―07 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part V) Mohammad Amjad Kamal, Md Asaduzzaman Khan
1173 [GO] Current Pharmaceutical Design 2022―May―27 Main Diagnostic Methods for Covid-19: Integrative Review Ana Sara Martins de Campos, Giandra Azolini Fernandes de Souza, Renan Almeida de Jesus, Giuliana Zardeto, Guilherme Donadel, Mariana Dalmagro, et al. (+7)
1174 [GO] Current Pharmaceutical Design 2022―May―22 Immunopathogenesis and immunogenetic variants in COVID-19 Pakorn Sagulkoo, Kitiporn Plaimas, Apichat Suratanee, Andrea Name Colado Simão, Edna Maria Vissoci Reiche, Michael Maes
1175 [GO] Current Pharmaceutical Design 2022―May―07 Can we s쳮d in the fight against SARS-CoV-2 with its emerging new variants? Shima Tavakol, Hani Tavakol, Mo S. Alavijeh, Alexander Seifalian
1176 [GO] Current Pharmaceutical Design 2022―Apr―30 Repositioning therapeutics for SARS-CoV-2: Virtual screening of plant-based Anti-HIV compounds as possible inhibitors against COVID-19 viral RdRp Mahadevamurthy Murali, Hittanahallikoppal Gajendramurthy Gowtham, Mohammad Azam Ansari, Mohammad N. Alomary, Saad Alghamdi, Mazen Almehmadi, et al. (+6)
1177 [GO] Current Pharmaceutical Design 2022―Apr―20 Interaction of Vitamin D and Corticosteroid Use in Hospitalized COVID-19 Patients: A Potential Explanation for Inconsistent Findings in the Literature Jimmy T. Efird, Ethan Anderson, Charulata Jindal, Ayako Suzuki
1178 [GO] Current Pharmaceutical Design 2022―Mar―29 Ivabradine in the management of COVID-19-related cardiovascular complications: A perspective Tomas Baka, Kristina Repova, Ivan Luptak, Fedor Simko
1179 [GO] Current Pharmaceutical Design 2022―Mar―23 Alterations in clinical characteristics of blood donors post COVID-19 recovery Fahad Al Ghamdi, Salma Naqvi, Fahad A. Alabassi, Sultan Alhayyani, Mirza Rafi Baig, Vikas Kumar, Firoz Anwar
1180 [GO] Current Pharmaceutical Design 2021―Dec―13 A review of the rational and current evidence on colchicine for COVID-19 Hazem S. Ghaith, Mohamed Diaa Gabra, Mohamed H. Nafady, Hamza Emad Elshawah, Ahmed Negida, Mohammad Amjad Kamal
1181 [GO] Current Pharmaceutical Design 2021―Oct―22 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part IV) Md Asaduzzaman Khan, Mohammad Amjad Kamal
1182 [GO] Current Pharmaceutical Design 2021―Oct―21 Covid-19 Epidemiology, Pathogenesis and Therapy Alessandro Antonelli, Clodoveo Ferri
1183 [GO] Current Pharmaceutical Design 2021―Oct―14 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part III) Md Asaduzzaman Khan, Mohammad Amjad Kamal
1184 [GO] Current Pharmaceutical Design 2021―Sep―03 Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, Massimo L’Andolina, Lorenzo Dagna, Antonio Tavoni, et al. (+79)
1185 [GO] Current Pharmaceutical Design 2021―Sep―01 Nanotechnology-Based Strategies for the Management of COVID-19: Recent Development and Challenges Ritu Singh, Monalisha Behera, Nisha Kumari, Sanjeev Kumar, Vishnu D. Rajput, Tatiana M Minkina, et al. (+3)
1186 [GO] Current Pharmaceutical Design 2021―Sep―01 The Use of Lectins as Tools to Combat SARS-CoV-2 Daniela Martinez, Diego Amaral, David Markovitz, Luciano Pinto
1187 [GO] Current Pharmaceutical Design 2021―Jul―16 Synopsis on Pharmotechnological Approaches in Diagnostic to Management Strategies in Fighting Against COVID-19 Asim Azhar, Nazia Hassan, Manvi Singh, Khaled Al-hosaini, Mohammad Amjad Kamal
1188 [GO] Current Pharmaceutical Design 2021―Jul―06 Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Khojasteh Malekmohammad, Mahmoud Rafieian-Kopaei
1189 [GO] Current Pharmaceutical Design 2021―Jul―05 Nanotechnology-Based Approaches and Investigational Therapeutics against COVID-19 Md. Mominur Rahman, Muniruddin Ahmed, Mohammad Touhidul Islam, Md. Robin Khan, Sharifa Sultana, Saila Kabir Maeesa, et al. (+6)
1190 [GO] Current Pharmaceutical Design 2021―Jun―10 Different Methods for Molecular and Rapid Detection of Human Novel Coronavirus Mohamad Hesam Shahrajabian, Wenli Sun, Qi Cheng
1191 [GO] Current Pharmaceutical Design 2021―Jun―09 The roles of vitamin D in increasing the body's immunity and reducing injuries due to viral infections: With an emphasis on its possible role in SARS-CoV-2 (COVID-19) Elahe Aleebrahim-Dehkordi, Niloofar Deravi, Shirin Yaghoobpoor, Dariush Hooshyar, Mahmoud Rafieian-Kopaei
1192 [GO] Current Pharmaceutical Design 2021―May―22 Preventive and Therapeutic Strategies to Fight COVID-19 Alexander Marcus Seifalian, Shima Tavakol
1193 [GO] Current Pharmaceutical Design 2021―Mar―24 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II) Md Asaduzzaman Khan, Mohammad Amjad Kamal
1194 [GO] Current Pharmaceutical Design 2021―Mar―16 Tocilizumab: From Rheumatic Diseases to Covid-19 Alberto Raiteri, Fabio Piscaglia, Alessandro Granito, Francesco Tovoli
1195 [GO] Current Pharmaceutical Design 2021―Mar―03 Identification of the interaction between Angiotensin-converting Enzyme Residues and Severe Acute Respiratory Syndrome Coronavirus 2. Youness Kadil, Mohammed Mouhcine, Imane Rahmoune, Houda Filali
1196 [GO] Current Pharmaceutical Design 2021―Mar―03 Diabetes and COVID-19; a review of possible mechanisms Reyhaneh Moradi-Marjaneh, Fereshteh Asgharzadeh, Elnaz Khordad, Mahdi Moradi Marjaneh
1197 [GO] Current Pharmaceutical Design 2021―Feb―25 COVID-19: Epidemiology, Pathology, Diagnosis, Treatment, and Impact Saimon Shahriar, Md. Sohel Rana, Md. Sabbir Hossain, Ariful Karim, Tasneem Nayla Mredula, Nadia Nourin, et al. (+2)
1198 [GO] Current Pharmaceutical Design 2021―Feb―23 The association of respiratory viruses with oxidative stress and antioxidants. Implications for the COVID-19 pandemic Marina Darenskaya, Liubov Kolesnikova, Sergei Kolesnikov
1199 [GO] Current Pharmaceutical Design 2021―Feb―04 Nano-Biomaterials as Sensing and Therapeutic Tool to Mitigate Viral Pathogenesis with Special Reference to COVID-19 Pallavi Singh Chauhan, Dhananjay Yadav, Anuj Dubey, Jun-O Jin
1200 [GO] Current Pharmaceutical Design 2021―Jan―26 The computational intervention of macrolide antibiotics in the treatment of COVID-19 Firoz Anwar, Hisham N. Altayb, Fahad A. Al-Abbasi, Vikas Kumar, Mohammad Amjad Kamal
1201 [GO] Current Pharmaceutical Design 2021―Jan―26 Emerging therapeutic approaches to COVID-19 Indrakant Kumar Singh, Pratibha Kumari, Pooja Mittal, Amit Kumar, Bharti Singal, Gulam Mustafa Hasan, et al. (+4)
1202 [GO] Current Pharmaceutical Design 2021―Jan―18 Therapeutic agents against COVID-19 with clinical evidence Cheng Tian, Ming Xiang
1203 [GO] Current Pharmaceutical Design 2021―Jan―18 Natural agents modulating ACE-2: A review of compounds with potential against SARS-CoV-2 infections Arquimedes Gasparotto Junior, Sara Emília Lima Tolouei, Francislaine Aparecida dos Reis Lívero, Francielli Gasparotto, Thaise Boeing, Priscila de Souza
1204 [GO] Current Pharmaceutical Design 2021―Jan―12 In silico Prediction and Designing of Potential siRNAs to be Used as Antivirals Against SARS-CoV-2 Sayed Sartaj Sohrab, Sherif Aly El-Kafrawy, Aymn T. Abbas, Leena H. Bajrai, Esam Ibraheem Azhar
1205 [GO] Current Pharmaceutical Design 2021―Jan―12 Natural Products, a Potential Therapeutic Modality in Management and Treatment of nCoV-19 Infection: Preclinical and Clinical based Evidence Ashif Iqubal, Mohammad Kashif Iqubal, Musheer Ahmed, Syed Ehtaishamul Haque
1206 [GO] Current Pharmaceutical Design 2021―Jan―04 COVID-19: An Update on Pathogenesis and Treatment Marwa Abduallah AL Dhamen, Abrar Fouad Alhashim, Hawra Hussain Alqattan, Faheem Hyder Pottoo
1207 [GO] Current Pharmaceutical Design 2021―Jan―04 Emergence and Reemergence of Human Coronaviruses: Spike Protein as the Potential Molecular Switch and Pharmaceutical Target Fahim Ahmad, Mohammad A. Kamal, Babu L. Tekwani
1208 [GO] Current Pharmaceutical Design 2021―Jan―03 Use of Natural Compounds as a potential therapeutic agent against COVID-19 Shadma Wahab, Irfan Ahmad, Safia Irfan, Mohammad Hassan Baig, Abd-ElAziem Farouk, Jae-Jun Dong
1209 [GO] Current Pharmaceutical Design 2020―Dec―24 In silico studies reveal antiviral effects of traditional Indian spices on COVID-19 Brijesh Kumar, Sama Zaidi, Shafiul Haque, Nandita Dasgupta, Arif Hussain, Sreepoorna Unni, et al. (+2)
1210 [GO] Current Pharmaceutical Design 2020―Dec―23 A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management Hussien Ahmed, Ahmed Sayed, Malak Munir, Mostafa H. Elberry, Ibrahim M Sayed, Mohammed Amjad Kamal, et al. (+3)
1211 [GO] Current Pharmaceutical Design 2020―Dec―14 An Overview of Natural and Synthetic Analogs of Quinoline for the Prophylaxis of COVID-19. Chloroquine Analogs: An Overview of Natural and Synthetic Quinolines as Broad Spectrum Antiviral Agents Veera Bramhachari Pallaval, Manasa Kanithi, Sangeetha Meenakshisundaram, Achanta Jagadeesh, Mattareddy Alavala, Thanigaimalai Pillaiyar, et al. (+2)
1212 [GO] Current Pharmaceutical Design 2020―Dec―11 Anti-malarial Drugs are Not Created Equal for SARS-CoV-2 Treatment: A Computational Analysis Evidence Simone Ronsisvalle, Federica Panarello, Rosaria Di Mauro, Renato Bernardini, Giovanni Li Volti, Giuseppina Cantarella
1213 [GO] Current Pharmaceutical Design 2020―Dec―11 Silybin B and Cianidanol Inhibit M pro and Spike Protein of SARS-CoV-2: Evidence from in Silico Molecular Docking Studies Rashi Srivastava, Shubham Tripathi, Sreepoorna Unni, Arif Hussain, Shafiul Haque, Nandita Dasgupta, et al. (+2)
1214 [GO] Current Pharmaceutical Design 2020―Dec―05 COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review Ayesha Aziz, Muhammad Asif, Ghazala Ashraf, Qiaoli Yang, Shenqi Wang
1215 [GO] Current Pharmaceutical Design 2020―Dec―03 Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A new Route to Fight against COVID-19? Shah Khalid, Faisal A. Almalki, Taibi Ben Hadda, Ammar Bader, Tareq Abu-Izneid, Malika Berredjem, et al. (+2)
1216 [GO] Current Pharmaceutical Design 2020―Nov―30 Viral Diseases and Natural Products: Prospects in COVID-19 Treatment Mohammad Amjad Kamal, Md Asaduzzaman Khan
1217 [GO] Current Pharmaceutical Design 2020―Nov―26 Therapeutic management of COVID-19 patients: Clinical manifestation and limitations Urooj Fatima, Syed Saif Abbas Rizvi, Neha Raina, Saher Fatima, Safikur Rahman, Mohammad Amjad Kamal, Md. Imtaiyaz Hassan
1218 [GO] Current Pharmaceutical Design 2020―Nov―26 Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm Monireh Torabi-Rahvar, Nima Rezaei
1219 [GO] Current Pharmaceutical Design 2020―Nov―20 Natural Products: A Rich Source of Antiviral Drug Lead Candidates for the Management of COVID-19 Yasanandana Supunsiri Wijayasinghe, Pravin Bhansali, Ronald E. Viola, Mohammad A. Kamal, Nitesh Kumar Poddar
1220 [GO] Current Pharmaceutical Design 2020―Nov―20 Natural Compounds as Inhibitors of SARS-CoV-2 Main Protease (3CLpro): A Molecular Docking and Simulation Approach to Combat COVID-19 Md Tabish Rehman, Mohamed F. AlAjmi, Afzal Hussain
1221 [GO] Current Pharmaceutical Design 2020―Nov―20 COVID-19 and domestic animals: Exploring the species barrier crossing, zoonotic and reverse zoonotic transmission of SARS-CoV-2 Rajesh Kumar, Seetha Harilal, Abdullah G. Al-Sehemi, Mehboobali Paninipara, Tapan Behl, Githa Elizabeth Mathew, Bijo Mathew
1222 [GO] Current Pharmaceutical Design 2020―Nov―20 Coronavirus Disease -2019 (COVID-19) in 2020: A Perspective Study of a Global Pandemic Mujtaba Aamir Bhat, Safikur Rahman, Irfan Ahmad Rather, Iqbal Banday, Shafiya Syed, Hamira Koser, et al. (+3)
1223 [GO] Current Pharmaceutical Design 2020―Nov―20 The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment Shabana Bibi, Ayesha Sarfraz, Ghazala Mustafa, Zeeshan Ahmed, Muhammad Aurang Zeb, Yuan-Bing Wang, et al. (+4)
1224 [GO] Current Pharmaceutical Design 2020―Nov―06 Current landscape of natural products against coronaviruses: perspectives in COVID-19 treatment and antiviral mechanism Jakaria Shawon, Zakia Akter, Md. Munnaf Hossen, Yeasmin Akter, Abu Sayeed, Md Junaid, et al. (+2)
1225 [GO] Current Pharmaceutical Design 2020―Nov―06 Properties of Ethno-Medicinal Plants and Their Bioactives-Possible Use for Prevention and Treatment of COVID-19: A Review Ambreen Shoaib, Lubna Azmi, Ila Shukla, Saad S. Alqahtani, Ibrahim A. Alsarra, Faiyaz Shakeel
1226 [GO] Current Pharmaceutical Design 2020―Oct―26 COVID-19 Vaccines on Clinical Trials and their Mode of Action for Immunity against the Virus Shima Tavakol, Mo S. Alavijeh, Alexander M. Seifalian
1227 [GO] Current Pharmaceutical Design 2020―Oct―16 The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID- 19) Peter J. Wilkin, Minnatallah Al-Yozbaki, Alex George, Girish Kumar Gupta, Cornelia M. Wilson
1228 [GO] Current Pharmaceutical Design 2020―Oct―02 miRNAs in SARS-CoV 2: A Spoke in the Wheel of Pathogenesis Rohit Satyam, Tulika Bhardwaj, Sachin Goel, Niraj Kumar Jha, Saurabh Kumar Jha, Parma Nand, et al. (+3)
1229 [GO] Current Pharmaceutical Design 2020―Oct―01 Potential Therapeutic Benefits of Dipyridamole in COVID-19 Patients Kholoud F. Aliter, Rami A. Al-Horani
1230 [GO] Current Pharmaceutical Design 2020―Sep―11 Emerging Novel Coronavirus is a Global Threat: Insight in the Biology of COVID-19 and its Hijacking Process of Hosts’ Cell Debmalya Roy, Ipshita Khanra, Zeling Wang, Siva Bharath Merugu, Fakhar-un-Nisa Yunus, Dhahiri Saidi Mashausi, Dawei Li
1231 [GO] Current Pharmaceutical Design 2020―Sep―03 Targeting Natural Products for the Treatment of COVID-19 - An Updated Review Ramachandra Reddy Pamuru, Naveen Ponneri, Amooru G Damu, Ramakrishna Vadde
1232 [GO] Current Pharmaceutical Design 2020―Aug―26 Emergence of human pathogenic Coronaviruses: Lectins as antivirals for SARS-CoV-2 Sayed Sartaj Sohrab, Mohd Suhail, Mohammad Amjad Kamal, Fahim Ahmad, Esam Ibraheem Azhar
1233 [GO] Current Pharmaceutical Design 2020―Aug―26 Neutralization of SARS-CoV-2 Spike Protein via Natural Compounds: A Multi Layered High Throughput Virtual Screening Approach Anupam Dhasmana, Vivek Kumar Kashyap, Swati Dhasmana, Sudhir Kotnala, Shafiul Haque, Ghulam Md Ashraf, et al. (+3)
1234 [GO] Current Pharmaceutical Design 2020―Aug―19 Prevention Knowledge and Its Practice Towards COVID-19 Among General Population of Saudi Arabia: A Gender-based Perspective Freah Alshammary, Ammar Ahmed Siddiqui, Junaid Amin, Muhammad Ilyas, Hassaan Anwer Rathore, Ibne Hassan, et al. (+2)
1235 [GO] Current Pharmaceutical Design 2020―Aug―13 Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2? Francisco José López-Iranzo, Ana María López-Rodas, Luis Franco, Gerardo López-Rodas
1236 [GO] Current Pharmaceutical Design 2020―Jul―22 A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research Pankaj Musyuni, Geeta Aggarwal, Manju Nagpal, Ramesh K. Goyal
1237 [GO] Current Pharmaceutical Design 2020―Jul―14 Current Status of the COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy Tapan Behl, Md. Habibur Rahman, Rokeya Akter, Md. Arifur Rahman Chowdhury, Manirujjaman Mohammed, Israt Jahan Bulbul, et al. (+2)
1238 [GO] Current Pharmaceutical Design 2020―Jul―07 Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19) Evellyn Claudia Wietzikoski Lovato, Lorena Neris Barboza, Samantha Wietzikoski, Amanda Nascimento Vasques de Souza, Pablo Alvarez Auth, Arquimedes Gasparotto Junior, Francislaine Aparecida dos Reis Lívero
1239 [GO] Current Probiotics 2022―May―09 Potential role of probiotics in the management of COVID-19 Sangeeta Huidrom, Mirza Atif Beg, Shalu Bawa, Shruti Malhotra
1240 [GO] Current Protein and Peptide Science 2024―Jan―24 Global Emergence of SARS-CoV2 Infection and Scientific Interventions to Contain its Spread Himanshu Ajmera, Sudarshan Singh Lakhawat, Naveen Malik, Akhilesh Kumar, Jasvinder Singh Bhatti, Vikram Kumar, et al. (+4)
1241 [GO] Current Protein and Peptide Science 2023―Aug―17 ACE2 receptor: a potential pharmacological target in COVID-19 Shiheng Zhu, Yaping Zhu, Shungeng Zhang, Zeguang Wang, Zhi Wang
1242 [GO] Current Protein and Peptide Science 2023―Feb―22 Evaluation of serum humanin and MOTS-c peptide levels in patients with COVID-19 and healthy subjects Ahmet Saracaloglu, Ayşe Özlem Mete, Duran Furkan Ucar, Seniz Demiryürek, Enes Erbagcı, Abdullah Tuncay Demiryürek
1243 [GO] Current Protein and Peptide Science 2022―Dec―02 Potential Of Angiotensin-(1-7) In Covid-19 Treatment Evelyn Mendoza-Torres, Patricia Luna, María Fernanda Pérez, Jairo Castellar, Aileen Chang, Yuliet Montoya, et al. (+2)
1244 [GO] Current Protein and Peptide Science 2022―Aug―12 SARS-CoV-2 infection and C1-esterase inhibitor: Camouflage pattern and new perspective Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naif A. Jalal, Saeed M Kabrah, Athanasios Alexiou, Gaber El-Saber Batiha
1245 [GO] Current Protein and Peptide Science 2022―Jun―28 Targeting and Modulation of the Natriuretic Peptide System in Covid-19: A single or double-edged effect? Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha
1246 [GO] Current Protein and Peptide Science 2022―Jun―13 Calprotectin: the link between acute lung injury and gastrointestinal injury in Covid-19: Ban or boon Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Marwa S. Al-Niemi, Athanasios Alexiou, Gaber El-Saber Batiha
1247 [GO] Current Protein and Peptide Science 2022―May―13 Covid-19 and L-arginine supplementations: Yet to find the missed key Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Gaber El-Saber Batiha
1248 [GO] Current Protein and Peptide Science 2022―Feb―02 Genetic and epigenetic diversity of protein molecules related to SARS-CoV-2 entry: where we are and where we should go Running title: Genetic and epigenetic diversity of protein molecules related to SARS-CoV-2 entry Shiheng Zhu, Fei Chen, Xiaoyun Li, Yankun Zhang, Xinqing Wang, Chun Luan
1249 [GO] Current Protein and Peptide Science 2022―Jan―28 Short Amphiphiles or Micelle Peptides May Help To Fight Against COVID-19 Sounik Manna, Trinath Chowdhury, Santi M. Mandal, Sujata Maiti Choudhury
1250 [GO] Current Protein and Peptide Science 2021―Sep―17 Interactions between ACE2 and SARS-CoV-2 S protein: peptide inhibitors for potential drug developments against COVID-19 Miribane Dërmaku-Sopjani, Mentor Sopjani
1251 [GO] Current Protein and Peptide Science 2021―Sep―13 Diversity in the Accessory Proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV Betacoronaviruses Christian Alfredo K. Cruz, Paul Mark B. Medina
1252 [GO] Current Protein and Peptide Science 2021―Mar―23 RNA sensors as a mechanism of innate immune evasion among SARS-CoV2, HIV and Nipah viruses Dalia Cicily Kattiparambil Dixon, Chameli Ratan, Bhagyalakshmi Nair, Sabitha Mangalath, Rachy Abraham, Lekshmi. R. Nath
1253 [GO] Current Protein and Peptide Science 2020―Nov―12 Are Hsp90 inhibitors good candidates against Covid-19? Carlos H. I. Ramos, Kehinde S. Ayinde
1254 [GO] Current Protein and Peptide Science 2020―Sep―21 Carbohydrate-Binding Agents: Potential of Repurposing for COVID-19 Therapy. Rajesh Kumar Gupta, Girish R. Apte, Kiran Bharat Lokhande, Satyendra Mishra, Jayanta K. Pal
1255 [GO] Current Protein and Peptide Science 2020―Sep―09 Fusion protein targeted antiviral peptides: fragment based drug design (FBDD) guided rational design of dipeptides against SARS-CoV-2 Sounik Manna, Piyush Baindara, Santi M. Mandal
1256 [GO] Current Proteomics 2022―Oct―18 Heteromerization as a Mechanism Modulating the Affinity of the ACE2 Receptor to the Receptor Binding Domain of SARS-CoV-2 Spike Protein Diego Guidolin
1257 [GO] Current Proteomics 2022―Apr―03 Identification of Potential Immunogenic Epitopes against SARS-CoV-2 using In-Silico Method: An Immunoinformatics Study Subikshaa. S, Sathishnath. P, Chethan Jaya Sai Nandamuri, Shruti Ramanathan, Shobana Sugumar
1258 [GO] Current Proteomics 2021―Jan―08 Bioinformatics-based characterization of proteins related to SARS-CoV-2 using the Polarity Index Method® (PIM®) and Intrinsic Disorder Predisposition Carlos Polanco, Vladimir N. Uversky, Guy W. Dayhoff II, Alberto Huberman, Thomas Buhse, Manlio F. Márquez, et al. (+5)
1259 [GO] Current Proteomics 2021―Jan―04 Heteromerization As a Mechanism Modulating the Affinity of the ACE2 Receptor to the Receptor Binding Domain of SARS-CoV-2 Spike Protein Diego Guidolin, Cinzia Tortorella, Deanna Anderlini, Manuela Marcoli, Guido Maura
1260 [GO] Current Proteomics 2020―Jun―13 Unique nCoV-2019 (COVID 19) spike glycoprotein processing by host protease: Analysis and Implication on infection Ajoy Basak, Sarmistha Basak
1261 [GO] Current Psychiatry Research and Reviews 2024―Jan―25 Effectiveness and Patient Satisfaction of Telepsychiatry Services for Reducing Anxiety in COVID-19 Outpatients: A Assessor Blinded RCT Mohammad Hossein Hayavi-Haghighi, Somayeh Davoodi, Marjan Mosallanejad
1262 [GO] Current Psychiatry Research and Reviews 2024―Jan―24 Factors Affecting Psychological Health in the COVID-19 Pandemic Sherien Santosha, Vatsalya Tiwari, Sharad Chand, Manoj S. Dikkatwar, Supriya Roy, Radhika Bindu
1263 [GO] Current Psychiatry Research and Reviews 2024―Jan―12 Assessing Depression, Anxiety, Perceived Stress, and Job Burnout in Hospital Medical Staff During COVID-19: A Cross-sectional Study in Hamedan, Iran, 2019 Saeid Yazdi-Ravandi, Nasrin Matinnia, Arya Haddadi, Mojtaba Tayebi, Mojgan Mamani, Ali Ghaleiha
1264 [GO] Current Psychiatry Research and Reviews 2023―Nov―07 Relation Between Monocyte-to-lymphocyte Ratio and Depressive Symptoms in Patients with Non-severe Covid-19 Infection Doaa Ibrahim, Shaymaa Mohammed Arafa, Eman Mostafa Moazen, Fatima Gaber Yehia, Ahmed Mohamed Khalifa, Sara Sallam, Eman Ali
1265 [GO] Current Psychiatry Research and Reviews 2023―Nov―07 The Psychological Status of Healthcare Workers of a COVID-19- Free Cancer Hospital during COVID-19 Pandemic in Turkey - A Cross-sectional Study Ali ÇAYKÖYLÜ, Hayriye Dilek HAMURCU, Ersin Hatice KARSLIOĞLU, Pakize Evşen ATA, Neşe Burcu BAL
1266 [GO] Current Psychiatry Research and Reviews 2023―Aug―16 Juggle between work, home, and stress; a qualitative analysis using NVIVO-12on working women during the Covid-19 pandemic Shivani Agarwal, Rekha Mewarfarosh
1267 [GO] Current Psychiatry Research and Reviews 2023―Aug―03 A Study on Psychological Impact of Working From Home of Employees During COVID 19 Pandemic- a Cross Sectional Study Sumedha Dondapati
1268 [GO] Current Psychiatry Research and Reviews 2023―May―17 Assessment of Patients' Referral Patterns with Complains of Self-harm and Aggression in the COVID-19 Era Maryam Bahreini, Amirmasoud Kazemzadeh Houjaghan, Pantea Arya, Sepideh Aarabi, Haleh Ashraf
1269 [GO] Current Psychiatry Research and Reviews 2023―Jan―18 Psycho-neuroendocrine-immune aspects of COVID-19 and its relationship with post-traumatic stress disorder Masoomeh Dadkhah, Sakineh Shafia, Sahand Talei, Soheila Molaei, Vahid Asghariazar
1270 [GO] Current Psychiatry Research and Reviews 2022―Dec―29 Mental Health Disorders in Healthcare Workers Exposed to COVID-19, Mashhad, Iran: A Cross-sectional Study Ali Khaksour, Amin Saeidinia, Ghazale Ghanabri, Adele Akbari, Fateme khazaei, Najme Khani, Mahdi Talebi
1271 [GO] Current Psychiatry Research and Reviews 2022―Dec―27 Worriers of the pandemic: How people with mental disorders cope with COVID-19 restrictions Mikhail Zinchuk, Evgenii Pashnin, Georgii Kustov, Sofya Popova, Nadezhda Voinova, Anna Gersamia, et al. (+2)
1272 [GO] Current Psychiatry Research and Reviews 2022―Aug―30 Psychological Profiles Of Positive Mental Health Of Women In Situation Of Confinement Due To Covid-19 Jorge Eduardo Navarro- Obeid, Efraín Javier De la Hoz-Granadillo, María Laura Vergara- Álvarez
1273 [GO] Current Psychiatry Research and Reviews 2022―Aug―26 Association between COVID-19 Pandemic and Serious Mental Illness: Systematic Review within Salutogenesis Model for Public Health Management Sweta Kaman, Ankita Sharma, Romi Banerjee
1274 [GO] Current Psychiatry Research and Reviews 2022―Aug―12 Use Of Psychotropics In Covid-19 - Another Anti-Inflammatory Pathway? Jessenia Morillo, Valery Morillo, Maria Angelica Marquina, Milagros Rojas, Manuel Nava
1275 [GO] Current Psychiatry Research and Reviews 2022―Aug―04 Psychiatry Research has Moved Past COVID-19 Rajendra Badgaiyan
1276 [GO] Current Psychiatry Research and Reviews 2022―Aug―02 COVID-19 anxiety and washing obsessive-compulsive symptoms: stress coping styles as a mediator.. Zahra Zanjani, Maryam Jandaghian, Vajiheh Ghorbani, Seyed Reza Alvani, Sanaz Joekar
1277 [GO] Current Psychiatry Research and Reviews 2022―Jul―14 Comorbidity and Association of Posttraumatic Stress, Depression, Anxiety and Somatic Complaints in COVID-19 Georgian Patients at the Beginning of Pandemic Giorgi Sikharulidze, Levan Ratiani, Mariam Sordia, Elene Sikharulidze, Tinatin Khutsishvili, Khatuna Lejava, Eric Vermetten
1278 [GO] Current Psychiatry Research and Reviews 2022―Jun―30 The levels of cognitive flexibility and cognitive resilience and their relationships with academic performance in college students during Covid 19 pandemic. Muath A Alammar, Dushad Ram, Khudhayr Nasser Albarragi, Abdullah Saad Alshahrani
1279 [GO] Current Psychiatry Research and Reviews 2022―Jun―24 Family Relations of University Students in Times of Pandemic by COVID 19: Feelings and Tensions.. Astrid Sofía Suárez-Barros, María del Pilar Morad-Haydar, Jennifer Del Castillo-Bolaños, Alfredo Rojas-Otálora, Yomaira García Acuña, Yolima Alarcón-Vásquez, et al. (+7)
1280 [GO] Current Psychiatry Research and Reviews 2022―Jun―13 The Psychological Sequelae of COVID-19 Among Disease Survivors in Argentina Franco Tisocco, Alejandra Doolan, María Laura Vicente, Mercedes Fernández Liporace, Alejandro Castro Solano
1281 [GO] Current Psychiatry Research and Reviews 2022―Jun―13 Sociodemographic correlates of coping styles among the general population in Saudi Arabia during the COVID-19 pandemic Waleed Ahmed Alghamdi, Sami Hamdan Alzahrani
1282 [GO] Current Psychiatry Research and Reviews 2022―May―16 Burnout Syndrome in Emergency Physicians in Venezuela early in the Covid-19 Pandemic Oscar Medina-Ortiz, Alejandro Oses Gil, Jenny Alcendra González, Juan Diego Vivas, María Parra Sánchez, Luis Parra Sánchez, et al. (+3)
1283 [GO] Current Psychiatry Research and Reviews 2022―May―13 The Racial and Ethnic Differences in Impact and Knowledge of COVID-19 among Patients with Psychiatric Illnesses Millie Nishikawa, Jeff Wang Jin, Tiffany Ho, Roja Manohar, Marsal Sanches, Stefanie Cavalcanti, Hanjing Wu
1284 [GO] Current Psychiatry Research and Reviews 2022―Apr―27 The Effect of Some Symptoms and Features During the İnfection Period on the Level of Anxiety and Depression of Adults After Recovery From COVID-19 Mehmet Tahir Huyut, İdris Kocaturk
1285 [GO] Current Psychiatry Research and Reviews 2021―Dec―08 Association Between Structural Determinants of Health and Posttraumatic Stress Symptoms during the COVID-19 Pandemic Zohreh Mahmoodi, Kian Javadi Koshesh, Ghaffar Almasi, Safura Pournajaf, Hadith Rastad, Nooshin Ghavidel
1286 [GO] Current Psychiatry Research and Reviews 2021―Oct―08 Brief psychotic disorder during COVID-19 infection: Marked stressor or neuropsychiatric symptoms? Jalal Doufik, Said Boujraf, Mina Ouhmou, Hicham Laaraj, Khalid Mouhadi, Ismail Rammouz
1287 [GO] Current Psychiatry Research and Reviews 2021―Sep―25 Rates of anxiety, depression and stress among high school students during the pandemic of COVID-19 Ensiyeh Jenabi, Saeid Bashirian, Salman Khazaei, Mohammad Poorsdavood, Rashid Heidarimoghadam, Majid Barati, et al. (+7)
1288 [GO] Current Psychiatry Research and Reviews 2020―Dec―29 Twitter Trends reveals: Focus of interest in the sleep trend analytics on response to COVID-19 outbreak Surbhi Bhatia, Anubhav Tyagi
1289 [GO] Current Psychiatry Research and Reviews 2020―Nov―19 The Effect of Tele-acupressure Self-practice for Mental Health and well-being in the Community During COVID-19 Yun Jin Kim
1290 [GO] Current Psychiatry Research and Reviews 2020―Oct―14 Mental and Emotional Wellbeing During COVID-19 Pandemic: The Unprecendented Malaysian Experience Zamalia Mahmud, Rosli Abdul Rahim, Aida Wati Zainan Abidin, Nik Nairan Nik Abdullah
1291 [GO] Current Psychiatry Research and Reviews 2020―Sep―18 Misinformation about COVID-19 and confidential information leakage: Impacts on the psychological well-being of Indians Surekha Borra, Nilanjan Dey
1292 [GO] Current Psychiatry Research and Reviews 2020―Sep―18 Impact of COVID-19 on Mental Dimension of Health: A Sensitive Issue to be Addressed at the Earliest Sunil Nepal, Sudip Nepal, C.S. Shastry, Sharad Chand, Nandakumar UP, Bishnu Dev Pant, et al. (+2)
1293 [GO] Current Psychopharmacologye 2022―Oct―28 The Impact of SSRI Use on the Clinical Outcome and Prognosis of COVID-19 Patients: A Single-Center Prospective Study Fatemeh Ghassem Boroujerdi, Mitra Safa, Seyed Ali Ziai, Afshin Moniri, Farzaneh Haji Zadeh, Amirali Soheili, et al. (+3)
1294 [GO] Current Psychopharmacologye 2021―Oct―08 In Drug Repurposing Tactics Against Covid-19 Aikan Gupta, Nitin Goel, Anuja Chopra, Navpreet Kaur, Divneet Kaur
1295 [GO] Current Psychopharmacologye 2021―Jan―26 The Rapidly Changing Composition of the Global Street Drug Supply and Its Effects on High-Risk Groups for COVID-19 Thom Browne, Mark S. Gold, David M. Martin
1296 [GO] Current Psychopharmacologye 2021―Jan―05 Endorphinergic Enhancement Attenuation of Post-Traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic Kenneth Blum, Edward J. Modestino, David Baron, Raymond Brewer, P. K. Thanos, Igor Elman, et al. (+7)
1297 [GO] Current Radiopharmaceuticals 2023―Mar―07 World's First Experience of the Low-dose radionuclide inhalation therapy in the treatment of COVID-19-associated viral pneumonia: phase 1/2 clinical trial Ilya Klabukov, Peter Shegay, Alexey Leontyev, Denis Baranovskii, German Davydov, Marina Poluektova, et al. (+13)
1298 [GO] Current Radiopharmaceuticals 2021―Oct―12 Potential Utility of Radiopharmaceuticals in the Battle Against SARS-Cov-2 and COVID-19 Pandemic Omer Sager, Ferrat Dincoglan, Selcuk Demiral, Murat Beyzadeoglu
1299 [GO] Current Radiopharmaceuticals 2020―Jun―23 PET and SPECT Imaging in the SARS-CoV-2 Pandemic Laura Evangelista, Pierpaolo Alongi, Orazio Schillaci
1300 [GO] Current Respiratory Medicine Reviews 2024―Mar―04 The Journal and the Challenges of COVID-19 Vaccine-related Injuries Diamond N. Burton, Joseph Varon
1301 [GO] Current Respiratory Medicine Reviews 2024―Feb―04 A Case Report of Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination Karbasforooshan Hedyieh, Amini Shahram, Boostani Reza, Mousavian Pourandokht, Hosseinjani Hesamoddin
1302 [GO] Current Respiratory Medicine Reviews 2024―Jan―04 Assessing Lung Function and Quality of Life in COVID-19 Patients: A Pilot Study Mitra Samareh Fekri, Faranak Salajegheh, Mohammad Rezaei Zadeh Rukerd, Mohsen Nakhaie, Maliheh Sadat Bazrafshani, Fatemeh Goharriz, Mohammad Sadegh Shahmoradzadeh Miri
1303 [GO] Current Respiratory Medicine Reviews 2023―Dec―01 COVID-19 Vaccines and the Menstrual Cycle: A Cross-Sectional Study Naser Alhusban, Sondos Al-Najjar, Fatima Alkubaisi, Abdulla Alzibdeh, Kenan S-Yasin, Alhareth Alhusban
1304 [GO] Current Respiratory Medicine Reviews 2023―Nov―22 NAT2 Gene Variants as a Provocative Factor for the Severe Course of COVID-19 Pneumonia in Ukrainian Patients Liliia Fishchuk, Zoia Rossokha, Valeriy Pokhylko, Yuliia Cherniavska, Svitlana Tsvirenko, Viktoriia Vershyhora, et al. (+4)
1305 [GO] Current Respiratory Medicine Reviews 2023―Nov―14 The Relationship between COVID-19 Severity and Plasma Levels of Vascular Endothelial Growth Factor (VEGF) Mitra Samareh Fekri, Elham Barfzade, Ahmad Shafahi, Mehrdad Farokhnia, Fatemeh Karami Robati, Sajjadeh Movahedinia, Shariar Dabiri
1306 [GO] Current Respiratory Medicine Reviews 2023―Nov―08 Comparison of Initial Thoracic CT Images of COVID-19 Patients with Non-Variant, Alpha, Delta, and Omicron Variants: A Retrospective Study Emrah Altuntas, Meltem Ceyhan Bilgici, Muzaffer Elmalı, Arda Onar, Orhan Bas
1307 [GO] Current Respiratory Medicine Reviews 2023―Nov―06 Utility of the Presence of Anti-SARS-CoV-2 Antibodies in Detecting COVID-19 in Symptomatic Children and Adolescents: An Analytical Cross-sectional Study Reza Sinaei, Kimia Iranmanesh, Sara Pezeshki, Mohammad Hasannejad, Ali Hosseininasab, Saeedeh Parvaresh, Roya Sinaei
1308 [GO] Current Respiratory Medicine Reviews 2023―Oct―13 Respiratory Viruses Causing Influenza Like Illness/Severe Acute Respiratory Infection During COVID-19 Pandemic L. Jothisri, Shukla Das, Narendra Pal Singh, Rumpa Saha, Alpana Raizada, Mohammad Ahmad Ansari, et al. (+2)
1309 [GO] Current Respiratory Medicine Reviews 2023―Sep―13 The Impact of Acute COVID-19 Infection on Sleep Disorders: A Real-life Descriptive Study During the Outbreak of COVID-19 Pandemic in Vietnam Sy Duong-Quy, Toi Nguyen-Van, Anh Nguyen-Tuan, Tram Tang-Thi-Thao, Quan Nguyen-Hoang, Huong Tran-Van, Anh Vo-Thi-Kim
1310 [GO] Current Respiratory Medicine Reviews 2023―Sep―13 Short-term SARS-CoV-2 re-infection rate in vaccinated health workers based on received vaccines: A cross-sectional study Reza Sinaei, Maedeh Jafari, Rezvan Karamozian, Sara Pezeshki, Roya Sinaei, Fatemeh Karami Robati, et al. (+2)
1311 [GO] Current Respiratory Medicine Reviews 2023―Jul―27 VAP causative agents during COVID-19 pandemic Era: Narrative Review Usha Rani Kandula, Techane Sisay Tuji, Anwar Abdulwahed, Ketema Diriba, Kassech Leta, Birhanu Alemu
1312 [GO] Current Respiratory Medicine Reviews 2023―Jul―26 Evaluation of DPP4/CD26 Potential Role for the Management of Inflammation in COVID-19 Patients Fatemeh Akbarian, Sanam Rezazadeh Chafjiri, Marziye Poornabi, Farzaneh Khani, Solmaz Abolhasanzadeh, Fatemeh Sadat Hosseini
1313 [GO] Current Respiratory Medicine Reviews 2023―Jul―21 Post and during SARS-Cov-2 syndrome in children Maedeh Jafari, Niloofar Karimi Afshar, Reza Sinaei, Ali Hoseininasab, Saeedeh Parvaresh, Maryam Ahmadipour, et al. (+3)
1314 [GO] Current Respiratory Medicine Reviews 2023―Jul―07 “Pulmonary Tuberculosis in Post Covid-19 Patients: Occurrence and Clinical Profile” Akshata J S, Anushree Chakraborthy, Swathi Karanth, Swapna. R, Nagaraja C
1315 [GO] Current Respiratory Medicine Reviews 2023―Jul―05 Hyper-coagulopathy state in COVID-19: a pivotal challenge Seyed Mohammad Sadegh Pezeshki, Najmeh Nameh Goshay Fard, Atena Vaghf, Ekhlas Torfi, Saeid Shahrabi
1316 [GO] Current Respiratory Medicine Reviews 2023―Jun―07 Evaluation of Frequency and Risk Factors of Barotrauma among Patients with Severe Covid-19 Pneumonia Underwent Non-Invasive Ventilation in Afzalipour Hospital Kerman Mohsen Shafiepour, Behnam Dalfardi, Seyed Mehdi Hashemi Bajgani, Mohammad Javad Najafzadeh, Mohadeseh Shafiei
1317 [GO] Current Respiratory Medicine Reviews 2023―Mar―22 Mortality Predictors of Pre-variant SARS-CoV-2 Infected ARDS Patients Receiving Favipiravir and Tocilizumab Fatma Yildirim, Meltem Simsek, Muhammed Apaydin, Irem Karaman, Halil Ibrahim Dural
1318 [GO] Current Respiratory Medicine Reviews 2023―Mar―15 Follow-up COVID-19 and lung ultrasound are fundamental to prove full recovery in children with interstitial lung disease requiring oxygen: a case report Marcella Contieri, Cristiana Indolfi, Sossio Vitale, Angela Klain, Giulio Dinardo, Fabio Decimo, Michele Miraglia del Giudice
1319 [GO] Current Respiratory Medicine Reviews 2023―Mar―15 The Outcome of Critical-phase COVID-19 in Liver Transplant Recipients Rozita Khodashahi, Mahnaz Mozdourian, Mohsen Aliakbarian
1320 [GO] Current Respiratory Medicine Reviews 2023―Feb―14 The Effect of the Covid-19 Pandemic on Smokers’ Behavior in Jordan Omayma Hassanin, Khaled Al Oweidat, Naser Al-Husban, Israa Ayed Al-Odat, Joud Osama Baki, Liyana Hassan Oweis, et al. (+3)
1321 [GO] Current Respiratory Medicine Reviews 2023―Jan―11 2023: The Journal, COVID-19, and Traveling in the Future Najia Hussaini, Sevda Salmasy, Joseph Varon
1322 [GO] Current Respiratory Medicine Reviews 2022―Sep―20 COVID-19 tests and international travel: How long will you test positive for SAR-CoV-2 Kam Lun Hon, Karen Ka Yan Leung
1323 [GO] Current Respiratory Medicine Reviews 2022―Sep―03 COVID-19: Recent Advances in Lung Ultrasound- Ramendra Pati Pandey, Riya Mukherjee, Chung-Ming Chang
1324 [GO] Current Respiratory Medicine Reviews 2022―Aug―27 Meta-analysis Of Lung Cancer Patients in COVID-19 Gajala Deethamvali Ghouse Peer, Ramendra Pati Pandey
1325 [GO] Current Respiratory Medicine Reviews 2022―Aug―20 Association of Asthma with COVID-19 Disease Severity in Pediatric Patients Solmaz Heidari, Mehdi Torabizadeh, Shokoufeh Shokouhifar, Mohammadreza Mirkarimi, Mohsen Alisamir, Shooka Mohammadi
1326 [GO] Current Respiratory Medicine Reviews 2022―Aug―15 Long-Haul COVID-19: Imaging or Functional Testing? Joseph Varon, Sushen Bhalla, Daniel Martini
1327 [GO] Current Respiratory Medicine Reviews 2022―Aug―11 A Machine Learning Approach to Predict In-Hospital Mortality in COVID-19 Patients with Underlying Cardiovascular Disease using Artificial Neural Network Samaneh Sabouri, Mohammad Hossein Khademian, Mehrdad Sharifi, Razieh Sadat Mousavi-Roknabadi, Vahid Ebrahimi
1328 [GO] Current Respiratory Medicine Reviews 2022―Aug―03 Coronavirus in the Arena: One More Time
1329 [GO] Current Respiratory Medicine Reviews 2022―Jul―17 Coronavirus in the Arena: One More Time Aishami, A
1330 [GO] Current Respiratory Medicine Reviews 2022―Jun―06 Why could High-intensity Interval Training be Inappropriate in Pulmonary Rehabilitation of COVID-19 Recovered Patients? Opinion Article Ahmad Mahdi Ahmad
1331 [GO] Current Respiratory Medicine Reviews 2022―May―11 Persistent/late complications of COVID-19 in affected emergency medical technicians; a case series and brief literature review Peyman Saberian, Behshad Pazooki, Zahra Shajari, Parisa Hasani-Sharamin, Mahnaz Jamshididana, Somayeh Karimi, Alireza Baratloo
1332 [GO] Current Respiratory Medicine Reviews 2022―Apr―27 Clinical and paraclinical predictive factors for in-hospital mortality in adult patients with COVID-19; a cross-sectional study in middle of Iran Seyed Alireza Mousavi, Reyhaneh Sadat Mousavi-Roknabadi, Fateme Nemati, Somaye Pourteimoori, Arefeh Ghorbani, Hesan Pourgholamali, et al. (+3)
1333 [GO] Current Respiratory Medicine Reviews 2022―Apr―15 The prognostic effect of clinical and laboratory findings on in-hospital mortality in patients with confirmed COVID-19 disease Ali Jangjou, Razieh Sadat Mousavi-Roknabadi, Hossein Faramarzi, Alireza Neydani, Seyed Rouhollah Hosseini-Marvast, Mostafa Moqadas
1334 [GO] Current Respiratory Medicine Reviews 2022―Apr―12 Cutaneous manifestations of Novel coronavirus disease (COVID-19): A case with staphylococcal scalded skin syndrome (SSSS) Ali Hosseininasab, Reza Sinaei, Sarehossadat Ebrahimi, Saeedeh Parvaresh, Maedeh Jafari
1335 [GO] Current Respiratory Medicine Reviews 2022―Feb―21 COVID Tarnish Lung: Residual Radiological Lung Consequences of Infection with COVID-19 Ahmed Mohammed Abumossalam, Taha Taha Abdelgawad, Mohamad Abomesllam Ibrahim, Mohamad Darwish Mohamad, Dalia Abdelsattar Ahmed, Hanan Abdelsattar Elhalaby
1336 [GO] Current Respiratory Medicine Reviews 2022―Feb―10 Investigating COVID-19 Severity Based on Serum Apelin-17 levels and Inflammatory Mediators Mitra Samareh Fekri, Elham Barfzade, Mehrdad Farokhniab, Seyed Mehdi Hashemi Bajgani, Ahmad Shafahi, Mohsen Shafiepourb, et al. (+3)
1337 [GO] Current Respiratory Medicine Reviews 2022―Feb―09 Risk factors for in-hospital mortality among cancer patients with COVID-19: A cross-sectional study Iman Ghasemzadeh, Masoud Mardani, Nasrinsadat Mirtalaee, Ghazal Sanadgol, Sara Abolghasemi
1338 [GO] Current Respiratory Medicine Reviews 2021―Dec―31 “The Future of COVID-19 Najia Hussaini, Joseph Varon
1339 [GO] Current Respiratory Medicine Reviews 2021―Dec―10 Outcomes of liver transplantation from deceased donors with Coronavirus-disease 2019 and late complications of infection Mohsen Aliakbarian, Rozita Khodashahi, Kambiz Akhavan Rezayat, Seyed Mousal-Reza Hosseini, Ebrahim Khaleghi, Soheila Milani
1340 [GO] Current Respiratory Medicine Reviews 2021―Dec―07 Impact of immunosuppressant agents on post liver transplant patients with COVID-19 Rozita Khodashahi, Mohsen Aliakbarian, Mandana Khodashahi
1341 [GO] Current Respiratory Medicine Reviews 2021―Dec―02 Prevalence of Coronavirus Disease 2019 in the Brain-Dead Candidates for Transplantation and Uncommon Manifestations of the Infection Mohsen Aliakbarian, Rozita Khodashahi, Atefe Vakilian, Hamid Reza Naderi, Mandana Khodashahi, Ebrahim Khaleghi, Maliheh Dadgar Moghaddam
1342 [GO] Current Respiratory Medicine Reviews 2021―Nov―30 Bacteriophages: A Possible Choice for Treatment of Viral Respiratory Infections and COVID-19 Faezeh Abbaszadeh, Narges Eslami, Parisa Shiri Aghbash, Hamed Ebrahimzadeh Leylabadlo, Hossein Bannazadeh Baghi
1343 [GO] Current Respiratory Medicine Reviews 2021―Nov―23 Comparison between kidney and liver transplant recipients admitted to a referral center regarding coronavirus-2019 manifestations in the Northeast of Iran during three peaks of pandemic Mohsen Aliakbarian, Rozita Khodashahi, Mahin Ghorban Sabbagh, Hamid Reza Naderi, Mandana Khodashahi, Shahrzad Jahanian, Maliheh Dadgar Moghaddam
1344 [GO] Current Respiratory Medicine Reviews 2021―Oct―18 “Misinformation and COVID-19 Najia Hussaini, Joseph Varon
1345 [GO] Current Respiratory Medicine Reviews 2021―Oct―15 Hydroxychloroquine, Arbidol and COVID-19: The Jury is Still Out! Elizabeth Gamboa, Joseph Varon
1346 [GO] Current Respiratory Medicine Reviews 2021―Aug―25 Features of the Course of COVID-19 in Health Care Workers of a Non-infectious Hospital Marina Leonova, Oleg Gaisenok
1347 [GO] Current Respiratory Medicine Reviews 2021―Mar―05 Antifibrotic drugs for COVID-19: From Orphan drugs to Blockbusters? Leander Corrie, Latha Kukatil, Devasari Manasa, Adepu Shirisha
1348 [GO] Current Respiratory Medicine Reviews 2021―Mar―01 Role of pulmonary ultrasound in COVID-19 pandemics Daniil Starostin, Artem Kuzovlev
1349 [GO] Current Respiratory Medicine Reviews 2021―Jan―29 Forecasting Of Covid-19 Cases Using Machine Learning Approach Sachin Kumar, Karan Veer
1350 [GO] Current Respiratory Medicine Reviews 2021―Jan―29 Comparison the effect of Arbidol plus Hydroxychloroquine vs Hydroxychloroquine alone in treatment of COVID-19 disease: A Randomized Clinical Trial Rozita Khodashahi, Hamidreza Naderi, Amin Bojdy, Ali Akbar Heydari, Ashraf Tavanaee Sani, Mohammad Javad Ghabouli, et al. (+10)
1351 [GO] Current Respiratory Medicine Reviews 2021―Jan―29 Pulmonary Rehabilitation In Covid-19: The Contribution Of Other Chronic Lung Syndromes For The Intervention Of A Novel Disease. Vicente Benavides-Córdoba, Diana Guerrero-Jaramillo, Jhonatan Betancourt-Peña
1352 [GO] Current Respiratory Medicine Reviews 2021―Jan―19 Point of Care Ultrasound in Coronavirus 2019: Helpful or Not? Abbas Alshami, Abdulrahman S. Museedi, Joseph Varon
1353 [GO] Current Respiratory Medicine Reviews 2020―Dec―04 Outbreak of respiratory infection: nCoV-2019 current status and its impact on global health Saurabh Kumar, Sandeep Kumar, Adil Karim, Kamlesh Bisht, Abdul Ghani, Vimal Singh Munda
1354 [GO] Current Respiratory Medicine Reviews 2020―Dec―03 Effectiveness of Antiviral and Immunomodulatory Agents in Treatment of COVID-19: A Systematic Review Rozita Khodashahi, Hamidreza Naderi, Amin Bojdy, Mandana Khodashahi
1355 [GO] Current Respiratory Medicine Reviews 2020―Nov―11 Initial Remedial Action to Coronavirus in India: a Study Karan Veer
1356 [GO] Current Respiratory Medicine Reviews 2020―Sep―25 Covid-19 Susceptibility and Severity Might be Modified by Vitamin D Status: Theoretical and Practical Considerations Alex Tanner, Divya Tiwari, Stephen Allen
1357 [GO] Current Respiratory Medicine Reviews 2020―Mar―02 Coronavirus in the Arena: One More Time Abbas Alshami, Joseph Varon, Steven Douedi
1358 [GO] Current Reviews in Clinical and Experimental Pharmacology 2024―Mar―05 Targeting SIRT1 by Scopoletin to Inhibit XBB.1.5 COVID-19 Life Cycle Mohammadjavad Sotoudeheian, Seyed-Mohamad-Sadegh Mirahmadi, Mohammad Pirhayati, Navid Farahmandian, Reza Azarbad, Hamidreza Pazoki Toroudi
1359 [GO] Current Reviews in Clinical and Experimental Pharmacology 2022―May―13 COVID-19 Vaccination Hesitancy: A Review of the Literature and Recommendations Nasr Alrabadi, Shouq Bany-Melhem, Karem H. Alzoubi, Osama O. Alzoubi, Majd Masadeh, Sawsan Abuhammad, Sabariah Noor Harun
1360 [GO] Current Reviews in Clinical and Experimental Pharmacology 2022―Jan―28 DPP4 inhibitors: Could they be one of the solutions for COVID-19 patients with prediabetes? Ntethelelo Hopewell Sibiya, Bongeka Cassandra Mkhize, Andile Khathi
1361 [GO] Current Reviews in Clinical and Experimental Pharmacology 2022―Jan―07 A review study of Antibiotics with Antiviral and Anti-inflammatory Potential against Covid-19 Banafshe Abadi, Mehran Ilaghi, Yasamin Shahsavani, Mahsa Faramarzpour, Mohammad Bagher Oghazian, Hamid-Reza Rahimi
1362 [GO] Current Rheumatology Reviews 2023―Oct―23 Bilateral Avascular Necrosis of the Femoral Heads After Covid-19 Infection without Steroid Treatment Adel Elbialy, Mona Mokhtar Elmetwally Megahed, Amira Shahin Ibrahim, Aml Mohamed Elmesiry, Maha S. Mohamed, Mohamed Magdy Ghit, et al. (+2)
1363 [GO] Current Rheumatology Reviews 2023―Mar―17 The Association Between COVID-19 and Reactive Arthritis: A Systematic Review of Case Reports and Case Series Moein Zangiabadian, Kosar Namakin, Sara Sadeghzadeh, Atena Tamimi, Ayfar Abdolzadeh, Zahra Khanjani, et al. (+8)
1364 [GO] Current Rheumatology Reviews 2022―Dec―06 COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases Mariam Ahmed Saad
1365 [GO] Current Rheumatology Reviews 2022―Dec―06 Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic Anass Adnine
1366 [GO] Current Rheumatology Reviews 2022―Oct―18 COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations? Maria Fatone
1367 [GO] Current Rheumatology Reviews 2022―Aug―18 De novo vasculitis after COVID-19 vaccination Xiaoxiao Tang, Fei Liu, Qiuyu Li, Haidong Fu, Jingjing Wang, Jianhua Mao
1368 [GO] Current Rheumatology Reviews 2022―Aug―03 COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases
1369 [GO] Current Rheumatology Reviews 2022―Aug―03 Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic
1370 [GO] Current Rheumatology Reviews 2022―Jul―17 COVID-19 and Autoimmune Diseases: A Systematic Review of Reported Cases Saad, MA
1371 [GO] Current Rheumatology Reviews 2022―Jul―17 Mental Health Problems Experienced by Patients with Rheumatic Diseases During COVID-19 Pandemic Adnine, A
1372 [GO] Current Rheumatology Reviews 2022―Apr―14 COVID-19 Mortality in Patients with Rheumatic Diseases: A Real Concern Nasra K. Al-Adhoubi, Maha Ali, Humaid Al Wahshi, Issa Al Salmi, Farida Al-Balushi, Talal Al Lawati, et al. (+5)
1373 [GO] Current Rheumatology Reviews 2022―Feb―11 Rheumatologic Manifestations of Post SARS-CoV-2 Infection: A Case Series Samy Metyas, Christina Chen, Tun Aung, Andrew Ballester, Sovanndy Cheav
1374 [GO] Current Rheumatology Reviews 2021―Oct―08 Rheumatologic aspects of the COVID-19 pandemic: a practical resource for physicians in Kuwait and the Gulf region based on recommendations by the Kuwait Association of Rheumatology (KAR)
1375 [GO] Current Rheumatology Reviews 2021―Jan―28 Mental health problems experienced by patients with rheumatic diseases during COVID-19 pandemic Anass Adnine, Khawla Nadiri, Ilias Soussan, Siriman Coulibaly, Khadija Berrada, Adil Najdi, Fatima E Abourazzak
1376 [GO] Current Rheumatology Reviews 2020―Dec―29 Patients with Rheumatic Diseases Overlooked during COVID-19 Pandemic: How are They Doing and how do They Behave? Anass Adnine, Ilias Soussan, Khawla Nadiri, Siriman Coulibaly, Khadija Berrada, Adil Najdi, Fatima Ezzahra Abourazzak
1377 [GO] Current Rheumatology Reviews 2020―Oct―30 Covid-19 and Autoimmune Diseases: A Systematic Review of Reported Cases Mariam Ahmed Saad, Mostafa Alfishawy, Mahmoud Nassar, Mahmoud Mohamed, Ignatius N Esene, Amira Elbendary
1378 [GO] Current Rheumatology Reviews 2020―Oct―30 Perfect storm: a rheumatologist's point of view on COVID-19 infection Senol Kobak
1379 [GO] Current Rheumatology Reviews 2020―Oct―06 COVID-19: a Great Mime or a Trigger Event of Autoimmune Manifestations? Maria Celeste Fatone
1380 [GO] Current Signal Transduction Therapy 2022―Dec―14 Empirical Study on Detecting COVID-19 in Chest X-ray Images Using Deep Learning-Based Methods Hatam Abdoli, Ramtin Babaeipour, Elham Azizi, Hassan Khotanlou
1381 [GO] Current Signal Transduction Therapy 2022―Apr―05 Even after vaccination, is the second wave of covid-19 in india more dangerous? Pooja Sachin Kumar, Karan Veer
1382 [GO] Current Signal Transduction Therapy 2022―Mar―08 EVALUATION AND PREDICTION OF END OF SECOND WAVE AND STARTING OF THIRD WAVE COVID-19 CASES IN INDIA Sachin Sharma, Karan Veer
1383 [GO] Current Signal Transduction Therapy 2021―Jul―02 IoT Solutions for Smart Management of Hospital Buildings: A General Review towards COVID-19, Future Pandemics and Infectious Diseases Omid Akbarzadeh, Mehrshid Baradaran, Mohammad Khosravi
1384 [GO] Current Signal Transduction Therapy 2021―Jan―26 Therapeutic Approaches for COVID-19 Based on the Interferon-mediated Immune Responses Pouria Mosaddeghi, Farbod Shahabinezhad, Zahra Dehghani, Mitra Farahmandnejad, Mohammad Javad Taghipour, Mohsen Moghadami, et al. (+3)
1385 [GO] Current Signal Transduction Therapy 2020―Aug―08 How India Fights with COVID-19 with Learning from Highly Affected Countries Pooja Sharma, Karan Veer
1386 [GO] Current Social Sciences 2024―Jan―29 Technology-Mediated Task-based Instruction During COVID-19: A Case Study from Higher Education in Morocco Abdellah El Boubekri, Marilyn Lewis
1387 [GO] Current Stem Cell Research & Therapy 2023―Jul―30 Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Asso-ciated ARDS
1388 [GO] Current Stem Cell Research & Therapy 2023―Jul―30 Efficacy and Safety of Mesenchymal Stromal Cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis
1389 [GO] Current Stem Cell Research & Therapy 2023―Apr―17 Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients Zohreh Saltanatpour, Fezzeh Heidari, Mehrdad Nasrollahzadeh Sabet, Reza Heidari, Amir Ali Hamidieh
1390 [GO] Current Stem Cell Research & Therapy 2023―Jan―18 Mesenchymal stem cells therapy for COVID-19: from basic research to clinical trial En-Qiang Chen, Ya-Chao Tao
1391 [GO] Current Stem Cell Research & Therapy 2022―Dec―22 The role of advanced technologies against COVID-19: Prevention, Detection, and Treatments Mozhgan Abasi, Elham Hasanzadeh, Adele Rafati, Seyedeh Masoumeh Seyed Hosseini Tamijani, Raheleh Rafaiee, Ali Golchin
1392 [GO] Current Stem Cell Research & Therapy 2022―Nov―25 Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment K Sreedhara Ranganath Pai, Vignesh Balaji E, Sairaj Satarker, Tanvi V Gujaran, jeena john, Anuranjana P V, et al. (+6)
1393 [GO] Current Stem Cell Research & Therapy 2022―Oct―18 The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19 Jundong Gu
1394 [GO] Current Stem Cell Research & Therapy 2022―Oct―18 Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential Jing Xiong
1395 [GO] Current Stem Cell Research & Therapy 2022―Aug―30 Mesenchymal Stem Cells: Case Report of an Adjuvant Ambulatory Therapy for a COVID-19 High-Risk and steroid-hypersensitive Patient Juan Pablo Aguilar Alemán, Grecia Andrea Cardoso-Hernández, Ana Luisa Camacho-Torres, Beni Camacho-Pérez, Fabio Antonio Gonzalez-Sanchez, José Navarro-Partida, et al. (+2)
1396 [GO] Current Stem Cell Research & Therapy 2022―Apr―27 Mesenchymal Stromal Cells and their EVs as potential leads for SARS-CoV2 treatment Vahid Kia, Reza Eshaghi-Gorji, Reyhaneh Nassiri Mansour, Hadi Hassannia, Elham Hasanzadeh, Mobina Gheibi, et al. (+2)
1397 [GO] Current Stem Cell Research & Therapy 2021―Dec―07 Efficacy and Safety of Mesenchymal Stromal cells Therapy for COVID-19 Infection: A Systematic Review and Meta-analysis Yaxin Li, Ziyang Wei, Xinyu Ma, Jing Xu, Xia Zhao, Qilong Cao, Guohu Di
1398 [GO] Current Stem Cell Research & Therapy 2021―Aug―15 Visualized analyses of investigations upon mesenchymal stem/stromal cell-based cytotherapy and underlying mechanisms for COVID-19 associated ARDS Wang Aitong, Zhang Leisheng, Yu Hao
1399 [GO] Current Stem Cell Research & Therapy 2021―Aug―15 The World Against Versatile SARS-Cov-2 Nanomachines; Mythological or Reality? Shima Tavakol, Hani Tavakol, Mo S. Alavijeh, Alexander Seifalian
1400 [GO] Current Stem Cell Research & Therapy 2020―Nov―26 Mesenchymal stem Cells as a Treatment Strategy for Coronavirus Disease 2019 (COVID-19): Need for Authority Regulations and Clinical Guidelines Ahmet Cevik Tufan
1401 [GO] Current Stem Cell Research & Therapy 2020―Jul―30 The Promise of Mesenchymal stem cells therapy for acute Respiratory Distress Syndrome Caused by COVID-19 Jundong Gu, Qinjun Zhao, Zhibo Han, Zhongchao Han
1402 [GO] Current Stem Cell Research & Therapy 2020―Jul―06 Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation Seidu A. Richard, Sylvanus Kampo, Marian Sackey, Maite Esquijarosa Hechavarria, Alexis D. B. Buunaaim, Eugene Dogkotenge Kuugbee, Thomas Winsum Anabah
1403 [GO] Current Stem Cell Research & Therapy 2020―Jun―01 Mesenchymal Stem Cell-Based Therapy for COVID-19: Possibility and Potential Jing Xiong, Lei Bao, Hongbo Qi, Zhichun Feng, Yuan Shi
1404 [GO] Current Topics in Medicinal Chemistry 2024―Feb―22 Repurposing of Plant-based Antiviral Molecules for the Treatment of COVID-19 Jabeena Khazir, Rakesh Kr Thakur, Sajad Ahmed, Manzoor Hussain, Sumit G. Gandhi, Sadhana Babbar, et al. (+7)
1405 [GO] Current Topics in Medicinal Chemistry 2024―Feb―06 Combating COVID-19 Crisis using Artificial Intelligence (AI) Based Approach: Systematic Review Kavya Singh, Navjeet Kaur, Ashish Prabhu
1406 [GO] Current Topics in Medicinal Chemistry 2023―Oct―19 Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza: A Perception on Combating Symptoms from COVID-19 Gene Chi Wai Man, Xu Zheng, Sze Wan Hung, Loucia Kit Ying Chan, Tao Zhang, Xiaoyan Chen, et al. (+5)
1407 [GO] Current Topics in Medicinal Chemistry 2023―Aug―30 Natural Products: A Potential New Hope to Defeat Post-Acute Sequelae of COVID-19 Shuang Zhao, Aliya Abdurehim, Yu Yuan, Tan Yang, Chao Li, Yanqing Zhang, et al. (+3)
1408 [GO] Current Topics in Medicinal Chemistry 2023―Aug―25 A Critical Assessment of COVID-19 Genomic Vaccines Dima A. Sabbah, Rima Hajjo, Suhair Sunoqrot
1409 [GO] Current Topics in Medicinal Chemistry 2023―Apr―14 SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research Edeildo Ferreira da Silva-Júnior, Weslany Souza Rocha, Peng Zhan
1410 [GO] Current Topics in Medicinal Chemistry 2023―Mar―28 Natural Products as Potential Therapeutic Agents for SARS-CoV-2: A Medicinal Chemistry Perspective Praveen Kumar Verma, Varun Aggarwal, Ekta Bala, Pawan Kumar, Pankaj Raizada, Pardeep Singh
1411 [GO] Current Topics in Medicinal Chemistry 2023―Feb―23 Investigating Biomarkers for COVID-19 Morbidity and Mortality Marco Fiore, Flavio Maria Ceci, Giampiero Ferraguti, Marco Lucarelli, Antonio Angeloni, Enea Bonci, et al. (+12)
1412 [GO] Current Topics in Medicinal Chemistry 2023―Jan―31 Contributions of Medicinal Chemistry During the Pandemic of Covid-19 Shampa Ghosh, Jitendra Kumar Sinha
1413 [GO] Current Topics in Medicinal Chemistry 2023―Jan―27 SAR Based Review on Diverse Heterocyclic Compounds with Various Potential Molecular Targets in the Fight against Covid-19: A Medicinal Chemist Perspective Mohammad Mumtaz Alam, Anish Madan, Mansi Garg, Garvit Satija, Barkha Sharma, M Shaquiquzzaman, et al. (+6)
1414 [GO] Current Topics in Medicinal Chemistry 2022―Dec―27 Piezoelectric biosensors and nanomaterials-based therapeutics for coronavirus and other viruses: A Mini-review Rakesh Bhaskar, Madeshwaran Sekkarapatti Ramasamy, Sung Soon Han
1415 [GO] Current Topics in Medicinal Chemistry 2022―Dec―26 Probing the neuro-psychological changes observed with the administration of COVID-19 Drugs Indranath Chatterjee, Videsha Bansal
1416 [GO] Current Topics in Medicinal Chemistry 2022―Dec―06 The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area Zhongji Meng
1417 [GO] Current Topics in Medicinal Chemistry 2022―Dec―06 An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors Dima A. Sabbah
1418 [GO] Current Topics in Medicinal Chemistry 2022―Dec―02 Repurposing of chemotherapeutics to combat COVID-19 Anil Kumar Saxena, Sisir Nandi, Bhabani Shankar Nayak, Mayank Kumar Khede
1419 [GO] Current Topics in Medicinal Chemistry 2022―Nov―04 Structure Based Drug Designing Approaches in SARS-CoV-2 Spike Inhibitor Design. Anusuya Shanmugam, Anbazhagan Venkattappan, M. Michael Gromiha
1420 [GO] Current Topics in Medicinal Chemistry 2022―Oct―24 Exploring the targets of novel corona virus and docking-based screening of potential natural inhibitors to combat COVID-19 Asmita Samadder, Sisir Nandi, Rishita Dey
1421 [GO] Current Topics in Medicinal Chemistry 2022―Oct―18 Therapeutic Targets and Computational Approaches on Drug Development for COVID-19 Anusuya Shanmugam
1422 [GO] Current Topics in Medicinal Chemistry 2022―Oct―18 Effective Chemicals against Novel Coronavirus (COVID-19) in China Wei Liu
1423 [GO] Current Topics in Medicinal Chemistry 2022―Oct―18 Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China Zhang Qi
1424 [GO] Current Topics in Medicinal Chemistry 2022―Oct―18 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery Ariane Sternberg
1425 [GO] Current Topics in Medicinal Chemistry 2022―Aug―03 Coronavirus Disease COVID-19: A New Threat to Public Health
1426 [GO] Current Topics in Medicinal Chemistry 2022―Jul―27 Host Cell Proteases Mediating SARS-CoV-2 Entry: An Overview. Mehdi Oubahmane, Ismail Hdoufane, Imane Bjij, Nouhaila Ait Lahcen, Didier Villemin, Rachid Daoud, et al. (+2)
1427 [GO] Current Topics in Medicinal Chemistry 2022―Jul―17 The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area Meng, ZJ
1428 [GO] Current Topics in Medicinal Chemistry 2022―Jul―07 Therapeutics for the management of cytokine release syndrome in COVID-19 Shampa Ghosh, Shantanu Durgvanshi, Sung Soo Han, Rakesh Bhaskar, Jitendra Kumar Sinha
1429 [GO] Current Topics in Medicinal Chemistry 2022―Jul―07 Novel Therapeutic Strategies for the Management of Neuropathology and Neuroprotection in COVID-19 Cindy Bandala
1430 [GO] Current Topics in Medicinal Chemistry 2022―May―17 COVID-19 in G6PD-deficient patients, oxidative stress, and neuropathology Beatriz Hernández-Ochoa, Daniel Ortega-Cuellar, Abigail González-Valdez, Noemí Cárdenas-Rodríguez, Julieta Griselda Mendoza-Torreblanca, Itzel Jatziri Contreras-García, et al. (+3)
1431 [GO] Current Topics in Medicinal Chemistry 2022―May―07 Mental disorders and poor COVID-19 prognosis: reevaluating the relationship through Ca2+/cAMP signalling Leandro Bueno Bergantin
1432 [GO] Current Topics in Medicinal Chemistry 2022―Apr―27 A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds Juan A. Castillo-Garit, Yudith Cañizares-Carmenate, Hai Pham-The, Virginia Pérez-Doñate, Francisco Torrens, Facundo Pérez-Giménez
1433 [GO] Current Topics in Medicinal Chemistry 2022―Apr―06 Potential Neuroprotective Effect of Cannabinoids in Covid-19 Patients. José Luis Cortes-Altamirano, Ariadna Yáñes-Pizaña, Samuel Reyes-Long, González-Maciel Angélica, Cindy Bandala, Herlinda Bonilla-Jaime, Alfonso Alfaro-Rodríguez
1434 [GO] Current Topics in Medicinal Chemistry 2022―Apr―03 Vitamin D and its possible relationship to neuroprotection in COVID-19: evidence in the literature Saray Quintero-Fabián, Cindy Bandala, Luz Adriana Pichardo-Macías, Itzel Jatziri Contreras-García, Saúl Gómez-Manzo, Beatriz Hernández-Ochoa, et al. (+3)
1435 [GO] Current Topics in Medicinal Chemistry 2022―Mar―08 BIBLIOMETRIC ANALYSIS: NANOTECHNOLOGY AND COVID-19 Claure Nain Lunardi, Fernanda Lima Subrinho, Mirella Paula de Freitas Barros, Raiane Cavalcante Lima, Ana Clara Magalhaes de Queiroz Melo, Daniela de Melo Barbosa, et al. (+6)
1436 [GO] Current Topics in Medicinal Chemistry 2022―Mar―04 HDAC inhibition as neuroprotection in COVID-19 infection Yudibeth Sixto-López, José Correa-Basurto
1437 [GO] Current Topics in Medicinal Chemistry 2021―Jul―28 Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment Harekrishna Roy, Asha Gummadi, Bhabani Shankar Nayak, Sisir Nandi, Anil Kumar Saxena
1438 [GO] Current Topics in Medicinal Chemistry 2021―Jul―19 Protease Inhibitors as Promising Weapons against COVID-19: Focus on Repurposing of Drugs Used to Treat HIV and HCV infections Luciana Jesus da Costa, Matheus Mendonça Pereira, Lívia de Souza Ramos, Thaís Pereira de Mello, Laura Nunes Silva, Marta Helena Branquinha, André Luis Souza dos Santos
1439 [GO] Current Topics in Medicinal Chemistry 2021―Jun―19 Chimeric virus-like particles of universal antigen epitopes of coronavirus and phage Qβ coat protein trigger the production of neutralizing antibodies Yukun Guo, Ruizhen Guo, Yingxian Ma, Wenru Chang, Shengli Ming, Guoyu Yang, Yujie Guo
1440 [GO] Current Topics in Medicinal Chemistry 2021―Jun―15 COVID-19 and diabetes mellitus: potential metabolic associations Pedro Henrique Abreu da Silva, Andressa Santos Garcia, Fábio Aguiar Alves, André Luis Souza dos Santos, Cátia Lacerda Sodré
1441 [GO] Current Topics in Medicinal Chemistry 2021―May―13 The effect of recombinant human interferon alpha nasal drops to prevent COVID-19 pneumonia for medical staff in an epidemic area Zhongji Meng, Tongyu Wang, Li Chen, Xinhe Chen, Longti Li, Xueqin Qin, et al. (+2)
1442 [GO] Current Topics in Medicinal Chemistry 2021―Mar―31 Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance Gabriela Seabra, Roberta Ferreira Ventura Mendes, Luiz Felipe Vieira dos Santos Amorim, Ingrid Vianez Peregrino, Marta Helena Branquinha, André Luis Souza dos Santos, Ana Paula Ferreira Nunes
1443 [GO] Current Topics in Medicinal Chemistry 2021―Jan―19 An Updated Review on Betacoronavirus Viral Entry Inhibitors: Learning from Past Discoveries to Advance COVID-19 Drug Discovery Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong
1444 [GO] Current Topics in Medicinal Chemistry 2020―Dec―08 An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel, Haizhen A. Zhong
1445 [GO] Current Topics in Medicinal Chemistry 2020―Nov―13 Recent Advances in Discovery of Potent Proteases Inhibitors Targeting the SARS Coronaviruses Arti Sharma, Kajal Kaliya, Sushil K. Maurya
1446 [GO] Current Topics in Medicinal Chemistry 2020―Nov―03 Most Promising Compounds for Treating COVID-19 and Recent Trends in Antimicrobial & Antifungal Agents Anuraj Nayarisseri
1447 [GO] Current Topics in Medicinal Chemistry 2020―Oct―01 Importance of Environmental Factors on Production of Computationally- Defined Natural Molecules against COVID-19 Pandemic Mohamed Abouleish, Ali El-Keblawy, Kareem A. Mosa, Sameh S.M. Soliman
1448 [GO] Current Topics in Medicinal Chemistry 2020―Oct―01 Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options Laura Nunes Silva, Thaís Pereira de Mello, Lívia de Souza Ramos, Marta Helena Branquinha, Maryam Roudbary, André Luis Souza dos Santos
1449 [GO] Current Topics in Medicinal Chemistry 2020―Sep―23 Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2 Satya P. Gupta
1450 [GO] Current Topics in Medicinal Chemistry 2020―Jul―20 COVID-19: Small-Molecule Clinical Trials Landscape Leonardo L.G. Ferreira, Adriano D. Andricopulo
1451 [GO] Current Topics in Medicinal Chemistry 2020―Jul―17 Ligand- and structure-based virtual screening of Lamiaceae diterpenes with potential activity against a novel coronavirus (2019-nCoV) Gabriela Cristina Soares Rodrigues, Mayara dos Santos Maia, Renata Priscila Barros de Menezes, Andreza Barbosa Silva Cavalcanti, Natália Ferreira de Sousa, Érika Paiva de Moura, et al. (+3)
1452 [GO] Current Topics in Medicinal Chemistry 2020―Jul―16 Therapeutic targets and computational approaches on drug development for COVID-19 Anusuya Shanmugam, Nisha Muralidharan, D. Velmurugan, M. Michael Gromiha
1453 [GO] Current Topics in Medicinal Chemistry 2020―Jul―04 Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. Ravina Khandelwal, Anuraj Nayarisseri, Maddala Madhavi, Chandrabose Selvaraj, Umesh Panwar, Khushboo Sharma, et al. (+2)
1454 [GO] Current Topics in Medicinal Chemistry 2020―May―19 The Evolution of Computational Chemistry Along with Coronaviruses Weng Ieong Tou, Kuok Wa Tam, Hou Ng
1455 [GO] Current Topics in Medicinal Chemistry 2020―May―17 Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery Ariane Sternberg, Dwight L. McKee, Cord Naujokat
1456 [GO] Current Topics in Medicinal Chemistry 2020―May―12 COVID-19 Pandemic - Are We Heading From Health Crisis Towards An Unprecedented Nutrition Crisis? Yogesh Kumar, Akanksha Jain
1457 [GO] Current Topics in Medicinal Chemistry 2020―May―12 COVID-19: An Update on Clinical Trials Yogesh Kumar, Anil Kumar Singh, Shiv Kumar
1458 [GO] Current Topics in Medicinal Chemistry 2020―May―12 Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China Zhang Qi, Yu Yu
1459 [GO] Current Topics in Medicinal Chemistry 2020―Apr―13 Coronavirus Disease (COVID-19) Pandemic: A Race Against Time Amit Kumar Banerjee, Neelima Arora
1460 [GO] Current Topics in Medicinal Chemistry 2020―Mar―05 Effective Chemicals against Novel Coronavirus (COVID-19) in China Wei Liu, Hai-liang Zhu, Yongtao Duan
1461 [GO] Current Topics in Medicinal Chemistry 2020―Mar―05 Coronavirus Disease COVID-19: A New Threat to Public Health Sumit Kumar, Brijesh Rathi
1462 [GO] Current Topics in Medicinal Chemistry 2020―Mar―05 China Coronavirus Outbreak: All the Latest Updates Luciana Scotti, Marcus T. Scotti
1463 [GO] Current Traditional Medicine 2024―Jan―25 Benefits of Medicinal Plants in Boosting Immunity against Viral Infections Including COVID-19 Uday Bhan Prajapati, Arun Lal Srivastav, Ajmer Singh Grewal
1464 [GO] Current Traditional Medicine 2023―Nov―29 Immunity Boosting Herbs For Fighting COVID-19 Prerna Sharma, Nidhi Rani, Vikas Sharma, Nitin Goel, Sanchit Dhankhar
1465 [GO] Current Traditional Medicine 2023―Nov―10 Therapeutic Potential of Traditional Medicines and Natural Products for COVID-19: A Review Rahul Kumar Sharma, Ramandeep Kaur, Ajay Singh Khushwah, Shailesh Sharma, Neelam Sharma, Punam Gaba
1466 [GO] Current Traditional Medicine 2023―Oct―13 Management of COVID-19 Pandemic by Immunity-modulating Ayurvedic Interventions: A Bright Panacea Ruchi Sharma, Shalini Rai, Heena Saini, Dimpal Rochlani, Varnika Singh, Richa Tripathi
1467 [GO] Current Traditional Medicine 2023―Sep―15 Unani approach to graded management of thrombosis in Covid-19 patients Zikra Tahseen. A, Ghulamuddin Sofi, Arisha Shahid, Shahila Aazam
1468 [GO] Current Traditional Medicine 2023―Aug―23 The Sequelae of Sleeping Issues and their Management in Post COVID-19: A Unani and Contemporary Narrative Review Shaheen Akhlaq, Anwar Jamal, Aisha Siddiqui, Shabnam Anjum Ara, Malik Itrat
1469 [GO] Current Traditional Medicine 2023―Aug―03 Herbal Remedies: An Emerging Alternative for the Treatment of Pandemic Diseases Neha T. Nistane, Mayur B. Kale, Renuka J. Das, Mohit D. Umare, Milind J. Umekar, Atul T. Hemke, Vishal R. Gajbhiye
1470 [GO] Current Traditional Medicine 2023―Jun―06 Anti-viral Application of Ganoderma Lucidum in COVID-19 Hamid Babavalian, Fatemeh Shakeri, Hamid Moghimi, Mahsa Pahlevan Afsharian, Aida Alipashazadeh, Sahar Zuhuriyan Izadi
1471 [GO] Current Traditional Medicine 2023―May―17 Populations using Traditional Home Remedy at Low Risk for Covid-19 Infection Vikas Gupta, Gunpreet Kaur, Ravinder Sharma, Parveen Bansal
1472 [GO] Current Traditional Medicine 2023―May―16 Effects of Covid-19 pandemic on the mental health of women and treatment of mental disorders in the Unani System of Medicine: An Overview Sana Kauser Ateeque Ahmed, Nasreen Jahan, Abid Ali Ansari
1473 [GO] Current Traditional Medicine 2023―Apr―14 The perpetual impact of COVID-19 on the geriatric population's quality of life and potential preventive and therapeutic measures in Unani medicine: An evidence-based review Shabnam Anjum Ara, Shaheen Akhlaq, BILAL AHMAD, Merajul Haque, Mohammad Fazil, Usama Akram, et al. (+2)
1474 [GO] Current Traditional Medicine 2023―Apr―14 Complementary Medication for COVID-19 Outbreak Concerns in the Leprosy Community - A Passionate Proposal Pugazhenthan Thangaraju, Sajitha Venkatesan, Meenalotchini Prakash Gurunthalingam, Hemasri Velmurugan, Sree Sudha TY, Thangadurai K, et al. (+2)
1475 [GO] Current Traditional Medicine 2023―Feb―23 A Comprehensive Review on Potentially Therapeutic Agents against COVID-19 from Natural Sources Rashid Alijani Ardeshir, Ali Shahali, Zahra Jafari Azar
1476 [GO] Current Traditional Medicine 2023―Feb―22 Need and Possibilities of Phytocompounds against SARS-CoV-2: Recent Advances in COVID-19 Therapy Pradeep Kumar R
1477 [GO] Current Traditional Medicine 2023―Feb―07 COVID-19: Impact, Diagnosis , Management and Phytoremediation Athar Ata, Samina Naz, Simran Sandhu, Bilge Sener
1478 [GO] Current Traditional Medicine 2023―Feb―06 Medicinal Plants Used Traditionally in Sudan to Treat Viral Infections Related to the Signs and Symptoms of COVID-19: A Systematic Review Sakina Yagi, Ahmed Yagi
1479 [GO] Current Traditional Medicine 2023―Jan―25 Impact of Yoga on Immune Response with Special Reference to COVID-19: A Review of Randomized Controlled Trials Neha Mishra, Saurabh Mishra
1480 [GO] Current Traditional Medicine 2023―Jan―19 Preventive Potential of Extracts of Some Dietary Plants Against SARS-CoV-2 Infection# M. Iqbal Choudhary, Saba Farooq
1481 [GO] Current Traditional Medicine 2023―Jan―12 Indian Traditional Medicine for COVID-19 Suresh Thangaraj, Amsaveni Sundarasamy, Thamarai Selvi Senniappan, Gothandam Kodiveri Muthukaliannan Muthukaliannan
1482 [GO] Current Traditional Medicine 2022―Aug―23 Herbal and Ayurvedic Plants as Remedial Approach for Viral Diseases with Focus on COVID-19: A Narrative Review Yashvita Joshi, Hema Rani, Gurpreet Kaur, Manish Kumar, Rakesh K. K. Sindhu, Ajay Singh Kushwah, Roopal Mittal
1483 [GO] Current Traditional Medicine 2022―Aug―10 Overview of COVID-19 Pandemic: Its Management and Prevention in Light of the Indian Traditional Medicine System Lav Singh, Arpit Singh, Divyanshu yadav, Apurv Chhavi, Ravi Prakash Srivastava, Shivaraman Pandey, et al. (+3)
1484 [GO] Current Traditional Medicine 2022―Jun―15 Ayurvedic Herbs Advised for COVID-19 Management: Therapeutic Potential and Clinical Relevance Prashant Kumar Gupta, Kishor Sonewane, Mariappan Rajan, Nagendra Singh Chauhan, Awanish Kumar
1485 [GO] Current Traditional Medicine 2022―Jun―03 Screening of Natural Antivirals Against COVID 19 Pandemic- A Compilation of Updates Baishakhi De, Tridib Kumar Goswami, Vijaya GS Raghavan
1486 [GO] Current Traditional Medicine 2022―May―20 Integrative Medicine in the Treatment of COVID-19: The Indian Way Ajay G. Namdeo, Ryan Varghese, Yogita Kapase, Pradnya Kumbhar
1487 [GO] Current Traditional Medicine 2022―Mar―30 Herbal medicines as potential immune boosters against coronavirus diseases Salome Amarachi Chime, Chika Phoebe Madumere
1488 [GO] Current Traditional Medicine 2022―Mar―22 The Potential Impact of Ayurvedic traditional Bhasma on SARS-CoV-2 Induced Pathogenesis Pankaj Kumar, Remya Jayakumar, Manoj Kumar Dash, Namrata Joshi
1489 [GO] Current Traditional Medicine 2021―Dec―21 A Review Article on the Therapeutic Potential of Medicinal Plants for Prevention and Treatment of secondary infection in patients with COVID-19 Swati Rathore, Richa Tripathy Tiwari, Neha Rai, Debarshi Kar Mahapatra, Shailendra Patil, Asmita Gajbhiye Patil
1490 [GO] Current Traditional Medicine 2021―Sep―20 Antiviral Properties of Food Plants Could Help to Reduce Contagion and Severity in SARS-CoV-2 Infections Betina Cardoso
1491 [GO] Current Traditional Medicine 2021―Sep―06 Survival Analysis Based on the Siddha Body Constitution of Asymptomatic SARS-CoV-2 Patients Under Integrative Management of Hydroxychloroquine (HCQ) and Kaba Sura Kudineer (KSK): A Retrospective, Cross-Sectional, Case Series in Tirupati Samraj Karunanithi, Sreenivasa Rao P, Manoj Kumar D.
1492 [GO] Current Traditional Medicine 2021―Apr―14 Ayurvedic system a new possible safe and effective way to get rid of this critical nCOVID-19 pandemic situation- A review Sumel Ashique, Navjot K Sandhu
1493 [GO] Current Traditional Medicine 2021―Mar―23 Physical Exercise and Yoga: as an alternative approach towards COVID-19 management Saurabh Kumar, Sakshi Sudha, Madhu Chopra, Famida Khan, Kanupriya Sharma
1494 [GO] Current Traditional Medicine 2021―Feb―11 Tackling COVID-19 through Ayurveda: A Review on the Herbs of Recommended Indian Remedies Udaykumar G Vegad, Devang J Pandya
1495 [GO] Current Traditional Medicine 2021―Jan―31 Nigella Sativa, as Preventive Strategy in COVID-19 Vaishali Mathur, Mahak Sharma
1496 [GO] Current Traditional Medicine 2021―Jan―18 Survival analysis to assess the length of stay of novel coronavirus (COVID-19) patients under Integrated Medicine - Zinc, Vitamin C & Kabasura Kudineer (ZVcKK) A. Nirmala, T. Ravikumar, K. Kanakavalli, P. Pathiban, K. Babu, D. Jamuna, et al. (+4)
1497 [GO] Current Traditional Medicine 2021―Jan―05 Alternative medicine as a treatment options for COVID-19 Mahfuza Marzan, Md. Shahedur Rahman, Md. Abu Hena Mostofa Jamal, Mohammad Hossain Shariare, Md. Anowar Khasru Parvez
1498 [GO] Current Traditional Medicine 2020―Dec―01 Traditional Medicine - A Possible Stop Codon for COVID-19 Nissar A. Reshi, Anup S. Deshpande, Namita A. Raytekar, Vasudeo P. Zambare
1499 [GO] Current Traditional Medicine 2020―Nov―26 Potential of Selected Indian Herbs for COVID-19 Ravindra Verma, Vaibhav Misra, Dileep Tiwari, Prakash S. Bisen
1500 [GO] Current Vascular Pharmacology 2022―May―16 COVID-19 and kidney disease: A clinical perspective Panagiotis Theofilis, Aikaterini Vordoni, Rigas G Kalaitzidis
1501 [GO] Current Vascular Pharmacology 2022―Apr―30 Implications of COVID-19 to stroke medicine: an epidemiological and pathophysiological perspective. Alan King, Karen M. Doyle
1502 [GO] Current Vascular Pharmacology 2022―Apr―05 COVID-19 and Inflammatory Markers Sevket Balta, Ilknur Balta
1503 [GO] Current Vascular Pharmacology 2021―Nov―22 Narrative review of recent studies on the role of vitamin D in the prevention of cardiac and renal risk and additional considerations for COVID-19 vulnerability Aikaterini E. Panteli, Panagiotis Theofilis, Aikaterini Vordoni, Georgios Vlachopanos, Maria Koukoulaki, Rigas G. Kalaitzidis
1504 [GO] Current Vascular Pharmacology 2021―Oct―15 COVID-19-associated Coagulopathy and Thromboembolism: Determination of their Patterns and Risk Factors as Predictors of Mortality Among Severe COVID-19 Patients Iftikhar Haider Naqvi, Muhammad Tanveer Alam, Muhammad Rehan, Khalid Mahmood, M Aurangzeb, Abu Talib
1505 [GO] Current Vascular Pharmacology 2021―Aug―26 Thromboprophylaxis in Patients with COVID-19: Systematic Review of National and International Clinical Guidance Reports Konstantinos G. Kyriakoulis, Anastasios Kollias, Ioannis G . Kyriakoulis, Ioanna A. Kyprianou, Chrysso Papachrysostomou, Panagiotis Makaronis, et al. (+4)
1506 [GO] Current Women s Health Reviews 2024―Jan―26 Impact of Covid-19 on Endometriosis Patients: An Integrative Review Zahra Behboodi Moghadam, Masoumeh Namazi
1507 [GO] Current Women s Health Reviews 2024―Jan―25 The Impact of the COVID-19 Pandemic on Women’s Health: A Review Deepika Singh
1508 [GO] Current Women s Health Reviews 2023―Aug―29 The Effect of Coronavirus Pandemic on the Treatment of Gynecological and Breast Cancers Hamid Salehiniya, Zohre Momenimovahed, Leila Allahqoli
1509 [GO] Current Women s Health Reviews 2023―Aug―23 Predictors of Fertility Desire During COVID-19 Pandemic: A Cross-Sectional Study Seyedeh Fatemeh Ghaffari, Monirolsadate Hosseini-Tabaghdehi, Roya Nikbakht, Shayesteh Jahanfar, Zohreh Shahhosseini
1510 [GO] Current Women s Health Reviews 2023―Jun―08 A Rare Combination of Breast, and Thyroid Carcinoma, with Superadded COVID-19 Infection in Mother: Struggle of a Doctor as a Daughter - Case Report Naina Kumar
1511 [GO] Current Women s Health Reviews 2023―May―08 Public Reproductive Health Concerns related to the COVID-19 Vaccination: A Retrospective Analysis of Google Trends Data in Iran Robab Latifnejad Roudsari, Elham Azmoude, Mona larki, Nahid Marvi
1512 [GO] Current Women s Health Reviews 2023―Apr―20 Perceptions and experiences of midwives during the COVID-19 pandemic in Iran: a qualitative exploration Robab Latifnejad Roudsari, Elham Latifnejad Manouchehri, Somayeh Alirezaei
1513 [GO] Current Women s Health Reviews 2023―Apr―19 Maternal worries during the Covid-19 pandemic: A cross-sectional study on postpartum women Parvin Abedi, Poorandoht Afshari, Maryam Beheshti Nasab, Mitra Tadayon Najafabadi
1514 [GO] Current Women s Health Reviews 2023―Mar―31 COVID-19 and Pregnancy Complications: Meta-Analysis and Systematic Review Dilsad Herkiloglu, Sefik Gokce
1515 [GO] Current Women s Health Reviews 2023―Feb―28 The Perceived Support received by Women with Breast Cancer during the COVID-19 Pandemic: A Qualitative Study Marjan Mardani-Hamooleh, Haydeh Heidari, Sally Pezaro
1516 [GO] Current Women s Health Reviews 2023―Feb―22 Everything Midwives Need to Know about Postpartum women's Health Care During the COVID-19 Pandemic: An Updated Evidence Review and Practical Guide Robab Latifnejad Roudsari, Mona Larki, Farangis Sharifi, Elham Manouchehri
1517 [GO] Current Women s Health Reviews 2023―Feb―21 Domestic Violence against women and COVID-19 quarantine: A Systematic review study Parvaneh Mirabi, Seideh Hanieh Alamolhoda, Elham Zare, Mahbobeh Ahmadi Doulabi
1518 [GO] Current Women s Health Reviews 2023―Feb―03 Maternal, fetal, and neonatal outcomes in pregnant women with COVID-19: a case-control study Saba Sepahvand, Mahtab Sattari, Banafshe Samari, Rezvanehsadat Beheshti, Maryam Farhadian, Azita Tiznobaik
1519 [GO] Current Women s Health Reviews 2022―Dec―14 Comparison of Maternal and Neonatal Outcomes among COVID-19 and Healthy Pregnant Women in the West of Iran: A Retrospective Cohort Study Fariba Daneshvar, Nahid Radnia, Neda Alimohammadi, Maryam Garousian, Elaheh Talebi-Ghane, Behnaz Basiri, et al. (+2)
1520 [GO] Current Women s Health Reviews 2022―Dec―02 Interruption of the use of contraceptive methods during the quarantine by COVID-19 in Peruvian women Natalia Valverde-Espinoza, Yuly Santos-Rosales, John Barja-Ore, Pamela Leon-Pastuso
1521 [GO] Current Women s Health Reviews 2022―Oct―24 Evaluation of Mental Health Status of the Pregnant Women Working in Hospitals during Covid-19 Era: a cross-sectional study Aazam Sadat Heydari Yazdi, Mahboubeh Eslamzadeh, Bita Najjari, Maryam Emadzadeh, Zhaleh Feyzi, Farzaneh Modaresi, et al. (+2)
1522 [GO] Current Women s Health Reviews 2022―May―31 Occupational Health of Pregnant Health Care Workers at the time of COVID-19 Mishu Mangla
1523 [GO] Current Women s Health Reviews 2022―May―20 Predictors of Early Pregnancy Fatigue among Iranian Women during the COVID-19 Pandemic: A Cross Sectional Study Afsaneh Veisy, Sakineh Mohammad Alizadeh Charandabi, Shamci Abbas-Alizadeh, Fariba Ghaderi, Mahmonir Haghighi, Mojgan Mirghafourvand
1524 [GO] Current Women s Health Reviews 2021―Oct―29 The association between maternal COVID-19 and the rates of cesarean: A systematic review Ensiyeh Jenabi, Niloofar Ladoni, Seyedeh Zahra Masoumi, Mansoureh Refaei, Sargol Shafiei
1525 [GO] Current Women s Health Reviews 2021―Sep―09 Impact of COVID-19 infection on maternal and neonatal outcomes: a review of 11078 pregnancies reported in the literature Fatemeh Azarkish, Roksana Janghorban
1526 [GO] Current Women s Health Reviews 2021―Jul―09 Impact of COVID-19 on Gender Equality, Sexual and Reproductive Health Rights of Adolescent Girls and Young Women: A Narrative Review Naina Kumar, Amit Kant Singh
1527 [GO] Current Women s Health Reviews 2021―Jan―12 The Hidden Impact of COVID-19 on Sexual and Reproductive Health and Rights of Women in India Vijayan Sharmila, Thirunavukkarasu Arun Babu
1528 [GO] Current Women s Health Reviews 2021―Jan―01 A case of Postpartum Maternal death with COVID-19 in the west of Iran Maryam Ahmadi, Mehrangiz Zamani Bonab, Sorour Akbari, Hamideh Parsapour, Shohreh Alimohammadi, Ensiyeh Jenabi
1529 [GO] Current Women s Health Reviews 2020―Sep―28 Prevalence of sexual dysfunction and related factors in Iranian pregnant women during the COVID-19 pandemic Azam Mohammadi, Fatemeh Effati-Daryani, Somayeh Zarei, Sakineh Ghasemi Yngyknd, Elnaz Hemmati, Mojgan Mirghafourvand
1530 [GO] Current Women s Health Reviews 2020―Sep―05 Balancing Science and Art in Medicine: COVID-19 and the Necessary Humanistic Shift in Medical Care Mary J. Yeh, John Yeh
1531 [GO] Current Women s Health Reviews 2020―Jul―23 Reinventing Electronic Health Records During COVID-19: Better Patient Data and Faster Research by Restructuring Electronic Health Record Systems John Yeh, Mary J. Yeh
1532 [GO] Drug Delivery Letters 2022―Aug―30 Nanomedicine “New Food for an Old Mouth”: Novel Approaches for the Treatment of COVID-19 Farid Abedin Dorkoosh, Somayeh Handali, Ismaeil Haririan, Mohammad Vaziri
1533 [GO] Drug Delivery Letters 2022―Mar―21 Molecular Docking and Pharmacokinetic Studies of Aquillochin and Grewin as SARS-CoV-2 Mpro Inhibitors Adnan Cetin
1534 [GO] Drug Metabolism Letters 2022―Nov―28 Potential polymorphic CYP1A2 and CYP2D6-mediated pharmacokinetic interactions between risperidone or olanzapine and selected drugs intended to treat COVID-19 Angel T. Alvarado, Ariana Rojas-Macetas, Geraldine Medalla-Garro, María Saravia, Ricardo Losno, Milton Valderrama-Wong, Ricardo Pariona
1535 [GO] Drug Metabolism Letters 2022―Apr―01 The Impact of the Coronavirus (COVID-19) Infection on the Drug-Metabolizing Enzymes Cytochrome P450s Imadeldin Elfaki
1536 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2024―Mar―18 The Role of SARS-CoV-2 Spike Protein in Long-term Damage of Tissues and Organs, the Underestimated Role of Retrotransposons and Stem Cells, a Working Hypothesis Mario G. Balzanelli, Reza Rastanesh, Pietro Distratis, Rita Lazzaro, Francesco Inchingolo, Raffaele Del Prete, et al. (+5)
1537 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2024―Feb―05 A Case of Intractable Hypophosphatemia in a Patient with Guillain-Barré Syndrome and Encephalitis after SARS-CoV-2 Infection Yawen Zheng, Yuanyuan Hou, Mingzhu Qi, Yongxiang Zhang, Chao Han, Hui Sun, Jiang Li
1538 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2024―Feb―02 A Review on the Role of Inflammation in Coronavirus Disease Arezoo Lotfi, Pouran Hajian, Laleh Abbasi, Morad Kohandel Gargari, Najmeh Nameh Goshay Fard, Delaram Naderi
1539 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2024―Jan―21 Predicting Factors of Worse Prognosis in COVID-19: Results from a Cross-sectional Study on 52 Inpatients Admitted to the Internal Medicine Department Giuseppe Lisco, Antonio Giovanni Solimando, Assunta Stragapede, Anna De Tullio, Cristiana Laraspata, Carola Laudadio, et al. (+6)
1540 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2024―Jan―21 Transient Central Diabetes Insipidus (Arginine Vasopressin Deficiency) Following SARS-CoV-2 Vaccination: A Case Report and Literature Review Pierluigi Mazzeo, Filippo Ceccato, Renzo Manara, Cinzia Mazzon, Mattia Barbot
1541 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2024―Jan―17 A Correlation Study to Comprehend the SAR-COV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of Assam, Northeast India Aparup Patra, Asis Bala, Mojibur R. Khan, Ashis K. Mukherjee
1542 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Dec―14 Follow-up of Patients with Hereditary Metabolic Diseases during the 3 Years of the Pandemic in the Reference Center for Hereditary Metabolism Diseases of the Centro Hospitalar Universitário Lisboa Norte Anabela Belo, Daniel Gomes, Patricia Nunes, Anabela Oliveira
1543 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Nov―10 Role of Enhancing Aerobic Capacity in Countering COVID-19-induced Liver Injury in Elderlies Ayman A. Mohamed, Ahmed A Abdalla, Yih-Kuen Jan
1544 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Oct―17 Current Views About the Link between SARS-CoV-2 and the Liver: Friends or Foe? Roberto Lovero, Ioannis Alexandros Charitos, Skender Topi, Francesca Castellaneta, Angela Pia Cazzolla, Marica Colella
1545 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Oct―11 Latent Mastocytosis Triggered by COVID-19 Vaccination: A Case Report Gianfranco Calogiuri, Caterina Foti, Maurizio Congedo, Eustachio Nettis, Luigi Paladini, Giuseppina Greco, et al. (+2)
1546 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Apr―20 A case of new-onset autoimmune type 1 diabetes mellitus following COVID-19 infection Işılay Taşkaldıran, Aslı Nar
1547 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Mar―15 Evaluation and Association of Hematological and Biochemical Parameters of Untreated COVID-19 Patients on the Basis of Differences in Ethnicity and Curcumin as a Possible Treatment Munir Akhtar, Rubaida Mehmood, Mukhtar Hussain, Momna Warraich, Hafeez Ullah, Zahida Batool, et al. (+2)
1548 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Feb―17 Neurosensory alterations and Interleukins Cascade in SARS-CoV-2 Infection - Results from a Retrospective Cohort of COVID-19 Inpatients Luigi Santacroce, Angela Pia Cazzolla, Roberto Lovero, Vincenzo Brescia, Domenico Ciavarella, Francesca Spirito, et al. (+4)
1549 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Feb―02 Admission avoidance for older adults facilitated by telemedicine during the COVID-19 pandemic Jemma Gregory, Benjamin Noble, Donna Ward, Zoe Wyrko, Luca Laghi
1550 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2023―Jan―16 The Impact of COVID-19 Lockdown on Patients with Type 2 Diabetes Mellitus: A Brief Report Giuseppe Lisco, Alfredo Vozza, Erasmo Porfido, Alessandra Delvino, Carlo Custodero, Vincenzo Triggiani, et al. (+2)
1551 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Dec―06 Death Due to COVID-19 in an Infant with Combined Immunodeficiencies Hamid Ahanchian
1552 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Dec―06 Oxytocin as a Potential Adjuvant Against COVID-19 Infection Pratibha Thakur
1553 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Dec―06 Anxiety, Insomnia and Body Mass Index Scores in Italian Nurses Engaged in the Care of COVID-19 Patients Elsa Vitale
1554 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Dec―06 An Alternative “Trojan Horse” Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology Mario Giosuè Balzanelli
1555 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Dec―06 Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection Annalisa Rizzo
1556 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Oct―18 Covid-19 in Man: A Very Dangerous Affair Giuseppe Lisco
1557 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Oct―18 The Role of Nutrition During the COVID-19 Pandemic: What We Know Elsa Vitale
1558 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Oct―18 Coronaviruses and Endocrine System: A Systematic Review on Evidence and Shadows Matteo Parolin
1559 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Oct―18 Focus on Receptors for Coronaviruses with Special Reference to Angiotensin- Converting Enzyme 2 as a Potential Drug Target - A Perspective Thea Magrone
1560 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Oct―18 Exploitation of Some Natural Products for the Prevention and/or Nutritional Treatment of SARS-CoV2 Infection Annalisa Rizzo
1561 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Aug―30 Therapeutic Role of Phytophenol Gallic Acid for the Cure of COVID-19 Pathogenesis Kirti Baraskar, Pratibha Thakur, Renu Shrivastava, Vinoy K Shrivastava
1562 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Aug―26 Comparative Study of Clinical Characteristics of COVID-19 Patients with or without Digestive Symptoms in Razi Hospital, Ahvaz, Khuzestan Reza Khedri, Hossein Bahrami Moghadam, Wesam Kooti, Ali Delirrooyfard, Payam Amini, Mahmood Maniati, et al. (+7)
1563 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Aug―12 Serological Evidence and Self-reported Outcomes in Patients with Adrenal Insufficiency during the first waves of COVID-19 in the North-East Italy Chiara Sabbadin, Mor Peleg Falb, Giacomo Voltan, Irene Tizianel, Andrea Padoan, Corrado Betterle, et al. (+5)
1564 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Aug―02 Tranexamic Acid and Plasminogen/Plasmin Glaring Paradox in COVID-19 Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Nasser A. Hadi Al-Harcan, Athanasios Alexiou, Gaber El-Saber Batiha
1565 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jul―17 Oxytocin as a Potential Adjuvant Against COVID-19 Infection Thakur, P
1566 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jul―17 Anxiety, Insomnia and Body Mass Index Scores in Italian Nurses Engaged in the Care of COVID-19 Patients Vitale, E
1567 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jun―24 The Role of Soluble ACE2 as a Prognostic Marker in Severe COVID-19: A Brief Meta-Analysis Nadereh Naderi, Mahsa Rahimzadeh
1568 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jun―21 A Case Report of Concurrent Graves’ Disease and Subacute Thyroiditis Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome (ASIA) Işılay Taşkaldıran, Feride Pınar Altay, Yusuf Bozkuş, Özlem Turan İyidir, Aslı Nar, Neslihan Başçıl Tütüncü
1569 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jun―17 A Case Report of Conversion From Hashimoto’s Thyroiditis to Graves’ Disease in a Type 1 Diabetic Patient Following the COVID-19 Vaccination Işılay Taşkaldıran, Feride Pınar Altay, Yusuf Bozkuş, Özlem Turan İyidir, Aslı Nar, Neslihan Başçıl Tütüncü
1570 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―May―17 Antidiabetic Drugs and their Potential Use in COVID-19: A Mechanistic Approach Bryan Alejandro Espinosa-Rodriguez, Aissa Michelle Nieto-Moreno, Jose Luis Gonzalez Llerena, Tania Alejandra Rico-Torres, Pilar Carranza-Rosales, Luis Fernando Mendez-Lopez, Isaias Balderas-Renteria
1571 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Apr―25 Eating Disorders in the Time of the Covid-19 Pandemic: A Perspective Simonetta Marucci, Guido Almerighi, Nadia Cerutti, Filomena Corbo, Roberta Zupo, Giulia De Iaco, et al. (+3)
1572 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Apr―20 Attitudes and Acceptance of the Palestinian Population towards COVID-19 Health Precautions and Vaccinations: A Cross-Sectional Study Anas Hamdan, Mustafa Ghanim, Rami Mosleh, Yazun Jarrar
1573 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Mar―30 Unwinding Link Between Coronavirus and Diabetes Patient Shailendra Singh Bhadauria, Rishabha Malviya, Pramod Kumar Sharma
1574 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jan―12 Natural immunity boosters as therapeutic interventions in the era of COVID-19 pandemic Sibgha Noureen, Kanwal Rehman, Muhammad Sajid Hamid Akash
1575 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jan―05 Metainflammation in COVID-19 Mojtaba Bakhtiari, Kamyar Asadipooya
1576 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2022―Jan―05 A multi-professional approach for transition of care at discharge in hyperglycemic inpatients with covid-19: a single center study Elena Castellano, Donatella Gaviglio, Micaela Pellegrino, Laura Gianotti, Giampaolo Magro, Francesco Tassone, et al. (+5)
1577 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Nov―26 A Simple Scoring Model Predicting the Outcome of COVID-19 Patients: Tanta COVID score Mohammed Elhendawy, Ferial El-Kalla, Sherief Abd-Elsalam, Dalia ElSharawy, Shaimaa S Soliman, Dina Abdelhai, et al. (+4)
1578 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Oct―12 Healthcare Management During a Pandemic: The Other Side of the Coin for the Treatment of Covid-19 Infection Danila De Vito, Antonio Fusco, Caterina Benincasa, Luca Laghi, Francesco M. Ceruso
1579 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Sep―10 Targeting citrate carrier (CIC) in inflammatory macrophages as a novel metabolic approach in COVID-19 patients: A perspective Mahsa Eshkevar Vakili, Zahra Saleh, Dieter Kabelitz, Kurosh Kalantar
1580 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Aug―09 Anti-Diabetic Drugs GLP-1 Agonists and DPP-4 Inhibitors may Represent Potential Therapeutic Approaches for COVID-19 Aliah Alshanwani, Tarek Kashour, Amira Badr
1581 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jul―25 Assessment of Burnout Levels before and during COVID-19 Pandemic: A Web-Based Survey by the (Italian) Association of Medical Endocrinologists (AME). Yura Loscalzo, Simonetta Marucci, Piernicola Garofalo, Roberto Attanasio, Giuseppe Lisco, Vincenzo De Geronimo, et al. (+3)
1582 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jul―16 The linkage “Body Mass Index-Insomnia Levels-Eating Disorder Flexibility” in Italian nurses during the Covid-19 outbreak: a psychoendocrinological employment disease. Elsa Vitale, Vito Galatola, Rocco Mea, Francesca Di Dio, Anna Canonico
1583 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jul―12 Insulin therapy and outcome from coronavirus disease 2019 (COVID-19): A Systematic Review, Meta-Analysis, and Meta-Regression Timotius Ivan Hariyanto, Nata Pratama Hardjo Lugito, Theo Audi Yanto, Jeremia Immanuel Siregar, Andree Kurniawan
1584 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jun―01 Revisiting the antiviral efficacy of terpenoids: Plausible adjunct therapeutics for novel SARS-CoV-2? Afza Ahmad, Rohit Kumar Tiwari, Irfan Ahmad Ansari
1585 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Mar―17 The Biochemical Parameters and Vitamin D Levels in ICU Patients with Covid-19: A Cross-Sectional Study Hamed Abdollahi, Farahnaz Salehinia, Mostafa Badeli, Elmira Karimi, Hossein Gandomkar, Amin Asadollahi, et al. (+2)
1586 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jan―28 An Alternative “Trojan Horse” Hypothesis for COVID-19: Immune Deficiency of IL-10 and SARS-CoV-2 Biology Mario Giosuè Balzanelli, Pietro Distratis, Sergey K Aityan, Felice Amatulli, Orazio Catucci, Angelo Cefalo, et al. (+10)
1587 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jan―18 The Role of Nutrition during the COVID-19 Pandemic: What We Know Elsa Vitale, Manrico Magrone, Vito Galatola, Thea Magrone
1588 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2021―Jan―03 Covid-19 In Man: A Very Dangerous Affair. Giuseppe Lisco, Vito A. Giagulli, Giovanni De Pergola, Anna De Tullio, Edoardo Guastamacchia, Vincenzo Triggiani
1589 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Dec―29 An Overview on COVID-19 and its Effect on Cardiovascular Diseases Abdullah Hamadi, Ali Mahzari, Abdulrahim Hakami, Salwa Hindawi, Gasim Dobie, M. I Sayyed, et al. (+3)
1590 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Dec―08 Why Do We Still Lack a COVID-19 Vaccine? Searching for the Missing Pieces Federico Perosa, Elvira Favoino, Marcella Prete
1591 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Dec―02 Chronic Diseases and COVID-19: A Review Mohammed Ajebli, Ayoub Amssayef, Mourad Akdad, Youness Algharrass, Abdelaadim Babakhouya, Dris Ghanimi, Mohamed Eddouks
1592 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Nov―19 Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country Sherief Abd-Elsalam, Eslam Saber Esmail, Mai Khalaf, Ghada N. El-Sarnagawy, Shahinaz M Shalaby, Mohamed Samir Abd El Ghafar, et al. (+5)
1593 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Oct―30 Prognosticating the spread of covid-19 pandemic based on optimal arima estimators Venuka Sandhir, Vinod Kumar, Vikash Kumar
1594 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Oct―26 Novel Coronavirus SARS-CoV-2 (COVID-19) and Pregnancy: A hypothetical view Ahmed RG
1595 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Oct―22 Death due to COVID-19 in an Infant with Combined Immunodeficiencies Hamid Ahanchian, Nasrin Moazzen, Seyed Hossein Joghatayi, Amin Saeidinia, Maryam Khoshkhui, Mohammad Hassan Aelami, et al. (+2)
1596 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Oct―18 Anxiety, Insomnia and Body Mass Index scores in Italian nurses engaged in the care of COVID-19 patients Elsa Vitale, Rocco Mea, Francesca Di Dio, Anna Canonico, Vito Galatola
1597 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Sep―17 Probiotics against viruses; COVID-19 is a paper tiger: A Systematic Review Zamzam Paknahad, Amir Reza Moravejolahkami
1598 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Sep―11 Oxytocin as a Potential Adjuvant against COVID-19 Infection Pratibha Thakur, Renu Shrivastava, Vinoy Kumar Shrivastava
1599 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Sep―05 Coronaviruses and Endocrine System: a Systematic Review on Evidences and Shadows Matteo Parolin, Matteo Parisotto, Francesca Zanchetta, Paola Sartorato, Ernesto De Menis
1600 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Sep―02 Exploitation of some natural products for prevention and/or nutritional treatment of SARS-CoV2 infection Annalisa Rizzo, Raffaele Luigi Sciorsci, Thea Magrone, Emilio Jirillo
1601 [GO] Endocrine Metabolic & Immune Disorders - Drug Targets 2020―Apr―27 Focus on Receptors for Coronaviruses with Special Reference to Angiotensin-converting Enzyme 2 as a Potential Drug Target - A Perspective Thea Magrone, Manrico Magrone, Emilio Jirillo
1602 [GO] Infectious Disorders - Drug Targets 2024―Mar―11 The Intriguing Connection between Cholestasis and the Renin-Angiotensin System Dysregulation Induced by SARS-CoV-2 and/or the Vaccinal Spike Protein Ziad Fajloun, Ziad Abi Khattar, Jean-Marc Sabatier
1603 [GO] Infectious Disorders - Drug Targets 2024―Mar―06 Comparison of Omicron and Delta Variants of SARS-CoV-2: A Systematic Review of Current Evidence SeyedAhmad SeyedAlinaghi, Amir Masoud Afsahi, Pegah Mirzapour, Arian Afzalian, Ramin Shahidi, Mohsen Dashti, et al. (+13)
1604 [GO] Infectious Disorders - Drug Targets 2024―Feb―12 Factors Associated with Mortality in Patients with Coronavirus Disease (COVID-19) in Babol, North of Iran Mansour Babaei, Behzad Heidari, Hossein Ghorbani, Zahra Ahmadnia, Samaneh Rouhi, Mahmoud Sadeghi Haddad Zavareh
1605 [GO] Infectious Disorders - Drug Targets 2024―Feb―07 Can an International Student Group at TUMS in Iran Be a Role Model in the Development of Applied Scientific Evidence in the Era of COVID-19 through Mentorship? Seyed Ahmad Seyed Alinaghi, Esmaeil Mehraeen
1606 [GO] Infectious Disorders - Drug Targets 2024―Feb―01 Estimating Hidden Population Size of COVID-19 Using Respondent- Driven Sampling Method - A Systematic Review Seyed Ahmad Seyed Alinaghi, Arian Afzalian, Mohsen Dashti, Afsaneh Ghasemzadeh, Zohal Parmoon, Ramin Shahidi, et al. (+8)
1607 [GO] Infectious Disorders - Drug Targets 2024―Jan―29 Two Birds with One Stone: Drug Regime Targets Viral Pathogenesis Phases and COVID-19 ARDS at the Same Time Ghazaleh Ghavami, Soroush Sardari
1608 [GO] Infectious Disorders - Drug Targets 2024―Jan―23 A New-fangled COVID-19 Variant, Eris, Might be the One to Lookout in 2023 or far from Over Suman Kumar Ray, Sukhes Mukherjee
1609 [GO] Infectious Disorders - Drug Targets 2024―Jan―05 Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies Shahid Nawaz, Sara Juniad, Aiman Fatima, Maira Saleem, Urooj Fatima, Asad Ali
1610 [GO] Infectious Disorders - Drug Targets 2023―Dec―20 Can Waves of Autoimmune Diseases Occur after The COVID-19 Pandemic? SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Esmaeil Mehraeen
1611 [GO] Infectious Disorders - Drug Targets 2023―Nov―10 Triple Burden: The Incorrigible Threat of Tuberculosis, HIV, and COVID-19 Parakriti Gupta, Diljot Sandhu, Varsha Gupta, Lipika Singhal
1612 [GO] Infectious Disorders - Drug Targets 2023―Nov―10 Can Vaccination with Various Types of Vaccines Make Communities Safer against COVID-19? SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Esmaeil Mehraeen
1613 [GO] Infectious Disorders - Drug Targets 2023―Nov―01 Estimating the Size of the Hidden Population of COVID-19 Esmaeil Mehraeen, Fatemeh Khajeh Akhtaran, Mohammad Reza Faridrohani, Arian Afzalian, Hengameh Mojdeganlou, Zeinab Ghanbari, et al. (+4)
1614 [GO] Infectious Disorders - Drug Targets 2023―Aug―23 Emergence of Monkeypox (MPX): A Close Relative of Small Pox during Covid-19 Era Ivneet Kour, Lipika Singhal, Sonia Mehta, Varsha Gupta
1615 [GO] Infectious Disorders - Drug Targets 2023―Aug―16 Advancement of Computational Design Drug Delivery System in COVID-19: Current Updates and Future Crosstalk- A Critical update Abu Mohiuddin, Sumanta Mondal
1616 [GO] Infectious Disorders - Drug Targets 2023―Jun―23 Covid-19: Potassium Contributes to Pathologies That Cause Disability Jean-Marc Sabatier, Ziad Fajloun, Yingliang Wu, Zhijian Cao, Hervé Kovacic
1617 [GO] Infectious Disorders - Drug Targets 2023―Jun―21 Covid-19 and Parkinson's Disease: the Link also Established! Jean-Marc Sabatier, Ziad Fajloun, Yingliang Wu, Zhijian Cao, Hervé Kovacic
1618 [GO] Infectious Disorders - Drug Targets 2023―Jun―14 Time-to-survival from COVID-19 disease and its associated factors in Osun State, Nigeria Olowe Olugbenga, Adeagbo O, Olaitan Peter, Olowe Rita, Opakunle O, Eniade OD, et al. (+2)
1619 [GO] Infectious Disorders - Drug Targets 2023―Jun―01 Th17 overexpression in severe COVID-19: a prospective observational study Arvind Kumar, Ankesh Gupta, Rakesh Kumar Deepak, Umang Arora, Aayush Agrawal, Manish Soneja, et al. (+7)
1620 [GO] Infectious Disorders - Drug Targets 2023―Jun―01 The Effectiveness of Face Masks in Preventing COVID-19 Transmission: A Systematic Review Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Amir Masoud Afsahi, Pegah Mirzapour, Sanaz Varshochi, et al. (+8)
1621 [GO] Infectious Disorders - Drug Targets 2023―May―31 COVID-19 and Alzheimer's Disease: The Link Finally Established Ziad Fajloun, Yingliang Wu, Zhijian Cao, Hervé Kovacic, Jean-Marc Sabatier
1622 [GO] Infectious Disorders - Drug Targets 2023―May―23 Does Widespread Use of Hydroxychloroquine Reduce the Transmissibility of SARS-CoV-2 / COVID-19? An Ecological Correlational Study Fabricio Souza Neves
1623 [GO] Infectious Disorders - Drug Targets 2023―May―17 Social avoidance and emotional deprivation of healthcare providers during the COVID-19 pandemic SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Parinaz Paranjkhoo, Daniel Hackett
1624 [GO] Infectious Disorders - Drug Targets 2023―May―11 COVID-19 and anti-COVID-19 vaccination: potential damages to the thyroid gland Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic
1625 [GO] Infectious Disorders - Drug Targets 2023―May―11 The use of remdesivir in patients with COVID-19 Soheil Ebrahimpour, Zeinab Mohseni Afshar, Dariush Hosseinzadeh, Rezvan Hosseinzadeh, Arefeh Babazadeh, Amirreza Allahgholipour, et al. (+4)
1626 [GO] Infectious Disorders - Drug Targets 2023―May―04 Hemofiltration as an alternative for IL-6 inhibitors in COVID-19 cytokines storm associated with underlaying bacterial infections: A review Article Sherief M Abd-Elsalam, Samy Zaky, Mohamed El Badry, Hoda A Makhlouf, Tarik S. Sarhan, Noha H. Eltaweel, et al. (+8)
1627 [GO] Infectious Disorders - Drug Targets 2023―May―04 SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, Roghayeh Salmani, Armin Razi, et al. (+11)
1628 [GO] Infectious Disorders - Drug Targets 2023―Apr―18 Post-Exposure Prophylaxis for COVID-19: A Systematic Review Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Zahra Pashaei, Parnian Shobeiri, Nazanin Janfaza, et al. (+13)
1629 [GO] Infectious Disorders - Drug Targets 2023―Apr―05 The Psychological, Philosophical, and Political Implications of COVID-19 Esmaeil Mehraeen, SeyedAhmad SeyedAlinaghi, Pegah Mirzapour, Daniel Hackett
1630 [GO] Infectious Disorders - Drug Targets 2023―Mar―10 Role of Supplements in the Management of COVID-19 - A Comprehensive Review Rajkapoor Balasubramanian, Naina Mohamed Pakkir Maideen, Sudha Muthusamy, Sambathkumar Ramanathan, Mohamed Harsath Jahir Hussain
1631 [GO] Infectious Disorders - Drug Targets 2023―Mar―06 Biochemical, serological and immunological tests for diagnosis of coronavirus disease 2019 (COVID-19) patients: a comprehensive systematic review and meta-analysis Reza Ranjbar, Milad Azami, Amirreza Jamshidbeigi, Hadi Esmaeili Gouvarchin Ghaleh
1632 [GO] Infectious Disorders - Drug Targets 2023―Mar―02 Can the new BA.2.75 sub-variant lead to one more COVID-19 wave? Sukhes Mukherjee, Suman Kumar Ray
1633 [GO] Infectious Disorders - Drug Targets 2023―Feb―28 Marburg Virus- A threat during SARS-CoV-2 era: A Review Sumel Ashique, Vatan Chaudhary, Soumen Pal, Jonee Panwar, Mukesh Kumar, Soumi Pramanik, et al. (+2)
1634 [GO] Infectious Disorders - Drug Targets 2023―Feb―24 Anti-Covid-19 Vaccination, Covid-19, and Female Contraception: The Exacerbated Risks (Thromboembolism) of the Estrogen-progestin Pill Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros
1635 [GO] Infectious Disorders - Drug Targets 2023―Feb―24 Potential of Black Seeds (Nigella Sativa) in the Management of Long COVID or Post-acute Sequelae of COVID-19 (PASC) and Persistent COVID-19 Symptoms - An Insight Naina Mohamed Pakkir Maideen, Abdurazak Hassan Jumale, Ibrahim Ramadan Barakat, Ayesha Khalifa Albasti
1636 [GO] Infectious Disorders - Drug Targets 2023―Feb―10 SIBO: the trail of a "new" human pathology associated with multiple severe and disabling Covid-19 and long Covid symptoms or induced by the anti-Covid-19 vaccine Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros
1637 [GO] Infectious Disorders - Drug Targets 2023―Jan―25 Estimating methods of the undetected infections in the COVID-19 outbreak: a systematic review SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Zahra Pashaei, Fatemeh Khajeh Akhtaran, Mohsen Dashti, Arian Afzalian, et al. (+8)
1638 [GO] Infectious Disorders - Drug Targets 2023―Jan―23 The impact of COVID-19 pandemic on the levels of physical activity: A systematic review SeyedAhmad SeyedAlinaghi, Esmaeil Mehraeen, Amirali Karimi, Seyed Peyman Mirghaderi, Pegah Mirzapour, Zahra Pashaei, et al. (+14)
1639 [GO] Infectious Disorders - Drug Targets 2023―Jan―12 Why can high-level athletes develop very severe or fatal forms after intense exercise following SARS-CoV-2 infection or anti-Covid vaccination? Jean-Marc Sabatier, Ziad Fajloun, Ziad Abi Khattar, Hervé Kovacic, Christian Legros
1640 [GO] Infectious Disorders - Drug Targets 2023―Jan―05 COVID-19 and Ehlers-Danlos syndrome: the dangers of the Spike protein of SARS-CoV-2 Jean-Marc Sabatier, Ziad Fajloun, Christian Legros
1641 [GO] Infectious Disorders - Drug Targets 2022―Nov―02 Discharge of Confirmed COVID-19 Patients Based on WHO or Regional Criteria? A Cohort Study Jamshid Vafaeimanesh, Seyed Hasan Adeli, Mahmoud Parham, Akram Asghari, Mohammad Bagherzade, Rasoul Shajari, et al. (+13)
1642 [GO] Infectious Disorders - Drug Targets 2022―Oct―28 Interplay between SARS-CoV-2 and Cancer: Plausible Risk factors, Cellular Immune Responses, Cancer Directed Therapy- Current Challenges Sukhes Mukherjee, Suman Kumar Ray
1643 [GO] Infectious Disorders - Drug Targets 2022―Sep―03 COVID-19 Mass Vaccination and Flu season: Concern for Decreased Public Health Measures and worsening the influenza situation Shahab Falahi, Azra Kenarkoohi, Jasem Mohamadi, Iraj Pakzad, Hojjat Sayyadi
1644 [GO] Infectious Disorders - Drug Targets 2022―Sep―03 Molecular docking study of potential antimicrobial photodynamic therapy as a potent inhibitor of SARS-CoV-2 main protease: An in silico insight Abbas Bahador, Maryam Pourhajibagher
1645 [GO] Infectious Disorders - Drug Targets 2022―Aug―31 A New Year, Newfangled COVID-19 Variant B.1.640.2 (IHU): What We Know So Far? Sukhes Mukherjee, Suman Kumar Ray
1646 [GO] Infectious Disorders - Drug Targets 2022―Aug―19 Latest in COVID-19 Vaccine 'Candidates' Race Manar Fayiz Atoum, Dalia Abu Zreig, Laith M Abu Zreig
1647 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) Suraj N. Mali
1648 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report. SeyedAhmad SeyedAlinaghi
1649 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review. Timotius Ivan Hariyanto
1650 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case Fereshteh Ghiasvand
1651 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients Cédric Annweiler
1652 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report Zahra Ahmadinejad
1653 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction. Nahid Akhtar
1654 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Transmission Modes of COVID-19: A Systematic Review. Esmaeil Mehraeen
1655 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital Fereshteh Ghiasvand
1656 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments Zhijian Cao
1657 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 Chloroquine as Chemoprophylaxis for COVID-19: Will This Work. Sherief Abd-Elsalam
1658 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases. Trinath Chowdhury
1659 [GO] Infectious Disorders - Drug Targets 2022―Jul―31 SARS-CoV-2: The Path of Prevention and Control Amal A. Mohamed
1660 [GO] Infectious Disorders - Drug Targets 2022―Jun―21 MMP3 in Severe COVID-19: A Biomarker or Therapeutic Target? Sultan Almuntashiri, Duo Zhang, Payaningal R. Somanath, Andrea Sikora
1661 [GO] Infectious Disorders - Drug Targets 2022―Jun―13 Postural orthostatic tachycardia syndrome and orthostatic hypotension post COVID-19 Masoud Eslami, Reza Mollazadeh, Shayan Mirshafiee, Parisa Sehat, Fatemeh Alizadeh, Zahra Emkanjoo, et al. (+2)
1662 [GO] Infectious Disorders - Drug Targets 2022―Jun―07 Divulging Incipient SARS-CoV-2 Delta (B.1.617.2) Variant: Possible Interference with Global Scenario Suman Kumar Ray, Sukhes Mukherjee
1663 [GO] Infectious Disorders - Drug Targets 2022―May―31 COVID-19 Associated Acute Pancreatitis: A Case Series from India Jitendra Singh, Nilesh Kumar, Kailash Kumar, Anju Dinkar
1664 [GO] Infectious Disorders - Drug Targets 2022―May―27 Epidemiological study of COVID-19 in Iran and the world: a review study Nasges Ansari, Samira Shokri, Mohadeseh Pirhadi, Saber Abbaszadeh, Aliasghar Manouchehri
1665 [GO] Infectious Disorders - Drug Targets 2022―Apr―29 Demographic, clinical, investigational characteristics of COVID-19 related Guillain-Barré syndrome with differences from typical and another virus-related Guillain-Barré syndrome Jitendra Singh, Nilesh Kumar, Anju Dinkar
1666 [GO] Infectious Disorders - Drug Targets 2022―Apr―26 ‘Convalescent Plasma’- An Effective Treatment Option to Prevent Emerging nCOVID-19- A Review Sumel Ashique, Tahamina Khatun, Garima Sahu, Aakash Upadhyay, Archana Adhana, Nitish Kumar, et al. (+2)
1667 [GO] Infectious Disorders - Drug Targets 2022―Apr―25 Infection and Severity of COVID-19 infection among health care workers: A report from Egypt Ehab F Moustafa, Sahar M Hassany, Asmaa Mohamed Ahmed Soliman, Mohammed Ezz-Eldin, Nariman Zaghloul, Sherief Abd-Elsalam
1668 [GO] Infectious Disorders - Drug Targets 2022―Apr―25 The emergence of Omicron SARS-CoV-2 variant (B.1.1.529) - the latest episode in the COVID-19 pandemic with a global riposte Suman Kumar Ray, Sukhes Mukherjee
1669 [GO] Infectious Disorders - Drug Targets 2022―Apr―22 Epigenetic-related effects of COVID-19 on the human cells Arezoo Faramarzi, Reza Safaralizadeh, Narges Dastmalchi, Shahram Teimourian
1670 [GO] Infectious Disorders - Drug Targets 2022―Apr―20 A clinically validated, broadly active, oral viral superinfection therapy could mitigate symptoms in early-stage COVID-19 patients Tibor Bakacs, Volker Sandig, Shimon Slavin, Serhat Gumrukcu, W David Hardy, Wolfgang Renz, Imre Kovesdi
1671 [GO] Infectious Disorders - Drug Targets 2022―Apr―20 Prevalence, presentation and outcome of secondary bloodstream infections among the COVID-19 patients Subhashree Samantaray, Priyabrat Karan, Anuradha Sharma, Vijayalakshmi Nag, Naveen Dutt, Mahendra Kumar Garg, et al. (+2)
1672 [GO] Infectious Disorders - Drug Targets 2022―Apr―20 COVID-19 vaccination, Peltzman Effect and possible increase in high-risk behaviors: a growing concern on risk compensation and reduced compliance to Public Health protective Measures after vaccines rollout Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, Iraj Pakzad, Ayoub Rashidi, Razi Naserifar, et al. (+2)
1673 [GO] Infectious Disorders - Drug Targets 2022―Apr―07 COVID-19 and Co-infections: A Serious Health Threat Requires Combination Diagnosis and Therapy Shahid Nawaz, Maira Saleem
1674 [GO] Infectious Disorders - Drug Targets 2022―Apr―07 SARS-CoV-2-Induced Neurological Disorders in Symptomatic Covid-19 and Long Covid Patients: Key Role of Brain Renin-Angiotensin System Ziad Fajloun, Hervé Kovacic, Cédric Annweiler, Yingliang Wu, Zhijian Cao, Jean-Marc Sabatier
1675 [GO] Infectious Disorders - Drug Targets 2022―Apr―03 A new wave of COVID-19 in 2021 with unique genetic characters -present global scenario and beholding onwards Sukhes Mukherjee, Suman Kumar Ray
1676 [GO] Infectious Disorders - Drug Targets 2022―Mar―25 Technology in the Era of COVID-19: A Systematic Review of Current Evidence Esmaeil Mehraeen, Mohammad Mehrtak, SeyedAhmad SeyedAlinaghi, Zahra Nazeri, Amir Masoud Afsahi, Farzane Behnezhad, et al. (+6)
1677 [GO] Infectious Disorders - Drug Targets 2022―Mar―23 Therapeutic strategies for COVID-19 patients: An update Muhammad Ibrahim Getso, So�h Etemadi, Vahid Raissi, Moein Mohseni, Maedeh Sadat Mohseni, Farid Raeisi, Omid Raiesi
1678 [GO] Infectious Disorders - Drug Targets 2022―Mar―22 An update review on complicated mechanisms of COVID-19 pathogenesis and therapy: direct viral damage, renin-angiotensin system dysregulation, immune system derangements, and endothelial dysfunction Shahab Falahi, Maryam Maleki, Azra Kenarkoohi
1679 [GO] Infectious Disorders - Drug Targets 2022―Mar―22 An Insight of Clinical Evidences of Ayurveda Interventions in the Management of COVID-19 Patients Naina Mohamed Pakkir Maideen, Rajkapoor Balasubramaniam, Gobinath Manavalan, Kumar Balasubramanian, Vasanth Kumar S
1680 [GO] Infectious Disorders - Drug Targets 2022―Mar―18 DO METHYLENE BLUE SATISFIES AN OPTION - IN COVID-19 ARDS Sri Hari TY, Sree Sudha TY, Krishna Sasanka KSBS, Pugazhenthan Thangaraju
1681 [GO] Infectious Disorders - Drug Targets 2022―Mar―18 Original antigenic sin in COVID-19: Hoskins effect and vaccine Mudassir Khan, Sobia Manzoor, Najeeb Ullah, Dilawar Khan
1682 [GO] Infectious Disorders - Drug Targets 2022―Feb―25 The Persistence Time of SARS-CoV-2 RNA in hospitalized COVID-19 Patients: A prospective Study Jila Yavarian, Mohammad Javaherian, Somayeh Shatizadeh Malekshahi, Zahra Ahmadinejad, Fatemeh Ghiasvand, Elaheh Ahmadi, et al. (+6)
1683 [GO] Infectious Disorders - Drug Targets 2022―Feb―22 Impact of tocilizumab on inflammatory markers and oxygen status in severe covid-19 patients: A single centre retrospective study. Abhishek Sharma, Deepak Nathiya, Supriya Suman, Hemant Bareth, Mahaveer Singh, Eshan Sharma
1684 [GO] Infectious Disorders - Drug Targets 2022―Feb―21 A Review on the New Indication of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in the Treatment of Coronavirus Disease 2019 Hedyieh Karbasforooshan, Sofia Salari, Hesamoddin Hosseinjani
1685 [GO] Infectious Disorders - Drug Targets 2022―Feb―16 Covid-19 Study, Pathology and Therapeutics Da-Yong Lu
1686 [GO] Infectious Disorders - Drug Targets 2022―Feb―09 Third waves of the COVID-19 pandemic: Prominence of initial public health Interference Sukhes Mukherjee, Suman Kumar Ray
1687 [GO] Infectious Disorders - Drug Targets 2022―Jan―28 Gallium Components-Based Drug Delivery: A Potential Treatment for COVID-19 Sara Torabi, Farbod Bahreini, Nima Rezaei
1688 [GO] Infectious Disorders - Drug Targets 2022―Jan―28 A case of multiple sclerosis with protracted course of COVID-19 Mehrdad Hasibi, Marjan Asadollahi, Ali Asadollahi-Amin
1689 [GO] Infectious Disorders - Drug Targets 2022―Jan―28 Diagnostic Stewardship in Times of Covid-19 Pandemic Lipika Singhal, Ivneet Kour, Varsha Gupta
1690 [GO] Infectious Disorders - Drug Targets 2022―Jan―24 An Overview of Antiviral Properties of Bacteriophages with Emphasis on the Treatment of COVID-19 Infection Mahsa Jalili, Nastaran Ansari, Behzad Pourhossein, Maryam Fazeli, Farid Azizi Jalilian
1691 [GO] Infectious Disorders - Drug Targets 2022―Jan―20 Molecular docking of phytochemical compounds of Momordica charantia as potential inhibitor against SARS-CoV-2 Yayu Mulsiani Evary, Ayu Masyita, Arie Ariezandi Kurnianto, Rangga Meidianto Asri, Yusnita Rifai
1692 [GO] Infectious Disorders - Drug Targets 2022―Jan―19 Ivermectin in COVID-19 Management: What is the current evidence? Madhavi Eerike, Gerard Marshall Raj, Rekha Priyadarshini, Gandham Ravi, Debasis Bisoi, Venu Gopala Rao Konda
1693 [GO] Infectious Disorders - Drug Targets 2022―Jan―18 Procalcitonin as a prognostic factor in patients with COVID-19 in southwestern Iran Milad Shahini Shams Abadi, Elham Taheri, Ahmad Raesi, Mohammad-Hassan Arjmand, Soleiman Kheirii, Najmeh Shahinfard, Zahra Habibi
1694 [GO] Infectious Disorders - Drug Targets 2022―Jan―18 Therapeutic Status of Famotidine in COVID-19 Patients: A Review Moein Mohseni, Vahid Raissi, Yasamin Sharifan, Kimia Barikro, Sasan Amiri, Maedeh Sadat Mohseni, et al. (+4)
1695 [GO] Infectious Disorders - Drug Targets 2022―Jan―18 Challenges in Engendering Herd Immunity to SARS-CoV-2 infection: Possibly Impossible but Plausibility with Hope Sukhes Mukherjee, Suman Kumar Ray
1696 [GO] Infectious Disorders - Drug Targets 2022―Jan―06 COVID-19 Infection in Pregnancy: A Review Sabrina Jahan Mily, Kazi Mahmuda Akter, Nowshin Jabin, Saikat Mitra, Talha Bin Emran, Monisha Nandi, et al. (+8)
1697 [GO] Infectious Disorders - Drug Targets 2022―Jan―06 The chance of COVID-19 infection after vaccination Ghazaleh Khalili-Tanha, Majid Khazaei, Saman Soleimanpour, Gordon A Ferns, Amir Avan
1698 [GO] Infectious Disorders - Drug Targets 2021―Dec―02 Case Report: Severe SARS-CoV-2 Infection with Remdesivir in a Patient with ESRD Raj H. Patel, Pablo M. Pella, Naeem Haider, Renato Blanco
1699 [GO] Infectious Disorders - Drug Targets 2021―Sep―30 COVID-19 in pediatrics: The current knowledge and practice Esmaeil Mehraeen, Shahram Oliaei, SeyedAhmad SeyedAlinaghi, Amirali Karimi, Pegah Mirzapour, Amir Masoud Afsahi, et al. (+9)
1700 [GO] Infectious Disorders - Drug Targets 2021―Sep―23 Vaccines for COVID-19: A Review of Feasibility and Effectiveness Esmaeil Mehraeen, Omid Dadras, Amir Masoud Afsahi, Amirali Karimi, Mehrzad MohsseniPour, Pegah Mirzapour, et al. (+11)
1701 [GO] Infectious Disorders - Drug Targets 2021―Sep―16 Liver injury in COVID-19: A Direct hit or Collateral damage? Balasubramaniyan Vairappan, Gavin Wright, Douglas Corrigal
1702 [GO] Infectious Disorders - Drug Targets 2021―Sep―13 Counter-Regulatory Renin-Angiotensin System: An Important Line of Research to Understand and Limit the Severity of COVID-19 Cédric Annweiler, Zhijian Cao, Nicolas Papon, Hervé Kovacic, Jean-Marc Sabatier
1703 [GO] Infectious Disorders - Drug Targets 2021―Sep―07 Persistent Hiccups as an Atypical Initial Presentation of COVID-19: A Case Report Omid Dadras, Alimohamad Asghari, Atefe Nosratzahi
1704 [GO] Infectious Disorders - Drug Targets 2021―Sep―06 SARS-CoV-2 transmission among health care workers in Iran: an urgent need for early identification and management Mohammad Reza Abdolsalehi, Shima Mahmoudi, Reza Shervin Badv, Babak Pourakbari, Keyvan Mirnia, Yasmine Mahmoudieh, Setareh Mamishi
1705 [GO] Infectious Disorders - Drug Targets 2021―Aug―30 DAMPening Severe COVID-19 with Dexamethasone Cédric Annweiler, Nicolas Papon, Jean-Marc Sabatier, Jean Barré
1706 [GO] Infectious Disorders - Drug Targets 2021―Aug―11 Can Antimalarial Phytochemicals be a Possible Cure for COVID-19? Molecular Docking Studies of Some Phytochemicals to SARS-CoV-2 3C-like Protease Anamul Hasan, Khoshnur Jannat, Tohmina Afroze Bondhon, Rownak Jahan, Md Shahadat Hossan, Maria de Lourdes Pereira, et al. (+3)
1707 [GO] Infectious Disorders - Drug Targets 2021―Jul―27 Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review Esmaeil Mehraeen, Zeinab Najafi, Bagher Hayati, Mohammad Javaherian, Sajad Rahimi, Omid Dadras, et al. (+3)
1708 [GO] Infectious Disorders - Drug Targets 2021―Jul―25 Genetics and Vaccine development for SARS-CoV2 in the era of Personalized Medicine Eirini Konstantina Tafanidou, Despoina Gkentzi
1709 [GO] Infectious Disorders - Drug Targets 2021―Jul―19 Shared Food, Meals and Drinks: 10 Arguments Suggesting an Oral Transmission Route of SARS-CoV-2 Jean-Michel Wendling, Aure Saulnier, Jean-Marc Sabatier
1710 [GO] Infectious Disorders - Drug Targets 2021―Jun―16 Hypothesis: Designation of Liposomal Scavenger System for Fighting against 2019-nCoV Nooshin Bagherani, Bruce R. Smoller
1711 [GO] Infectious Disorders - Drug Targets 2021―May―28 A short review on key role of plants and their extracts in boosting up immune response to combat COVID-19 Mudassir Khan, Muhammad Abu Bakar Saddique, Huzaifa Tahir, Muhammad Dawood Amjad, Abdullah Ahmad, Usama Masood, Dilawar Khan
1712 [GO] Infectious Disorders - Drug Targets 2021―Mar―23 Investigation of structural, treatment and clinical characteristics of COVID-19 along with the challenges caused by its prevalence Maham Doagooyan, Seyedeh Hoda Alavizadeh, Javad Akhtari, Amirhossein Sahebkar, Saeed Ghanbari Hasan Kiade, Pariya Haghgoo Kochesfahani, Fatemeh Gheybi
1713 [GO] Infectious Disorders - Drug Targets 2021―Mar―03 COVID-19 and Infectious Disease Speciality - A necessity of Time in India. Gopal K Bohra, Deepak Kumar, Mahendra K Garg
1714 [GO] Infectious Disorders - Drug Targets 2021―Mar―03 The recovery of an elderly woman with asthma and diabetes from COVID-19 infection: a case report Abas Ghaysouri, Maryam Safari, Elham Mohammadyari, Firooz Balavandi, Ali Nazari, Jalil Feizi, et al. (+4)
1715 [GO] Infectious Disorders - Drug Targets 2021―Mar―01 A mini review on the pathogenesis, diagnosis and treatment options for COVID-19 Farzad Rahmani, Aghigh Ziaeemehr, Sajede Alijannejad, Gordon A Ferns, Majid Khazaei, Soodabeh Shahidsales, Amir Avan
1716 [GO] Infectious Disorders - Drug Targets 2021―Mar―01 COVID-19: Potential Repurposing Drugs Wattana Leowattana
1717 [GO] Infectious Disorders - Drug Targets 2021―Feb―19 COVID-19 and Neurology - An Emerging Association Amit Gupta, Prakrati Yadav, Deepak Kumar
1718 [GO] Infectious Disorders - Drug Targets 2021―Feb―19 Natural Derived Nasal Spray; a Proposed Approach for COVID-19 Disease Control Zahra Hoseini-Tavassol, Hanieh-Sadat Ejtahed, Ahmad-Reza Soroush, Zahra Sajjadpour, Shirin Hasani-Ranjbar, Bagher Larijani
1719 [GO] Infectious Disorders - Drug Targets 2021―Feb―19 Hepatic involvement as Hyperbilirubinemia in Patients with COVID-19: Case Series from Iran Ahmad Hormati, Mohammad Reza Ghadir, Mohammad Saeidi, Reza Aminnejad, Mahboubeh Afifian, Sajjad Ahmadpour
1720 [GO] Infectious Disorders - Drug Targets 2021―Feb―04 COVID-19 and Alcohol Misuse: A Case Report Ali Asadollahi-Amin, Ali Nowroozi, Mehrdad Hasibi, Behzad Asanjarani, SeyedAhmad SeyedAlinaghi
1721 [GO] Infectious Disorders - Drug Targets 2021―Feb―04 Co-morbidity of Covid-19 and Stenotrophomonas maltophilia in a patient with Hodgkin's lymphoma history from north of Iran David Darvishnia, Mahdieh Sadeghi, Ali Sharifpour, Zakaria Zakariaei, Elham Sadat Banimostafavi, Mahdi Fakhar, Rabeeh Tabaripour
1722 [GO] Infectious Disorders - Drug Targets 2021―Jan―19 The Role of Justicia Adhatoda as prophylaxis for COVID-19 - Analysis based on docking study Pugazhenthan Thangaraju, Sree Sudha TY, Praveen Kumar Pasala, Sri Hari TY, Sajitha Venkatesan, Eswaran Thangaraju
1723 [GO] Infectious Disorders - Drug Targets 2021―Jan―05 SARS-CoV-2: An insight into detection tools Shaghayegh Khanmohammadi, Mohammadreza Tabary, Farnaz Araghi, Seyed Mohammad Tavangar
1724 [GO] Infectious Disorders - Drug Targets 2021―Jan―05 Modifications of Medical Care of Chronic Liver Diseases during COVID19 Pandemic: Necessity or Novelty? Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem, Sherief Abd-Elsalam
1725 [GO] Infectious Disorders - Drug Targets 2021―Jan―04 An Updated Review on COVID-19 Mahmoud Ahmed Ebada, Ahmed Wadaa Allah, Eshak Bahbah, Ahmed Negida
1726 [GO] Infectious Disorders - Drug Targets 2020―Dec―21 Pharmacological strategies for COVID-19 - A review of the most promising repurposed antiviral drugs. Deepti Chopra, Jaspreet K Boparai, Bharti Bhandari, Anurag Srivastava, Rakesh Gupta
1727 [GO] Infectious Disorders - Drug Targets 2020―Dec―21 Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker Tarun Sharma, Sidharth Mehan
1728 [GO] Infectious Disorders - Drug Targets 2020―Dec―10 Constrictive Pericarditis Associated with Coronavirus Disease 2019 (COVID-19): A Case Report SeyedAhmad SeyedAlinaghi, Maryam Ghadimi, Mehrnaz Asadi Gharabaghi, Fereshteh Ghiasvand
1729 [GO] Infectious Disorders - Drug Targets 2020―Dec―10 Coronavirus Disease 2019: Virology and Drug Targets Praveen Thaggikuppe Krishnamurthy
1730 [GO] Infectious Disorders - Drug Targets 2020―Dec―08 Evaluation of the Binding Affinity of Anti-Viral Drugs against Main Protease of SARS-CoV-2 through a Molecular Docking Study Milon Mondal, Chandan Sarkar, Sarmin Jamaddar, Abul Bashar Ripon Khalipha, Muhammad Torequl Islam, Azmi Mahafzah, Mohammad S. Mubarak
1731 [GO] Infectious Disorders - Drug Targets 2020―Nov―27 COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases Fereshteh Ghiasvand, Maryam Ghadimi, Sara Sadr, Fatemeh Jafari, Navid Manafi, Zahra Ah-madinejad, et al. (+2)
1732 [GO] Infectious Disorders - Drug Targets 2020―Nov―17 Pharmacological inhibition of MMP3 as a potential therapeutic option for COVID-19 associated acute respiratory distress syndrome Rana Kadry, Andrea Sikora Newsome, Payaningal R. Somanath
1733 [GO] Infectious Disorders - Drug Targets 2020―Nov―17 A Patient with COVID-19 Pneumonia Presenting with Plural Effusion: A Case Report. Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi, Samaneh Tirgar, Mohamad Reza Salehi, Banafsheh Moradmand-Badie
1734 [GO] Infectious Disorders - Drug Targets 2020―Nov―17 Transmission Modes of COVID-19: A Systematic Review Esmaeil Mehraeen, Mohammad Amin Salehi, Farzane Behnezhad, Hamed Rezakhani Moghaddam, SeyedAhmad SeyedAlinaghi
1735 [GO] Infectious Disorders - Drug Targets 2020―Nov―13 Postoperative COVID-19 pneumonia in an asymptomatic patient: a case report Ali Asadollahi-Amin, Elnaz Shahmohamadi, Mehrdad Hasibi, Maryam Moosivand, Maryam Taghizadeh, Seyed Ahmad Seyed Alinaghi
1736 [GO] Infectious Disorders - Drug Targets 2020―Nov―10 An overview on COVID-19 pandemic: from discovery to treatment Kalpana Panati, Venkatramana Reddy Arva Tatireddygari, Venkata Ramireddy Narala
1737 [GO] Infectious Disorders - Drug Targets 2020―Oct―30 Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review Timotius Ivan Hariyanto, Elizabeth Kristine, Catherine Jillian Hardi, Andree Kurniawan
1738 [GO] Infectious Disorders - Drug Targets 2020―Oct―20 A Viewpoint On Potential Biomarkers For Infectious COVID-19 severity: An Updated Literature Survey Suraj N. Mali, Fatemeh Mohajer, Ghodsi Mohammadi Ziarani, Amit P. Pratap
1739 [GO] Infectious Disorders - Drug Targets 2020―Oct―18 BCG vaccine, a ray of hope in treating Severe Acute Respiratory Syndrome (SARS) Amit Bandyopadhyay Banerjee, Thakur Gurjeet Singh, Abhimanyu Prashar
1740 [GO] Infectious Disorders - Drug Targets 2020―Oct―14 COVID-19 And Type 2 Diabetes Mellitus: Hydroxychloroquine May Be The Holy Grail Rimesh Pal, Manoj K. Bhasin, Sanjay K. Bhadada
1741 [GO] Infectious Disorders - Drug Targets 2020―Oct―07 Covid-19, SARS -CoV-2, Origin, transmission and treatment aspects, a brief review Shahid Nawaz
1742 [GO] Infectious Disorders - Drug Targets 2020―Sep―22 Immuno-Informatics Quest against COVID-19/SARS-COV-2: Determining Putative T-Cell Epitopes for Vaccine Prediction Nahid Akhtar, Amit Joshi, Bhupender Singh, Vikas Kaushik
1743 [GO] Infectious Disorders - Drug Targets 2020―Sep―05 Impact of COVID-19 on Indian Pharmaceutical Industry and WayForward Nikita Vijay Jadhav, Nisha Singh, Monika Targhotra, Meenakshi K. Chauhan
1744 [GO] Infectious Disorders - Drug Targets 2020―Aug―05 Role of key point Mutations in Receptor Binding Domain of SARS-CoV-2 Spike Glycoprotein Bipin Singh
1745 [GO] Infectious Disorders - Drug Targets 2020―Jul―30 Ocular COVID-19: Eyes as a reservoir to conceal and spread SARS-CoV-2 Abdul Mannan Baig, Saara Ahmad, Areeba Khaleeq, Hamna Rafique, Shafiqa Rajput, Mehaer Angez, et al. (+3)
1746 [GO] Infectious Disorders - Drug Targets 2020―Jul―28 In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases Trinath Chowdhury, Gourisankar Roymahapatra, Santi M. Mandal
1747 [GO] Infectious Disorders - Drug Targets 2020―Jul―27 Chloroquine as chemoprophylaxis for COVID-19: Will this work? Sherief Abd-Elsalam, Mahmoud Elkadeem, Khadija Ahmed Glal
1748 [GO] Infectious Disorders - Drug Targets 2020―Jul―21 Newly Emergent 2019-nCoV and New Uses of an Old Medicine, Doxycycline; A Hypothesis. Tommy Richard Sun-Wing TONG
1749 [GO] Infectious Disorders - Drug Targets 2020―Jun―22 Targeting infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) applications: Evidence based opinion Suraj N. Mali, Amit P. Pratap
1750 [GO] Infectious Disorders - Drug Targets 2020―Jun―09 Pleural Effusion as a Sign of Coronavirus Disease 2019 (COVID-19) Pneumonia: A Case Report Zahra Ahmadinejad, Faeze Salahshour, Omid Dadras, Hesan Rezaei, SyyedAhmad Alinaghi
1751 [GO] Infectious Disorders - Drug Targets 2020―May―21 Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital Fereshteh Ghiasvand, SeyedAhmad SeyedAlinaghi
1752 [GO] Infectious Disorders - Drug Targets 2020―May―20 SARS-CoV-2: The Path of Prevention and Control Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, et al. (+2)
1753 [GO] Infectious Disorders - Drug Targets 2020―May―18 Counter-regulatory ‘Renin-Angiotensin’ System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients Cédric Annweiler, Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Stéphanie Mouhat, Hervé Kovacic, Jean-Marc Sabatier
1754 [GO] Infectious Disorders - Drug Targets 2020―May―11 A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19) Suraj N. Mali, Bapu R. Thorat, Atul R. Chopade
1755 [GO] Infectious Disorders - Drug Targets 2020―May―06 SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments Zhijian Cao, Yingliang Wu, Emmanuelle Faucon, Jean-Marc Sabatier
1756 [GO] Infectious Disorders - Drug Targets 2020―Apr―29 A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case Fereshteh Ghiasvand, Sepideh Zahak Miandoab, Hamid Harandi, Fereshteh Shahmari Golestan, Seyed Ahmad Seyed Alinaghi
1757 [GO] International Journal of Sensors Wireless Communications and Control 2020―Dec―11 An Efficient Approach for Detection and Verification of Infected Cases of Covid-19 Virus through Block Chain: A Survey Kanika Gupta, Aatif Jamshed
1758 [GO] Journal of Fuzzy Logic and Modeling in Engineering 2022―May―11 Multi-Shift Single-Vehicle Routing Problem Under Fuzzy Uncertainty During the COVID-19 Pandemic- F. Nucci
1759 [GO] Letters in Drug Design & Discovery 2023―Aug―11 Natural phytochemicals, phenformin, and docosahexaenoic acid (DHA) as Novel Inhibitors of leukotriene B4 and ACE2 receptors, a Therapeutic Strategy for targeting COVID-19 Cell Entry and Cytokine Storm. (An In-silico Approach) Abdullah Haikal, Amr Ahmed, Ishrat Rahman, Hazar S Alharbi, Enas S. Radwan, Amr S. Abouzied, et al. (+9)
1760 [GO] Letters in Drug Design & Discovery 2023―May―03 Discovery of Natural Compounds As SARS-CoV-2’s Main Protease Inhibitors by Docking-based Virtual Screening Hui Yu, Zhanli Wang, Jing Wang, Yu Jiang, Yingnan Wu, Yuheng Ma
1761 [GO] Letters in Drug Design & Discovery 2023―May―01 Coronavirus Inhibitory Activity of Tamarind Indica Kishor Danao, Ruchi Shivhare, Deweshri Nandurkar, Vijayshri Rokde, Ujwala Mahajan
1762 [GO] Letters in Drug Design & Discovery 2023―Feb―24 Delineating Potential De Novo Therapeutics and Repurposed Drugs Against Novel Protein Lrrc15 to Treat Sars-Cov-2 Abul Bashar Mir Md. Khademul Islam, Maliha Afroj Zinnia
1763 [GO] Letters in Drug Design & Discovery 2023―Jan―13 Computational Repurposing of Potential Dimerization Inhibitors against SARS-CoV-2 Main Protease Vikash Kumar Dubey, Subhomoi Borkotoky, Archisha Prakash, Gyan Prakash Modi
1764 [GO] Letters in Drug Design & Discovery 2022―Dec―15 QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors Sisir Nandi, Mohit Kumar, Anil Kumar Saxena
1765 [GO] Letters in Drug Design & Discovery 2022―Oct―18 Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective Yee Choong
1766 [GO] Letters in Drug Design & Discovery 2022―Oct―18 Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL Protease (3CL pro) Qingxiu He
1767 [GO] Letters in Drug Design & Discovery 2022―Sep―30 Screening Active Phytochemicals of Some Ayurvedic Medicinal Plants to Identify Potential Inhibitors against SARS-CoV-2 Mpro by Computational Investigation V. Alagarsamy, V. Raja Solomon, M. T. Sulthana, P. Shyam Sundar, A. Dharshini Aishwarya, B. Narendhar
1768 [GO] Letters in Drug Design & Discovery 2022―Sep―13 Designing of a Novel Candidate Multi-Epitope Vaccine to Boost Immune Responses Against SARS-COV-2 Using Immunoinformatics and Machine Learning Based Approach Mahdi Barazesh, Shiva Mohammadi, So� Kavusi Pour, Sajad Jalili
1769 [GO] Letters in Drug Design & Discovery 2022―Aug―19 Discovery of Potential Compounds against SARS-COV-2 Based on 3CLpro/RdRp Dual-target: An In Silico Approach Jiaojiao Li, Lin Zhu, Zheng Qin, Zhengfu Li, Xun Gao, Jing Ji, Jinyang Shen
1770 [GO] Letters in Drug Design & Discovery 2022―Jul―04 Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses Linda Benincasa, Eleonora Molesti, Alessandro Manenti, Emanuele Montomoli, Alessio Malacrida, Valentina Zuliani, et al. (+3)
1771 [GO] Letters in Drug Design & Discovery 2022―Jun―28 Landscape determinants of infectivity and insights into vaccine development and effectiveness - Novel Coronavirus Saba Hasan, Manish Dwivedi, Sutanu Mukhopadhyay, Nandini Gupta
1772 [GO] Letters in Drug Design & Discovery 2022―Jun―23 Attacking the SARS-CoV-2 replication machinery with the Pathogen Box’s molecules Cleidy Osorio-Mogollón, Gustavo E. Olivos-Ramírez, Kewin Otazu, Manuel E. Chenet-Zuta, Georcki Ropón-Palacios, Cinthia das Dores Aguiar, et al. (+5)
1773 [GO] Letters in Drug Design & Discovery 2022―Jun―21 Association of SARS-CoV-2 infection and Triple Negative Breast Cancer (TNBC)-A Computational illustrative study Hima Vyshnavi A M, P K Krishnan Namboori
1774 [GO] Letters in Drug Design & Discovery 2022―May―31 HDAC inhibitors against SARS-CoV-2 Negar Omidkhah, Farzin Hadizadeh, Razieh Ghodsi
1775 [GO] Letters in Drug Design & Discovery 2022―May―11 Bioinformatic screening of compounds from Iranian Lamiaceae family members against SARS-CoV-2 spike protein Abbas Alibakhshi, Shima Gharibi, Shahrzad Ahangarzadeh, Fatemeh Yarian
1776 [GO] Letters in Drug Design & Discovery 2022―Apr―03 Triamcinolone as a potential inhibitor of SARS-CoV-2 main protease and cytokine storm: An in-silico study Amaresh Mishra, Faizan Abul Qais, Yamini Pathak, Ihosvany Camps, Vishwas Tripathi
1777 [GO] Letters in Drug Design & Discovery 2022―Mar―08 Screening of Phytoconstituents from Traditional Plants against SARS-Cov2 using Molecular Docking Approach Deepika Saini, Kumud Madan, Shilpi Chauhan
1778 [GO] Letters in Drug Design & Discovery 2022―Jan―07 Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CLpro: a study by applying Virtual Screening, Molecular Dynamics, MM-PBSA Calculations and Covalent Docking Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva-Júnior
1779 [GO] Letters in Drug Design & Discovery 2021―Dec―30 Potential Inhibitors Identification of Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Angiotensin-Converting Enzyme 2 and Main Protease from Anatolian Traditional Plants Namık Kılınç, Mikail Açar, Salih Tuncay, Ömer Faruk Karasakal
1780 [GO] Letters in Drug Design & Discovery 2021―Oct―12 Computational Design of a Novel Candidate Multi-Epitope Vaccine to Boost Immune Responses against SARS-COV-2 Shiva Mohammadi, So� Kavusi Pour, Mahdi Barazesh, Yadollah Bahrami, Sajad Jalili
1781 [GO] Letters in Drug Design & Discovery 2021―Oct―08 Repurposing of drugs and HTS to combat SARS-CoV-2 main protease utilizing structure-based molecular docking Sisir Nandi, Mohit Kumar, Anil Kumar Saxena
1782 [GO] Letters in Drug Design & Discovery 2021―Oct―04 Screening and Structure-Activity Relationship of Potential Compounds against Proposed Targets of COVID-19 Infection Majid Ali, Asma Zaidi, Umar Farooq, Syed Majid Bukhari
1783 [GO] Letters in Drug Design & Discovery 2021―Aug―05 Sequence analysis, structure prediction of receptor proteins and In silico study of potential inhibitors for management of life threatening COVID-19 Hriday K. Basak, Soumen Saha, Joydeep Ghosh, Uttam Paswan, Sujoy Karmakar, Ayon Pal, Abhik Chatterjee
1784 [GO] Letters in Drug Design & Discovery 2021―Jun―01 Determination of binding potential of HCV protease inhibitors against SARS-CoV-2 Papain-like protease with computational docking Zihni Onur Çalışkaner
1785 [GO] Letters in Drug Design & Discovery 2021―May―31 Virtual screening attributes male biased COVID-19 mortality to predicted antiviral activity of female sex hormones Galal Yahya, Basem Mansour, Kristina Keuper, Moataz Shaldam, Ahmed El-Baz
1786 [GO] Letters in Drug Design & Discovery 2021―May―12 Molecular Docking Studies for Protein-Targeted Drug Development in SARS-CoV-2 Ahmad Dzulfikri Nurhan, Maria Apriliani Gani, Saipul Maulana, Siswandono Siswandono, Chrismawan Ardianto, Junaidi Khotib
1787 [GO] Letters in Drug Design & Discovery 2021―Apr―28 Design, synthesis and in silico studies of novel N-(2-aminophenyl)-2,3-diphenylquinoxaline-6-sulfonamide derivatives targeting receptor-binding domain (RBD) of SARS-CoV-2 Spike Glycoprotein and evaluation as antimicrobial and antimalarial agents Falak A. Siddiqui, Sharuk L. Khan, Rajendra P Marathe, Nitin V. Nemac
1788 [GO] Letters in Drug Design & Discovery 2021―Mar―19 In silico screening of phytoconstituents with antiviral activities against SARS-COV-2 main protease, Nsp12 polymerase and Nsp13 helicase proteins Jainey James, Divya Jyothi, Sneh Priya
1789 [GO] Letters in Drug Design & Discovery 2021―Mar―03 Nanotechnology can provide therapeutic agent by targeting molecular structures of SARS-CoV-2 (COVID-19): A Mini-Review Sarwar Allah Ditta, Atif Yaqub, Fouzia Tanvir
1790 [GO] Letters in Drug Design & Discovery 2020―Dec―26 Current scenario of COVID-19 Priyank Purohit, Ravi Kumar Mittal, Kanika Bhatt
1791 [GO] Letters in Drug Design & Discovery 2020―Dec―26 New Viral Infection COVID-19: Current Status, Challenges and Possible Treatments Vipan Kumar, Amruta Suryan, Jyoti Singh, Sandeep Kumar, Pradeep Kamboj, Aakash Deep
1792 [GO] Letters in Drug Design & Discovery 2020―Dec―15 Selection of Active Antiviral Compounds Against Covid-19 Disease Targeting Coronavirus Endoribonuclease Nendou/NSP15 Via Ligand- Based Virtual Screening and Molecular Docking Gaurav Joshi, Ramarao Poduri
1793 [GO] Letters in Drug Design & Discovery 2020―Dec―15 Design of Inhibitory Peptides of the Interaction between the RBD Domain of the S1 Protein of SARS-CoV-2 and the Angiotensin Converting Enzyme 2 (ACE2) Receptor Carlos Andrés Rodríguez-Salazar, Delia Piedad Recalde-Reyes, Jhon Carlos Castaño-Osorio
1794 [GO] Letters in Drug Design & Discovery 2020―Dec―15 Molecular Docking, DFT Studies and ADMET Simulations for Evaluating Already Approved FDA Drugs as Inhibitors for SARS-Cov-2 RNADependent Polymerase Manos C. Vlasiou, Kyriakos I. Ioannou, Kyriaki S. Pafiti
1795 [GO] Letters in Drug Design & Discovery 2020―Dec―11 In-Silico Study to Identify Dietary Molecules as Potential SARS-CoV-2 Agents Mohammad Faheem Khan, Mohsin Ali Khan, Zaw Ali Khan, Tanveer Ahamad, Waseem Ahmad Ansari
1796 [GO] Letters in Drug Design & Discovery 2020―Nov―11 Chitosan: a promising protective component against SARS-CoV-2 and influenza virus Mohammad Reza Rahbar, Hadi Esmaeili Gouvarchin Galeh, Saeed Khalili, Abolfazl Jahangiri
1797 [GO] Letters in Drug Design & Discovery 2020―Nov―05 Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective Yee Siew Choong, Theam Soon Lim, Hanyun Liu, Rubin Jiang, Zimu Cai, Yuan Ge
1798 [GO] Letters in Drug Design & Discovery 2020―Oct―01 Virtual Screening of Chinese Medicine Small Molecule Compounds Targeting SARS-CoV-2 3CL protease (3CL pro) Qingxiu He, Xin Chen, Xi Yang, Guangpin Li, Haiqiong Guo, Han Chu, et al. (+2)
1799 [GO] Letters in Drug Design & Discovery 2020―Aug―02 Preliminary Identification of Hamamelitannin and Rosmarinic Acid as COVID-19 Inhibitors Based on Molecular Docking Kaushik Sarkar, Rajesh Kumar Das
1800 [GO] Letters in Drug Design & Discovery 2020―Aug―02 Novel Coronavirus 2019 Outbreak: A Global Epidemic Sweta Kamboj, Rohit Kamboj, Shikha Kamboj, Kumar Guarve, Rohit Dutt
1801 [GO] Letters in Drug Design & Discovery 2020―Jul―31 Drug re-purposing from SARS-CoV led the identification of potential candidate drug target and alternate drug molecules against SARS-CoV-2 PV Parvati Sai Arun, Razak Hussain, Yusuf Akhter, Mandava Venkata Basaveswara Rao, Perugu Shyam, Sailu Yellaboina
1802 [GO] Letters in Drug Design & Discovery 2020―Jun―13 Novel Coronavirus (COVID-19) Outbreak: Hope and Search for Effective Therapeutic Agent Saurabh Kumar
1803 [GO] Letters in Drug Design & Discovery 2020―Apr―26 The 2019 Novel Coronavirus (COVID-19) Outbreak in China and World: A New Lesson for Public Health System Kamil Kuca
1804 [GO] Letters in Drug Design & Discovery 2020―Apr―06 Current Strategies and Approaches in combating SARS-CoV-2 virus that causes COVID-19 D. Sivaraman, P.S. Pradeep, S. Sundar Manoharan, C. Ramachandra Bhat, K.V. Leela, V. Venugopal
1805 [GO] Letters in Drug Design & Discovery 2020―Mar―17 The 2019 Novel Coronavirus (COVID-19) Outbreak in China and World: A New Lesson for Public Health System Kamil Kuca
1806 [GO] Letters in Organic Chemistry 2024―Jan―25 Towards Antiviral Potential of Biomolecules Derived from Adhatod avasica as Competent Natural Molecules to Treat COVID-19 Virus Variant Mohammad Asif, Mohd Yusuf, Mazen M. Almehmadi, Ahad Alsaiari, Mamdouh Allahyani, Abdulelah Aljuaid, Abdulaziz Alsharif
1807 [GO] Letters in Organic Chemistry 2023―Aug―15 In-Silico Identification of Dexamethasone-similar Compounds Against SARS-Cov-2 Spike Protein: A Drug Repurposing Approach Vishwas Tripathi, Yamini Pathak, Ihosvany Camps, Faizan Abul Qais, Amaresh Mishra
1808 [GO] Letters in Organic Chemistry 2023―Mar―30 DFT and Molecular Docking Studies of 1, 2 Disubstituted Benzimidazole Derivatives with COVID -19 Receptors: An Approach for Medications to Treat COVID-19 Bendi Anjaneyulu
1809 [GO] Letters in Organic Chemistry 2022―Jun―23 In Silico Screening of Some Anti-Cancer Drugs Against the Main Protease of COVID-19 Using Molecular Docking Leila Ouni, Ali Ramazani
1810 [GO] Letters in Organic Chemistry 2022―Mar―10 A Comprehensive Review on in silico Predicted Potential Phytochemicals against SARS-CoV-2: Food for Thought to Researchers Shilpi Pathak, Neetu Agrawal, Ahsas Goyal
1811 [GO] Medicinal Chemistry 2024―Feb―03 Systematic Review On Major Antiviral Phytocompounds from Common Medicinal Plants Against SARS-CoV-2 Suvendu Ghosh, Partha Singha, Lakshmi Kanta Das, Debosree Ghosh
1812 [GO] Medicinal Chemistry 2024―Jan―11 Structure-based Virtual Screening from Natural Products as Inhibitors of SARS-CoV-2 Spike Protein and ACE2-h Receptor Binding and their Biological Evaluation In vitro Timoteo Delgado-Maldonado, Luis Donaldo Gonzalez-Morales, Alfredo Juarez-Saldivar, Edgar E. Lara-Ramírez, Guadalupe Rojas-Verde, Adriana Rodriguez-Moreno, et al. (+2)
1813 [GO] Medicinal Chemistry 2023―Nov―10 Determination of Novel SARS-CoV-2 Inhibitors by Combination of Machine Learning and Molecular Modeling Methods Ersin Güner, Özgür Özkan, Gözde Yalcin Ozkat, Süreyya Ölgen
1814 [GO] Medicinal Chemistry 2023―Apr―18 An in silico investigation to identify promising inhibitors for SARS-CoV-2 Mpro target V. Alagarsamy, P. Shyam Sundar, B. Narendhar, M. T. Sulthana, Vishaka S. Kulkarni, A. Dharshini Aishwarya, et al. (+5)
1815 [GO] Medicinal Chemistry 2023―Feb―28 Recent Advances in N-Heterocycles for COVID-19 Treatment- A Mini Review Monica Dinodia
1816 [GO] Medicinal Chemistry 2022―Oct―18 The Coronavirus Epidemic A. Hilgeroth
1817 [GO] Medicinal Chemistry 2022―Oct―12 Would the Development of a Multitarget Inhibitor of 3CLpro and TMPRSS2 be Promising in the Fight Against SARS-CoV-2? Igor José dos Santos Nascimento, Ricardo Olimpio de Moura
1818 [GO] Medicinal Chemistry 2022―Aug―30 An Insight into COVID-19 and Traditional Herbs: Bangladesh Perspective Abdur Rauf, Md. Mominur Rahman, Sheikh Shohag, Md. Rezaul Islam, Shomaya Akhter, Sadia Afsana Mim, Rohit Sharma
1819 [GO] Medicinal Chemistry 2022―Jun―17 Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in Development of COVID-19 Lok Yong Hui, Chan Sook Mun, Lai Cong Sing, Harish Rajak, Rohini Karunakaran, Veerasamy Ravichandran
1820 [GO] Medicinal Chemistry 2022―Feb―14 Recent Development of Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery Sujit Mahato
1821 [GO] Medicinal Chemistry 2021―Aug―09 Structural bioinformatics used to predict the protein targets of remdesivir and flavones in SARS-CoV-2 infection Avram Speranta, Laura Manoliu, Catalina Sogor, Maria Mernea, Corina Duda Seiman, Daniel Duda Seiman, Carmen Chifiriuc
1822 [GO] Medicinal Chemistry 2021―Jun―21 Discovery of a “Cocktail” of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. (“Lagundi”) Ruel Cayona, Evelyn Creencia
1823 [GO] Medicinal Chemistry 2021―Feb―10 Coumarins and Quinolones as Effective Multiple Targeted Agents Versus Covid-19: An in Silico Study Mojgan Nejabat, Razieh Ghodsi, Farzin Hadizadeh
1824 [GO] Medicinal Chemistry 2020―Jul―28 In silico study to evaluate the antiviral activity of novel structures against 3C-like protease of Novel Coronavirus (COVID-19) and SARS-CoV Kiran Chunduru, Runali Sankhe, Farmiza Begum, Nalini Sodum, Nitesh Kumar, Anoop Kishore, et al. (+3)
1825 [GO] Medicinal Chemistry 2020―Apr―18 The Coronavirus Epidemic A. Hilgeroth
1826 [GO] Micro and Nanosystems 2021―Sep―03 The Challenges of Biomedical Waste Management During the Ongoing Coronavirus Disease-19 (COVID-19) Pandemic: The Current Scenario Sabitha Vadakedath, Venkataramana Kandi, Tarun Kumar Suvvari, L V Simhachalam Kutikuppala, Vikram Godishala, Praveen R. Shahapur
1827 [GO] MicroRNA 2022―Aug―19 Plant MicroRNA Potential in Targeting Sars-CoV-2 Genome Offering Efficient Antiviral MiRNA-Based Therapies Behzad Hajieghrari, Sara Rahmanian-Koshkaki
1828 [GO] MicroRNA 2022―Aug―17 Tiny Regulators in Viral Infection: Carving SARS-CoV-2 by miRNAs Natalia Martínez-Acuña, Sonia Amelia Lozano-Sepúlveda, María del Carmen Martínez-Guzmán, Ana María Rivas-Estilla
1829 [GO] MicroRNA 2021―Dec―29 The microRNA days: The COVID-19 pandemic from the point of view of short RNAs Alberto Izzotti
1830 [GO] Mini-Reviews in Medicinal Chemistry 2023―Sep―15 Ebselen: A Review on its Synthesis, Derivatives, Anticancer Efficacy and Utility in Combating SARS-COV-2 Farak Ali, Shahnaz Alom, Sheikh Rezzak Ali, Biswanarayan kondoli, Prativa Sadhu, Chinmoyee Borah, et al. (+6)
1831 [GO] Mini-Reviews in Medicinal Chemistry 2023―May―04 Antiviral Flavonoids: A natural scaffold with prospects as phytomedicines against SARS-CoV2 Sandipan Chakraborty, Chiranjeet Saha, Roumi Naskar
1832 [GO] Mini-Reviews in Medicinal Chemistry 2023―Apr―18 A Review of Thyroid Dysfunction due to COVID-19 Alireza Arefzadeh
1833 [GO] Mini-Reviews in Medicinal Chemistry 2023―Mar―27 Significance of Vitamin Supplementation in Reducing the Severity of COVID-19 Kota V Ramana, Myia Aiges
1834 [GO] Mini-Reviews in Medicinal Chemistry 2022―Nov―18 Gastrointestinal, liver, pancreas, oral and psychological long-term symptoms of COVID-19 after recovery; A review Shaban Alizadeh, Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, Kiana Moayedi, Omid Soleimanifar, et al. (+3)
1835 [GO] Mini-Reviews in Medicinal Chemistry 2022―Oct―18 Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) Habeb Al-Kamel
1836 [GO] Mini-Reviews in Medicinal Chemistry 2022―Oct―18 Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19 Pan Luo
1837 [GO] Mini-Reviews in Medicinal Chemistry 2022―Oct―18 Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century Nitesh Sanghai
1838 [GO] Mini-Reviews in Medicinal Chemistry 2022―Oct―18 Possible Targets and Therapies of SARS-CoV-2 Infection Kasturi Sarkar
1839 [GO] Mini-Reviews in Medicinal Chemistry 2022―Jun―17 Targeting Virus-Induced Reprogrammed Cell Metabolism via Glycolytic Inhibitors: An Effective Therapeutic Approach Against SARS-CoV-2 Mamta Singh, Dolly Sharma, Rajat Gupta, Manoj Garg, Andrea Altieri, Alexander Kurkin, et al. (+2)
1840 [GO] Mini-Reviews in Medicinal Chemistry 2022―Jun―06 Pathophysiology of SARS-CoV2 Mediated Depression, Therapeutics and Consequences: A Comprehensive Narrative Nikhat J. Siddiqi, B. Sharma
1841 [GO] Mini-Reviews in Medicinal Chemistry 2022―May―12 An Updated and Focused Review on Heterocyclic Inhibitors for SARS-CoV and SARS-CoV-2 3CLpro Ajay Manaithiya, Ozair Alam, Shruti Mittal, Mohd. Javed Naim, Mohd. Imran, Ahmed Subeh Alshrari, et al. (+2)
1842 [GO] Mini-Reviews in Medicinal Chemistry 2022―Mar―30 The Immune Response to SARS-CoV-2: Mechanisms, Aging, Sequelae and Vaccines Carolina Espinoza, Marcelo Alarcón
1843 [GO] Mini-Reviews in Medicinal Chemistry 2022―Mar―02 Antiviral Compounds Based on Natural ASTRAGALUS POLYSACCHARIDE (APS): Researches and Foresight in the Strategies for Combating SARS-CoV-2 (COVID-19) Elahe Aleebrahim Dehkordi, Ehsan Heidari-Soureshjani, Alisam Aryan, Zahra Ganjirad, Faezeh Soveyzi, Afsaneh Hoseinsalari, et al. (+2)
1844 [GO] Mini-Reviews in Medicinal Chemistry 2022―Feb―02 SARS-CoV-2 Infections, Impaired Tissue, and Metabolic Health: Pathophysiology and Potential Therapeutics Shailendra Pratap Singh, Aayushi Bhatnagar, Sujeet Kumar Singh, Sanjib K. Patra, Navjot Kanwar, Abhinav Kanwal, et al. (+2)
1845 [GO] Mini-Reviews in Medicinal Chemistry 2022―Jan―28 Interleukin Receptor Antagonists and Janus Kinase Inhibitors Repurposed for Treatment of COVID-19 Nitin Tandon, Vijay Luxami, Runjhun Tandon, Kamaldeep Paul
1846 [GO] Mini-Reviews in Medicinal Chemistry 2022―Jan―13 Aptamers Against COVID-19: An Untested Opportunity Annekathrin Haberland, Johannes Müller
1847 [GO] Mini-Reviews in Medicinal Chemistry 2022―Jan―05 Thymoquinone: A Review of Pharmacological Importance, Oxidative Stress, COVID-19, and Radiotherapy Seyithan Taysi, Firas Shawqi Algburi, Zaid Mohammed, Omeed Akbar Ali, Muhammed Enes Taysi
1848 [GO] Mini-Reviews in Medicinal Chemistry 2022―Jan―05 Tuberculosis, BCG Vaccination and COVID-19: Are They Connected? Kellen Christina Malheiros Borges, Adeliane Castro da Costa, Lília Cristina de Souza Barbosa, Kaio Mota Ribeiro, Laura Raniere Borges dos Anjos, André Kipnis, Ana Paula Junqueira-Kipnis
1849 [GO] Mini-Reviews in Medicinal Chemistry 2021―Oct―28 The effect of plant metabolites on coronaviruses: A comprehensive review focusing on their IC50 values and molecular docking scores Parastou Farshi, Eda Ceren Kaya, Fataneh Hashempour-Baltork, Kianoush Khosravi-Darani
1850 [GO] Mini-Reviews in Medicinal Chemistry 2021―Aug―15 Synthetic Attempts Towards Eminent Anti-Viral Candidates of SARS-CoV Subhradip Kundu, Debayan Sarkar
1851 [GO] Mini-Reviews in Medicinal Chemistry 2021―Aug―06 The Promising Enzymes for Inhibitors Development against COVID-19 Zhi-Gang Sun, Feng-Ling Yu, Xiang-Ting Qiu, Shuang Li, Xue-Tang Li, Hai-Liang Zhu
1852 [GO] Mini-Reviews in Medicinal Chemistry 2021―Aug―06 Nature-derived hit, lead, and drug-like small molecules: Current status and future aspects against key target proteins of Coronaviruses Md. Junaid, Yeasmin Akter, Aysha Siddika, S. M. Abdul Nayeem, Afsana Nahrin, Syeda Samira Afrose, et al. (+2)
1853 [GO] Mini-Reviews in Medicinal Chemistry 2021―Jun―30 Neurological Effects of Sars-Cov-2 And Neurotoxicity of Antiviral Drugs Against Covid-19 Büşra Ünlü, Rahime Simsek, Selinay Başak Erdemli Köse, Anıl Yirün, Pinar Erkekoglu
1854 [GO] Mini-Reviews in Medicinal Chemistry 2021―Apr―23 RNA Coronaviruses’ Outbreaks: Recent Progress on the SARS-CoV-2 Pandemic Diagnostic Tests, Vaccination and Therapeutics Ghadeer A. R. Y. Suaifan, Bayan A. Alkhawaja, Aya A. M. Mohammed
1855 [GO] Mini-Reviews in Medicinal Chemistry 2021―Apr―13 A therapeutic journey of potential drugs against COVID-19 Fayaz Ali, Shahid Hussain, Yi Zhun Zhu
1856 [GO] Mini-Reviews in Medicinal Chemistry 2021―Apr―02 Effectiveness of Azithromycin as add-on Therapy in COVID-19 Management Shadma Wahab, Md Faruque Ahmad, Arshad Hussain, Shazia Usmani, Ambreen Shoaib, Wasim Ahmad
1857 [GO] Mini-Reviews in Medicinal Chemistry 2021―Mar―10 The situation of small molecules targeting key proteins to combat SARS-CoV-2: Synthesis, metabolic pathway, mechanism of action, and potential therapeutic applications Farzaneh Sorouri, Zahra Emamgholipour, Maryam Keykhaee, Alireza Najafi, Loghman Firoozpour, Omid Sabzevari, et al. (+3)
1858 [GO] Mini-Reviews in Medicinal Chemistry 2021―Feb―26 Elucidating the drug repurposing spectra of COVID-19 with its analogues SARS and MERS Jayanti Mishra, Chakrawarti Prasun, P.K. Sahoo, Maya S Nair
1859 [GO] Mini-Reviews in Medicinal Chemistry 2021―Feb―25 Treatment approaches for COVID-19: A critical review Nalini Sodum, Gautam Kumar, Vanishree Rao, Nitesh Kumar, Chamallamudi Mallikarjuna Rao
1860 [GO] Mini-Reviews in Medicinal Chemistry 2021―Feb―18 A review on Remdesivir: A broad-spectrum antiviral molecule for possible COVID-19 treatment Jabeena Khazir, Tariq Maqbool, Bilal Ahmad Mir
1861 [GO] Mini-Reviews in Medicinal Chemistry 2021―Feb―12 S.A.R.S Covid-19 A Medicinal Chemistry Approach Gautam Bhardwaj, Rajiv Kumar Tonk, Harish Garg, Vijay Bhalla
1862 [GO] Mini-Reviews in Medicinal Chemistry 2021―Feb―11 Glycyrrhizin as a Potential Treatment for the Novel Coronavirus (COVID-19) Habeb Al-Kamel, Oliver Grundmann
1863 [GO] Mini-Reviews in Medicinal Chemistry 2021―Feb―04 Natural substances and semisynthetic derivatives as potential alternative products against SARS-CoV-2 Virginia Fuochi, Pio Maria Furneri
1864 [GO] Mini-Reviews in Medicinal Chemistry 2021―Jan―26 Coronavirus (COVID -19): Chemical entities of biological interest Aman Mahajan, Princy Gupta
1865 [GO] Mini-Reviews in Medicinal Chemistry 2021―Jan―05 A mini review on emerging targets and Approaches for the synthesis of Anti-Viral compounds: In perspective to COVID-19 Maheswara Rao Gokada, Visweswara Rao Pasupuleti, Hari Babu Bollikolla
1866 [GO] Mini-Reviews in Medicinal Chemistry 2020―Dec―29 Drug discovery of small molecules for the treatment of COVID-19: A review on clinical studies Bharat Goel, Nivedita Bhardwaj, Nancy Tripathi, Shreyans K. Jain
1867 [GO] Mini-Reviews in Medicinal Chemistry 2020―Dec―23 Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials Subha Sankar Paul, Goutam Biswas
1868 [GO] Mini-Reviews in Medicinal Chemistry 2020―Dec―18 A short review on important drugs under clinical trial against Covid-19 Namita Misra
1869 [GO] Mini-Reviews in Medicinal Chemistry 2020―Dec―05 Synthetic and semi-synthetic drugs as promising therapeutic option for the treatment of COVID-19 Ekta Shirbhate, Preeti Patel, Vijay K Patel, Ravichandran Veerasamy, Prabodh C Sharma, Barij N Sinha, Harish Rajak
1870 [GO] Mini-Reviews in Medicinal Chemistry 2020―Nov―25 Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak Nitin Tandon, Vijay Luxami, Runjhun Tandon, Kamaldeep Paul
1871 [GO] Mini-Reviews in Medicinal Chemistry 2020―Nov―19 Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV-2 Infection (COVID-19) Surendra Kumar Nayak
1872 [GO] Mini-Reviews in Medicinal Chemistry 2020―Nov―13 Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19 Eeda Koti Reddy, Srisravanthi Battula, Shaik Anwar, Ayyiliath M Sajith
1873 [GO] Mini-Reviews in Medicinal Chemistry 2020―Oct―28 Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19 Pan Luo, Yi Liu, Dong Liu, Juan Li
1874 [GO] Mini-Reviews in Medicinal Chemistry 2020―Aug―24 Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century Nitesh Sanghai, Kashfia Shafiq, Geoffrey K. Tranmer
1875 [GO] Mini-Reviews in Medicinal Chemistry 2020―Aug―08 Recent Discovery for Inhibitors Targeting in SARS-CoV-2 and Developed anti-NCP Mohd. Faheem, Vinay K. Singh
1876 [GO] Mini-Reviews in Medicinal Chemistry 2020―Aug―08 Possible Targets and Therapies of SARS-CoV-2 Infection Kasturi Sarkar, Parames C. Sil, Seyed Fazel Nabavi, Ioana Beridan Neagoe, Cosmin Andrei Cismaru, Seyed Mohammad Nabavi, Solomon Habtemariam
1877 [GO] Mini-Reviews in Organic Chemistry 2023―Aug―22 Anti-inflammatory alkaloids targeting IL-1 against Respiratory Viral infections: A Special insight into drug development against SARS-CoV 2 Salma Batool, Laiba Asim, Jin Zhang, Fawad Raffaq Qureshi, Rahman Shah Zaib Saleem
1878 [GO] Mini-Reviews in Organic Chemistry 2021―Jun―30 COVID-19 Global Pandemic Fight by Drugs: A Mini-Review on Hope and Hype Sunil Tekale, Vishnu Gore, Pravin Kendrekar, Shivaji Thore, László Kótai, Rajendra Pawar
1879 [GO] Mini-Reviews in Organic Chemistry 2021―Mar―31 Synthesis of Four Heterocyclic Drug Molecules Repurposed for Covid-19 Richa Srivastava, Ram Singh
1880 [GO] Mini-Reviews in Organic Chemistry 2020―Nov―04 Pharmacological Perspectives of Ayurvedic herbs viz. Alstonia scholaris L., Picrorhiza kurroa, Swertia chirata and Caesalpinia crista against COVID-19: A Mini Review Vijay Kumar, Shyam Babu Singh, Simranjeet Singh
1881 [GO] New Emirates Medical Journal 2024―Mar―01 Bronchiolitis in Infants and Children before the Surge of Covid-19: Predictors of Outcome and Length of Stay Almontaser Hussein, Ahmed Shams, Haitham Azmy, Mohideen Jeilani Syed, AlSayed Mohamed, Mohamed Elhussein
1882 [GO] New Emirates Medical Journal 2024―Feb―23 Health Belief Model for Public Acceptance of Implementing COVID-19 Vaccination in Singkawang City, Indonesia Theresia Lidia, Aris Widayati, Pramitha Esha Nirmala Dewi
1883 [GO] New Emirates Medical Journal 2024―Jan―29 H3N2: A Perspective on Re-emergence of Influenza Pandemic Shakti Rath
1884 [GO] New Emirates Medical Journal 2023―Nov―02 Seroprotection of Measles, Rubella, Pertussis and its Relation with Occurrence of COVID-19 among a Cohort of University Female Students Malay Jhancy, Suresh Kumar Srinivasamurthy
1885 [GO] New Emirates Medical Journal 2023―Jul―21 Solid Organ Transplantation from SARS-CoV-2-infected Donor to Uninfected Recipients: First in the United Arab Emirates and the Neighboring Region Fatima A. Al Dhaheri, Ahmed A. Al Hammadi, Reginaldo C. Boni, Amina A. Randhawa, Emmanuel F. Nsutebu, Mohamad Mooty, et al. (+3)
1886 [GO] New Emirates Medical Journal 2023―Jul―14 Sunitinib Induced Disseminated Intravascular Coagulation after COVID-19 Infection in a Patient with Neuroendocrine Tumor: A Case Report Faraz Khan, Mona Tareen, Julieta O Zuluaga, Maroun El khoury, Sameh Salem
1887 [GO] New Emirates Medical Journal 2023―May―26 The Implication of Behavioral and Molecular Factors on COVID-19 Infection Huda Omran, Safaa Imran, Mohamed Salman Almaliki, Qusay Mohammed, Duna Alrudani, Mohammed Mossa Imran
1888 [GO] New Emirates Medical Journal 2023―May―22 COVID-19 Related Complications During Pregnancy: A Systematic Review Basheer Abdullah Marzoog
1889 [GO] New Emirates Medical Journal 2023―Apr―05 Multisystemic Inflammatory Syndrome Post COVID-19 Infection in an Arab Female: A Case Report of a Rare Manifestation Malay Jhancy, Areen Yousef Al Tamakee, Hesham Mohamed Fayad
1890 [GO] New Emirates Medical Journal 2023―Mar―17 Impact of COVID-19 Vaccination on the Trend of Hospital Admission and Mortality in Two Tertiary Care Hospitals in the United Arab Emirates: A Retrospective Study Ashraf Al Zaabi, Rohit Pradhan, Luai A. Ahmed, Nawal Al Kaabi, Waddah Ibrahim El Subki
1891 [GO] New Emirates Medical Journal 2023―Mar―02 Effects of COVID-19 Pandemic on Young Individuals - A Mini Review Rohan Rishabh Susarla, Rania Zein Eldin, Ritika Coelho
1892 [GO] New Emirates Medical Journal 2023―Jan―13 A retrospective single centre analysis of the incidence of hospital admission for Acute Coronary Syndrome during the COVID-19 pandemic. Nadim Shah, Naser Jamil, Geili Abdalla, Khalifa Omar Muhammed, Haitham Al Hashimi, Fahad Baslaib
1893 [GO] New Emirates Medical Journal 2022―Aug―18 COVID-19 infection in hemodialysis patients, incidence, risk factors and mortality. Single Centre Study Dileep Kumar Nanik Ram, Kashif Gulzar, Fakhriya Alalawi, Maseer Ahmed, Rosa Manuel, Amna Alhadari
1894 [GO] New Emirates Medical Journal 2021―Dec―30 Healthcare Professional’s Perceptions of E-Learning during the COVID-19 Pandemic Adel Khalifa Sultan Hamad, Abdulla Shehab, Khalifa Abdulrahman Ali, Dayaram Makwana, Ghada AlQassim
1895 [GO] New Emirates Medical Journal 2021―Dec―30 Good Uptake of the COVID-19 Vaccine Among Patients with Rheumatic Diseases in the United Arab Emirates (UAE) Azza A.M. Elsheikh, Humeira Badsha
1896 [GO] New Emirates Medical Journal 2021―Dec―13 A Systematic Review of Subacute Thyroiditis Related to COVID-19 Mohammad Al Shatnawi, Mohammad Sunoqrot, Basil Al Bakri, Mohammad Al Oqaily, Saif Aldeen Al Ryalat
1897 [GO] New Emirates Medical Journal 2021―Dec―13 Diagnostic Performance of Standard and Inverted Grey-Scale CXR in Detection of Lung Lesions in COVID-19 Patients: A Single Institute Study in the Region of Abu Dhabi Abeer A. Al Helali, Mohamed A. Kukkady, Ghufran A. Saeed, Tamer I. Elholiby, Rabab A. Al Mansoori, Luai A. Ahmed
1898 [GO] New Emirates Medical Journal 2021―Dec―13 SARS-CoV-2: Possible Factors Contributing to Serious Consequences of COVID-19? Ruqaiyyah Siddiqui, Mohammad Ridwane Mungroo, Mohamed Yehia Abouleish, Naveed A. Khan
1899 [GO] New Emirates Medical Journal 2021―Jul―16 Repurposing Ruxolitinib in Combating COVID-19: a mini review Inshia Begum, Fathima Murthuza, Juwairiya Syed Iqbaluddin, Hafsah Fatima Arsal
1900 [GO] New Emirates Medical Journal 2021―Jun―01 Combination Therapy with Favipiravir for Treatment of Hospitalized COVID-19 Adults Maria-Fernanda Bonilla, Martin E. Lascano, Rania El-Lababidi, Ahmad Nusair, Mohamad Mooty, Maher Balkis, et al. (+3)
1901 [GO] New Emirates Medical Journal 2021―Apr―06 The Role of Chest High Resolution CT and Rt-Pcr in Diagnosis of Different Stages of Coronavirus (Covid-19) Pneumonia Mohamed N.E. Kassem, Doaa T. Masallat
1902 [GO] New Emirates Medical Journal 2021―Feb―04 Impact of COVID-19 Pandemic on Cardiology Resident Training and Education Prashanth Kulkarni, Manjappa Mahadevappa
1903 [GO] New Emirates Medical Journal 2021―Jan―12 Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences Angeline Sophia Rajakumar, Siva Ranganathan Green, Lokesh S., Prasanna Venkatesh, V.K. Gowtham
1904 [GO] New Emirates Medical Journal 2020―Nov―10 Tele-Oncology: An Emerging Technology in Developing Countries during the COVID-19 Pandemic Atlal M. Abusanad, Humaid O. Al-Shamsi
1905 [GO] New Emirates Medical Journal 2020―Sep―09 Flu Viral Multiplex Testing and its Implication for COVID-19 Testing Aaron Han, Janet Hicban
1906 [GO] New Emirates Medical Journal 2020―Jul―14 Knowledge and Perception of COVID-19 among Healthcare Professionals in the United Arab Emirates: A Cross-sectional Online Survey Akshaya Srikanth Bhagavathula, Abdullah Shehab
1907 [GO] New Emirates Medical Journal 2020―Jun―15 Trends of Mortalities and Morbidities due to COVID-19, from Explosiveness to Aggressiveness, Gaps in System Response, and Transmission Chain Hamid Yahya Hussain, Nezar Ahmed Salim, Bushra Baderkhan, Mohamed Hamid, Abdulla Hamid, Fouad Hussein Chehab, et al. (+2)
1908 [GO] New Emirates Medical Journal 2020―Feb―26 The Story of Mysterious Pneumonia and the Response to Deadly Novel Coronavirus (2019-nCoV): So Far! Akshaya Srikanth Bhagavathula, Abdulla Shehab
1909 [GO] New Emirates Medical Journal 2020―Feb―25 The Story of Mysterious Pneumonia and the Response to Deadly Novel Coronavirus (2019-nCoV): So Far! Akshaya Srikanth Bhagavathula, Abdulla Shehab
1910 [GO] Open Medicine Journal 2023―Dec―28 Complications of Acute Kidney Injury in COVID-19 Patients: A Systematic Review Anish Abraham, Merin Dickson, Anjana Abhilash, Sumit K.U, Amisha Kunjumon
1911 [GO] Open Medicine Journal 2020―Aug―20 Grab and Go COVID-19 Intubation Kit and Emergency Medication Kit Vladislav Mansurov, Beena Yousuf, Kandela Swancy Sujatha, Huda Alfoudri
1912 [GO] Pharmaceutical Nanotechnology 2022―Oct―20 Experimental Pharmacology For Covid-19 Treatment: A Geoanalytical Bibliometric Analysis Victor M. Castaño, Cesar Aguado
1913 [GO] Pharmaceutical Nanotechnology 2020―Oct―18 Antiviral essential oils incorporated in nanocarriers: strategy for prevention from COVID-19 and future infectious pandemics. Malkiet Kaur, Gayatri Devi, Manju Nagpal, Manjinder Singh, Gitika Arora Dhingra, Geeta Aggarwal
1914 [GO] Pharmaceutical Nanotechnology 2020―Aug―19 COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development Alaa A A Aljabali, Hamid A. Bakshi, Saurabh Satija, Meenu Metha, Parteek Prasher, Raed M. Ennab, et al. (+9)
1915 [GO] Protein and Peptide Letters 2024―Feb―20 Interleukin 6 Antagonists in Severe COVID-19 Disease: Cardiovascular and Respiratory Outcomes Shahzad Khan
1916 [GO] Protein and Peptide Letters 2022―Jun―03 Insights into Coronavirus Papain-like Protease Structure, Function and Inhibitors. Shujuan Jin, Mengjiao Zhang
1917 [GO] Protein and Peptide Letters 2022―Apr―06 Mutational Analysis of Interleukin-11 and its Consequences on Cancer and COVID-19 Related Cytokine Storm -An Extensive Molecular Dynamics Study Sujay Ray, Shreya Luharuka
1918 [GO] Protein and Peptide Letters 2021―Feb―23 Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19 Amir Hossein Kheirkhah, Seyed Hossein Shahcheraghi, Malihe lotfi, Marzieh lotfi, Sanaz Raeisi, Zulfiqar Mirani
1919 [GO] Recent Advances in Anti-Infective Drug Discovery 2023―Sep―15 The efficacy of colchicine as an adjunct therapy in non-hospitalized COVID-19 patients: A randomized placebo-controlled trial Sepideh Hejazi, Zohreh Jahani, Sepideh Elyasi, Davoud Salarbashi, Mona Kabiri
1920 [GO] Recent Advances in Anti-Infective Drug Discovery 2023―Mar―31 Outpatient Intravenous Remdesivir to Prevent Progression to Severe COVID-19: An Observational Study from a Greek Hospital Nikolaos Kintrilis, Iosif Galinos
1921 [GO] Recent Advances in Anti-Infective Drug Discovery 2023―Mar―31 Covid-19 Study, Diagnostic and Therapeutic Transition Da Yong Lu, Ting Ren Lu
1922 [GO] Recent Advances in Anti-Infective Drug Discovery 2023―Feb―23 Effect of TeleYoga before COVID-19 and during pandemic: A Narrative Review Dua R, Malik S, Kumar R, Sharma I, Kumar S, Mirza AA, Sindhwani G
1923 [GO] Recent Advances in Anti-Infective Drug Discovery 2023―Feb―23 Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review Mirza AA, Usmani H, Malik S, Arya A, Mahto PK, Kant R, et al. (+3)
1924 [GO] Recent Advances in Anti-Infective Drug Discovery 2023―Jan―19 SARS CoV2 pandemic - Therapeutics in Warp Speed Sourav Sen, Nitin Kumar
1925 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Nov―11 COVID-19: An Update Prasan Kumar Panda
1926 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Oct―12 COVID-19 Infection after vaccination among Healthcare Workers at a Tertiary Level Health Care Center in Northern India: A Cross-Sectional Study Mahendra Singh, Nandita Sharma, Pradeep Aggarwal, Yogesh Bahurupi, P. K. Panda, Gaurika Saxena
1927 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Sep―09 Triggers for Acceptance of COVID-19 Vaccination: A Community-Based Study Mohammed A. Medhat, Mohamed O. Nour, Ahmed Yousef, Fathiya El-Raey, Heba Aly, Sherief Mousa, et al. (+9)
1928 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Sep―03 Atorvastatin efficacy in the management of mild to moderate hospitalized COVID-19: a pilot randomized triple-blind placebo-controlled clinical trial Farzam Mircheraghi, Najmeh Davoodian, Sepideh Hejazi, Sepideh Elyasi, Davoud Salarbashi, Hasan Mahrad Majd
1929 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Aug―18 Whether Early Steroid dose is associated with lower mortality in COVID-19 critically ill Patients- An exploratory chart review Abhishek Goyal, Ankur Joshi, Saurabh Saigal, Dodda Brahmam, Yogesh Niwariya, Alkesh Khurana, et al. (+2)
1930 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Jul―22 Clinical profile, risk factors, and therapeutic outcome of cavitating fungal pneumonia coinfection in COVID-19 patients: A retrospective analysis Arjun Kumar, Mayank Mishra, Saikat Banerjee, Lokesh Kumar Saini, Prakhar Sharma, Ruchi Dua, Girish Sindhwani
1931 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―Jul―04 Utility of walk tests in progression of mild COVID-19 infection at a tertiary hospital in North India Souradeep Chowdhury, Tamoghna Ghosh, Aastha Goel, Anupam K Singh, Arvind Kumar, Naveet Wig
1932 [GO] Recent Advances in Anti-Infective Drug Discovery 2022―May―20 Mapping of new pharmacological alternatives in the face of the emergence of antibiotic resistance in COVID-19 patents treated for opportunistic respiratory bacterial pathogens Anamaria Mendonça Santos, Mariana Mendonça Santos, José Adão Carvalho Nascimento Júnior, João Rafael Lisboa Rêgo Brito, Tatianny de Araújo Andrade, Luiza Abrahão Frank, Mairim Russo Serafini
1933 [GO] Recent Advances in Anti-Infective Drug Discovery 2021―Nov―25 The newfangled upsurge of Double mutant SARS-CoV-2 virus in a 2021-Current scenario and inspecting ahead Sukhes Mukherjee, Suman Kumar Ray
1934 [GO] Recent Advances in Anti-Infective Drug Discovery 2021―Nov―23 The spectrum of biochemical alterations with molecular and serological biomarkers in the diagnosis of COVID-19: searching for novel one to identify disease earlier with better prognosis and drug discovery Suman Kumar Ray, Sukhes Mukherjee
1935 [GO] Recent Advances in Anti-Infective Drug Discovery 2021―Jun―17 Taming the storm in the heart: exploring different therapeutic choices against myocardial inflammation in COVID-19 Abhigyan Choudhury, Suprabhat Mukherjee
1936 [GO] Recent Advances in Computer Science and Communications 2023―Aug―29 A Deep Learning Model to Detect Fake News About Covid-19 S. Selva Birunda, Rangaswamy Kanniga Devi, Muthiah Muthukannan
1937 [GO] Recent Advances in Computer Science and Communications 2022―Sep―20 An Effective COVID-19 CT Image Denoising Method Based on a Deep Convolutional Neural Network Xiaojing Fan, Hanyue Liu, Chunsheng Zhang, Zichao Wang, Qingming Lin, Zhanjiang Lan, et al. (+3)
1938 [GO] Recent Advances in Computer Science and Communications 2020―Nov―11 Correlations and Hierarchical Clustering investigation between weather and SARS-CoV-2. Kaoutar El handri, Abdellah Idrissi
1939 [GO] Recent Advances in Computer Science and Communications 2020―Oct―23 A novel work on analyzing Stress and Depression level of Indian population during COVID-19 Amit Kumar Gupta, Priya Mathur, Shruti Bijawat, Abhishek Dadhich
1940 [GO] Recent Advances in Drug Delivery and Formulation 2022―Jul―27 3D-printed microfluidics potential in combating future and current pandemics (COVID-19). Heba A. Eassa, Nada A. Helal, Ahmed M Amer, Aliaa Fouad, Asser F Bedair, Reem Nagib, et al. (+6)
1941 [GO] Recent Advances in Drug Delivery and Formulation 2021―Nov―23 The Potential Use of Cyclosporine Ultrafine Solution Pressurised Metered-Dose Inhaler in the Treatment of COVID-19 Patients Touraj Ehtezazi
1942 [GO] Recent Advances in Electrical & Electronic Engineering (Formerly Recent Patents on Electrical & Electronic Engineering) 2023―Sep―18 New Proxy Signature Scheme over Elliptic Curves using Chaotic Maps Applicable during Pandemic COVID-19 Namita Tiwari, Mayur Rahul, Ayushi Prakash, Sonu Kumar Jha, Vikash Yadav
1943 [GO] Recent Advances in Electrical & Electronic Engineering (Formerly Recent Patents on Electrical & Electronic Engineering) 2023―Feb―08 A DMA-WSN Based Routing Strategy to Maximize Efficiency and Reliability in a Ship to Communicate Data on Coronavirus Deepak Sethi, Jyoti Anand, Meenu Shukla, Ankita Tripathi
1944 [GO] Recent Advances in Electrical & Electronic Engineering (Formerly Recent Patents on Electrical & Electronic Engineering) 2022―Aug―18 Cluster-based Sampling for Fake News on Healthcare during COVID-19 Infodemic Isha Agarwal, Dipti Rana, Aemie Jariwala, Sahil Bondre
1945 [GO] Recent Advances in Electrical & Electronic Engineering (Formerly Recent Patents on Electrical & Electronic Engineering) 2022―Jun―13 Estimating COVID-19 Cases Using Machine Learning Regression Algorithms Vaishali Deshwal, Vimal Kumar, Rati Shukla, Vikash Yadav
1946 [GO] Recent Advances in Food Nutrition & Agriculture 2023―Aug―10 Influence of Vitamin D level on inflammatory and prognostic markers in COVID-19 - A retrospective study Rajesh Kumar, Prashant Kesharwani, Amirhossein Sahebkar, Sunil Kumar Singh, Shruti Singh, Proteesh Rana, et al. (+2)
1947 [GO] Recent Advances in Inflammation & Allergy Drug Discovery 2023―Oct―23 Olfactory Dysfunction in Healthcare Workers with COVID-19: Prevalence and Associated Factors Imene Kacem, Mohamed Kahloul, Amel Ghenim, Mohamed Ajmi, Asma Chouchane, Asma Aloui, et al. (+6)
1948 [GO] Recent Advances in Inflammation & Allergy Drug Discovery 2023―Oct―15 The Prognostic Role of Corticosteroid Administration in Hospitalized Patients with Severe COVID-19: A Cross-sectional Study Mohammad Ali Yaghoubi, Hassan Mehrad-Majd, Ali Moradi, Mohammad Moein Vakilzadeh, Zahra Mazloum Khorasani, Mahmoud Ghavi, Amirhossein Sahebkar
1949 [GO] Recent Advances in Inflammation & Allergy Drug Discovery 2023―Jun―02 Bile Acids and SARS-CoV-2: Ursodeoxycholic Acid as a Potential Treatment of COVID-19 Stefano Fiorucci, Ginevra Urbani, Eleonora Distrutti
1950 [GO] Recent Advances in Inflammation & Allergy Drug Discovery 2022―Dec―07 COVID-19 associated Pancytopenia (CAP): A Clinical Impact Anju Dinkar, Jitendra Singh, Nilesh Kumar, Kailash Kumar
1951 [GO] Recent Advances in Inflammation & Allergy Drug Discovery 2022―Nov―28 Role of mRAGEs and ACE2 in SARS-CoV-2-Related Inflammation Ginevra Urbani, Stefano Fiorucci
1952 [GO] Recent Advances in Inflammation & Allergy Drug Discovery 2022―Mar―21 Increased ACE2, sRAGE, and immune activation, but lowered calcium and magnesium in COVID-19. Hussein Kadhem Al-Hakeim, Hawraa Kadhem Al-Jassas, Gerwyn Morris, Michael Maes
1953 [GO] Recent Patents on Anti-Cancer Drug Discovery 2022―Dec―06 Novel 4-chloro-N-phenyl Benzamide Derivatives as p38α Mitogen-activated Protein Kinase Inhibitors for Treating Cancer, COVID-19, and Other Diseases Surya K. De
1954 [GO] Recent Patents on Anti-Infective Drug Discovery 2022―Jul―31 The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19 Afroze Ali
1955 [GO] Recent Patents on Anti-Infective Drug Discovery 2020―Sep―24 Understanding the Role of Corona Virus based on Current Scientific Evidence - a Review with Emerging Important in Pandemic Sukhes Mukherjee, Suman K. Ray
1956 [GO] Recent Patents on Anti-Infective Drug Discovery 2020―Sep―23 The Role of Tocilizumab in Cytokine Storm and Improving Outcomes in COVID-19 Afroze Ali, Milad H. Kamjani, Marc M. Kesselman
1957 [GO] Recent Patents on Anti-Infective Drug Discovery 2020―Sep―16 Transmissibility and Epidemicity of COVID-19 in India: A Case Study Bevish Y. Jinila, Prayla S. Shyry
1958 [GO] Recent Patents on Anti-Infective Drug Discovery 2020―Aug―24 Is ocular toxicity expected in chloroquine/hydroxychloroquine prescription as a therapeutic or prophylactic option in COVID-19? Masood Bagheri, Zahra Rashe, Mohammad Hosein Ahur, Mojtaba Eidizadeh
1959 [GO] Recent Patents on Biotechnology 2023―Nov―28 The Inhibitory Effects of the Herbals Secondary Metabolites (7α-acetoxyroyleanone, Curzerene, Incensole, Harmaline, and Cannabidiol) on COVID-19: A Molecular Docking Study Farshid Zargari, Mehdi Mohammadi, Alireza Nowroozi, Mohammad Hossein Morowvat, Ebrahim Nakhaei, Fatemeh Rezagholi
1960 [GO] Recent Patents on Biotechnology 2023―Oct―02 Innovation and Patenting Activities During COVID-19 and Advancement of Biochemical and Molecular Diagnosis in the PostCOVID-19 Era Suman Kumar Ray, Sukhes Mukherjee
1961 [GO] Recent Patents on Biotechnology 2023―Jun―13 An Outline of the Immunogenic Potential of Progressing SARS-CoV-2 Vaccine Technologies among Children and Adolescents Hytham Ghanem, Shehab Ghanem, Ehsan AlMutawa
1962 [GO] Recent Patents on Biotechnology 2023―May―26 In silico design and evaluation of a novel therapeutic agent against the spike protein as a novel treatment strategy for COVID-19 treatment Mohammad Hossein Morowvat, Soroush Sarmadi, Mohammad Reza Rahbar, Hamideh Najafi, Onyeka S. Chukwudozie
1963 [GO] Recent Patents on Biotechnology 2022―Jun―20 Impact of COVID-19 on brain and psychological health, its possible mechanisms, and coping strategies Faizan Zarreen Simnani, Dibyangshee Singh, Anmol Choudhury, Ansab Akhtar
1964 [GO] Recent Patents on Biotechnology 2022―May―11 Proteome Exploration of human coronaviruses for Identifying Novel vaccine candidate: A Hierarchical Subtractive Genomics and Reverse Vaccinology Approach Hesam Dorosti, Mahboubeh Zarei, Navid Nezafat
1965 [GO] Recent Patents on Biotechnology 2022―Apr―11 Herd Immunity against Coronavirus: A Review Shreeja Datta, Arpita Roy
1966 [GO] Recent Patents on Biotechnology 2022―Apr―11 Alzheimer's Disease: A Silent Pandemic - A Systematic Review on the Situation and Patent Landscape of the Diagnosis Luis Daniel Goyzueta-Mamani, Miguel Angel Chávez-Fumagalli, Karla Alvarez-Fernandez, Jorge A. Aguilar-Pineda, Rita Nieto-Montesinos, Gonzalo Davila Del-Carpio, et al. (+2)
1967 [GO] Recent Patents on Biotechnology 2022―Apr―05 Coronavirus-A Crippling Affliction to Humans Rimple Kaul, Sunita Devi
1968 [GO] Recent Patents on Biotechnology 2022―Mar―22 Powerful Stress Relieving Medicinal Plants for Anger, Anxiety, Depression and Stress during Global Pandemic Mohamad Hesam Shahrajabian
1969 [GO] Recent Patents on Biotechnology 2022―Jan―24 In-vitro and In-vivo Experimental Models for MERS-CoV, SARS-CoV and SARS-CoV-2 Viral Infection: A Compendious Review Sonia Singh, Aman Kumar, Himanshu Sharma
1970 [GO] Recent Patents on Biotechnology 2022―Jan―07 Monoclonal antibodies and their target specificity against SARS-CoV-2 infections: Perspectives and challenges Short title: Monoclonal antibodies and SARS-CoV-2 infections Mohammed Ali Bakkari, Sivakumar Sivagurunathan Moni, Muhammad Hadi Sultan, Osama A. Madkhali
1971 [GO] Recent Patents on Biotechnology 2021―Dec―10 From Bench Side to Bed-Travelling on a Road to Get a Safe and Effective Vaccine Against COVID-19, Day to Save the Life Suman Kumar Ray, Sukhes Mukherjee
1972 [GO] Recent Patents on Biotechnology 2021―Aug―06 The insights of novel coronavirus disease 2019 (COVID-19): Current understanding, research and therapeutic updates Dudala Sai Sushma, Varun Jaiswal, Arvind Verma, Asha Sharma, Tarun Pal
1973 [GO] Recent Patents on Biotechnology 2021―Apr―02 Knowledge Disclosed in Patent Documents as Source of Information to Address Emergencies: A Strategy to Achieve Technological Developments Addressing COVID-19 Tatiana Duque Martins, Diéricon Sousa Cordeiro
1974 [GO] Recent Patents on Biotechnology 2021―Jan―28 Patents related to pathogenic human coronaviruses Michelli dos Santos, André Vinícius Fernandes Ferreira, Jonatas Oliveira da Silva, Laís Moreira Nogueira, Juliana Martins Machado, Mariana Ferraz Chaves Francisco, et al. (+3)
1975 [GO] Recent Patents on Engineering 2023―Nov―10 Sustainable Teaching and Learning E-learning Model towards Redesigning Transformative Learning Model for Knowledge Sharing & Infrastructure Enhancements Post COVID-19 Veeramanickam M R M, Gaganpreet Kaur, Amevi Acakpovi, Pavan Kumar Vadrevu, Ciro Rodriguez R., A. V. Kalpana
1976 [GO] Recent Patents on Engineering 2021―Jun―21 COVID-19 improved diagnoses based on the open-morphology filter and deep-learning Majid Dherar Younus, Mohammad J M Zedan, Fahad Layth Malallah, Mustafa Ghanem Saeed
1977 [GO] Recent Patents on Engineering 2021―Jun―19 Depression Diagnosis in Covid-19 Communities using Deep Learning Sourabh Sharma, Saloni Yadav, Vaishali Kalra
1978 [GO] Recent Patents on Engineering 2021―May―26 Predictive Time Series Analysis and Forecasting of COVID-19 Dataset R S M Lakshmi Patibandla, B. Tarakeswara Rao, M. Ramakrishna Murty, V. Lakshman Narayana
1979 [GO] Recent Patents on Inflammation & Allergy Drug Discovery 2021―Sep―17 Molecular Docking and Dynamics Simulation of Natural Phenolic Compounds with GSK-3β: A Putative Target to Combat Mortality in Patients with COVID-19 Zahra Khamverdi, Zeinab Mohamadi, Amir Taherkhani
1980 [GO] Recent Patents on Nanotechnology 2022―Oct―18 Research and Patents on Coronavirus and COVID-19: A Review Pilar Aranda
1981 [GO] Recent Patents on Nanotechnology 2022―Aug―20 A Comprehensive Review on COVID-19: Emphasis on Current Vaccination and Nanotechnology Aspects Akriti Rai, Kamal Shah, Rajeev Sharma, Hitesh Kumar Dewangan
1982 [GO] Recent Patents on Nanotechnology 2021―Jul―25 Nanovaccine: A hope to triumph the battle against novel Coronavirus disease 2019 (COVID-19) Anurag Singh, Anand Maurya, Gaurav Mishra, Rajendra Awasthi, Kamal Dua, Giriraj Kulkarni
1983 [GO] Recent Patents on Nanotechnology 2021―Jun―10 State-of-the-art and projected developments of nanofiber filter material for face mask against covid-19 Gayatri Patel, BinduKumari Yadav, Priya Patel
1984 [GO] Recent Patents on Nanotechnology 2020―Nov―11 Recent Patents and Advances on Nanotechnologies against Coronavirus Roozbeh Abedini-Nassab, Naeemeh Mahdaviyan
1985 [GO] Recent Patents on Nanotechnology 2020―Oct―22 Nanotechnology research and patents on coronavirus and COVID-19: a review P. Aranda, B. Wicklein, C. Ruiz-Garcia, R. Martín-Sampedro, M. Darder, G. del Real, E. Ruiz-Hitzky
1986 [GO] Reviews on Recent Clinical Trials 2023―Apr―18 SARS-CoV-2 Detection and COVID-19 Diagnosis: A Bird’s Eye View Imran Shahid, Abdullah R. Alzahrani, Qaiser Jabeen, Saeed S. Al-Ghamdi, Naiyer Shahzad, Sidra Rehman, et al. (+4)
1987 [GO] Reviews on Recent Clinical Trials 2023―Jan―31 Plasma Levels of MMPs and TIMP-1 in Patients with Osteoarthritis after Recovery from COVID-19 Tetyana Falalyeyeva, Yuriy Tuharov, Daryna Krenytska, Tetiana Halenova, Larysa Kot, Nataliia Raksha, et al. (+4)
1988 [GO] Reviews on Recent Clinical Trials 2022―Dec―12 Role of the Clinical Data Managers during the COVID-19 Pandemic: An Overview Rishitha sajja
1989 [GO] Reviews on Recent Clinical Trials 2022―Dec―06 Impact of Covid-19 on Mental Health: An Overview Minal M. Kshirsagar
1990 [GO] Reviews on Recent Clinical Trials 2022―Dec―06 Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review Shanmugaraj Kulanthaivel
1991 [GO] Reviews on Recent Clinical Trials 2022―Oct―18 Prevention of COVID-19 Infection in the Medical Population: Possible Help from Anosmia? Giuseppe Chiarella
1992 [GO] Reviews on Recent Clinical Trials 2022―Oct―18 Physical and Mental Functions of Cardiovascular Diseased Patients Decrease During the State of Emergency Initiated by the COVID-19 Pandemic in Japan Kodai Ishihara
1993 [GO] Reviews on Recent Clinical Trials 2022―Oct―18 COVID-19: Perspectives on the Potential Novel Global Threat
1994 [GO] Reviews on Recent Clinical Trials 2022―Oct―18 Erythema Pernio-Like in Four Adolescents in the Era of the Coronavirus-2 Infection
1995 [GO] Reviews on Recent Clinical Trials 2022―Jul―31 COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view. Gustavo Zubieta-Calleja
1996 [GO] Reviews on Recent Clinical Trials 2022―Jul―31 Impact of Covid-19 on Mental Health: An Overview Minal M. Kshirsagar
1997 [GO] Reviews on Recent Clinical Trials 2022―Jul―31 COVID-19: Perspectives on the Potential Novel Global Threat Ivan Gentile
1998 [GO] Reviews on Recent Clinical Trials 2022―Jul―31 Epidemiology of Coronavirus Disease Outbreak: The Italian Trends Ludovico Abenavoli
1999 [GO] Reviews on Recent Clinical Trials 2022―Jul―17 Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review Kulanthaivel, S
2000 [GO] Reviews on Recent Clinical Trials 2022―Jun―03 Alcoholic consumption of young Italians during the SARS-CoV-2 pandemic Alessandro Federico, Chiara Mazzarella, Annamaria Spina, Marcello Dallio, Mario Romeo, Mario Masarone, et al. (+6)
 [1]  [2] [ Next > ]

2388 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 1.052 sec